Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23408.Triglycerides in VLDL,ADIPOQ,Adiponectin,38013,-0.251170967305078,0.00608428111508333,-0.263096158290641,-0.239245776319514,0
NMR metabolomics,X23408.Triglycerides in VLDL,AGRP,Agouti-related protein,40516,0.289695894061368,0.00464230128382737,0.280596983545066,0.298794804577669,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCN1,CCN family member 1,40280,0.395943856849221,0.00685982333737942,0.382498603107957,0.409389110590484,0
NMR metabolomics,X23408.Triglycerides in VLDL,CES1,Liver carboxylesterase 1,40352,0.304487203594952,0.00697306013941496,0.290820005721698,0.318154401468205,0
NMR metabolomics,X23408.Triglycerides in VLDL,F7,Coagulation factor VII,40376,0.119658194991705,0.00274046697259323,0.114286879725423,0.125029510257988,0
NMR metabolomics,X23408.Triglycerides in VLDL,FURIN,Furin,40411,0.134391142835979,0.00308316688957381,0.128348135732415,0.140434149939544,0
NMR metabolomics,X23408.Triglycerides in VLDL,GCG,Pro-glucagon,39980,0.525596044059315,0.0113197891711255,0.503409257283909,0.547782830834721,0
NMR metabolomics,X23408.Triglycerides in VLDL,GHR,Growth hormone receptor,37671,0.108441920492744,0.00264087408353046,0.103265807289025,0.113618033696464,0
NMR metabolomics,X23408.Triglycerides in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.303958951617431,0.00684166984204451,0.290549278727024,0.317368624507839,0
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF9,Protein turtle homolog A,37990,0.309580870329238,0.00725912936881659,0.295352976766357,0.323808763892118,0
NMR metabolomics,X23408.Triglycerides in VLDL,INHBC,Inhibin beta C chain,40332,0.157794799251334,0.0039344293712994,0.150083317683587,0.16550628081908,0
NMR metabolomics,X23408.Triglycerides in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0844557643775375,0.00203285158248166,0.0804713752758735,0.0884401534792015,0
NMR metabolomics,X23408.Triglycerides in VLDL,LDLR,Low-density lipoprotein receptor,40356,0.42777048798428,0.00377669658715644,0.420368162673454,0.435172813295107,0
NMR metabolomics,X23408.Triglycerides in VLDL,LPL,Lipoprotein lipase,40359,-0.18901118345201,0.0041827262151409,-0.197209326833686,-0.180813040070334,0
NMR metabolomics,X23408.Triglycerides in VLDL,MFGE8,Lactadherin,40332,0.238528656718212,0.00362572495689824,0.231422235802692,0.245635077633733,0
NMR metabolomics,X23408.Triglycerides in VLDL,NPY,Pro-neuropeptide Y,40489,0.375123517832011,0.00574019825307076,0.363872729255992,0.386374306408029,0
NMR metabolomics,X23408.Triglycerides in VLDL,PRAP1,Proline-rich acidic protein 1,37998,0.168302316627971,0.00385249505567307,0.160751426318852,0.17585320693709,0
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES2,Retinoic acid receptor responder protein 2,40424,0.182122859325432,0.00422573027840741,0.173840427979753,0.19040529067111,0
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.131053734460194,0.00302374596654148,0.125127192365772,0.136980276554615,0
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS15,Enteropeptidase,40305,0.345580498807423,0.00847458421242879,0.328970313751062,0.362190683863783,0
NMR metabolomics,X23408.Triglycerides in VLDL,PTH,Parathyroid hormone,37572,0.285525962729127,0.00724209726564994,0.271331452088453,0.299720473369801,1.11253692925371e-308
NMR metabolomics,X23408.Triglycerides in VLDL,CCL27,C-C motif chemokine 27,40359,0.214800419072488,0.00550383036826854,0.204012911550682,0.225587926594295,1.11253692940314e-308
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A5,Zinc transporter ZIP5,40341,0.192818439976093,0.00495417047598259,0.183108265843167,0.202528614109019,1.11253693625189e-308
NMR metabolomics,X23408.Triglycerides in VLDL,NRP1,Neuropilin-1,40424,-0.100883690850815,0.0026088130066074,-0.105996964343765,-0.0957704173578641,1.11257920075266e-308
NMR metabolomics,X23408.Triglycerides in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.149296083466611,0.00390194939355215,0.141648262655249,0.156943904277974,1.55878246006295e-306
NMR metabolomics,X23408.Triglycerides in VLDL,CPM,Carboxypeptidase M,40415,0.119704762635176,0.00318092609196754,0.113470147494919,0.125939377775432,5.14161557110167e-297
NMR metabolomics,X23408.Triglycerides in VLDL,GPR37,Prosaposin receptor GPR37,40042,0.234079044726425,0.00623217609237213,0.221863979585376,0.246294109867474,1.21716098527943e-295
NMR metabolomics,X23408.Triglycerides in VLDL,CCL23,C-C motif chemokine 23,40422,0.142344048358542,0.00380691008416576,0.134882504593577,0.149805592123506,2.07849113279873e-293
NMR metabolomics,X23408.Triglycerides in VLDL,PROC,Vitamin K-dependent protein C,40372,0.0866074236529834,0.0023461738894724,0.0820089228296175,0.0912059244763493,2.73719521249611e-286
NMR metabolomics,X23408.Triglycerides in VLDL,DSG2,Desmoglein-2,40332,-0.091995042891355,0.00250815766064532,-0.0969110319062199,-0.0870790538764902,8.77886804989549e-283
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.270621007027662,0.00748149500856279,0.255957276810879,0.285284737244445,3.79501357609304e-275
NMR metabolomics,X23408.Triglycerides in VLDL,CD4,T-cell surface glycoprotein CD4,40309,0.102092224894524,0.00284322777967022,0.0965194984463705,0.107664951342678,1.55181540403724e-271
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.293145434536619,0.00817011392962996,0.277132011234544,0.309158857838694,3.82084566499152e-271
NMR metabolomics,X23408.Triglycerides in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.260037344281366,0.00737050816850959,0.245591148271087,0.274483540291645,1.46711159300232e-262
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR1,Asialoglycoprotein receptor 1,40228,0.0963017382447399,0.00273588992286927,0.0909393939959162,0.101664082493564,2.33729536720148e-261
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.342979847858312,0.00977129499682547,0.323828109664534,0.36213158605209,5.25558422645313e-260
NMR metabolomics,X23408.Triglycerides in VLDL,TTR,Transthyretin,37871,0.0830734542357215,0.00237562070629106,0.078417237651391,0.087729670820052,1.78133714049316e-256
NMR metabolomics,X23408.Triglycerides in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.218214360068146,0.00629919302428703,0.205867941740543,0.230560778395749,1.52629329752262e-253
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.101388032854523,0.00293690834998603,0.0956316924885499,0.107144373220495,6.92404252069608e-252
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.111614217112765,0.00324541213551551,0.105253209327155,0.117975224898376,3.76393423946597e-250
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.472784169654652,0.0138217264035384,0.445693585903717,0.499874753405587,2.18572242247194e-247
NMR metabolomics,X23408.Triglycerides in VLDL,APCS,Serum amyloid P-component,37882,0.112761835726067,0.0033486424818282,0.106198496461683,0.11932517499045,1.01474304807124e-238
NMR metabolomics,X23408.Triglycerides in VLDL,GUSB,Beta-glucuronidase,40419,0.179790231185884,0.00548283298887239,0.169043878527695,0.190536583844074,2.70198649344978e-228
NMR metabolomics,X23408.Triglycerides in VLDL,F9,Coagulation factor IX,40372,0.0551055531656867,0.00168472060937941,0.0518035007713031,0.0584076055600704,3.57229260193926e-227
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL6,C-X-C motif chemokine 6,40516,0.238350565310835,0.00728907446105354,0.22406397936717,0.252637151254499,4.10007084035791e-227
NMR metabolomics,X23408.Triglycerides in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.257558630593042,0.00788701831727944,0.242100074691174,0.27301718649491,2.56575560378735e-226
NMR metabolomics,X23408.Triglycerides in VLDL,AGR3,Anterior gradient protein 3,39963,0.181738986005531,0.00558149642158504,0.170799253019224,0.192678718991837,5.09313569005955e-225
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF1,Pigment epithelium-derived factor,37790,0.0786861995218394,0.0024228929610814,0.0739373293181198,0.0834350697255589,9.67737118393047e-223
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.35421446987851,0.0110183234992108,-0.375810383936963,-0.332618555820057,8.33696938972535e-220
NMR metabolomics,X23408.Triglycerides in VLDL,SERPIND1,Heparin cofactor 2,37981,0.0823824149245517,0.00256085888943587,0.0773631315012574,0.087401698347846,7.33271463806476e-219
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA5,Plasma serine protease inhibitor,37835,0.0985456513713625,0.00308274330733933,0.0925034744889774,0.104587828253748,3.78401183805433e-216
NMR metabolomics,X23408.Triglycerides in VLDL,CFI,Complement factor I,38013,0.0600091226839903,0.00188258862120482,0.0563192489864289,0.0636989963815518,4.48356826934514e-215
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN3,Contactin-3,40332,0.104463944027447,0.00328684037035738,0.0980217369015461,0.110906151153347,5.76091001044058e-215
NMR metabolomics,X23408.Triglycerides in VLDL,ACY1,Aminoacylase-1,40359,0.176019378766304,0.00558975403252389,0.165063460862557,0.186975296670051,3.45577270113032e-211
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.154180535103257,0.00490693204585239,0.144562948293387,0.163798121913128,2.39738044511345e-210
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA1,Glutathione S-transferase A1,40333,0.244034934599274,0.00777278232206375,0.228800281248029,0.259269587950519,5.65801026332329e-210
NMR metabolomics,X23408.Triglycerides in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.171701389024841,0.00550994777699582,0.160901891381929,0.182500886667753,7.68590869599079e-207
NMR metabolomics,X23408.Triglycerides in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.301377590321895,0.00969389411913531,0.282377557848389,0.3203776227954,4.76193629741797e-206
NMR metabolomics,X23408.Triglycerides in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0899471258730582,0.00290270784152532,0.0842578185036685,0.0956364332424478,8.61994758730407e-205
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LG,CMRF35-like molecule 9,40332,-0.10956151460447,0.00354980025396199,-0.116519123102235,-0.102603906106704,3.45250246375074e-203
NMR metabolomics,X23408.Triglycerides in VLDL,CRIP2,Cysteine-rich protein 2,40228,0.104269985480821,0.00340053117496012,0.0976049443778987,0.110935026583742,1.30539287870094e-200
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF8,Immunoglobulin superfamily member 8,40359,0.0857561668561496,0.00281358654877995,0.0802415372205409,0.0912707964917583,2.3625976509573e-198
NMR metabolomics,X23408.Triglycerides in VLDL,CFH,Complement factor H,37301,0.0662524664411909,0.00216925917129881,0.0620007184654452,0.0705042144169366,7.85146638290782e-198
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA3,Glutathione S-transferase A3,39980,0.2161895545286,0.00712605314341558,0.202222490367506,0.230156618689695,1.86688062916271e-196
NMR metabolomics,X23408.Triglycerides in VLDL,UPB1,Beta-ureidopropionase,37990,0.260709635609027,0.00858570041516254,0.243881662795308,0.277537608422745,5.40719559843832e-196
NMR metabolomics,X23408.Triglycerides in VLDL,AMBP,Protein AMBP,40470,0.057066536669191,0.00188686555907441,0.0533682801734051,0.0607647931649768,1.86794801906182e-195
NMR metabolomics,X23408.Triglycerides in VLDL,PON3,Serum paraoxonase/lactonase 3,40422,-0.0780838094219217,0.00258176474956647,-0.083144068331072,-0.0730235505127714,1.92292367638379e-195
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP6,Charged multivesicular body protein 6,37990,0.158564454223828,0.00524101765766337,0.148292059614808,0.168836848832848,1.2686438503924e-194
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.180668463910725,0.00598822385330846,-0.192405382663209,-0.16893154515824,1.49766698869752e-194
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0538751633975367,0.00178688008288833,0.0503728784350756,0.0573774483599978,3.07149734012203e-194
NMR metabolomics,X23408.Triglycerides in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.15439298174392,0.00513167969188066,0.144334889547834,0.164451073940006,2.35544866183877e-193
NMR metabolomics,X23408.Triglycerides in VLDL,AFM,Afamin,38013,0.052827982814197,0.00175337996057698,0.0493913580914661,0.0562646075369278,4.30427707720094e-193
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0522845235322877,0.00174189918719839,0.0488704011253789,0.0556986459391966,1.97093076670555e-192
NMR metabolomics,X23408.Triglycerides in VLDL,GLA,Alpha-galactosidase A,37642,0.102420596504327,0.00340451921234081,0.0957477388481389,0.109093454160515,2.29952855813947e-192
NMR metabolomics,X23408.Triglycerides in VLDL,FGF21,Fibroblast growth factor 21,40453,0.330021206648083,0.0110436709716156,0.308375611543716,0.351666801752449,5.50622245964809e-191
NMR metabolomics,X23408.Triglycerides in VLDL,C9,Complement component C9,37987,-0.13674882696552,0.00458234465633206,-0.145730222491931,-0.12776743143911,1.41330574807392e-189
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA4,Kallistatin,37781,0.06729528301314,0.00225535662641257,0.0628747840253714,0.0717157820009087,1.97796210668251e-189
NMR metabolomics,X23408.Triglycerides in VLDL,RBP5,Retinol-binding protein 5,40305,0.154717943890954,0.0052117130835999,0.144502986247098,0.16493290153481,1.5859301287039e-188
NMR metabolomics,X23408.Triglycerides in VLDL,PLTP,Phospholipid transfer protein,40461,-0.0958009537392334,0.00322798956887043,-0.102127813294219,-0.0894740941842474,1.79610427461905e-188
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.153885487925062,0.00519681599098261,0.143699728582736,0.164071247267388,1.30286280644667e-187
NMR metabolomics,X23408.Triglycerides in VLDL,PAMR1,Inactive serine protease PAMR1,40332,0.0774294656663181,0.00263733624825517,0.072260286619738,0.0825986447128983,1.50795507280696e-184
NMR metabolomics,X23408.Triglycerides in VLDL,SNAPIN,SNARE-associated protein Snapin,37959,0.158873508932845,0.00540467949730277,0.148280337118131,0.169466680747558,3.69595547510404e-184
NMR metabolomics,X23408.Triglycerides in VLDL,P4HB,Protein disulfide-isomerase,40266,0.106635944090648,0.00364809362624724,0.0994856805832037,0.113786207598093,5.61228540302667e-183
NMR metabolomics,X23408.Triglycerides in VLDL,GRP,Gastrin-releasing peptide,37628,0.15020558396097,0.00513111224275794,0.140148603965164,0.160262563956776,1.47228460813164e-182
NMR metabolomics,X23408.Triglycerides in VLDL,NOS3,"Nitric oxide synthase, endothelial",39961,0.150836267564811,0.00516509562052159,0.140712680148589,0.160959854981033,1.49099348505273e-182
NMR metabolomics,X23408.Triglycerides in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.203681521144482,0.00698006192177562,0.190000599777802,0.217362442511162,2.31323576501052e-182
NMR metabolomics,X23408.Triglycerides in VLDL,FLI1,Friend leukemia integration 1 transcription factor,39980,0.299341213333825,0.0102562923931053,0.279238880243338,0.319443546424311,2.34928081206834e-182
NMR metabolomics,X23408.Triglycerides in VLDL,CCL16,C-C motif chemokine 16,40536,0.145680859240882,0.00499519183513777,0.135890283244012,0.155471435237752,2.95616715364228e-182
NMR metabolomics,X23408.Triglycerides in VLDL,F10,Coagulation factor X,37987,0.0714064711484282,0.00244460267813446,0.0666150498992846,0.0761978923975717,6.04066170741904e-182
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI,Tissue factor pathway inhibitor,40309,0.0855283025737581,0.00293883377617935,0.0797681883724466,0.0912884167750696,1.88162976577791e-181
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0949811039030153,0.00326790027680332,-0.10138618844555,-0.0885760193604808,4.62798278170415e-181
NMR metabolomics,X23408.Triglycerides in VLDL,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0701329727552415,0.0024160274817328,0.0653975588910452,0.0748683866194378,1.50588654971695e-180
NMR metabolomics,X23408.Triglycerides in VLDL,BCHE,Cholinesterase,37748,0.0770865494140243,0.0026648601237799,0.0718634235714157,0.0823096752566329,1.73255592729409e-178
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.162511131242075,0.00565422227672895,-0.173593406904464,-0.151428855579686,4.09575515600141e-177
NMR metabolomics,X23408.Triglycerides in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.124633477076083,0.00434408625011315,0.116119068025862,0.133147886126305,1.73175051362715e-176
NMR metabolomics,X23408.Triglycerides in VLDL,PLAT,Tissue-type plasminogen activator,40490,0.132847244598541,0.00463287557346427,0.123766808474551,0.141927680722531,2.14690899514899e-176
NMR metabolomics,X23408.Triglycerides in VLDL,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0825496311111565,0.00287747327659254,-0.0881894787332778,-0.0769097834890351,1.21387859524642e-175
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS8,Prostasin,40293,0.108788933264984,0.00381590111593508,0.101309767077751,0.116268099452216,2.1985948384988e-174
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA1,Ephrin type-A receptor 1,40400,0.0918835364270257,0.00322617550512953,0.0855602324369718,0.0982068404170795,4.49157132341051e-174
NMR metabolomics,X23408.Triglycerides in VLDL,KYNU,Kynureninase,40516,0.119799548636854,0.00421503012940985,0.11153808958321,0.128061007690497,2.0548729839815e-173
NMR metabolomics,X23408.Triglycerides in VLDL,LATS1,Serine/threonine-protein kinase LATS1,37598,0.226723453883902,0.00795569896976155,0.211130283903169,0.242316623864635,2.1706821400103e-173
NMR metabolomics,X23408.Triglycerides in VLDL,CFP,Properdin,38013,0.0586889062300918,0.00206329100993744,0.0546448558506145,0.0627329566095692,6.48799135589384e-173
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.181355979612243,0.00640873843569311,0.168794852278285,0.193917106946202,3.57588788680484e-171
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR2,Fibroblast growth factor receptor 2,40411,0.0569314616022082,0.00202190555005962,0.0529685267240913,0.060894396480325,2.75577648393084e-170
NMR metabolomics,X23408.Triglycerides in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.221480384152023,0.00786281750446129,0.206069261843279,0.236891506460767,1.13493696951549e-169
NMR metabolomics,X23408.Triglycerides in VLDL,SHBG,Sex hormone-binding globulin,37987,-0.142950451941358,0.00509336005734737,-0.152933437653758,-0.132967466228957,1.62269063838461e-168
NMR metabolomics,X23408.Triglycerides in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.109644197854577,0.00392237041153608,0.101956351847966,0.117332043861187,6.84725780067255e-168
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.193119061405558,0.00693736976656048,0.1795218166631,0.206716306148017,1.60383913614191e-166
NMR metabolomics,X23408.Triglycerides in VLDL,NUMB,Protein numb homolog,37598,0.219765360212185,0.00788014468210324,0.204320276635263,0.235210443789108,2.43015946063323e-166
NMR metabolomics,X23408.Triglycerides in VLDL,NOMO1,Nodal modulator 1,40332,0.0619302105254869,0.00224188878771077,0.0575361085015738,0.0663243125494001,4.21816851289222e-164
NMR metabolomics,X23408.Triglycerides in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.365046788362784,0.0131872324772355,0.339199812707403,0.390893764018166,4.38975682883653e-164
NMR metabolomics,X23408.Triglycerides in VLDL,NCS1,Neuronal calcium sensor 1,40489,0.0745938892124886,0.00270563119497418,0.0692908520703392,0.079896926354638,1.62187245187354e-163
NMR metabolomics,X23408.Triglycerides in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.175395694986988,0.00637593284754191,0.162898866605806,0.18789252336817,1.06033400603615e-162
NMR metabolomics,X23408.Triglycerides in VLDL,F11R,Junctional adhesion molecule A,40332,0.146998221253454,0.00535306874784471,0.136506206507678,0.15749023599923,3.12554135172703e-162
NMR metabolomics,X23408.Triglycerides in VLDL,SNCA,Alpha-synuclein,37671,0.295836464301803,0.0107685462762493,0.274730113600354,0.316942815003251,1.24614033623945e-161
NMR metabolomics,X23408.Triglycerides in VLDL,CREG1,Protein CREG1,40145,0.0934388784794807,0.00341167972292396,0.0867519862225498,0.100125770736412,2.31706181910878e-161
NMR metabolomics,X23408.Triglycerides in VLDL,ENO3,Beta-enolase,37628,0.147229336766688,0.00537218761796751,0.136699849035471,0.157758824497904,7.23790112448169e-161
NMR metabolomics,X23408.Triglycerides in VLDL,FAM20A,Pseudokinase FAM20A,37990,0.0732443766324799,0.00267516602590766,0.0680010512217009,0.0784877020432589,1.10281544999354e-160
NMR metabolomics,X23408.Triglycerides in VLDL,LAT2,Linker for activation of T-cells family member 2,40305,0.314665573437428,0.0115650124601096,0.291998149015613,0.337332997859243,2.30944581415167e-159
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0540609640189287,0.00198720952777456,0.0501660333444906,0.0579558946933668,2.32960484234426e-159
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS1,Protein MTSS 1,37901,0.284948542946348,0.0104738745815211,0.264419748766566,0.305477337126129,1.0569837847643e-158
NMR metabolomics,X23408.Triglycerides in VLDL,IL16,Pro-interleukin-16,40516,0.102714844992628,0.00382543595976396,0.0952169905114905,0.110212699473765,2.19352219511649e-155
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB1,BPI fold-containing family B member 1,40261,-0.156708180626596,0.00584007329623024,-0.168154724287207,-0.145261636965985,3.86510978944953e-155
NMR metabolomics,X23408.Triglycerides in VLDL,STAB2,Stabilin-2,37998,0.0711369957913317,0.00264741668894859,0.0659480590809924,0.0763259325016709,5.43593417114271e-155
NMR metabolomics,X23408.Triglycerides in VLDL,SYAP1,Synapse-associated protein 1,37671,0.143786849096952,0.00535023298786148,0.133300392440743,0.15427330575316,6.04878539080456e-155
NMR metabolomics,X23408.Triglycerides in VLDL,NAA80,N-alpha-acetyltransferase 80,37572,0.300781242398261,0.0112442951842296,0.278742423837171,0.322820060959351,1.57012604935774e-153
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0870927260011165,0.00327348206277027,0.0806767011580867,0.0935087508441462,1.22590478543525e-152
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL17,C-X-C motif chemokine 17,40516,0.104200363568674,0.00392579928881482,0.096505796962597,0.111894930174751,5.82920499501885e-152
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP29,Synaptosomal-associated protein 29,40411,0.228512973643086,0.00864375426670785,0.211571215280339,0.245454732005833,8.96978763120059e-151
NMR metabolomics,X23408.Triglycerides in VLDL,PYY,Peptide YY,37562,0.237690297074067,0.00900074753894323,0.220048831897738,0.255331762250396,8.87752439758045e-150
NMR metabolomics,X23408.Triglycerides in VLDL,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0690747908725945,0.00262288408959344,0.0639339380569914,0.0742156436881977,1.20440790843621e-149
NMR metabolomics,X23408.Triglycerides in VLDL,DPY30,Protein dpy-30 homolog,40414,0.147846752655268,0.00563953225141931,0.136793269442486,0.15890023586805,2.36220835914289e-148
NMR metabolomics,X23408.Triglycerides in VLDL,NHLRC3,NHL repeat-containing protein 3,37370,0.0794868788556203,0.00302798243364345,0.0735520332856791,0.0854217244255614,5.14363419263904e-148
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0971189406640867,0.00371202604388467,0.0898433696180728,0.104394511710101,8.45625616682523e-148
NMR metabolomics,X23408.Triglycerides in VLDL,DTYMK,Thymidylate kinase,37990,0.171931939837491,0.00656383572049696,0.159066821825317,0.184797057849665,1.43913394436477e-147
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC4,Apical endosomal glycoprotein,37900,0.135612069160489,0.00517696530295463,0.125465217166698,0.14575892115428,1.46547284518768e-147
NMR metabolomics,X23408.Triglycerides in VLDL,EEF1D,Elongation factor 1-delta,37990,0.227113628505722,0.00868378636615028,0.210093407228067,0.244133849783376,3.91043423641676e-147
NMR metabolomics,X23408.Triglycerides in VLDL,SCLY,Selenocysteine lyase,40434,0.11796942187274,0.00452499529922932,0.109100431086251,0.126838412659229,9.04229785423607e-147
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR5,Cadherin-related family member 5,40359,0.0960772642746385,0.00369399178537405,0.0888370403753053,0.103317488173972,4.35468139857941e-146
NMR metabolomics,X23408.Triglycerides in VLDL,ABL1,Tyrosine-protein kinase ABL1,40305,0.167222130208237,0.00644013563149561,0.154599464370506,0.179844796045969,1.31821367835747e-145
NMR metabolomics,X23408.Triglycerides in VLDL,IL18R1,Interleukin-18 receptor 1,40516,0.0800043727372945,0.0030903430552781,0.0739473003489495,0.0860614451256396,8.23829597852058e-145
NMR metabolomics,X23408.Triglycerides in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.166938824169314,0.00645138278825485,0.154294113904334,0.179583534434293,4.90778769369851e-144
NMR metabolomics,X23408.Triglycerides in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.217562449270189,0.00843308189657495,0.201033608752902,0.234091289787476,8.74300847665403e-144
NMR metabolomics,X23408.Triglycerides in VLDL,MYH9,Myosin-9,37998,0.274669647061519,0.0106563082317865,0.253783282927217,0.29555601119582,4.58442138179492e-143
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.139901835439024,0.00543026355054157,0.129258518879962,0.150545151998085,7.62406674727897e-143
NMR metabolomics,X23408.Triglycerides in VLDL,YES1,Tyrosine-protein kinase Yes,40305,0.276238827470667,0.0107616670182075,0.25514596011498,0.297331694826353,2.08344693838877e-142
NMR metabolomics,X23408.Triglycerides in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.19409921156724,0.00756122839142177,0.179279203920054,0.208919219214427,6.38273982585897e-142
NMR metabolomics,X23408.Triglycerides in VLDL,MLN,Promotilin,40341,0.215789997590963,0.00842333658110675,0.199280257891993,0.232299737289932,7.16143976943796e-142
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4R,Reticulon-4 receptor,40489,0.0823971886403112,0.00321681153404148,0.0760922380335899,0.0887021392470325,7.36721009803388e-142
NMR metabolomics,X23408.Triglycerides in VLDL,CKB,Creatine kinase B-type,37998,-0.147555765820974,0.00574994705840041,-0.158825662055439,-0.136285869586509,7.389856572726e-142
NMR metabolomics,X23408.Triglycerides in VLDL,FYB1,FYN-binding protein 1,40311,0.222114564083098,0.00868184023904507,0.20509815721457,0.239130970951627,1.68694262623056e-141
NMR metabolomics,X23408.Triglycerides in VLDL,CTBS,Di-N-acetylchitobiase,37819,0.0658212439623591,0.00257027887645036,0.0607834973645164,0.0708589905602018,3.02768896168e-141
NMR metabolomics,X23408.Triglycerides in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0491293311347001,0.00193104796992287,0.0453444771136512,0.0529141851557489,5.50469118934982e-140
NMR metabolomics,X23408.Triglycerides in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.148816551054181,0.00585292600121707,0.137344816091796,0.160288286016567,9.26171997829621e-140
NMR metabolomics,X23408.Triglycerides in VLDL,MVK,Mevalonate kinase,40044,0.184518335547352,0.00728185326538728,0.170245903147193,0.198790767947511,7.46075826101057e-139
NMR metabolomics,X23408.Triglycerides in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.174927568162359,0.00689376574958442,0.161415787293174,0.188439349031545,8.19859391390193e-139
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR2,Cadherin-related family member 2,40305,0.184377418793489,0.00729265407130643,0.170083816813728,0.198671020773249,2.68808034951423e-138
NMR metabolomics,X23408.Triglycerides in VLDL,CLUL1,Clusterin-like protein 1,40338,-0.109125386172885,0.00432316347710495,-0.117598786588011,-0.100651985757759,7.12553380486418e-138
NMR metabolomics,X23408.Triglycerides in VLDL,CCL22,C-C motif chemokine 22,40204,0.12331572097715,0.00489035417525738,0.113730626793645,0.132900815160654,1.40787487005206e-137
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL13,C-X-C motif chemokine 13,40471,0.151364140509784,0.00602625700218038,0.139552676785511,0.163175604234058,1.39137440310918e-136
NMR metabolomics,X23408.Triglycerides in VLDL,KDR,Vascular endothelial growth factor receptor 2,40411,0.0602641642257972,0.00240062400957166,0.0555589411670367,0.0649693872845576,1.99127266119972e-136
NMR metabolomics,X23408.Triglycerides in VLDL,KLKB1,Plasma kallikrein,37721,0.060147387420497,0.00239175020730253,0.055459557014184,0.06483521782681,2.26957413898607e-136
NMR metabolomics,X23408.Triglycerides in VLDL,SORT1,Sortilin,40330,0.0864329289052603,0.00345008326008586,0.079670765715492,0.0931950920950285,7.05810966354797e-136
NMR metabolomics,X23408.Triglycerides in VLDL,CTSD,Cathepsin D,39243,0.0946585846244647,0.00379057167796091,0.0872290641356613,0.102088105113268,7.5018986847841e-135
NMR metabolomics,X23408.Triglycerides in VLDL,ATRN,"Attractin, Isoform 2",38013,0.0387430987732401,0.00155410184736803,0.0356970591523988,0.0417891383940814,3.64590108789966e-134
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0887522132937776,0.00356917937065271,-0.0957478048602569,-0.0817566217272983,6.05196151894677e-134
NMR metabolomics,X23408.Triglycerides in VLDL,SOST,Sclerostin,40330,0.0913311259103267,0.00367298685875378,0.0841320716671693,0.0985301801534841,6.31086121141766e-134
NMR metabolomics,X23408.Triglycerides in VLDL,HEG1,Protein HEG homolog 1,37671,0.0624606960610935,0.00251104865890827,0.0575390406896333,0.0673823514325537,1.61727240243399e-133
NMR metabolomics,X23408.Triglycerides in VLDL,HJV,Hemojuvelin,37959,0.108943836056262,0.00438257628629366,0.100353986535126,0.117533685577397,2.04364965511694e-133
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.199267696929675,0.00802536751281113,0.183537976604565,0.214997417254785,4.77770887400094e-133
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0930343977168365,0.00376776630142571,-0.100419219667631,-0.0856495757660421,3.94035372846148e-132
NMR metabolomics,X23408.Triglycerides in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0721193736099131,0.00292231900121499,0.0663916283675317,0.0778471188522945,5.52162439861712e-132
NMR metabolomics,X23408.Triglycerides in VLDL,YTHDF3,YTH domain-containing family protein 3,40044,0.198882852706199,0.00805957874941987,0.183086078357336,0.214679627055062,6.39306124309584e-132
NMR metabolomics,X23408.Triglycerides in VLDL,PROS1,Vitamin K-dependent protein S,38013,0.058906805875789,0.00238564667475272,0.0542309383932737,0.0635826733583044,1.02973503979519e-131
NMR metabolomics,X23408.Triglycerides in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.119860161647244,0.0048583617888552,0.110337772541088,0.1293825507534,1.79844528761576e-131
NMR metabolomics,X23408.Triglycerides in VLDL,SARG,Specifically androgen-regulated gene protein,37931,0.254528607023785,0.0103234332074948,0.234294677937095,0.274762536110474,2.55435981465244e-131
NMR metabolomics,X23408.Triglycerides in VLDL,KHK,Ketohexokinase,37628,0.15080731992231,0.00612966480128425,0.138793176911793,0.162821462932827,1.02398145785136e-130
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL2,Angiopoietin-related protein 2,40377,0.0929928149574846,0.00379140807016392,0.0855616551399633,0.100423974775006,1.96720209586399e-130
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0946723544842716,0.00386953589017809,-0.102256644829021,-0.0870880641395226,8.48595051028343e-130
NMR metabolomics,X23408.Triglycerides in VLDL,PPY,Pancreatic prohormone,40337,0.234424868847036,0.00959541343615377,0.215617858512175,0.253231879181897,1.94177487124022e-129
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.220644580039776,0.00905683157488462,0.202893190153003,0.23839596992655,9.78218247216191e-129
NMR metabolomics,X23408.Triglycerides in VLDL,CES2,Cocaine esterase,40305,0.123940209575272,0.00508772038821953,0.113968277614362,0.133912141536183,1.02728802538455e-128
NMR metabolomics,X23408.Triglycerides in VLDL,TJAP1,Tight junction-associated protein 1,40411,0.190789379727735,0.00784941111305494,0.175404533946147,0.206174225509323,3.56608163721094e-128
NMR metabolomics,X23408.Triglycerides in VLDL,TXLNA,Alpha-taxilin,40228,0.20599626691891,0.00847609715946453,0.189383116486359,0.22260941735146,4.06574191588372e-128
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3F,Semaphorin-3F,40359,0.0597016100619014,0.00246038994920107,0.0548792457614673,0.0645239743623355,9.51323350733956e-128
NMR metabolomics,X23408.Triglycerides in VLDL,NPPC,C-type natriuretic peptide,40341,0.0994658210413396,0.004101129598609,0.091427607028066,0.107504035054613,1.26253461428082e-127
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0626569810652208,0.00258822022206407,0.0575840694299753,0.0677298927004664,3.52755034776315e-127
NMR metabolomics,X23408.Triglycerides in VLDL,SORD,Sorbitol dehydrogenase,40417,0.154003889127575,0.00636349594870323,0.141531437068116,0.166476341187033,4.17273260971103e-127
NMR metabolomics,X23408.Triglycerides in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.128154869075943,0.00530259115519595,0.117761790411759,0.138547947740127,1.01472714084007e-126
NMR metabolomics,X23408.Triglycerides in VLDL,FCN2,Ficolin-2,40291,0.0938661915120354,0.00390339857702235,0.0862155303010716,0.101516852722999,1.56874552735042e-125
NMR metabolomics,X23408.Triglycerides in VLDL,DKK1,Dickkopf-related protein 1,40471,0.136528697985957,0.00567813843538539,0.125399546652602,0.147657849319313,1.57733026850982e-125
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.165777906858159,0.00688684475162109,0.152279691144982,0.179276122571336,2.46713358734964e-125
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0919938430868324,0.00382648703291245,0.084493928502324,0.0994937576713408,4.32180106133831e-125
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.191180017502209,0.00798173245987862,0.175535821880847,0.206824213123571,3.40292811295979e-124
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK9,Mitogen-activated protein kinase 9,40341,0.0975227037555603,0.00408600542872164,0.0895141331152659,0.105531274395855,9.93958804370266e-124
NMR metabolomics,X23408.Triglycerides in VLDL,EHBP1,EH domain-binding protein 1,37990,0.169783526480101,0.00710319462654563,0.155861265012071,0.18370578794813,1.03835140316668e-123
NMR metabolomics,X23408.Triglycerides in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.219969269176944,0.00924294259832793,0.201853101684221,0.238085436669667,4.91605705149775e-123
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.102730249396137,0.00432403695914802,0.0942551369562069,0.111205361836067,1.25273266164579e-122
NMR metabolomics,X23408.Triglycerides in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.10948088716816,0.00461538066114412,0.100434741072318,0.118527033264003,2.93655658809098e-122
NMR metabolomics,X23408.Triglycerides in VLDL,BECN1,Beclin-1,37628,0.137686958545051,0.00580930731298247,0.126300716211605,0.149073200878497,1.21159286418241e-121
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF2,Alpha-2-antiplasmin,37755,0.0306106346274394,0.001291867139841,0.028078575033351,0.0331426942215277,1.32224378769356e-121
NMR metabolomics,X23408.Triglycerides in VLDL,NUCB2,Nucleobindin-2,40447,0.0835663520546679,0.00353739766113284,0.0766330526388475,0.0904996514704883,2.60795080499946e-121
NMR metabolomics,X23408.Triglycerides in VLDL,HGF,Hepatocyte growth factor,40516,0.0770461030050221,0.00326197766189222,0.0706526267877133,0.0834395792223308,2.81615497360432e-121
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0606789852574718,0.00256721087072182,0.055647251950857,0.0657107185640866,4.73436523744073e-121
NMR metabolomics,X23408.Triglycerides in VLDL,ADH1B,All-trans-retinol dehydrogenase,37671,0.166247425461016,0.00703876424572215,0.1524514475394,0.180043403382631,7.72126182368732e-121
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.183833098010901,0.0078185218941698,0.168508795098328,0.199157400923474,3.27307590210385e-120
NMR metabolomics,X23408.Triglycerides in VLDL,FETUB,Fetuin-B,40372,0.075638932877284,0.00321768214777333,0.0693322758676483,0.0819455898869198,3.79411080679542e-120
NMR metabolomics,X23408.Triglycerides in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.186282722281128,0.00791271522910367,0.170773800432085,0.201791644130171,4.38723731086318e-120
NMR metabolomics,X23408.Triglycerides in VLDL,CTSO,Cathepsin O,40516,0.0673109470016967,0.00286588847496396,0.0616938055907674,0.0729280884126261,5.7833135754606e-120
NMR metabolomics,X23408.Triglycerides in VLDL,CD2AP,CD2-associated protein,40359,0.142863793516987,0.00608872665329079,0.130929889276537,0.154797697757437,1.02677960838564e-119
NMR metabolomics,X23408.Triglycerides in VLDL,CES3,Carboxylesterase 3,40305,0.153178944039351,0.00653029215293523,0.140379571419598,0.165978316659104,1.22209369484153e-119
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1B,C-type lectin domain family 1 member B,40471,0.215066014169848,0.00917511192302964,0.19708279480071,0.233049233538986,1.69620353614683e-119
NMR metabolomics,X23408.Triglycerides in VLDL,AP3S2,AP-3 complex subunit sigma-2,37942,0.104103311631348,0.0044422238077961,0.0953965529680676,0.112810070294628,4.43538249439359e-119
NMR metabolomics,X23408.Triglycerides in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0667048991828046,0.0028515472490612,0.0611158665746446,0.0722939317909645,1.17283842837262e-118
NMR metabolomics,X23408.Triglycerides in VLDL,BTD,Biotinidase,38013,0.0459701004490414,0.00196794430587169,0.0421129296095329,0.0498272712885499,2.3637845221776e-118
NMR metabolomics,X23408.Triglycerides in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.120462222639997,0.0051700428515468,0.110328938650965,0.130595506629029,4.33171642671264e-118
NMR metabolomics,X23408.Triglycerides in VLDL,MME,Neprilysin,40305,0.180282320654643,0.00774202730732726,0.165107947132282,0.195456694177005,5.79371931962366e-118
NMR metabolomics,X23408.Triglycerides in VLDL,TARBP2,RISC-loading complex subunit TARBP2,39961,0.175054559666698,0.00751769576509238,0.160319875967116,0.189789243366279,6.47028392798553e-118
NMR metabolomics,X23408.Triglycerides in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.107696481332578,0.0046282068501867,0.0986251959062125,0.116767766758944,2.03158095681222e-117
NMR metabolomics,X23408.Triglycerides in VLDL,AXIN1,Axin-1,40341,0.207058393148664,0.00895210782195831,0.189512261817626,0.224604524479703,1.9419674060206e-116
NMR metabolomics,X23408.Triglycerides in VLDL,ARF6,ADP-ribosylation factor 6,37901,0.23187370420158,0.0100124636795435,0.212249275389675,0.251498133013485,2.22540464082903e-116
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN1,Dynactin subunit 1,40489,0.144869545954979,0.00626715909827162,0.132585914122367,0.157153177787592,2.54847793764489e-116
NMR metabolomics,X23408.Triglycerides in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.100017315880826,0.00433642250464178,0.0915179277717282,0.108516703989924,1.9772170010049e-115
NMR metabolomics,X23408.Triglycerides in VLDL,CD63,CD63 antigen,40203,0.1143221208404,0.00496822145434306,0.104584406789888,0.124059834890912,2.87841847791386e-115
NMR metabolomics,X23408.Triglycerides in VLDL,ACE2,Angiotensin-converting enzyme 2,40042,0.107196392610272,0.00466101564139818,0.0980608019531319,0.116331983267413,3.9456358971131e-115
NMR metabolomics,X23408.Triglycerides in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0466547232396246,0.00202581210084373,0.0426841315219709,0.0506253149572783,4.22479816619244e-115
NMR metabolomics,X23408.Triglycerides in VLDL,CEP20,Centrosomal protein 20,39980,0.161296269715609,0.00701671312350166,0.147543511993546,0.175049027437672,5.13624735729962e-115
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.153250873636417,0.00667041361301214,0.140176862954913,0.166324884317921,6.81817033382185e-115
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0634223075770989,0.00276808960309073,0.057996851955041,0.0688477631991567,5.13964982798181e-114
NMR metabolomics,X23408.Triglycerides in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.142266208234589,0.00622195646166924,0.130071173569717,0.154461242899461,1.4428220749974e-113
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.243099910239507,0.0106440303611678,0.222237610731618,0.263962209747396,2.83439055116231e-113
NMR metabolomics,X23408.Triglycerides in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.157365969555392,0.00690471338670476,0.143832731317451,0.170899207793334,3.55487020355709e-113
NMR metabolomics,X23408.Triglycerides in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0819317218332473,0.00359812059715253,0.0748794054628284,0.0889840382036663,5.71360931163418e-113
NMR metabolomics,X23408.Triglycerides in VLDL,IDUA,Alpha-L-iduronidase,40489,0.0981619189262805,0.00431312027396684,0.0897082031893055,0.106615634663255,7.14034761308495e-113
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.235233477317455,0.0103265730544073,0.214993394130816,0.255473560504093,9.98273784904634e-113
NMR metabolomics,X23408.Triglycerides in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.229556534954264,0.0101029463397699,0.209754760128315,0.249358309780214,1.68341880468895e-112
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL7,Angiopoietin-related protein 7,40489,0.0801346242548927,0.00353163688439426,0.0732126159614799,0.0870566325483054,3.22871713674389e-112
NMR metabolomics,X23408.Triglycerides in VLDL,EZR,Ezrin,40471,0.0509811949860065,0.00225781194443336,0.0465558835749171,0.0554065063970959,3.68545810971667e-111
NMR metabolomics,X23408.Triglycerides in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.106500423534092,0.00473084514250425,0.0972279670547838,0.1157728800134,1.84490093006828e-110
NMR metabolomics,X23408.Triglycerides in VLDL,CCL17,C-C motif chemokine 17,40333,0.19423806165698,0.00863796281033337,0.177307654548727,0.211168468765234,2.93913441228117e-110
NMR metabolomics,X23408.Triglycerides in VLDL,PAXX,Protein PAXX,37671,0.0973303830777006,0.0043250605325131,0.0888532644339749,0.105807501721426,4.39556333276248e-110
NMR metabolomics,X23408.Triglycerides in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.205505374968142,0.00914204403109628,0.187586968667194,0.223423781269091,6.80521736119822e-110
NMR metabolomics,X23408.Triglycerides in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0494866379288499,0.00221131142553563,0.0451524675348001,0.0538208083228997,3.02833481729964e-109
NMR metabolomics,X23408.Triglycerides in VLDL,AGRN,Agrin,40422,0.0708325646839279,0.0031661256930711,0.0646269583255086,0.0770381710423473,3.48987658507998e-109
NMR metabolomics,X23408.Triglycerides in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.142762702160925,0.00638857244195293,0.130241100174697,0.155284304147153,6.74801329457427e-109
NMR metabolomics,X23408.Triglycerides in VLDL,SELP,P-selectin,40403,0.122783989335103,0.00549805440822922,0.112007802694974,0.133560175975233,8.3090876277967e-109
NMR metabolomics,X23408.Triglycerides in VLDL,THOP1,Thimet oligopeptidase,40288,0.0637834745231057,0.00285614540580654,0.0581854295277249,0.0693815195184865,8.58513492375361e-109
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0807261381733284,0.00361543466036015,0.0736398862390225,0.0878123901076343,8.86734296732824e-109
NMR metabolomics,X23408.Triglycerides in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.228608833125124,0.0102439400091488,0.208530710707193,0.248686955543056,2.31099106332454e-108
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNA4,Plexin-A4,40341,0.175188981657152,0.00787295092942209,0.159757997835485,0.19061996547882,4.79525140914107e-108
NMR metabolomics,X23408.Triglycerides in VLDL,CEP85,Centrosomal protein of 85 kDa,39980,0.133463905103447,0.00601022338512813,0.121683867268596,0.145243942938298,1.4070136549875e-107
NMR metabolomics,X23408.Triglycerides in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.103902312504172,0.00468386890237611,0.0947219294555148,0.113082695552829,2.03461235564e-107
NMR metabolomics,X23408.Triglycerides in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.15876574014218,0.00714765555914065,0.144756335246264,0.172775145038096,2.41191530730717e-107
NMR metabolomics,X23408.Triglycerides in VLDL,OXT,Oxytocin-neurophysin 1,40471,0.279889377030408,0.0126244627415891,0.255145430056893,0.304633324003923,2.7099509123556e-107
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS2,Protein MTSS 2,37900,0.208257456254275,0.00938465487744319,0.189863532694486,0.226651379814064,3.46211271976437e-107
NMR metabolomics,X23408.Triglycerides in VLDL,DAB2,Disabled homolog 2,40489,0.232923947509347,0.0105201536217906,0.212304446410638,0.253543448608057,5.11316817448675e-107
NMR metabolomics,X23408.Triglycerides in VLDL,KAZN,Kazrin,37901,0.219204471874612,0.00990797828299204,0.199784834439947,0.238624109309276,1.46120972599498e-106
NMR metabolomics,X23408.Triglycerides in VLDL,LBR,Delta(14)-sterol reductase LBR,40471,0.138230656842942,0.00626038284638496,0.125960306464027,0.150501007221856,1.8856417684018e-106
NMR metabolomics,X23408.Triglycerides in VLDL,ATG16L1,Autophagy-related protein 16-1,37901,0.178612304041155,0.00807891975233561,0.162777621326577,0.194446986755733,2.03968071223746e-106
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN1,Perilipin-1,39961,0.0747039484995949,0.00338528383200764,0.0680687921888599,0.0813391048103299,2.80059271663433e-106
NMR metabolomics,X23408.Triglycerides in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0590939420546112,0.00267855469045164,0.053843974861326,0.0643439092478964,2.86808157012176e-106
NMR metabolomics,X23408.Triglycerides in VLDL,LSP1,Lymphocyte-specific protein 1,40341,0.0840463819966416,0.00381295524604151,0.0765729897144003,0.091519774278883,4.37782855629205e-106
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD7B,OTU domain-containing protein 7B,37959,0.132940592039035,0.0060363880106486,0.121109271538164,0.144771912539907,1.23496805551768e-105
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0509031789581146,0.00231472904014212,0.0463663100394361,0.0554400478767932,1.29350811743426e-105
NMR metabolomics,X23408.Triglycerides in VLDL,MUC13,Mucin-13,39961,0.105391557081892,0.00479472488512909,0.0959938963070392,0.114789217856745,1.78429913848909e-105
NMR metabolomics,X23408.Triglycerides in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.114830674136659,0.00523953775887136,0.104561180129271,0.125100168144047,7.19444527244701e-105
NMR metabolomics,X23408.Triglycerides in VLDL,NPL,N-acetylneuraminate lyase,37990,0.0902892620911282,0.00411837816900161,0.082217240879885,0.0983612833023713,1.01879607481356e-104
NMR metabolomics,X23408.Triglycerides in VLDL,FABP5,Fatty acid-binding protein 5,40432,0.144461243902218,0.00660162529525422,0.13152205832352,0.157400429480917,1.29876264732933e-104
NMR metabolomics,X23408.Triglycerides in VLDL,KRT18,"Keratin, type I cytoskeletal 18",40305,0.160574669074154,0.00734469731290045,0.146179062340869,0.174970275807439,2.04403497852238e-104
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.216104780126083,0.009891803582041,0.196716845105283,0.235492715146883,2.8384587266183e-104
NMR metabolomics,X23408.Triglycerides in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.216965646440942,0.0099414816767423,0.197480342354527,0.236450950527357,4.64970806311019e-104
NMR metabolomics,X23408.Triglycerides in VLDL,TNIP1,TNFAIP3-interacting protein 1,37942,0.184978982350729,0.00846740028325659,0.168382877795546,0.201575086905912,5.3339581296957e-104
NMR metabolomics,X23408.Triglycerides in VLDL,S100A4,Protein S100-A4,40411,0.119748658524286,0.00551209453521238,0.10894495323527,0.130552363813303,3.72489437596619e-103
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.142742291332724,0.00659158676106133,0.129822781281044,0.155661801384404,1.74692492780428e-102
NMR metabolomics,X23408.Triglycerides in VLDL,MCAM,Cell surface glycoprotein MUC18,40403,-0.0702827868745333,0.00324842615803874,-0.0766497021442892,-0.0639158716047774,2.428741301028e-102
NMR metabolomics,X23408.Triglycerides in VLDL,ERBIN,Erbin,40305,0.211362761491082,0.00977112788581297,0.192211350834888,0.230514172147275,2.73081028128957e-102
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R9B,Neurabin-2,40516,0.19382231650448,0.00896183678442527,0.176257116407007,0.211387516601954,2.83367439674675e-102
NMR metabolomics,X23408.Triglycerides in VLDL,STC1,Stanniocalcin-1,40471,0.0854576997548674,0.00395527353183672,0.0777053636324675,0.0932100358772674,4.49740205338762e-102
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFC,Vascular endothelial growth factor C,40411,0.115171257069134,0.00533263365124709,0.10471929511269,0.125623219025578,5.4528094918848e-102
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP23,Synaptosomal-associated protein 23,40359,0.179145196188714,0.00829956994734096,0.162878039091926,0.195412353285503,7.17838304430004e-102
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.153088148686455,0.00708310841294995,0.139205256197073,0.166971041175837,8.01292861527628e-102
NMR metabolomics,X23408.Triglycerides in VLDL,BACH1,Transcription regulator protein BACH1,40341,0.149271167404302,0.006931929954707,0.135684584693076,0.162857750115527,2.10280380848794e-101
NMR metabolomics,X23408.Triglycerides in VLDL,CD6,T-cell differentiation antigen CD6,40502,0.109256670450895,0.00507495396707883,0.0993097606754208,0.11920358022637,2.27181935906136e-101
NMR metabolomics,X23408.Triglycerides in VLDL,ELN,Elastin,37990,0.0723070739327838,0.00335908021985159,0.0657232767018747,0.0788908711636929,4.376009093561e-101
NMR metabolomics,X23408.Triglycerides in VLDL,GH1,Somatotropin,40330,-0.359453074977575,0.0167200518590076,-0.39222437662123,-0.32668177333392,4.4369380864965e-101
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM7,PDZ and LIM domain protein 7,40422,0.256328807078545,0.0119354672883486,0.232935291193382,0.279722322963708,6.91481882105065e-101
NMR metabolomics,X23408.Triglycerides in VLDL,IKBKG,NF-kappa-B essential modulator,40341,0.188511250609246,0.00877910334499357,0.171304208053059,0.205718293165433,7.56381120586764e-101
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL5,C-X-C motif chemokine 5,40309,0.235048522174953,0.0109594053699496,0.213568087649852,0.256528956700054,1.29795709895263e-100
NMR metabolomics,X23408.Triglycerides in VLDL,BCR,Breakpoint cluster region protein,40341,0.186119710402992,0.00869207564420035,0.169083242140359,0.203156178665625,2.65642906707967e-100
NMR metabolomics,X23408.Triglycerides in VLDL,FN1,Fibronectin,38013,0.0536675667727999,0.00250478144814079,0.048758195134444,0.0585769384111559,3.47128456597807e-100
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0769884615916161,0.00359781777299262,0.0699367387565506,0.0840401844266816,6.7473533684634e-100
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.210174312162947,0.00983287032189279,0.190901886332038,0.229446737993857,1.12289756677604e-99
NMR metabolomics,X23408.Triglycerides in VLDL,AAMDC,Mth938 domain-containing protein,37628,0.109512715628201,0.00513335044146558,0.0994513487629288,0.119574082493474,2.62705727758482e-99
NMR metabolomics,X23408.Triglycerides in VLDL,GLB1,Beta-galactosidase,40228,0.0828917814821662,0.00389847561286782,0.0752507692809453,0.0905327936833871,6.13574395458257e-99
NMR metabolomics,X23408.Triglycerides in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0889491569285963,0.00418542080443435,0.080745732151905,0.0971525817052876,7.50692078945339e-99
NMR metabolomics,X23408.Triglycerides in VLDL,CPB2,Carboxypeptidase B2,37981,0.0454249604033685,0.0021355290746852,0.0412393234169855,0.0496105973897515,8.66034125131781e-99
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.202579213480143,0.00955207183782248,0.183857152678011,0.221301274282275,1.80103313846523e-98
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.119933480041007,0.00565857055687916,0.108842681749524,0.13102427833249,2.4839352174283e-98
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0464580495900756,0.00219281769065842,0.0421601269163851,0.0507559722637661,2.9042969789443e-98
NMR metabolomics,X23408.Triglycerides in VLDL,EGLN1,Egl nine homolog 1,40341,0.107356545099512,0.00506993822431723,0.0974194661798501,0.117293624019174,3.66429700501223e-98
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINH1,Serpin H1,37714,0.260592300580308,0.0123122151805872,0.236460358826357,0.284724242334259,8.19469656470401e-98
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS9,Galectin-9,40350,0.0649031019105496,0.00307417452573719,0.0588777198401047,0.0709284839809945,1.33336516332802e-97
NMR metabolomics,X23408.Triglycerides in VLDL,LEP,Leptin,40359,0.128520619057692,0.00610336023570032,0.116558032995719,0.140483205119664,4.12442427328373e-97
NMR metabolomics,X23408.Triglycerides in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.171337184123458,0.00814408097529914,0.155374785411872,0.187299582835044,6.16716459261378e-97
NMR metabolomics,X23408.Triglycerides in VLDL,SLA2,Src-like-adapter 2,37959,0.207622173655631,0.0098638653625314,0.188288997545069,0.226955349766192,8.35118882416144e-97
NMR metabolomics,X23408.Triglycerides in VLDL,DOK2,Docking protein 2,40359,0.241923058364785,0.0115294748898434,0.219325287580692,0.264520829148878,1.89328567847642e-96
NMR metabolomics,X23408.Triglycerides in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.165131936293914,0.00787152002581583,0.149703757043315,0.180560115544513,2.23540360624665e-96
NMR metabolomics,X23408.Triglycerides in VLDL,SRPK2,SRSF protein kinase 2,40341,0.165275001245006,0.00790072205710374,0.149789586013083,0.18076041647693,7.02947919674092e-96
NMR metabolomics,X23408.Triglycerides in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.214094681542317,0.0102377039839738,0.194028781733729,0.234160581350906,1.33235354970932e-95
NMR metabolomics,X23408.Triglycerides in VLDL,PHACTR2,Phosphatase and actin regulator 2,37959,0.228050978226267,0.0109083951484149,0.206670523735374,0.249431432717161,1.52804201234702e-95
NMR metabolomics,X23408.Triglycerides in VLDL,YOD1,Ubiquitin thioesterase OTU1,37562,0.127012745418886,0.00608030920937299,0.115095339368515,0.138930151469257,2.38175160570951e-95
NMR metabolomics,X23408.Triglycerides in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.100146178352754,0.00480573837500607,0.0907269311377424,0.109565425567766,3.85515005772415e-95
NMR metabolomics,X23408.Triglycerides in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0788879154413432,0.00378961641432464,0.0714602672692669,0.0863155636134195,9.43294119807603e-95
NMR metabolomics,X23408.Triglycerides in VLDL,OGFR,Opioid growth factor receptor,40305,0.0656076825929079,0.00315583841806498,0.0594222392935006,0.0717931258923153,9.89617896519037e-95
NMR metabolomics,X23408.Triglycerides in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.138555282943271,0.00666491967489786,0.125492040380472,0.151618525506071,1.04997223785435e-94
NMR metabolomics,X23408.Triglycerides in VLDL,NCK2,Cytoplasmic protein NCK2,40422,0.207546848335775,0.00998605031994986,0.187974189708673,0.227119506962877,1.08629409997809e-94
NMR metabolomics,X23408.Triglycerides in VLDL,TCTN3,Tectonic-3,37990,0.0580892008568447,0.00279240977361413,0.052616077700561,0.0635623240131284,1.2325165407289e-94
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD2,Protein disulfide isomerase CRELD2,40396,0.102787673112364,0.00495063438117743,0.0930844297252567,0.112490916499472,1.67562505714073e-94
NMR metabolomics,X23408.Triglycerides in VLDL,CCL5,C-C motif chemokine 5,40403,0.198236319784288,0.00957423665102958,0.17947081594827,0.217001823620306,5.34073245421936e-94
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFA,Vascular endothelial growth factor A,40456,0.116188594191267,0.00561669352238003,0.105179874887402,0.127197313495132,7.74966472057232e-94
NMR metabolomics,X23408.Triglycerides in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0830448347960293,0.0040145147742633,0.0751763858384732,0.0909132837535854,7.77763811203047e-94
NMR metabolomics,X23408.Triglycerides in VLDL,CCN2,CCN family member 2,40358,0.113742984965074,0.00550668116817314,0.102949889875455,0.124536080054694,1.46894366164653e-93
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.166389118358916,0.0080481071442907,0.150614828356106,0.182163408361726,1.6438765387778e-93
NMR metabolomics,X23408.Triglycerides in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.225788141312433,0.0109282332451916,0.204368804151857,0.247207478473008,2.17905506255986e-93
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD5,Programmed cell death protein 5,40471,0.115036791226177,0.00557877476135773,0.104102392693916,0.125971189758438,2.91671171367069e-93
NMR metabolomics,X23408.Triglycerides in VLDL,PLSCR3,Phospholipid scramblase 3,37919,0.118189653027526,0.00573057210062506,0.106957731710301,0.129421574344751,4.51787638128614e-93
NMR metabolomics,X23408.Triglycerides in VLDL,BID,BH3-interacting domain death agonist,40341,0.131819630661423,0.00640238169748909,0.119270962534344,0.144368298788501,5.59664433440476e-93
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0408599949271176,0.00198454096987817,0.0369702946261563,0.0447496952280788,5.83033096483975e-93
NMR metabolomics,X23408.Triglycerides in VLDL,STAT5B,Signal transducer and activator of transcription 5B,40305,0.270725933461429,0.0131538264699642,0.244944433580299,0.296507433342559,6.56364051629246e-93
NMR metabolomics,X23408.Triglycerides in VLDL,PSIP1,PC4 and SFRS1-interacting protein,40341,0.121983449706716,0.00592830287889464,0.110363976064082,0.133602923349349,7.22400156694944e-93
NMR metabolomics,X23408.Triglycerides in VLDL,TPD52L2,Tumor protein D54,37671,0.212694878044136,0.0103309621033997,0.192446192321473,0.2329435637668,9.92777216464583e-93
NMR metabolomics,X23408.Triglycerides in VLDL,HEXIM1,Protein HEXIM1,40341,0.160247890590819,0.00780970989128077,0.144940859203909,0.17555492197773,2.28497827406259e-92
NMR metabolomics,X23408.Triglycerides in VLDL,LAT,Linker for activation of T-cells family member 1,40516,0.148179553884588,0.00722408117592831,0.134020354779768,0.162338752989407,2.56131510758766e-92
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO1,Forkhead box protein O1,40341,0.165797779224704,0.00808763342185216,0.149946017717874,0.181649540731534,3.33624140054247e-92
NMR metabolomics,X23408.Triglycerides in VLDL,TOP2B,DNA topoisomerase 2-beta,37598,0.155287709299785,0.00756598557138422,0.140458377579872,0.170117041019698,3.60211229176206e-92
NMR metabolomics,X23408.Triglycerides in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.185441458991369,0.00905115905355952,0.167701187246392,0.203181730736345,4.32571697649011e-92
NMR metabolomics,X23408.Triglycerides in VLDL,CMIP,C-Maf-inducing protein,37900,0.16106845580797,0.00785821333628234,0.145666357668857,0.176470553947083,5.80755566433053e-92
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.186580061622785,0.00911462334304424,0.168715399870419,0.204444723375152,5.97916060751256e-92
NMR metabolomics,X23408.Triglycerides in VLDL,NFX1,Transcriptional repressor NF-X1,37562,0.132582966809261,0.0064977720309161,0.119847333628665,0.145318599989856,3.95426067694291e-91
NMR metabolomics,X23408.Triglycerides in VLDL,CD99L2,CD99 antigen-like protein 2,40332,0.0463574411773968,0.0022762916532516,0.0418959095370236,0.0508189728177699,4.92570367205357e-91
NMR metabolomics,X23408.Triglycerides in VLDL,SH2D1A,SH2 domain-containing protein 1A,40341,0.106520810829558,0.00524250742844952,0.0962454962697966,0.116796125389319,1.24315496762501e-90
NMR metabolomics,X23408.Triglycerides in VLDL,MINK1,Misshapen-like kinase 1,37942,0.18029227293246,0.0088689941104651,0.162909044475948,0.197675501388971,1.62837597948243e-90
NMR metabolomics,X23408.Triglycerides in VLDL,DCXR,L-xylulose reductase,40411,0.101465238234645,0.00499952283649716,0.091666173475111,0.11126430299418,1.96667948828982e-90
NMR metabolomics,X23408.Triglycerides in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.149849252769168,0.00737576782662031,0.135392747828992,0.164305757709344,2.04012284780788e-90
NMR metabolomics,X23408.Triglycerides in VLDL,SIAE,Sialate O-acetylesterase,40374,0.0908395526781038,0.00448025635305465,0.0820582502261167,0.0996208551300909,2.90972145294989e-90
NMR metabolomics,X23408.Triglycerides in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.108322346097303,0.00535089297894449,0.0978345958585718,0.118810096336034,5.33214733844542e-90
NMR metabolomics,X23408.Triglycerides in VLDL,SELE,E-selectin,40536,0.0967354851299501,0.00478269969441423,0.0873613937288982,0.106109576531002,7.5381579346967e-90
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.210920898901282,0.0104209288841005,0.190495878288445,0.231345919514119,9.37575339586672e-90
NMR metabolomics,X23408.Triglycerides in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.133524312065375,0.00660469437686214,0.120579111086725,0.146469513044025,1.47671265711676e-89
NMR metabolomics,X23408.Triglycerides in VLDL,PGF,Placenta growth factor,40516,0.050733899983873,0.00251308116924903,0.0458082608921449,0.0556595390756011,1.60820106598273e-89
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE1,Plasminogen activator inhibitor 1,40536,0.130374268730977,0.00646074588552323,0.117711206795352,0.143037330666603,1.89528200004437e-89
NMR metabolomics,X23408.Triglycerides in VLDL,USO1,General vesicular transport factor p115,40305,0.174727973414186,0.00866183591436213,0.157750775022037,0.191705171806336,2.26924028249434e-89
NMR metabolomics,X23408.Triglycerides in VLDL,FUOM,Fucose mutarotase,37671,0.120568523129475,0.00597601780825825,0.108855528225289,0.132281518033661,3.52490205631066e-89
NMR metabolomics,X23408.Triglycerides in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.18568018242688,0.00923232952366745,0.167584816560492,0.203775548293268,7.74562473973379e-89
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0843623099917855,0.00420070346569238,0.0761289311990285,0.0925956887845426,1.36993692125163e-88
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFC,Platelet-derived growth factor C,39980,0.0570784640109852,0.00284271399193547,0.0515067445867917,0.0626501834351788,1.49845053679842e-88
NMR metabolomics,X23408.Triglycerides in VLDL,CEP43,Centrosomal protein 43,39934,0.132042379986974,0.00660280211730555,0.119100887837055,0.144983872136893,7.36432090540396e-88
NMR metabolomics,X23408.Triglycerides in VLDL,STK11,Serine/threonine-protein kinase STK11,40042,0.139548422817393,0.00698063025641139,0.125866387514827,0.15323045811996,8.31875563634081e-88
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL10,C-X-C motif chemokine 10,40422,0.128585576816623,0.00646142053477672,0.115921192568461,0.141249961064785,4.56436825332259e-87
NMR metabolomics,X23408.Triglycerides in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.212642819527125,0.010687068900649,0.191696164481853,0.233589474572397,5.04041782814469e-87
NMR metabolomics,X23408.Triglycerides in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.122195422752282,0.00614138081084634,0.110158316363023,0.134232529141541,5.22461977607201e-87
NMR metabolomics,X23408.Triglycerides in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.17314256480924,0.00870867660195594,0.156073558669407,0.190211570949074,1.02847027262897e-86
NMR metabolomics,X23408.Triglycerides in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.137301370007065,0.00692665633268855,0.123725123594995,0.150877616419134,3.24678116713005e-86
NMR metabolomics,X23408.Triglycerides in VLDL,CTSZ,Cathepsin Z,40345,0.0587995914964304,0.00297418183849101,0.0529701950929881,0.0646289878998728,5.81096442582285e-86
NMR metabolomics,X23408.Triglycerides in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.145779568616968,0.00737122358247102,0.131331970395325,0.160227166838611,7.68924735460567e-86
NMR metabolomics,X23408.Triglycerides in VLDL,CCL7,C-C motif chemokine 7,40341,0.115014414147503,0.00582246114933325,0.10360239029481,0.126426438000197,7.98911596360158e-86
NMR metabolomics,X23408.Triglycerides in VLDL,VNN1,Pantetheinase,37987,0.137117524710846,0.00693413191818943,0.123526626151195,0.150708423270497,8.03234145120685e-86
NMR metabolomics,X23408.Triglycerides in VLDL,CDC27,Cell division cycle protein 27 homolog,39980,0.115119446008161,0.00582820244899459,0.103696169208132,0.126542722808191,8.67141912558942e-86
NMR metabolomics,X23408.Triglycerides in VLDL,RABEP1,Rab GTPase-binding effector protein 1,37671,0.149418785071738,0.00756545625746972,0.134590490807097,0.164247079336379,1.36477771960857e-85
NMR metabolomics,X23408.Triglycerides in VLDL,GIGYF2,GRB10-interacting GYF protein 2,37959,0.143320938524243,0.00726436997533521,0.129082773372586,0.1575591036759,1.92015225983788e-85
NMR metabolomics,X23408.Triglycerides in VLDL,FKBPL,FK506-binding protein-like,37901,0.111217825778735,0.0056490260119937,0.100145734795228,0.122289916762243,4.29708198257378e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.193495149262321,0.00983056951114085,0.174227233020485,0.212763065504157,4.72601453431705e-85
NMR metabolomics,X23408.Triglycerides in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.121710535019598,0.00618553822758533,0.109586880093531,0.133834189945665,5.24696212651536e-85
NMR metabolomics,X23408.Triglycerides in VLDL,DNMBP,Dynamin-binding protein,40228,0.115925737053476,0.00589752454081515,0.104366588953478,0.127484885153473,5.26168032941549e-85
NMR metabolomics,X23408.Triglycerides in VLDL,HAO1,Hydroxyacid oxidase 1,40489,0.245371387701934,0.0124870181639231,0.220896832100645,0.269845943303224,5.74977645664615e-85
NMR metabolomics,X23408.Triglycerides in VLDL,EREG,Proepiregulin,40192,0.150978843864104,0.00768511484560879,0.13591601876671,0.166041668961497,6.54272881426892e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CD36,Platelet glycoprotein 4,37598,0.0836560873221775,0.00425321277142622,0.0753197902901822,0.0919923843541729,6.58805864769433e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.194911997412368,0.00992878142434115,0.175451585820659,0.214372409004077,8.38187819575337e-85
NMR metabolomics,X23408.Triglycerides in VLDL,SNCG,Gamma-synuclein,40228,0.125725680396122,0.00640833850634823,0.113165336923679,0.138286023868564,1.08384486008544e-84
NMR metabolomics,X23408.Triglycerides in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.14279262321128,0.00728032993343712,0.128523176541743,0.157062069880816,1.19341165791366e-84
NMR metabolomics,X23408.Triglycerides in VLDL,PCBP2,Poly(rC)-binding protein 2,37959,0.13508179296522,0.00688084118077945,0.121595344250892,0.148568241679548,1.25128194769686e-84
NMR metabolomics,X23408.Triglycerides in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.114838564368527,0.00585916826504414,0.103354594569041,0.126322534168014,1.63153956227186e-84
NMR metabolomics,X23408.Triglycerides in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.171947803481235,0.00878801838985271,0.154723287437124,0.189172319525347,3.07154860873342e-84
NMR metabolomics,X23408.Triglycerides in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.209187253598181,0.0106956255142346,0.188223827590281,0.230150679606081,3.42640450048323e-84
NMR metabolomics,X23408.Triglycerides in VLDL,ISM1,Isthmin-1,40341,0.0729499534666055,0.00373454301930862,0.0656302491487606,0.0802696577844504,5.46231643563519e-84
NMR metabolomics,X23408.Triglycerides in VLDL,PON2,Serum paraoxonase/arylesterase 2,40042,0.0642748859293843,0.00329261567027186,0.0578213592156514,0.0707284126431171,7.29731821389033e-84
NMR metabolomics,X23408.Triglycerides in VLDL,THPO,Thrombopoietin,40042,0.0713544689707724,0.00365689328812027,0.0641869581260566,0.0785219798154881,8.600187783754e-84
NMR metabolomics,X23408.Triglycerides in VLDL,CCL13,C-C motif chemokine 13,40483,0.130087353411001,0.00667411889912584,0.117006080368714,0.143168626453287,1.20695396231481e-83
NMR metabolomics,X23408.Triglycerides in VLDL,DAG1,Dystroglycan,40422,0.0882403689658494,0.00453199727026858,0.079357654316123,0.0971230836155759,1.80960287905578e-83
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.157905144013315,0.00810265374141484,0.142023942680142,0.173786345346488,2.09083711994658e-83
NMR metabolomics,X23408.Triglycerides in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.116451917790452,0.00597752065560957,0.104735977305457,0.128167858275447,2.18980581172042e-83
NMR metabolomics,X23408.Triglycerides in VLDL,A1BG,Alpha-1B-glycoprotein,38013,0.032699702745585,0.00167911077092984,0.0294086456345625,0.0359907598566074,2.47821177756485e-83
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RB,Interleukin-17 receptor B,40126,-0.0995267365473617,0.00511916894660734,-0.109560307682712,-0.0894931654120113,3.24908264642581e-83
NMR metabolomics,X23408.Triglycerides in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0498129891539958,0.0025621694804825,0.0447911369722501,0.0548348413357415,3.34246656897627e-83
NMR metabolomics,X23408.Triglycerides in VLDL,AP3B1,AP-3 complex subunit beta-1,37901,0.142386955416855,0.0073180050697032,0.128043665480236,0.156730245353473,3.51893120686087e-83
NMR metabolomics,X23408.Triglycerides in VLDL,AHSG,Alpha-2-HS-glycoprotein,37987,0.0504170423079028,0.0025934289512126,0.0453339215635261,0.0555001630522795,4.75828067472695e-83
NMR metabolomics,X23408.Triglycerides in VLDL,METAP2,Methionine aminopeptidase 2,40453,0.109238698683589,0.00563840579856186,0.0981874233184077,0.12028997404877,1.12965775082329e-82
NMR metabolomics,X23408.Triglycerides in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.10740065005154,0.00553740137598873,0.0965473433546019,0.118253956748478,1.12995690826402e-82
NMR metabolomics,X23408.Triglycerides in VLDL,CNST,Consortin,40359,0.199610022979952,0.0103238066430987,0.179375361959479,0.219844684000426,2.40174265167016e-82
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0381651820291184,0.00197726203869202,0.034289748433282,0.0420406156249547,4.50818706250783e-82
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1A,Meprin A subunit alpha,37901,0.126784790402371,0.00656307882203234,0.113921155911188,0.139648424893554,4.89237908221478e-82
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFB,Platelet-derived growth factor subunit B,40422,0.158300347779725,0.00820668653854184,0.142215242164183,0.174385453395267,5.65814535722391e-82
NMR metabolomics,X23408.Triglycerides in VLDL,ARSB,Arylsulfatase B,40305,0.101211848695578,0.00525626176399117,0.0909095756381549,0.111514121753,1.0861166897458e-81
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD1,COMM domain-containing protein 1,37628,0.113872917044403,0.00590687407139675,0.102295443864466,0.125450390224341,1.09083297135987e-81
NMR metabolomics,X23408.Triglycerides in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.124622520742358,0.00647462026415733,0.11193226502461,0.137312776460106,1.31433941257896e-81
NMR metabolomics,X23408.Triglycerides in VLDL,HYOU1,Hypoxia up-regulated protein 1,40536,0.039857451638258,0.00207412486508712,0.0357921669026872,0.0439227363738287,2.19660116955995e-81
NMR metabolomics,X23408.Triglycerides in VLDL,PSME1,Proteasome activator complex subunit 1,40216,0.069368769692146,0.00361041828048658,0.0622923498623923,0.0764451895218998,2.42453149827326e-81
NMR metabolomics,X23408.Triglycerides in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.129329562913885,0.00672354965893117,0.116151405582379,0.14250772024539,2.4333766374224e-81
NMR metabolomics,X23408.Triglycerides in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.131361156973006,0.0068321396900536,0.117970163180501,0.144752150765511,2.82371317370144e-81
NMR metabolomics,X23408.Triglycerides in VLDL,CDH2,Cadherin-2,40359,0.0648337302338222,0.00337632124234226,0.0582161405988314,0.071451319868813,2.92758329265842e-81
NMR metabolomics,X23408.Triglycerides in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.112199773349203,0.00586017410536546,0.100713832102687,0.123685714595719,8.46576948966958e-81
NMR metabolomics,X23408.Triglycerides in VLDL,MTDH,Protein LYRIC,37598,0.168110313284491,0.00877550198711926,0.150910329389737,0.185310297179244,1.06488009257728e-80
NMR metabolomics,X23408.Triglycerides in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0809712924769763,0.00423277500675493,0.0726750534637366,0.0892675314902159,1.15894956481616e-80
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB3,Plexin-B3,40310,0.0854537311934539,0.004469747992799,0.0766930251275678,0.09421443725934,1.43293202402563e-80
NMR metabolomics,X23408.Triglycerides in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0967029978775154,0.0050573231489561,0.0867906445055614,0.106615351249469,2.01808137930648e-80
NMR metabolomics,X23408.Triglycerides in VLDL,SYTL4,Synaptotagmin-like protein 4,37990,0.134121771095419,0.00702226586231988,0.120358130005272,0.147885412185566,2.88799397534938e-80
NMR metabolomics,X23408.Triglycerides in VLDL,QDPR,Dihydropteridine reductase,40290,0.080046186518973,0.00419559764968741,0.0718228151255856,0.0882695579123603,3.01670925921561e-80
NMR metabolomics,X23408.Triglycerides in VLDL,NIT2,Omega-amidase NIT2,37936,0.138362399617182,0.00724647831644354,0.124159302116953,0.152565497117411,3.24607493749819e-80
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM5,Tripartite motif-containing protein 5,40341,0.155509958090805,0.00815472718342511,0.139526692811292,0.171493223370318,3.52633248475942e-80
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH2,Neutral ceramidase,40228,0.0959505800931696,0.00503363272459498,0.0860846599529635,0.105816500233376,4.15650393113288e-80
NMR metabolomics,X23408.Triglycerides in VLDL,MYDGF,Myeloid-derived growth factor,37990,0.183618634539578,0.00962822051216321,0.164747322335739,0.202489946743418,4.92310441721367e-80
NMR metabolomics,X23408.Triglycerides in VLDL,MASP1,Mannan-binding lectin serine protease 1,40192,0.0434191167906408,0.00227928926244742,0.0389517098362439,0.0478865237450378,5.27258450968192e-80
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.166499250087601,0.00873204210917753,0.149384447553613,0.183614052621589,5.2755885607485e-80
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA5,Integrin alpha-5,40332,0.0454706931898074,0.00238719028118605,0.0407918002386827,0.050149586140932,5.33794352298328e-80
NMR metabolomics,X23408.Triglycerides in VLDL,STAMBP,STAM-binding protein,40192,0.117853912895996,0.00619657087034182,0.105708633990126,0.129999191801866,9.26166086601035e-80
NMR metabolomics,X23408.Triglycerides in VLDL,SEC31A,Protein transport protein Sec31A,37628,0.139732440511437,0.00734379159098335,0.12533860899311,0.154126272029765,1.18150828442293e-79
NMR metabolomics,X23408.Triglycerides in VLDL,WASHC3,WASH complex subunit 3,37942,0.13685069433523,0.00719428503379222,0.122749895668998,0.150951493001463,1.22910269521513e-79
NMR metabolomics,X23408.Triglycerides in VLDL,CMC1,COX assembly mitochondrial protein homolog,37990,0.16397475551315,0.00863349036868582,0.147053114390526,0.180896396635774,2.09869574092608e-79
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP8,Vesicle-associated membrane protein 8,37598,0.161617619608869,0.00850858425864307,0.144940794461929,0.178294444755809,2.17658272370957e-79
NMR metabolomics,X23408.Triglycerides in VLDL,TAX1BP1,Tax1-binding protein 1,37942,0.116852401988698,0.00615367252356281,0.104791203842515,0.128913600134881,2.27149403231335e-79
NMR metabolomics,X23408.Triglycerides in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.167404709034279,0.00882897655836058,0.150099914979893,0.184709503088666,2.79962257960728e-79
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF3,Immunoglobulin superfamily member 3,40305,0.0626637024095945,0.00330655926667395,0.0561828462469136,0.0691445585722754,3.22988376418212e-79
NMR metabolomics,X23408.Triglycerides in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0925946675948899,0.00488631026250187,0.0830174994803862,0.102171835709394,4.73268718781105e-79
NMR metabolomics,X23408.Triglycerides in VLDL,SRP14,Signal recognition particle 14 kDa protein,40305,0.107242978396107,0.00568122589277951,0.0961077756462595,0.118378181145955,1.28858639949914e-78
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.18880773675355,0.0100039113179048,0.169200070570457,0.208415402936643,1.35130016203654e-78
NMR metabolomics,X23408.Triglycerides in VLDL,PXN,Paxillin,39961,0.0936301973929705,0.00496101108884757,0.0839066156588292,0.103353779127112,1.4363146161211e-78
NMR metabolomics,X23408.Triglycerides in VLDL,MITD1,MIT domain-containing protein 1,40228,0.174067411197045,0.00925860778757487,0.155920539933398,0.192214282460692,5.31018735772796e-78
NMR metabolomics,X23408.Triglycerides in VLDL,BAG4,BAG family molecular chaperone regulator 4,37598,0.0877822429904259,0.0046689962421672,0.0786310103557782,0.0969334756250736,7.73845913409947e-78
NMR metabolomics,X23408.Triglycerides in VLDL,AMN,Protein amnionless,40044,0.0857515382870464,0.0045685742718466,0.0767971327142271,0.0947059438598657,9.56974996238361e-78
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0501332186886115,0.00267125928032733,0.0448975504991699,0.055368886878053,9.59513326510075e-78
NMR metabolomics,X23408.Triglycerides in VLDL,AZI2,5-azacytidine-induced protein 2,37959,0.0992796924117896,0.00528775741493274,0.0889156878785214,0.109643696945058,1.16646273039419e-77
NMR metabolomics,X23408.Triglycerides in VLDL,RGCC,Regulator of cell cycle RGCC,37959,0.13486876045437,0.00718756194258476,0.120781139046904,0.148956381861836,1.43250320961581e-77
NMR metabolomics,X23408.Triglycerides in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0887481959139139,0.00473617798103647,0.0794652870710824,0.0980311047567454,1.64612500639427e-77
NMR metabolomics,X23408.Triglycerides in VLDL,CST3,Cystatin-C,40372,0.0503400680283117,0.00268973673992464,0.0450681840180594,0.055611952038564,2.49370357756826e-77
NMR metabolomics,X23408.Triglycerides in VLDL,CIRBP,Cold-inducible RNA-binding protein,37901,0.170919889995322,0.00914258614260321,0.15300042115582,0.188839358834824,5.13996737506082e-77
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.117753138826556,0.00630254941001533,0.105400141982926,0.130106135670186,6.28228273616747e-77
NMR metabolomics,X23408.Triglycerides in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0883335924581325,0.00473921411674848,0.0790447327893055,0.0976224521269595,1.51193252372595e-76
NMR metabolomics,X23408.Triglycerides in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.10387159537857,0.0055851792013934,0.0929246441438393,0.114818546613301,2.14881278191607e-76
NMR metabolomics,X23408.Triglycerides in VLDL,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0354468572040876,0.00190471784568788,0.0317136102265393,0.0391801041816358,2.39748426171332e-76
NMR metabolomics,X23408.Triglycerides in VLDL,GIT1,ARF GTPase-activating protein GIT1,37598,0.174531861162446,0.00938292992927107,0.156141318501075,0.192922403823818,2.99351421255203e-76
NMR metabolomics,X23408.Triglycerides in VLDL,DLK1,Protein delta homolog 1,40536,0.0944209773362408,0.00508273986453883,0.0844588072017447,0.104383147470737,3.10497798864705e-76
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE4,Ribonuclease 4,37575,0.0487936904096046,0.00262530870808051,0.0436480853417668,0.0539392954774423,3.95456243614089e-76
NMR metabolomics,X23408.Triglycerides in VLDL,TBCC,Tubulin-specific chaperone C,40228,0.144496399445015,0.00778759427497905,0.129232714666056,0.159760084223974,4.81129438392056e-76
NMR metabolomics,X23408.Triglycerides in VLDL,DTNB,Dystrobrevin beta,37878,0.0744103302530219,0.00400768441550237,0.0665552687986372,0.0822653917074065,5.31014784408923e-76
NMR metabolomics,X23408.Triglycerides in VLDL,NT5E,5'-nucleotidase,40411,0.102885944266511,0.00554786132763874,0.0920121360643394,0.113759752468683,5.60451252750044e-76
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA1,GDNF family receptor alpha-1,40453,0.0495175034857876,0.00267035987117844,0.0442835981382778,0.0547514088332973,5.76083350007455e-76
NMR metabolomics,X23408.Triglycerides in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.104392559597673,0.00562460622431528,0.0933683313980154,0.115416787797331,6.22872191413561e-76
NMR metabolomics,X23408.Triglycerides in VLDL,CD5,T-cell surface glycoprotein CD5,40470,0.0594000455733689,0.00320562500858388,0.0531170205565445,0.0656830705901933,7.34318951432396e-76
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.159023244272506,0.00857868283341013,0.142209025919022,0.17583746262599,9.09920441864397e-76
NMR metabolomics,X23408.Triglycerides in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.050789031299808,0.00274294880365645,0.0454128516446414,0.0561652109549747,9.35637014847587e-76
NMR metabolomics,X23408.Triglycerides in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.17835603217465,0.00963274577274472,0.15947585046007,0.19723621388923,9.67202991065107e-76
NMR metabolomics,X23408.Triglycerides in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.188994410624831,0.0101998960554544,0.16900261435614,0.208986206893521,1.08339997380085e-75
NMR metabolomics,X23408.Triglycerides in VLDL,SH2B3,SH2B adapter protein 3,39980,0.172802052757783,0.00936477527617401,0.154447093216482,0.191157012299084,3.17715079903134e-75
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0554466763020914,0.00300576995252123,0.0495553671951498,0.061337985409033,4.86324780269027e-75
NMR metabolomics,X23408.Triglycerides in VLDL,BRAP,BRCA1-associated protein,37778,0.193814747216069,0.010508190232457,0.173218694360454,0.214410800071685,4.97440509347579e-75
NMR metabolomics,X23408.Triglycerides in VLDL,LYN,Tyrosine-protein kinase Lyn,40305,0.147728839536337,0.00803826828973712,0.131973833688453,0.163483845384222,1.16980473701075e-74
NMR metabolomics,X23408.Triglycerides in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.133107755071134,0.00725351807140511,0.11889085965118,0.147324650491088,1.92297953560427e-74
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT5,ADP-sugar pyrophosphatase,40332,0.0917061754014712,0.00500685867097497,0.0818927324063603,0.101519618396582,3.56984499808589e-74
NMR metabolomics,X23408.Triglycerides in VLDL,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0823623411517957,0.00449827902954797,0.0735457142538817,0.0911789680497097,5.46924140107164e-74
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP45,Rho GTPase-activating protein 45,37671,0.14460951054132,0.00790099613374064,0.129123558119189,0.160095462963452,6.42875792595763e-74
NMR metabolomics,X23408.Triglycerides in VLDL,DDHD2,Phospholipase DDHD2,37959,0.116304021316706,0.00635609697072441,0.103846071254086,0.128761971379325,6.68825469568258e-74
NMR metabolomics,X23408.Triglycerides in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.13921228886895,0.00761008024458148,0.124296531589571,0.15412804614833,7.29919882895721e-74
NMR metabolomics,X23408.Triglycerides in VLDL,SNX15,Sorting nexin-15,37671,0.0952115591421388,0.00520610321733543,0.0850075968361613,0.105415521448116,8.29531291412613e-74
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0563667961274621,0.00309007016971157,0.0503102585948274,0.0624233336600968,1.37580950200066e-73
NMR metabolomics,X23408.Triglycerides in VLDL,GAS6,Growth arrest-specific protein 6,40429,-0.0449504525250137,0.00246588278033763,-0.0497835827744755,-0.0401173222755519,1.6889433985463e-73
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0519756798575889,0.00285321691247858,0.0463833747091308,0.0575679850060469,2.12117022104682e-73
NMR metabolomics,X23408.Triglycerides in VLDL,NSFL1C,NSFL1 cofactor p47,40471,0.116447620650592,0.00639618854082195,0.103911091110581,0.128984150190603,2.54561608787865e-73
NMR metabolomics,X23408.Triglycerides in VLDL,OGA,Protein O-GlcNAcase,37901,0.122791996414819,0.00674072080681646,0.109580183633459,0.136003809196179,2.89836486843743e-73
NMR metabolomics,X23408.Triglycerides in VLDL,CRKL,Crk-like protein,40374,0.185838307388642,0.0102120140377713,0.16582275987461,0.205853854902673,2.95547158092832e-73
NMR metabolomics,X23408.Triglycerides in VLDL,CPB1,Carboxypeptidase B,40536,0.0982914862890742,0.00540451288223081,0.0876986410399018,0.108884331538247,3.54228389629674e-73
NMR metabolomics,X23408.Triglycerides in VLDL,TDRKH,Tudor and KH domain-containing protein,39961,0.148426400033497,0.00816033252906341,0.132432148276533,0.164420651790461,3.64586875771353e-73
NMR metabolomics,X23408.Triglycerides in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.110314068947092,0.00608090577350324,0.0983954936310259,0.122232644263159,8.52200427604946e-73
NMR metabolomics,X23408.Triglycerides in VLDL,STAT2,Signal transducer and activator of transcription 2,37598,0.133932697746535,0.00737896678842301,0.119469922841226,0.148395472651844,9.79155819177411e-73
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.055510598250173,0.0030600227390106,0.0495129536817122,0.0615082428186338,1.11148297302088e-72
NMR metabolomics,X23408.Triglycerides in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.187567567277736,0.0103485145302358,0.167284478798474,0.207850655756998,1.460319195157e-72
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0924728700650458,0.00510198442621266,0.082472980589669,0.102472759540423,1.47756965333931e-72
NMR metabolomics,X23408.Triglycerides in VLDL,DGKA,Diacylglycerol kinase alpha,37598,0.0944988729699588,0.00521824438226222,0.0842711139807249,0.104726631959193,2.03662579968907e-72
NMR metabolomics,X23408.Triglycerides in VLDL,RAB27B,Ras-related protein Rab-27B,37990,0.142392277876993,0.00787661073992111,0.126954120826748,0.157830434927239,3.35720015957229e-72
NMR metabolomics,X23408.Triglycerides in VLDL,LEFTY2,Left-right determination factor 2,40453,0.0899847677978419,0.00498318113504518,0.0802177327731534,0.0997518028225305,3.57031700801942e-72
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS8,Galectin-8,40471,0.104663993699103,0.00579613386587045,0.0933035713219968,0.116024416076209,3.57283295228351e-72
NMR metabolomics,X23408.Triglycerides in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.148273577154992,0.00821423424768024,0.132173678029538,0.164373476280445,5.69810744676764e-72
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0478540022914006,0.00265450736915905,0.0426511678478489,0.0530568367349523,6.19770889106018e-72
NMR metabolomics,X23408.Triglycerides in VLDL,FAM13A,Protein FAM13A,37901,0.116693334206078,0.00646808454324289,0.104015888501322,0.129370779910835,6.47911415956402e-72
NMR metabolomics,X23408.Triglycerides in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.200109055645769,0.0111099676440021,0.178333519063525,0.221884592228013,8.19661393347938e-72
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.138393864263247,0.0076840250700865,0.123333175125877,0.153454553400616,8.323182710509e-72
NMR metabolomics,X23408.Triglycerides in VLDL,C1S,Complement C1s subcomponent,38013,0.0358769167242445,0.00199246691815671,0.0319716815646573,0.0397821518838316,1.18568537757941e-71
NMR metabolomics,X23408.Triglycerides in VLDL,MPHOSPH8,M-phase phosphoprotein 8,40042,0.128970376029047,0.00717061102836804,0.114915978413445,0.143024773644648,1.32726056576187e-71
NMR metabolomics,X23408.Triglycerides in VLDL,CCL11,Eotaxin,40516,0.0649222868742675,0.00361098203259287,0.0578447620903855,0.0719998116581496,1.42711831028429e-71
NMR metabolomics,X23408.Triglycerides in VLDL,ESM1,Endothelial cell-specific molecule 1,40357,-0.0583968218841595,0.00325093295327281,-0.0647686504725742,-0.0520249932957447,1.9246051971806e-71
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.046527413006926,0.00259306325290212,0.0414450090312379,0.0516098169826142,2.76591663073682e-71
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS2,Trypsin-2,40403,0.0863324291931291,0.00481374621451688,0.076897486612676,0.0957673717735822,3.16979730524886e-71
NMR metabolomics,X23408.Triglycerides in VLDL,ELOA,Elongin-A,40305,0.0876043899550724,0.00488977186699656,0.0780204370957591,0.0971883428143856,4.4520337625567e-71
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0633677709581329,0.00353680229220133,0.0564356384654183,0.0702999034508475,5.79376096183049e-71
NMR metabolomics,X23408.Triglycerides in VLDL,COCH,Cochlin,37990,0.0801673191722446,0.00447983168953827,0.0713868490607496,0.0889477892837396,8.39628561233514e-71
NMR metabolomics,X23408.Triglycerides in VLDL,HS1BP3,HCLS1-binding protein 3,37628,0.153861711233624,0.00859689618726214,0.137011794706591,0.170711627760658,8.50017246981652e-71
NMR metabolomics,X23408.Triglycerides in VLDL,TALDO1,Transaldolase,37966,0.0767171742087384,0.00428937633188761,0.0683099965982387,0.0851243518192381,9.99791807544097e-71
NMR metabolomics,X23408.Triglycerides in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0926025150876416,0.00519345304647003,0.0824233471165603,0.102781683058723,1.98363061608866e-70
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.151661878135895,0.00850473959482865,0.13499258853003,0.168331167741759,2.01205445954742e-70
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D23,TBC1 domain family member 23,40305,0.153158868511,0.00859156446036245,0.13631940216869,0.169998334853311,2.13411450251862e-70
NMR metabolomics,X23408.Triglycerides in VLDL,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0971114160308026,0.00544301625481902,0.0864431041713573,0.107779727890248,2.26684497816405e-70
NMR metabolomics,X23408.Triglycerides in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.106214234512839,0.00595824704197634,0.0945360703105651,0.117892398715112,2.96771493711118e-70
NMR metabolomics,X23408.Triglycerides in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0759562220183206,0.00427086448487917,0.0675853276279575,0.0843271164086838,4.59234301975182e-70
NMR metabolomics,X23408.Triglycerides in VLDL,GOLM2,Protein GOLM2,40471,0.0382386848556384,0.00215394165566454,0.0340169592105359,0.0424604105007409,7.63557023099483e-70
NMR metabolomics,X23408.Triglycerides in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0598358022943853,0.00336988334607386,0.0532308309360805,0.0664407736526901,1.0367113013017e-69
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.132611289180536,0.0074821867516204,0.11794620314736,0.147276375213712,1.30290692388124e-69
NMR metabolomics,X23408.Triglycerides in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0855685441524108,0.00482942395028703,0.0761028732098482,0.0950342150949734,1.41463447743035e-69
NMR metabolomics,X23408.Triglycerides in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.123685560501927,0.00698187602968378,0.110001083483747,0.137370037520107,1.48124977487224e-69
NMR metabolomics,X23408.Triglycerides in VLDL,GIP,Gastric inhibitory polypeptide,37628,0.088149626479946,0.00497234174447737,0.0784038366607703,0.0978954162991216,1.63240446642917e-69
NMR metabolomics,X23408.Triglycerides in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.148265293774981,0.008373767653951,0.131852709173237,0.164677878376725,1.74456984782107e-69
NMR metabolomics,X23408.Triglycerides in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.1528578278918,0.00863478354890745,0.135933652135941,0.169782003647659,2.54851536872859e-69
NMR metabolomics,X23408.Triglycerides in VLDL,OCLN,Occludin,37959,0.0741845124970377,0.00419255026493801,0.0659671139777592,0.0824019110163162,2.79862442033772e-69
NMR metabolomics,X23408.Triglycerides in VLDL,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0828085204988975,0.00469283060614111,0.0736105725108609,0.0920064684869341,5.17996120483954e-69
NMR metabolomics,X23408.Triglycerides in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.121831645584325,0.00691567718202757,0.108276918307551,0.135386372861099,8.26099262412158e-69
NMR metabolomics,X23408.Triglycerides in VLDL,DBNL,Drebrin-like protein,40422,0.155920340018478,0.00885662537971828,0.13856135427423,0.173279325762726,1.00587196354231e-68
NMR metabolomics,X23408.Triglycerides in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0806903349276103,0.00458391989943749,0.0717058519247128,0.0896748179305078,1.37277326951292e-68
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX2,Heme oxygenase 2,39961,0.0769826552871081,0.0043804943805383,0.0683968863012531,0.0855684242729632,1.79596420933183e-68
NMR metabolomics,X23408.Triglycerides in VLDL,GZMA,Granzyme A,40516,0.0593327299261907,0.00337899764935399,0.0527098945334569,0.0659555653189245,2.19798975616245e-68
NMR metabolomics,X23408.Triglycerides in VLDL,GASK1A,Golgi-associated kinase 1A,37562,0.0732529006782582,0.0041674335872875,0.0650847308471747,0.0814210705093417,2.22666462289472e-68
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R2,Protein phosphatase inhibitor 2,40359,0.133489883634325,0.00760659524397581,0.118580956956132,0.148398810312517,2.6520312721946e-68
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM5,PDZ and LIM domain protein 5,37959,0.199840120855033,0.0113783182956137,0.17753861699563,0.222141624714436,2.70030750248629e-68
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.112670886201525,0.00643499260038833,0.100058300704764,0.125283471698286,5.24690559982261e-68
NMR metabolomics,X23408.Triglycerides in VLDL,OPHN1,Oligophrenin-1,37942,0.179743493019389,0.0102747622719697,0.159604958966329,0.19988202707245,8.94723212859001e-68
NMR metabolomics,X23408.Triglycerides in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.247817240993203,0.0141672659593107,0.220049399712954,0.275585082273452,9.21969765058226e-68
NMR metabolomics,X23408.Triglycerides in VLDL,TWF2,Twinfilin-2,37998,0.138976552058219,0.00796688836643535,0.123361450860006,0.154591653256432,2.07253400524947e-67
NMR metabolomics,X23408.Triglycerides in VLDL,GTPBP2,GTP-binding protein 2,37572,0.133805697727703,0.00767674117986521,0.118759285015167,0.148852110440239,2.79194463933679e-67
NMR metabolomics,X23408.Triglycerides in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.201392041090393,0.0115729964545339,0.178708968039506,0.224075114141279,3.50897182723612e-67
NMR metabolomics,X23408.Triglycerides in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.076490153499687,0.00439672480824875,0.0678725728755195,0.0851077341238546,3.64067320836917e-67
NMR metabolomics,X23408.Triglycerides in VLDL,CASC3,Protein CASC3,37572,0.0685951794718126,0.00393958128832009,0.0608736001467053,0.07631675879692,3.81126224197572e-67
NMR metabolomics,X23408.Triglycerides in VLDL,GOLGA3,Golgin subfamily A member 3,37959,0.131031271828564,0.00753478847934876,0.11626308640904,0.145799457248087,5.24954937615541e-67
NMR metabolomics,X23408.Triglycerides in VLDL,FUS,RNA-binding protein FUS,39960,0.0656782965136274,0.00378674727508735,0.0582562718544562,0.0731003211727986,9.29201465306389e-67
NMR metabolomics,X23408.Triglycerides in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.058783321425199,0.00339025889395834,0.0521384139930406,0.0654282288573573,9.82384996276994e-67
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL3,C-X-C motif chemokine 3,40350,0.154912715553761,0.0089370614403251,0.137396075130724,0.172429355976798,1.07345082031782e-66
NMR metabolomics,X23408.Triglycerides in VLDL,SPART,Spartin,37671,0.128748432849933,0.00742138821032227,0.114202511957701,0.143294353742165,1.11079975318436e-66
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS1,Galectin-1,40359,0.0559483974373775,0.00322990241532415,0.0496177887033422,0.0622790061714128,1.31035094857825e-66
NMR metabolomics,X23408.Triglycerides in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.113865059686149,0.00656918242060533,0.100989462141762,0.126740657230535,1.38543754735177e-66
NMR metabolomics,X23408.Triglycerides in VLDL,RTBDN,Retbindin,40305,0.0486081211252507,0.0028079368637484,0.0431045648723038,0.0541116773781976,1.5891314483961e-66
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.137255492500689,0.0079263254959952,0.121719894528539,0.15279109047284,1.85698270193764e-66
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD1,Sushi domain-containing protein 1,40042,0.0817975974026213,0.00472934526138281,0.072528080690311,0.0910671141149316,2.10826967269158e-66
NMR metabolomics,X23408.Triglycerides in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0641658675007236,0.00371141216997426,0.056891499647574,0.0714402353538731,2.96768576758232e-66
NMR metabolomics,X23408.Triglycerides in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.162603701297699,0.00942178811028899,-0.181070405993866,-0.144136996601533,3.87955558598763e-66
NMR metabolomics,X23408.Triglycerides in VLDL,IST1,IST1 homolog,37812,0.16624071057304,0.00962661053010398,0.147372553934037,0.185108867212044,4.20559265267784e-66
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.139019387357893,0.00805786471943473,0.123225972507801,0.154812802207985,4.26908578342156e-66
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP1A,Charged multivesicular body protein 1a,40228,0.131457118645945,0.00762690097817803,0.116508392728716,0.146405844563174,5.72904669993372e-66
NMR metabolomics,X23408.Triglycerides in VLDL,CPA1,Carboxypeptidase A1,40536,0.0945944604729029,0.00549459778502233,0.0838250488142591,0.105363872131547,7.84580592201144e-66
NMR metabolomics,X23408.Triglycerides in VLDL,RWDD1,RWD domain-containing protein 1,40471,0.106489736237362,0.0061861981548181,0.0943647878539182,0.118614684620805,8.13568852141757e-66
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP3,Metalloproteinase inhibitor 3,40422,0.217747276639034,0.0126653063995829,0.192923276095851,0.242571277182216,1.17931738477257e-65
NMR metabolomics,X23408.Triglycerides in VLDL,NIT1,Deaminated glutathione amidase,37628,0.0821230167866796,0.00477367482508885,0.0727666141295054,0.0914794194438537,1.30386171793479e-65
NMR metabolomics,X23408.Triglycerides in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0525645457507395,0.0030594999438836,0.0465679258607276,0.0585611656407513,1.43699605164044e-65
NMR metabolomics,X23408.Triglycerides in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.111208416233451,0.0064698381647815,0.0985275334304788,0.123889299036422,1.65836867762108e-65
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR2,GMP reductase 2,37671,0.112091281597273,0.00652301408552361,0.0993061739896471,0.1248763892049,1.79753027585273e-65
NMR metabolomics,X23408.Triglycerides in VLDL,F13B,Coagulation factor XIII B chain,37934,0.0426373864336865,0.00248201097905301,0.0377726449147426,0.0475021279526304,1.90818044832256e-65
NMR metabolomics,X23408.Triglycerides in VLDL,ICA1,Islet cell autoantigen 1,40044,0.130575145611058,0.00761650508774968,0.115646795639069,0.145503495583048,2.77608336394914e-65
NMR metabolomics,X23408.Triglycerides in VLDL,PLG,Plasminogen,37705,0.0369797546307694,0.00215611784221106,0.0327537636600358,0.0412057456015031,3.11573398636889e-65
NMR metabolomics,X23408.Triglycerides in VLDL,APOD,Apolipoprotein D,37345,-0.0734842574597113,0.00428613321756994,-0.0818850785661484,-0.0650834363532743,3.62988630842608e-65
NMR metabolomics,X23408.Triglycerides in VLDL,DOK1,Docking protein 1,37942,0.224394674913998,0.0131118983784049,0.198695354092324,0.250093995735671,5.670770810864e-65
NMR metabolomics,X23408.Triglycerides in VLDL,C3,Complement C3,37360,0.0773784053572859,0.00452659248600211,0.0685062840847218,0.08625052662985,8.45655759606787e-65
NMR metabolomics,X23408.Triglycerides in VLDL,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0545044377560764,0.00319394215515235,0.0482443111319778,0.060764564380175,1.01476704761948e-64
NMR metabolomics,X23408.Triglycerides in VLDL,MAVS,Mitochondrial antiviral-signaling protein,39980,0.152006342319454,0.00890923839060441,0.134544235073869,0.169468449565038,1.11198959310872e-64
NMR metabolomics,X23408.Triglycerides in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.128302003669282,0.00752548093672186,0.113552061033307,0.143051946305257,1.37512692261584e-64
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF2,TNF receptor-associated factor 2,40341,0.116429071765638,0.00683539110676575,0.103031705196377,0.129826438334899,1.73755485266457e-64
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH1A1,Retinal dehydrogenase 1,40332,0.0864072064723609,0.00507527173326911,0.0764596738751534,0.0963547390695683,1.9930929724631e-64
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.086377303336492,0.00507520702618525,0.0764298975651689,0.0963247091078151,2.25761008244831e-64
NMR metabolomics,X23408.Triglycerides in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0924352316857823,0.00543952256143011,0.0817737674653793,0.103096695906185,3.39861090180344e-64
NMR metabolomics,X23408.Triglycerides in VLDL,STIP1,Stress-induced-phosphoprotein 1,40307,0.106789555603178,0.00629092040684382,0.0944593516057646,0.119119759600592,4.61161692911822e-64
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.042126303315508,0.00248823475583945,0.0372493631940626,0.0470032434369533,9.6189800881912e-64
NMR metabolomics,X23408.Triglycerides in VLDL,IFNLR1,Interferon lambda receptor 1,40341,0.0608327754793749,0.00359368459460777,0.0537891536739436,0.0678763972848061,1.01698436553165e-63
NMR metabolomics,X23408.Triglycerides in VLDL,CD69,Early activation antigen CD69,40288,0.142759832306541,0.00844356464299976,0.126210445606262,0.159309219006821,1.42935770354803e-63
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR,GMP reductase 1,40516,0.0827318978064651,0.00490239462868118,0.07312320433425,0.0923405912786802,2.38086319537027e-63
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.144829337929636,0.00858583749566627,0.12800109643813,0.161657579421142,2.73819317411958e-63
NMR metabolomics,X23408.Triglycerides in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0935657041436472,0.0055435377413644,0.082700370170573,0.104431038116721,2.90546504391342e-63
NMR metabolomics,X23408.Triglycerides in VLDL,NUB1,NEDD8 ultimate buster 1,40341,0.135129565239801,0.00801759227046079,0.119415084389698,0.150844046089905,3.46116714250446e-63
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY4,Protein canopy homolog 4,40305,0.120737770357825,0.00717518243161769,0.106674412791854,0.134801127923796,5.43391173151306e-63
NMR metabolomics,X23408.Triglycerides in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.137949259199192,0.00822769021684738,0.121822986374171,0.154075532024213,1.5228036009678e-62
NMR metabolomics,X23408.Triglycerides in VLDL,AMOT,Angiomotin,37671,0.067347795855599,0.00401708537389633,0.0594743085227622,0.0752212831884358,1.92928492870632e-62
NMR metabolomics,X23408.Triglycerides in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0418626175750415,0.00249925381109936,0.0369640801052868,0.0467611550447963,2.49358456881791e-62
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.11577075749086,0.0069196641810725,0.102208215695958,0.129333299285762,3.44989297084831e-62
NMR metabolomics,X23408.Triglycerides in VLDL,DFFA,DNA fragmentation factor subunit alpha,40516,0.1089287297137,0.00652254688890996,0.0961445378114363,0.121712921615963,4.35010230216998e-62
NMR metabolomics,X23408.Triglycerides in VLDL,UBXN1,UBX domain-containing protein 1,37671,0.111150771376873,0.0066512117388103,0.098114396368805,0.124187146384941,4.6884309064858e-62
NMR metabolomics,X23408.Triglycerides in VLDL,RILPL2,RILP-like protein 2,37990,0.156282118738577,0.00935917962879641,0.137938126666136,0.174626110811018,5.61803996113097e-62
NMR metabolomics,X23408.Triglycerides in VLDL,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0518181738408978,0.00311003943781511,0.0457224965427802,0.0579138511390154,8.36165765337924e-62
NMR metabolomics,X23408.Triglycerides in VLDL,ST13,Hsc70-interacting protein,37671,0.0914517158434167,0.00548493461819751,0.0807012439917496,0.102202187695084,8.75990790840211e-62
NMR metabolomics,X23408.Triglycerides in VLDL,FGF19,Fibroblast growth factor 19,40422,0.122535103087017,0.00736219201894579,0.108105206729883,0.13696499944415,1.10941813212248e-61
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R2,Interleukin-1 receptor type 2,40330,0.031179530257378,0.00187640839745124,0.0275017697983735,0.0348572907163824,1.74616125615411e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CCL3,C-C motif chemokine 3,40341,0.0981537509223169,0.00591197274138662,0.0865662843491991,0.109741217495435,2.19686310204091e-61
NMR metabolomics,X23408.Triglycerides in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.108874036994895,0.00656047059477207,0.0960155146291418,0.121732559360648,3.15906010322255e-61
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0915170504299115,0.00552871808762201,0.0806807629781723,0.102353337881651,4.97790361775502e-61
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.166207373620753,0.0100437352116499,0.14652165260592,0.185893094635587,5.32776785400645e-61
NMR metabolomics,X23408.Triglycerides in VLDL,MAX,Protein max,39961,0.166151913724579,0.0100411406280164,0.146471278093667,0.185832549355491,5.59428496221226e-61
NMR metabolomics,X23408.Triglycerides in VLDL,RBM17,Splicing factor 45,37959,0.121480365190862,0.00734632365763064,0.107081570821906,0.135879159559818,7.9656491944523e-61
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.133695661364766,0.00808759335508339,0.117843978388803,0.14954734434073,8.93635373794222e-61
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.113110538874111,0.00684897487060057,0.0996865481277334,0.126534529620488,9.14788263687596e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.128085668205315,0.00774976820450456,0.112896122524486,0.143275213886144,9.48834564996069e-61
NMR metabolomics,X23408.Triglycerides in VLDL,RFC4,Replication factor C subunit 4,37900,0.0326582146217469,0.00197695284812128,0.0287833870394292,0.0365330422040646,1.05198842212612e-60
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0752707648384789,0.00455945163558485,0.0663342396327326,0.0842072900442252,1.2450987066214e-60
NMR metabolomics,X23408.Triglycerides in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0954076358147665,0.00578476046233941,0.0840695053085812,0.106745766320952,1.34422092325805e-60
NMR metabolomics,X23408.Triglycerides in VLDL,SPRY2,Protein sprouty homolog 2,40044,0.145903792964234,0.00885277798486954,0.12855234811389,0.163255237814578,1.62852266479147e-60
NMR metabolomics,X23408.Triglycerides in VLDL,CRADD,Death domain-containing protein CRADD,40192,0.121263819466551,0.00735899980717236,0.106840179844493,0.135687459088608,1.68661246628405e-60
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GLB2,Endophilin-B2,37942,0.106291581252998,0.00644690763002241,0.0936556422981539,0.118927520207842,1.76839988322798e-60
NMR metabolomics,X23408.Triglycerides in VLDL,SDC4,Syndecan-4,40359,0.0715888403852205,0.00434660931782765,0.0630694861222783,0.0801081946481627,1.90576809146783e-60
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.123099766703632,0.0074677711476201,0.108462935254297,0.137736598152967,1.9194517106175e-60
NMR metabolomics,X23408.Triglycerides in VLDL,PALM2,Paralemmin-2,37942,0.0586557210144262,0.0035588634685973,0.0516803486159755,0.0656310934128769,1.93751939867934e-60
NMR metabolomics,X23408.Triglycerides in VLDL,SPARC,SPARC,40411,0.111780844468457,0.00680229139215528,0.0984483533398325,0.125113335597081,3.47467107098516e-60
NMR metabolomics,X23408.Triglycerides in VLDL,TP53,Cellular tumor antigen p53,39980,0.0679631599390227,0.00414172096182514,0.0598453868538454,0.0760809330242,5.23911808607614e-60
NMR metabolomics,X23408.Triglycerides in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0909412763108858,0.00553972683335345,0.080083411717513,0.101799140904259,5.77879951553887e-60
NMR metabolomics,X23408.Triglycerides in VLDL,IL18,Interleukin-18,40292,0.0746053121009167,0.00455232484415643,0.0656827554063701,0.0835278687954634,7.19532902283426e-60
NMR metabolomics,X23408.Triglycerides in VLDL,PPBP,Platelet basic protein,37934,0.132417981320578,0.0080742366937873,0.116592477400755,0.148243485240401,7.25027854277688e-60
NMR metabolomics,X23408.Triglycerides in VLDL,CETN3,Centrin-3,37901,0.121010681223209,0.00738779229346027,0.106530608328027,0.135490754118391,1.00824461711693e-59
NMR metabolomics,X23408.Triglycerides in VLDL,YJU2,Splicing factor YJU2,37900,0.0504273402264541,0.00308164235898507,0.0443873212028434,0.0564673592500648,1.30546227775729e-59
NMR metabolomics,X23408.Triglycerides in VLDL,PF4,Platelet factor 4,37934,0.153055248332312,0.00936030161672988,0.134709057163522,0.171401439501103,1.58501611109648e-59
NMR metabolomics,X23408.Triglycerides in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.121609672011722,0.00744713467126265,0.107013288056048,0.136206055967397,1.85045105504465e-59
NMR metabolomics,X23408.Triglycerides in VLDL,APPL2,DCC-interacting protein 13-beta,37671,0.175543879502807,0.0107472555918829,0.154479258542716,0.196608500462897,2.16193862053956e-59
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA11,Annexin A11,40312,0.105545828851814,0.00647051394817877,0.0928636215133834,0.118228036190244,2.47288600629694e-59
NMR metabolomics,X23408.Triglycerides in VLDL,LPP,Lipoma-preferred partner,37562,0.105268966568539,0.0064627566243436,0.0926019635848254,0.117935969552252,4.52010461406582e-59
NMR metabolomics,X23408.Triglycerides in VLDL,NUDC,Nuclear migration protein nudC,40516,0.0988881072910684,0.00607771346815233,0.0869757888934898,0.110800425688647,4.73157682862189e-59
NMR metabolomics,X23408.Triglycerides in VLDL,KIFBP,KIF-binding protein,40305,0.128668883644595,0.00790941529951813,0.11316642965754,0.144171337631651,5.02039664797347e-59
NMR metabolomics,X23408.Triglycerides in VLDL,RRAS,Ras-related protein R-Ras,37572,0.204351166494721,0.0125532614821075,0.17974677398979,0.228955558999652,5.28524988627624e-59
NMR metabolomics,X23408.Triglycerides in VLDL,DLG4,Disks large homolog 4,37942,0.109827520529544,0.00675051577100341,0.0965965096183772,0.123058531440711,5.91077362909442e-59
NMR metabolomics,X23408.Triglycerides in VLDL,GHRL,Appetite-regulating hormone,40359,0.123211031565797,0.00757893698706125,0.108356315071157,0.138065748060437,5.94699261686393e-59
NMR metabolomics,X23408.Triglycerides in VLDL,FMNL1,Formin-like protein 1,39961,0.0936648419945957,0.00576324529583589,0.0823688812147573,0.104960802774434,6.61791682715482e-59
NMR metabolomics,X23408.Triglycerides in VLDL,ESYT2,Extended synaptotagmin-2,37942,0.127663786290276,0.00785451149740086,0.11226894375537,0.143058628825181,7.62887863452631e-59
NMR metabolomics,X23408.Triglycerides in VLDL,PENK,Proenkephalin-A,37671,0.0482946363734887,0.00297137081069784,0.042470749584521,0.0541185231624565,7.86053857621955e-59
NMR metabolomics,X23408.Triglycerides in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0541985585557889,0.00334312545486017,0.0476460326642629,0.0607510844473148,1.21606500781292e-58
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD6B,Deubiquitinase OTUD6B,37901,0.0919269090460138,0.0056670707390658,0.0808194503974449,0.103034367694583,1.28390695958842e-58
NMR metabolomics,X23408.Triglycerides in VLDL,ATOX1,Copper transport protein ATOX1,40411,0.111715382394151,0.00689360457255351,0.0982039174319459,0.125226847356356,1.35019659861845e-58
NMR metabolomics,X23408.Triglycerides in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.087274212798781,0.0053906413903675,0.0767085556736607,0.0978398699239013,1.74818949198267e-58
NMR metabolomics,X23408.Triglycerides in VLDL,YWHAQ,14-3-3 protein theta,37671,0.115124032673327,0.0071056868985264,0.101196886352215,0.129051178994439,1.79326425811681e-58
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.150522745854422,0.00930850463557803,0.132278076768689,0.168767414940155,2.87466958120336e-58
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2,Microtubule-associated protein 2,37942,0.0713927287243973,0.00441581193626906,0.06273773732931,0.0800477201194847,3.01213358909365e-58
NMR metabolomics,X23408.Triglycerides in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.149487382968304,0.00925956700789996,0.13133863163282,0.167636134303788,3.62615704771468e-58
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.171382645898079,0.0106224328411631,0.1505626775294,0.192202614266759,4.23493499502292e-58
NMR metabolomics,X23408.Triglycerides in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.131190616170804,0.00813129041185813,0.115253286963562,0.147127945378046,4.36173328581819e-58
NMR metabolomics,X23408.Triglycerides in VLDL,GPI,Glucose-6-phosphate isomerase,37987,0.0727542220185686,0.00450685039228721,0.0639207952496857,0.0815876487874516,4.42888316734246e-58
NMR metabolomics,X23408.Triglycerides in VLDL,JAM3,Junctional adhesion molecule C,37671,0.0787299517868156,0.0048776666489205,0.0691697251549314,0.0882901784186997,4.71794428916955e-58
NMR metabolomics,X23408.Triglycerides in VLDL,PKD2,Polycystin-2,37562,0.0926095578356654,0.00573774907908245,0.0813635696406638,0.103855546030667,4.80610295948882e-58
NMR metabolomics,X23408.Triglycerides in VLDL,UMOD,Uromodulin,40502,-0.0839936628711564,0.00521310675699438,-0.0942113521148654,-0.0737759736274474,5.98194234063014e-58
NMR metabolomics,X23408.Triglycerides in VLDL,CACYBP,Calcyclin-binding protein,37642,0.158841157623782,0.00987238908163495,0.139491275023777,0.178191040223786,1.07047191172068e-57
NMR metabolomics,X23408.Triglycerides in VLDL,GRAP2,GRB2-related adapter protein 2,40359,0.195677070140374,0.012189482502272,0.171785684435921,0.219568455844827,1.54326622885069e-57
NMR metabolomics,X23408.Triglycerides in VLDL,TMED8,Protein TMED8,37901,0.15867099941285,0.0098846112866078,0.139297161291099,0.178044837534601,1.88034883586265e-57
NMR metabolomics,X23408.Triglycerides in VLDL,CD207,C-type lectin domain family 4 member K,40029,0.0592464161236172,0.00369419547800297,0.0520057929867314,0.066487039260503,2.00805114203621e-57
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFA,Platelet-derived growth factor subunit A,40536,0.110726601095171,0.00690988631400454,0.0971832239197219,0.12426997827062,2.39962370285379e-57
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3B,Protein FAM3B,40305,0.0555498912243926,0.00346971544680927,0.0487492489486464,0.0623505335001387,3.0606780539103e-57
NMR metabolomics,X23408.Triglycerides in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.15213481314454,0.00950283846401905,0.133509249755063,0.170760376534018,3.15263468324424e-57
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.119699147401598,0.00748976861017027,0.105019200925665,0.134379093877532,4.88609289676473e-57
NMR metabolomics,X23408.Triglycerides in VLDL,STX4,Syntaxin-4,40305,0.0916395095347624,0.00573807200879399,0.0803928883975262,0.102886130671999,5.71160686520397e-57
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.104066348100211,0.00651558397608378,0.0912958035070869,0.116836892693335,6.89333429581664e-57
NMR metabolomics,X23408.Triglycerides in VLDL,IGBP1,Immunoglobulin-binding protein 1,37959,0.0941693608839492,0.0058994111328066,0.0826065150636482,0.10573220670425,7.7121076940388e-57
NMR metabolomics,X23408.Triglycerides in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0835010628862422,0.00523590763500838,0.0732386839216257,0.0937634418508586,8.16497635680255e-57
NMR metabolomics,X23408.Triglycerides in VLDL,CD226,CD226 antigen,37598,0.0644099074587412,0.00403721750706818,0.0564969611448876,0.0723228537725948,9.10016207018926e-57
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB2,BPI fold-containing family B member 2,37951,0.104348374866037,0.00654141234347377,0.0915272066728281,0.117169543059245,9.1081916835204e-57
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.075691415211316,0.00475233265710058,0.0663768432033988,0.0850059872192331,1.37199799825413e-56
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0493764873332843,0.00310501518470842,0.0432906575712558,0.0554623170953128,1.67331332774664e-56
NMR metabolomics,X23408.Triglycerides in VLDL,MENT,Protein MENT,37671,-0.0332281085699468,0.00208972195463118,-0.0373239636010239,-0.0291322535388696,2.08603583562537e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SCG2,Secretogranin-2,40392,0.0493019372185869,0.00310358223266016,0.043218916042573,0.0553849583946008,2.16267964976038e-56
NMR metabolomics,X23408.Triglycerides in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.11694134520729,0.0073614589999798,0.10251288556733,0.131369804847251,2.21557225888247e-56
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0685726430040257,0.00432930247717031,0.0600872101487719,0.0770580758592795,4.51502897952232e-56
NMR metabolomics,X23408.Triglycerides in VLDL,PRKG1,cGMP-dependent protein kinase 1,37671,0.19093806678112,0.0120626070427221,0.167295356977384,0.214580776584855,6.40857184884046e-56
NMR metabolomics,X23408.Triglycerides in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.101298351621571,0.00640498099344183,0.0887445888744253,0.113852114368717,7.86323708237713e-56
NMR metabolomics,X23408.Triglycerides in VLDL,GYS1,"Glycogen [starch] synthase, muscle",40042,0.141422449328055,0.00895003210121104,0.123880386409682,0.158964512246429,8.25575503482811e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4D,Semaphorin-4D,40471,0.0453377586210207,0.00287016317445195,0.0397122387990948,0.0509632784429465,8.70760092161655e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SULT2A1,Bile salt sulfotransferase,40341,0.0808385074088687,0.00512074229098713,0.070801852518534,0.0908751622992035,1.02185583231217e-55
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE2,Glia-derived nexin,37990,0.0976909173871033,0.00618479704602857,0.0855687151768873,0.109813119597319,1.05245200346397e-55
NMR metabolomics,X23408.Triglycerides in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.157870588653765,0.0100055199601096,0.13825976953195,0.17748140777558,1.40857758250997e-55
NMR metabolomics,X23408.Triglycerides in VLDL,TBCB,Tubulin-folding cofactor B,40228,0.153173411701436,0.00972205936806064,0.134118175340038,0.172228648062835,1.674446273474e-55
NMR metabolomics,X23408.Triglycerides in VLDL,EGF,Pro-epidermal growth factor,40324,0.155653895217691,0.00988042496175005,0.136288262292661,0.175019528142722,1.70347830156839e-55
NMR metabolomics,X23408.Triglycerides in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0875811722719395,0.00556090535813016,0.0766817977700044,0.0984805467738746,1.86587197114188e-55
NMR metabolomics,X23408.Triglycerides in VLDL,STX8,Syntaxin-8,40341,0.0738812831328285,0.0046972892438205,0.0646745962149403,0.0830879700507167,2.52164944515197e-55
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0827080202811462,0.00526141004099206,0.0723956566008018,0.0930203839614906,2.94171418680864e-55
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RB,Interleukin-10 receptor subunit beta,40422,0.043043095578433,0.00273919113076965,0.0376742809621244,0.0484119101947415,3.15350467990311e-55
NMR metabolomics,X23408.Triglycerides in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0684120829006094,0.00435387279911371,-0.0769456735868723,-0.0598784922143465,3.18728519352167e-55
NMR metabolomics,X23408.Triglycerides in VLDL,AP2B1,AP-2 complex subunit beta,37572,0.0741049520136817,0.00471280188547063,0.0648678603181593,0.0833420437092041,3.29366586632782e-55
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0641538207056925,0.00408679020481019,0.0561437119042646,0.0721639295071205,4.12783637480932e-55
NMR metabolomics,X23408.Triglycerides in VLDL,IMPACT,Protein IMPACT,37942,0.0860807667993877,0.00548221358564162,0.0753356281715301,0.0968259054272453,4.51276028098568e-55
NMR metabolomics,X23408.Triglycerides in VLDL,ADD1,Alpha-adducin,37671,0.106220222821035,0.00676490010419209,0.0929610186168186,0.119479427025252,4.6277303352843e-55
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0971870725320522,0.00619088803015681,0.0850529319929448,0.10932121307116,4.77426543010445e-55
NMR metabolomics,X23408.Triglycerides in VLDL,GLOD4,Glyoxalase domain-containing protein 4,40328,0.054689775252417,0.00349634190829863,0.0478369451121517,0.0615426053926823,9.65105799286252e-55
NMR metabolomics,X23408.Triglycerides in VLDL,NEXN,Nexilin,37987,0.102928164879628,0.00657807220928265,0.0900351433494337,0.115821186409822,1.0466457759483e-54
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0824940926943412,0.00528449432537695,0.0721364838166024,0.09285170157208,1.57714069806229e-54
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL2,Interleukin-1 receptor-like 2,40044,0.060840966902068,0.00389885756977683,0.0531992060653055,0.0684827277388306,1.74313103418955e-54
NMR metabolomics,X23408.Triglycerides in VLDL,STK24,Serine/threonine-protein kinase 24,39961,0.0927079417212069,0.00594366882622744,0.0810583508218011,0.104357532620613,1.95330278562556e-54
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0681076450254459,0.00436640344693503,-0.0766657957814385,-0.0595494942694532,2.2336198056832e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SLMAP,Sarcolemmal membrane-associated protein,37901,0.124947939719883,0.00801929022692073,0.109230130875118,0.140665748564647,2.92282579202343e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB2,Lysosome membrane protein 2,40011,0.0462267636473369,0.00297014120127239,0.0404052868928431,0.0520482404018308,3.28464552529631e-54
NMR metabolomics,X23408.Triglycerides in VLDL,TP53I3,Quinone oxidoreductase PIG3,37419,0.0805733585823828,0.00517294698974678,0.0704343824824791,0.0907123346822865,3.2857143068767e-54
NMR metabolomics,X23408.Triglycerides in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.128110914723144,0.00823597947285062,0.111968394956357,0.144253434489932,4.32977527419305e-54
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN3,Ataxin-3,37942,0.0934189610736595,0.00600781608798245,0.0816436415412139,0.105194280606105,4.71441193752981e-54
NMR metabolomics,X23408.Triglycerides in VLDL,RASSF2,Ras association domain-containing protein 2,39980,0.0822154490509905,0.00529172537028674,0.0718436673252285,0.0925872307767525,5.00099629172703e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0924410149278848,0.00594701927920802,0.080784857140637,0.104097172715132,5.12076390198415e-54
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0946653999673306,0.00609236014411515,0.0827243740848649,0.106606425849796,5.72037668971264e-54
NMR metabolomics,X23408.Triglycerides in VLDL,BAG6,Large proline-rich protein BAG6,40042,0.0536115098600967,0.0034555011407474,0.0468387276242318,0.0603842920959616,6.96060114754044e-54
NMR metabolomics,X23408.Triglycerides in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0915013568891488,0.00590493946958772,0.0799276755287569,0.103075038249541,9.13359356837513e-54
NMR metabolomics,X23408.Triglycerides in VLDL,GPC5,Glypican-5,40228,0.0834805335841172,0.00538724190591833,0.0729215394485172,0.0940395277197171,9.19513866933952e-54
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0922622720676993,0.00595342389812859,0.0805935612273672,0.103930982908031,1.04504398636162e-53
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.138570644083024,0.00894707672784573,0.121034373696447,0.156106914469602,1.21190800974284e-53
NMR metabolomics,X23408.Triglycerides in VLDL,MMP10,Stromelysin-2,40341,-0.0892312744710176,0.00576736797101397,-0.100535315694205,-0.0779272332478302,1.32396024154775e-53
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT1,Dynein light chain Tctex-type 1,37572,0.120819361196523,0.00780835316249003,0.105514988998042,0.136123733395003,1.56494616577231e-53
NMR metabolomics,X23408.Triglycerides in VLDL,CALCA,Calcitonin,40192,0.0818386172969583,0.00529404277747463,0.071462293453108,0.0922149411408085,1.63206388673128e-53
NMR metabolomics,X23408.Triglycerides in VLDL,CDCP1,CUB domain-containing protein 1,40228,0.0721658337480573,0.00467104180693033,0.0630105918064739,0.0813210756896408,1.86899776427285e-53
NMR metabolomics,X23408.Triglycerides in VLDL,BIN2,Bridging integrator 2,40332,0.13483894179869,0.00873200429554281,0.117724213379427,0.151953670217954,2.09008818799075e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FIS1,Mitochondrial fission 1 protein,40354,0.114663107691954,0.00742679081240274,0.100106597699644,0.129219617684263,2.17890117584537e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FOXJ3,Forkhead box protein J3,37598,0.0649883827531559,0.0042111075427533,0.0567346119693594,0.0732421535369523,2.89405551799475e-53
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0567992322715342,0.00368572124102308,0.049575218639129,0.0640232459039395,3.35374713044695e-53
NMR metabolomics,X23408.Triglycerides in VLDL,LACTB2,Endoribonuclease LACTB2,40359,0.0977868169993788,0.00634936181961001,0.0853420678329432,0.110231566165814,3.8938184998595e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0469015086712397,0.00304576615512933,0.0409318070071863,0.0528712103352932,4.01063428909797e-53
NMR metabolomics,X23408.Triglycerides in VLDL,UROD,Uroporphyrinogen decarboxylase,37671,0.104482931418519,0.00678327633927044,0.0911877097935491,0.117778153043489,4.51248267146868e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.12863361549968,0.00835267765973386,0.112262367286602,0.145004863712758,4.62066237691304e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM24,Transcription intermediary factor 1-alpha,37687,0.095472301785013,0.00619931869584878,0.0833216371411494,0.107622966428877,4.6860788256873e-53
NMR metabolomics,X23408.Triglycerides in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.062693420251185,0.00407314016173256,0.0547100655341892,0.0706767749681808,5.32271469858714e-53
NMR metabolomics,X23408.Triglycerides in VLDL,ERP29,Endoplasmic reticulum resident protein 29,37671,0.175743016667386,0.0114199175148986,0.153359978338184,0.198126054996587,5.56907311611228e-53
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2L,Ataxin-2-like protein,37959,0.0715620119188909,0.00465308641047538,0.0624419625543591,0.0806820612834227,6.3100544547545e-53
NMR metabolomics,X23408.Triglycerides in VLDL,DNM3,Dynamin-3,37959,0.0812093589158942,0.00528720830053899,0.0708464306468378,0.0915722871849506,8.53101410568529e-53
NMR metabolomics,X23408.Triglycerides in VLDL,F2,Prothrombin,38013,0.0217780056081705,0.00141810861706082,0.0189985127187313,0.0245574984976097,8.82647571612516e-53
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.118546818797065,0.00772026966360535,0.103415090256398,0.133678547337731,9.1086175867128e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0931246133279801,0.00606995636121641,0.0812274988599959,0.105021727795964,9.50822580412088e-53
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0693996413697829,0.00452928227334023,0.0605222481140361,0.0782770346255298,1.49392665080762e-52
NMR metabolomics,X23408.Triglycerides in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0999985489660015,0.00653177433704088,0.0871962712654013,0.112800826666602,1.56362874145672e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CASP7,Caspase-7,37942,0.123575623187109,0.00807189021495974,0.107754718365788,0.13939652800843,1.82647659128074e-52
NMR metabolomics,X23408.Triglycerides in VLDL,MGLL,Monoglyceride lipase,40396,0.126791339913566,0.00829937256346814,0.110524569689168,0.143058110137964,2.54577477486672e-52
NMR metabolomics,X23408.Triglycerides in VLDL,RBKS,Ribokinase,39991,0.0730602608483457,0.00478191132477409,0.0636877146517884,0.0824328070449029,2.55395582525134e-52
NMR metabolomics,X23408.Triglycerides in VLDL,MIF,Macrophage migration inhibitory factor,40307,0.10115099389823,0.00663303253039958,0.088150250138647,0.114151737657813,3.88312560781492e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CASP10,Caspase-10,39961,0.105250489923143,0.00690850418923857,0.091709821712235,0.11879115813405,4.93654424512067e-52
NMR metabolomics,X23408.Triglycerides in VLDL,RAB33A,Ras-related protein Rab-33A,37562,0.0980117379783383,0.00642948098613316,0.0854099552455173,0.110613520711159,5.02901774139792e-52
NMR metabolomics,X23408.Triglycerides in VLDL,TMSB10,Thymosin beta-10,40332,0.111107853564262,0.00730734576135881,0.0967854558719984,0.125430251256525,7.59895582211418e-52
NMR metabolomics,X23408.Triglycerides in VLDL,KLK10,Kallikrein-10,40354,0.0574396002894987,0.00378100164992436,0.050028837055647,0.0648503635233505,9.27409252962739e-52
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0845101728738477,0.00556834859421732,0.0735962096291817,0.0954241361185136,1.18090381929325e-51
NMR metabolomics,X23408.Triglycerides in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.08543047299188,0.00563091602420498,0.0743938775844382,0.0964670683993217,1.25314406279741e-51
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT1,Angiopoietin-1,40263,0.123791889901339,0.00816190284293295,0.107794560329191,0.139789219473488,1.34852181037429e-51
NMR metabolomics,X23408.Triglycerides in VLDL,F2R,Proteinase-activated receptor 1,40396,0.083834188790333,0.00552863843681574,0.0729980574541742,0.0946703201264919,1.40969697134301e-51
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB1,Leukocyte elastase inhibitor,40287,0.129802280688522,0.00856181090163485,0.113021131321318,0.146583430055727,1.48325180824679e-51
NMR metabolomics,X23408.Triglycerides in VLDL,APP,Amyloid-beta precursor protein,40309,0.0977784298872654,0.00645023026053662,0.0851359785766137,0.110420881197917,1.51995864609663e-51
NMR metabolomics,X23408.Triglycerides in VLDL,CETN2,Centrin-2,39961,0.0979888041380411,0.00646791056194222,0.0853116994366344,0.110665908839448,1.76971641270245e-51
NMR metabolomics,X23408.Triglycerides in VLDL,F12,Coagulation factor XII,38013,0.0609347446485213,0.00402602654769862,0.053043732615032,0.0688257566820106,2.49042308423097e-51
NMR metabolomics,X23408.Triglycerides in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.145518412769003,0.00961407369293499,0.126674828330851,0.164361997207156,2.54803787402413e-51
NMR metabolomics,X23408.Triglycerides in VLDL,TADA3,Transcriptional adapter 3,37900,0.0567425644959664,0.00375211679871435,0.0493884155704862,0.0640967134214465,3.02110572267553e-51
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.12325963714444,0.00816176798597846,-0.139256702396958,-0.107262571891922,3.54503674552876e-51
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB6,Serpin B6,40433,0.0867196538383062,0.00575021540912578,0.0754492316364197,0.0979900760401927,4.84010467978959e-51
NMR metabolomics,X23408.Triglycerides in VLDL,REEP4,Receptor expression-enhancing protein 4,37959,0.0904088961442532,0.0059931208124795,0.0786623793517933,0.102155412936713,5.25348903103074e-51
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.159738504884159,0.0105975899180243,0.138967228644831,0.180509781123486,5.46537322009778e-51
NMR metabolomics,X23408.Triglycerides in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0671422387153029,0.00445576110372173,0.0584089469520084,0.0758755304785975,6.90935892295506e-51
NMR metabolomics,X23408.Triglycerides in VLDL,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0897120780757285,0.00596133513344241,0.0780278612141813,0.101396294937276,9.253143704696e-51
NMR metabolomics,X23408.Triglycerides in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0682828762788751,0.00454235887180875,0.0593798528901299,0.0771858996676202,9.97802753335134e-51
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3C,Protein FAM3C,40330,0.0428919189666867,0.00285600519683327,0.0372941487808935,0.0484896891524799,1.2434260667644e-50
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK3,NT-3 growth factor receptor,40471,-0.0315598581423687,0.00210170394119643,-0.0356791978671137,-0.0274405184176237,1.26888430812888e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6AP2,Renin receptor,39980,0.0602724949802817,0.00401531397787328,0.05240247958365,0.0681425103769133,1.41505328336594e-50
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINC1,Antithrombin-III,37981,0.0213141958431029,0.00141929627312013,0.0185323751477875,0.0240960165384184,1.44181444754752e-50
NMR metabolomics,X23408.Triglycerides in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.110603656729776,0.00737233944395167,0.0961538714196307,0.125053442039921,1.56361117568527e-50
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF1,Scavenger receptor class F member 1,40536,0.0611333432255173,0.00407573694127917,0.0531448988206102,0.0691217876304245,1.6281633121733e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CTRB1,Chymotrypsinogen B,40332,0.0768570593354033,0.00512717886453892,0.066807788760907,0.0869063299098995,1.88553536834135e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL3,Angiopoietin-related protein 3,40355,0.0523385065080961,0.00349183829172182,0.0454945034563214,0.0591825095598709,1.92051246949592e-50
NMR metabolomics,X23408.Triglycerides in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.0627288448937962,0.00418300659251083,0.054530151972475,0.0709275378151174,1.99408383586016e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.13494107003754,0.00899800668224372,0.117304976940342,0.152577163134738,2.00773564873993e-50
NMR metabolomics,X23408.Triglycerides in VLDL,THTPA,Thiamine-triphosphatase,37884,0.127994536508387,0.00853815834985145,0.111259746142678,0.144729326874095,2.15159215775387e-50
NMR metabolomics,X23408.Triglycerides in VLDL,POSTN,Periostin,37998,-0.0547573711841589,0.00365479972652244,-0.0619207786481429,-0.0475939637201749,2.423550128489e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CD274,Programmed cell death 1 ligand 1,40228,0.0500819132078558,0.00334499222319411,0.0435257284503954,0.0566380979653163,2.4725985688344e-50
NMR metabolomics,X23408.Triglycerides in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.106087852489129,0.00708476007058202,0.0922017227507883,0.11997398222747,2.8085682244832e-50
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH9,Protocadherin-9,37901,0.0488152236412033,0.00326124912016689,0.0424231753656762,0.0552072719167304,3.00368801480945e-50
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA4,Protein disulfide-isomerase A4,37998,0.0872435264823295,0.0058306109512087,0.0758155290179604,0.0986715239466985,3.22451224205811e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.140814929755261,0.00941741608435229,0.122356794229931,0.159273065280592,3.85813645446224e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0557818223427166,0.00373215072527561,0.0484668069211764,0.0630968377642567,4.14398874448492e-50
NMR metabolomics,X23408.Triglycerides in VLDL,JPT2,Jupiter microtubule associated homolog 2,37901,0.126185240442643,0.00845292090541975,0.109617515468021,0.142752965417266,5.44323235612374e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4G,C-type lectin domain family 4 member G,40341,0.0472664258516103,0.00316904645722264,0.0410550947954539,0.0534777569077666,5.73142925444635e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CIAPIN1,Anamorsin,40411,0.0914960472324752,0.00614093270256119,0.0794598191354553,0.103532275329495,7.19810553285243e-50
NMR metabolomics,X23408.Triglycerides in VLDL,MPI,Mannose-6-phosphate isomerase,40305,0.122834012937473,0.00825499408008811,0.1066542245405,0.139013801334445,9.63321163717624e-50
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.130919149550622,0.00879574685353664,0.11367948571769,0.148158813383554,1.05680666700659e-49
NMR metabolomics,X23408.Triglycerides in VLDL,HPSE,Heparanase,37848,0.133169840724824,0.00896370451684804,0.115600979871802,0.150738701577846,1.56309575279111e-49
NMR metabolomics,X23408.Triglycerides in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.134421390968946,0.00905821629727216,0.116667287026292,0.152175494911599,1.73934714574126e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0942003889783156,0.0063493864497317,0.0817555915368415,0.10664518641979,1.82185763266814e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CASP2,Caspase-2,40341,0.0964535339765899,0.00650418299562749,0.0837053353051601,0.10920173264802,2.0220958864025e-49
NMR metabolomics,X23408.Triglycerides in VLDL,APOF,Apolipoprotein F,37987,-0.0345350394715367,0.00232812731092534,-0.0390981690009504,-0.029971909942123,2.16202250972554e-49
NMR metabolomics,X23408.Triglycerides in VLDL,TPP1,Tripeptidyl-peptidase 1,40255,0.0636673394961102,0.00430369090198165,0.0552321053282261,0.0721025736639942,3.43364570500094e-49
NMR metabolomics,X23408.Triglycerides in VLDL,PPP3R1,Calcineurin subunit B type 1,40228,0.0588129996582426,0.00397720471713418,0.0510176784126596,0.0666083209038256,3.76167389750559e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CPA2,Carboxypeptidase A2,40398,0.0912286311465838,0.00617409720114202,0.0791274006323455,0.103329861660822,4.41593484394495e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0292851477372769,0.00198452236227553,-0.0331748115673369,-0.0253954839072168,5.84660464570184e-49
NMR metabolomics,X23408.Triglycerides in VLDL,RILP,Rab-interacting lysosomal protein,40434,0.0855644978686963,0.00580084091928691,0.0741948496668939,0.0969341460704986,6.41779417095013e-49
NMR metabolomics,X23408.Triglycerides in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.153529457544108,0.0104108543949516,0.133124182930002,0.173934732158213,7.73164081819638e-49
NMR metabolomics,X23408.Triglycerides in VLDL,VASP,Vasodilator-stimulated phosphoprotein,37987,0.102559800161455,0.00695480050104404,0.0889283911794085,0.116191209143501,7.73767562391657e-49
NMR metabolomics,X23408.Triglycerides in VLDL,COMT,Catechol O-methyltransferase,39877,0.120682067468076,0.00818972205148417,0.104630212247167,0.136733922688985,8.15225601091072e-49
NMR metabolomics,X23408.Triglycerides in VLDL,MESD,LRP chaperone MESD,40332,0.171677986026558,0.0116527970672638,0.148838503774721,0.194517468278395,8.3375115844249e-49
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.142582208244825,0.00968125063161741,0.123606957006855,0.161557459482795,8.97903524320527e-49
NMR metabolomics,X23408.Triglycerides in VLDL,VSNL1,Visinin-like protein 1,37942,0.0532548256885799,0.00361466570301484,0.0461700809106709,0.060339570466489,9.46530502481329e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0536271314606235,0.00364234990147316,0.046488125653736,0.0607661372675109,9.71577879308245e-49
NMR metabolomics,X23408.Triglycerides in VLDL,KLK13,Kallikrein-13,40032,0.0614821010139741,0.00417664994607779,0.0532958671196616,0.0696683349082866,1.01240515517413e-48
NMR metabolomics,X23408.Triglycerides in VLDL,PARK7,Parkinson disease protein 7,40332,0.0758690518013901,0.00515546001179403,0.0657643501782738,0.0859737534245064,1.0610084035795e-48
NMR metabolomics,X23408.Triglycerides in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.104065931812693,0.00706701931990519,0.0902145739456789,0.117917289679707,1.07012586324323e-48
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0820807893891515,0.00557781594716338,0.0711482701327112,0.0930133086455917,1.08940610295608e-48
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.134188228969971,0.0091343159180343,0.116284969770624,0.152091488169318,1.5502146697165e-48
NMR metabolomics,X23408.Triglycerides in VLDL,EHD3,EH domain-containing protein 3,37628,0.166166523104777,0.0113048986612064,0.144008921728812,0.188324124480741,1.59249730362515e-48
NMR metabolomics,X23408.Triglycerides in VLDL,MICALL2,MICAL-like protein 2,37572,0.0970310985141248,0.00660154523213369,0.0840920698591428,0.109970127169107,1.60752799677386e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0567795061293869,0.00386444149160611,0.049205200805839,0.0643538114529349,1.69295427332902e-48
NMR metabolomics,X23408.Triglycerides in VLDL,DBI,Acyl-CoA-binding protein,40270,0.111492008951318,0.00759902509893256,0.0965979197574103,0.126386098145226,2.03038772876395e-48
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3BP,Galectin-3-binding protein,38013,0.0419138194596004,0.0028564636766505,0.0363151506533654,0.0475124882658353,2.24332050567187e-48
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0863096154637352,0.00588910509333273,0.0747669694808031,0.0978522614466674,2.54156780114384e-48
NMR metabolomics,X23408.Triglycerides in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.106357606240165,0.00725815020346593,0.0921316318413723,0.120583580638959,2.68900528492627e-48
NMR metabolomics,X23408.Triglycerides in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.126854896646368,0.00866013501980458,0.109881032007551,0.143828761285185,3.23646311718338e-48
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0715264839259301,0.00489086725805596,0.0619403841001405,0.0811125837517198,4.58281700290888e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CTF1,Cardiotrophin-1,40042,0.118921107672874,0.0081417846197048,0.102963209818252,0.134879005527495,5.31594120007615e-48
NMR metabolomics,X23408.Triglycerides in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0671110515162898,0.00459568780084142,0.0581035034266406,0.076118599605939,6.22560330462584e-48
NMR metabolomics,X23408.Triglycerides in VLDL,C2,Complement C2,40372,0.0336646860064268,0.00230789339419201,0.0291412149538105,0.0381881570590432,6.9451686339571e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CD22,B-cell receptor CD22,40516,0.0575360388534368,0.00394572920600973,0.0498024096096577,0.0652696680972159,7.40899121345851e-48
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.076737834507895,0.0052599250393898,0.0664283814306909,0.087047287585099,7.74749671595233e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D5,TBC1 domain family member 5,40341,0.109967333402889,0.00754284140697981,0.0951833642452088,0.12475130256057,7.77666674502487e-48
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0833442038926996,0.00571793293020159,0.0721370553495045,0.0945513524358947,8.26730261436771e-48
NMR metabolomics,X23408.Triglycerides in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.129969538813256,0.00891507271325187,0.112495996295283,0.14744308133123,9.05904574147081e-48
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB1,Heat shock protein beta-1,40116,0.0950227193346241,0.00652255592065085,0.0822385097301485,0.1078069289391,9.16989611325623e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0448740917220772,0.00308154999650364,0.0388342537289301,0.0509139297152243,9.96995630824634e-48
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.05133759164088,0.00352414445151871,0.0444302685159033,0.0582449147658567,1.06016111460513e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0404316727192301,0.00277661935388162,0.0349894987856221,0.0458738466528381,1.15445501027577e-47
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0533750375303444,0.00367360390656838,0.0461747738734704,0.0605753011872184,1.58097100964534e-47
NMR metabolomics,X23408.Triglycerides in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.131951114929595,0.00910309779229612,0.114109043256694,0.149793186602495,2.95033776312269e-47
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM106A,Transmembrane protein 106A,37900,0.0978877163573023,0.00675924680458847,0.0846395926203089,0.111135840094296,3.56193245894404e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CTSS,Cathepsin S,37057,0.0344203264382217,0.00237646554374705,0.0297624539724775,0.0390781989039659,3.66481622664665e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0371469071815216,0.00256765171343768,0.0321143098231837,0.0421795045398594,3.8819556701814e-47
NMR metabolomics,X23408.Triglycerides in VLDL,MYO9B,Unconventional myosin-IXb,40044,0.092421009028421,0.00638985954859742,0.07989688431317,0.104945133743672,4.1461485778761e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CCT5,T-complex protein 1 subunit epsilon,39980,0.0633318775241493,0.00437913137402029,0.0547487800310695,0.0719149750172291,4.24837932879419e-47
NMR metabolomics,X23408.Triglycerides in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.13658273363175,0.00944554872631017,0.118069458128182,0.155096009135318,4.85698075907277e-47
NMR metabolomics,X23408.Triglycerides in VLDL,ARSA,Arylsulfatase A,40332,0.062017926602732,0.00429424520096784,0.0536012060088351,0.070434647196629,5.57958541912899e-47
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.103544233565042,0.00716822896725563,0.0894945047892211,0.117593962340863,6.02993179995913e-47
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L1,Bcl-2-like protein 1,37942,0.139057178227916,0.00962767393258099,0.120186937320057,0.157927419135775,6.16898182315844e-47
NMR metabolomics,X23408.Triglycerides in VLDL,NRGN,Neurogranin,37987,0.126142041110572,0.0087349745380329,0.109021491016027,0.143262591205116,6.37233938845975e-47
NMR metabolomics,X23408.Triglycerides in VLDL,FCN1,Ficolin-1,37967,0.078592313473098,0.00544248967246,0.0679250337150764,0.0892595932311196,6.42776144390355e-47
NMR metabolomics,X23408.Triglycerides in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.103138153927329,0.00714256501199776,0.0891387265038139,0.117137581350845,6.47207905740607e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CD244,Natural killer cell receptor 2B4,40516,0.037007070257546,0.00256440135115913,0.0319808436092741,0.0420332969058179,6.48321949998817e-47
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.073978414978553,0.00512819351928628,0.0639271556807519,0.0840296742763541,7.93915744127277e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CASP3,Caspase-3,40536,0.122142268940047,0.00847638270317019,0.105528558841833,0.138755979038261,8.79264299565984e-47
NMR metabolomics,X23408.Triglycerides in VLDL,TSC22D1,TSC22 domain family protein 1,37959,0.0934874703655229,0.00649519647211767,0.0807568852801722,0.106218055450873,1.26065457441949e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CALB2,Calretinin,39961,0.0436734102212637,0.0030358852398784,0.037723075151102,0.0496237452914254,1.26930960780005e-46
NMR metabolomics,X23408.Triglycerides in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.155512530094879,0.0108192113815774,0.134306875786987,0.17671818440277,1.50585851637548e-46
NMR metabolomics,X23408.Triglycerides in VLDL,LAP3,Cytosol aminopeptidase,40044,0.0680060806050803,0.00473471350550555,0.0587260421342894,0.0772861190758712,1.74120059809263e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.13045947274671,0.00908975025692721,0.112643562243133,0.148275383250287,2.01169039776985e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.08997052790774,0.00627079914099875,0.0776797615913824,0.102261294224098,2.42577645595325e-46
NMR metabolomics,X23408.Triglycerides in VLDL,GMFG,Glia maturation factor gamma,37990,0.0992698060508335,0.00691913801320514,0.0857082955449514,0.112831316556716,2.42722843073769e-46
NMR metabolomics,X23408.Triglycerides in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.141851540333475,0.00989066856933274,0.122465829937583,0.161237250729367,2.66847095500048e-46
NMR metabolomics,X23408.Triglycerides in VLDL,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0429014446374773,0.00299264455292872,0.037035861313737,0.0487670279612176,2.8868545987858e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CEP170,Centrosomal protein of 170 kDa,37628,0.106872140295366,0.00746419428865197,0.0922423194896082,0.121501961101124,3.7491678920442e-46
NMR metabolomics,X23408.Triglycerides in VLDL,SMTN,Smoothelin,37905,0.132893365752866,0.00929339648252669,0.114678308647114,0.151108422858619,4.77410325043105e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MMP7,Matrilysin,40015,0.0664235754874141,0.00465040268367315,0.0573087862274147,0.0755383647474134,5.42328977052559e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0560809121094996,0.00392722811388632,0.0483835450062824,0.0637782792127167,6.30343937980375e-46
NMR metabolomics,X23408.Triglycerides in VLDL,ANG,Angiogenin,40309,0.0473570037389865,0.00331925632809652,0.0408512613359173,0.0538627461420557,6.72411857988016e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL16,C-X-C motif chemokine 16,40517,0.0326448457405415,0.00228846144111231,0.0281594613159614,0.0371302301651216,6.89620788704767e-46
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA4,Ephrin-A4,40203,0.0404442964566376,0.00283722946890283,0.0348833266975881,0.0460052662156872,8.05976999364687e-46
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB9,Serpin B9,40228,0.046063488992635,0.00323222750174846,0.039728323089208,0.0523986548960619,8.46495331099795e-46
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0490754946417694,0.00344654041957429,0.0423202754194037,0.055830713864135,1.1469047839592e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CERT,Ceramide transfer protein,39961,0.0843168756213328,0.00592805638695711,0.0726978851028968,0.0959358661397687,1.27036668163306e-45
NMR metabolomics,X23408.Triglycerides in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.119892485148908,0.00842837563538892,0.103372868903545,0.13641210139427,1.39293789742903e-45
NMR metabolomics,X23408.Triglycerides in VLDL,ATG4A,Cysteine protease ATG4A,39980,0.0815029517503778,0.00573591240149951,0.0702605634434387,0.0927453400573168,1.54903151654104e-45
NMR metabolomics,X23408.Triglycerides in VLDL,IL7,Interleukin-7,40341,0.0881334702397443,0.00620394738033781,0.0759737333742822,0.100293207105206,1.59688143491902e-45
NMR metabolomics,X23408.Triglycerides in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0492067073013136,0.00346663458221536,0.0424121035201715,0.0560013110824557,1.90992076475884e-45
NMR metabolomics,X23408.Triglycerides in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.141240607898034,0.00995216133990813,0.121734371671814,0.160746844124254,2.18418296519235e-45
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.135629524801765,0.00955839646767599,0.11689506772512,0.15436398187841,2.25136806534546e-45
NMR metabolomics,X23408.Triglycerides in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0509817071735575,0.00359557744701576,0.0439343753774066,0.0580290389697084,2.32057552871533e-45
NMR metabolomics,X23408.Triglycerides in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0918335880288994,0.00647431568156783,0.0791439292930264,0.104523246764772,2.47964578779455e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CCL2,C-C motif chemokine 2,40203,0.0721999512629692,0.00509579412103419,0.0622121947857422,0.0821877077401962,2.72217388756534e-45
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G15,Phospholipase A2 group XV,40411,0.0351090742052181,0.00247860647826317,0.0302510055078223,0.0399671429026139,2.84363602482266e-45
NMR metabolomics,X23408.Triglycerides in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0528987109504305,0.00373381551596357,0.0455804325391419,0.0602169893617191,3.13405549004051e-45
NMR metabolomics,X23408.Triglycerides in VLDL,SUGT1,Protein SGT1 homolog,39980,0.111029043285709,0.00784278983716473,0.0956571752048665,0.126400911366552,3.23832660907566e-45
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0396208446323051,0.0028024668385086,0.0341280096288283,0.045113679635782,4.13798390183809e-45
NMR metabolomics,X23408.Triglycerides in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0833701908921806,0.00589869069143717,0.0718087571369637,0.0949316246473974,5.00910462955151e-45
NMR metabolomics,X23408.Triglycerides in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0779138964081513,0.00551969512115024,0.0670952939706968,0.0887324988456057,5.66131965942956e-45
NMR metabolomics,X23408.Triglycerides in VLDL,DXO,Decapping and exoribonuclease protein,37942,0.0624102797489353,0.00442317682710566,0.0537408531678082,0.0710797063300624,6.88765990207846e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL11,C-X-C motif chemokine 11,40471,0.107953445496182,0.0076587918564146,0.0929422134576092,0.122964677534754,7.51758293883281e-45
NMR metabolomics,X23408.Triglycerides in VLDL,LARP1,La-related protein 1,37900,0.086409350889002,0.00612689689185072,0.0744006329809746,0.0984180687970294,7.5648229770063e-45
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0429065718703883,0.00304441670920151,-0.0488736286204233,-0.0369395151203534,7.6939668828925e-45
NMR metabolomics,X23408.Triglycerides in VLDL,MSR1,Macrophage scavenger receptor types I and II,40471,0.0606386636938262,0.00430887013220673,0.052193278234701,0.0690840491529514,1.02790896922465e-44
NMR metabolomics,X23408.Triglycerides in VLDL,DCTD,Deoxycytidylate deaminase,37671,0.128398264342783,0.00911937550821195,0.110524288346687,0.146272240338878,1.06423661191967e-44
NMR metabolomics,X23408.Triglycerides in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.108248785019365,0.00769457281229936,0.0931674223072586,0.123330147731472,1.2546943000555e-44
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB6,Heat shock protein beta-6,40489,0.0494219142789889,0.00351567355477657,0.0425311941116269,0.056312634446351,1.27346355078839e-44
NMR metabolomics,X23408.Triglycerides in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.047691311027415,0.00339079441070626,0.0410453539824307,0.0543372680723993,1.29145733096912e-44
NMR metabolomics,X23408.Triglycerides in VLDL,IL12A_IL12B,Interleukin-12,40305,0.106066646962699,0.00754612313761026,0.0912762456129828,0.120857048312415,1.31532439870452e-44
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP1,Metalloproteinase inhibitor 1,40167,0.0380860942670494,0.00271068166813257,0.0327731581975096,0.0433990303365893,1.42595617205105e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CSTB,Cystatin-B,40097,0.0566990592791223,0.00403561587762748,0.0487892521589724,0.0646088663992721,1.44408010094155e-44
NMR metabolomics,X23408.Triglycerides in VLDL,GGCT,Gamma-glutamylcyclotransferase,37978,0.065535848858198,0.00466712637203105,0.0563882811690171,0.0746834165473788,1.76957309838964e-44
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP5,Microfibrillar-associated protein 5,40536,0.0553724359911655,0.00395122466578434,0.0476280356462282,0.0631168363361028,2.33400840178285e-44
NMR metabolomics,X23408.Triglycerides in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.109236667880458,0.0078001794069182,0.0939483162428979,0.124525019518017,2.68751588367028e-44
NMR metabolomics,X23408.Triglycerides in VLDL,GP5,Platelet glycoprotein V,37671,0.0485699334836151,0.00346703958499139,0.041774535897032,0.0553653310701982,2.84367285146107e-44
NMR metabolomics,X23408.Triglycerides in VLDL,DDT,D-dopachrome decarboxylase,37998,0.0553110611398581,0.00395084990874638,0.0475673953187152,0.063054726961001,3.17779718998691e-44
NMR metabolomics,X23408.Triglycerides in VLDL,DIABLO,"Diablo homolog, mitochondrial",40314,0.147493366572056,0.0105427529925053,0.126829570706745,0.168157162437366,3.28419596733201e-44
NMR metabolomics,X23408.Triglycerides in VLDL,IMMT,MICOS complex subunit MIC60,37900,0.0600256011615875,0.00429082198819616,0.0516155900647231,0.068435612258452,3.69392877992748e-44
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF6,SLAM family member 6,39980,0.0512030969309157,0.00366416879557659,0.0440213260915855,0.0583848677702458,4.15536011641699e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CCL8,C-C motif chemokine 8,40470,0.081214946242717,0.00581741423555121,0.0698128143410367,0.0926170781443974,4.90742974448594e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.102878448368678,0.00736830716897035,0.0884365663174965,0.11732033041986,5.35741652559224e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PMVK,Phosphomevalonate kinase,39951,0.148887899688605,0.0106752758083225,0.127964359104293,0.169811440272917,6.04913250490283e-44
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA3,Annexin A3,40442,0.0940253365574633,0.00674273970239126,0.0808095667407764,0.10724110637415,6.13013127679175e-44
NMR metabolomics,X23408.Triglycerides in VLDL,GP6,Platelet glycoprotein VI,40311,0.118058336189323,0.0084795940207871,0.10143833190858,0.134678340470066,8.35597355551153e-44
NMR metabolomics,X23408.Triglycerides in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0880145251692658,0.00632164708382816,0.0756240968849625,0.100404953453569,8.4521086927734e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0461006907061308,0.00331479403051847,-0.052597687005947,-0.0396036944063145,1.02806733048135e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CD72,B-cell differentiation antigen CD72,37671,0.0569020660022827,0.00409190697016648,0.0488819283407564,0.064922203663809,1.18190957009617e-43
NMR metabolomics,X23408.Triglycerides in VLDL,NBN,Nibrin,40044,0.0682319342600568,0.00491116801327863,0.0586060449540306,0.0778578235660829,1.26707400258265e-43
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0488941364745699,0.00351857438038669,0.0419977306890119,0.0557905422601278,1.35630083179378e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CCL4,C-C motif chemokine 4,40376,0.0903132402856781,0.00651896468688829,0.077536069499377,0.103090411071979,2.15062078511404e-43
NMR metabolomics,X23408.Triglycerides in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0413181874820421,0.00298670396770768,0.0354642477053351,0.0471721272587492,2.8284973937074e-43
NMR metabolomics,X23408.Triglycerides in VLDL,TBCA,Tubulin-specific chaperone A,37671,0.11557757118499,0.0084156500303074,0.099082897125588,0.132072245244393,1.25194106752895e-42
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0802364596896996,0.0058553063586083,0.0687600592268273,0.0917128601525719,1.69437239104836e-42
NMR metabolomics,X23408.Triglycerides in VLDL,C1RL,Complement C1r subcomponent-like protein,37993,0.0256669435908463,0.0018726152485372,0.0219966177037134,0.0293372694779792,1.78341781644215e-42
NMR metabolomics,X23408.Triglycerides in VLDL,PSAP,Prosaposin,37901,0.0375992947597038,0.00274820388694918,0.0322128151412834,0.0429857743781242,2.51740658136851e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB1,Beta-crystallin B1,37990,0.0855501559786166,0.006257429788528,0.0732855935931018,0.0978147183641315,2.85660816778335e-42
NMR metabolomics,X23408.Triglycerides in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0422013691293244,0.00308856233084486,0.0361477869608685,0.0482549512977803,2.88214356103316e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CDC37,Hsp90 co-chaperone Cdc37,40411,0.109818440658346,0.0080632162543934,0.0940145367997345,0.125622344516957,5.25257110642836e-42
NMR metabolomics,X23408.Triglycerides in VLDL,NACC1,Nucleus accumbens-associated protein 1,37900,0.0722998694122177,0.00530667212230723,0.0618987920524955,0.0827009467719399,5.45165218623239e-42
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.080114311964388,0.00589341852567203,0.0685632116540708,0.0916654122747051,7.46503639698819e-42
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.144776263510596,0.0106543576911226,0.123893722435996,0.165658804585196,8.11312494029988e-42
NMR metabolomics,X23408.Triglycerides in VLDL,BDNF,Brain-derived neurotrophic factor,37998,0.108552371978195,0.00798815129471729,0.0928955954405492,0.124209148515841,8.7216091898964e-42
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.113216150862697,0.00833237522352621,0.0968846954245856,0.129547606300808,8.94364568823464e-42
NMR metabolomics,X23408.Triglycerides in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.120062700203928,0.00885226196051012,0.102712266761328,0.137413133646528,1.13304606580877e-41
NMR metabolomics,X23408.Triglycerides in VLDL,C19orf12,Protein C19orf12,39961,0.0812013233962319,0.00599197776856362,0.0694570469698472,0.0929455998226166,1.33598763643597e-41
NMR metabolomics,X23408.Triglycerides in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0389509283978392,0.00287482399804287,0.0333162733616752,0.0445855834340032,1.37486304243448e-41
NMR metabolomics,X23408.Triglycerides in VLDL,BMPER,BMP-binding endothelial regulator protein,37671,0.0293888642256275,0.00217159911394858,0.0251325299622883,0.0336451984889667,1.8780609020584e-41
NMR metabolomics,X23408.Triglycerides in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.154592680540009,0.0114441137220731,0.132162217644746,0.177023143435272,2.35099154617324e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ERMAP,Erythroid membrane-associated protein,37598,0.058628791811011,0.00433860394818985,0.0501251280725589,0.0671324555494631,2.46427935163897e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0798331116411484,0.00590779811277392,0.0682538273401115,0.0914123959421853,2.47098516279298e-41
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO3,Forkhead box protein O3,39980,0.126209903860093,0.00934866458894968,0.107886521265752,0.144533286454435,2.66264095589049e-41
NMR metabolomics,X23408.Triglycerides in VLDL,RP2,Protein XRP2,40305,0.0536971524359891,0.00397847124442745,0.0458993487969113,0.0614949560750669,2.75602219897392e-41
NMR metabolomics,X23408.Triglycerides in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0779250060654727,0.0057762203918061,0.0666036140975327,0.0892463980334127,2.99800892606387e-41
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3,Galectin-3,40374,0.0384711853901794,0.00285207679757882,0.0328811148669249,0.0440612559134339,3.06534366414656e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0885328232584198,0.00656264177992676,0.0756700453697633,0.101395601147076,3.35250031844476e-41
NMR metabolomics,X23408.Triglycerides in VLDL,WDR46,WD repeat-containing protein 46,37900,0.0463524727700663,0.00343754557017386,0.0396148834525255,0.053090062087607,3.58778721384822e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CTSL,Cathepsin L1,40359,0.0314594888480731,0.00233600424993731,0.026880920518196,0.0360380571779503,4.09671092797412e-41
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM2,Neural cell adhesion molecule 2,40332,-0.0350900003619375,0.00260583109299367,-0.0401974293042051,-0.02998257141967,4.17054637923413e-41
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0544144080156451,0.00404321451542074,0.0464897075654205,0.0623391084658698,4.61287506938698e-41
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1,Allograft inflammatory factor 1,39980,0.068427650295112,0.00508709496898427,0.0584569441559028,0.0783983564343212,5.13850977337746e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.114978107493923,0.00855185549767384,0.0982164707184821,0.131739744269364,6.04558716335959e-41
NMR metabolomics,X23408.Triglycerides in VLDL,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0559747048583794,0.00416661265808992,0.0478081440485232,0.0641412656682357,7.1077796614936e-41
NMR metabolomics,X23408.Triglycerides in VLDL,APLP1,Amyloid-like protein 1,40359,-0.0672131093433356,0.00501482664200475,-0.077042169561665,-0.0573840491250063,9.67592296478911e-41
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN2,Nectin-2,40330,0.0372961107549085,0.00278588983051008,0.0318357666871087,0.0427564548227082,1.18855537254849e-40
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0825524853165298,0.00616994938835731,0.0704593845153495,0.0946455861177102,1.31623981324314e-40
NMR metabolomics,X23408.Triglycerides in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0352871811614614,0.00263742259005979,0.0301178328849442,0.0404565294379786,1.32348151975858e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0908558833632151,0.00680497636551797,0.0775181296867998,0.10419363703963,2.10373671326139e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CFB,Complement factor B,37770,0.0423150326919552,0.00316967392753923,0.0361024717939783,0.0485275935899321,2.15415393815888e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0533703869041852,0.00399960394400598,0.0455311631739335,0.0612096106344369,2.34409296723653e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CEMIP2,Cell surface hyaluronidase,37598,0.0435108819429794,0.00326551842895192,0.0371104658222336,0.0499112980637251,3.04710905383883e-40
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0870922311743016,0.00654457277706669,0.0742648685312508,0.0999195938173523,3.47302618642189e-40
NMR metabolomics,X23408.Triglycerides in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.161177884264463,0.0121326280647805,0.137397933257494,0.184957835271433,5.06445955570936e-40
NMR metabolomics,X23408.Triglycerides in VLDL,AGXT,Serine--pyruvate aminotransferase,40359,0.0982491098221176,0.00740568151557019,0.0837339740516,0.112764245592635,5.88611440897929e-40
NMR metabolomics,X23408.Triglycerides in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.076439094852452,0.00576011225070722,0.0651492748410659,0.0877289148638382,6.10254115215138e-40
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL2,ADAMTS-like protein 2,37998,0.039616524659788,0.00298713280811226,0.0337617443558879,0.045471304963688,6.78064038974242e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0377211056811318,0.00284941905420459,0.0321362443348908,0.0433059670273728,8.60803663586404e-40
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP1,Syntaxin-binding protein 1,37959,0.0986464472105854,0.0074741508371142,0.0839971115698416,0.113295782851329,1.57510610512249e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CTSE,Cathepsin E,37671,0.0657584551054813,0.004984104603331,0.0559896100829526,0.0755273001280101,1.69592987591772e-39
NMR metabolomics,X23408.Triglycerides in VLDL,FADD,FAS-associated death domain protein,40359,0.0968578229759358,0.00735797193995555,0.0824361979736229,0.111279447978249,2.28153597784988e-39
NMR metabolomics,X23408.Triglycerides in VLDL,NFASC,Neurofascin,40516,0.0344759079919237,0.00262542790845761,0.0293300692913468,0.0396217466925006,3.45710208695486e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM1,Probable carboxypeptidase X1,40411,0.0869811157738311,0.00662695376221788,0.073992286399884,0.0999699451477782,3.7593698374446e-39
NMR metabolomics,X23408.Triglycerides in VLDL,KLRD1,Natural killer cells antigen CD94,40516,0.0576842599133558,0.0043973669316722,0.0490654207272783,0.0663030990994333,4.13063711550679e-39
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC3,PDZ domain-containing protein GIPC3,37901,0.123837151193107,0.00944989107136373,0.105315364693234,0.14235893769298,5.36992854254893e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CCL18,C-C motif chemokine 18,40172,0.0887071279292915,0.00677590068623067,0.0754263625842794,0.101987893274304,5.88253300785682e-39
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0618599116656691,0.00472267037341833,0.0526034777337692,0.071116345597569,5.88752631132327e-39
NMR metabolomics,X23408.Triglycerides in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0895681514809845,0.00684442183857198,0.0761530846773834,0.102983218284586,6.78967997537489e-39
NMR metabolomics,X23408.Triglycerides in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.136419127767958,0.0104246289755941,0.115986854975793,0.156851400560122,7.01822709533523e-39
NMR metabolomics,X23408.Triglycerides in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0671670767667788,0.0051338952648969,0.0571046420475809,0.0772295114859767,7.19583607380526e-39
NMR metabolomics,X23408.Triglycerides in VLDL,MZT1,Mitotic-spindle organizing protein 1,39980,0.0664911119186459,0.00508645548026837,0.0565216591773199,0.0764605646599719,7.61304429063041e-39
NMR metabolomics,X23408.Triglycerides in VLDL,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0394407204808996,0.00301849608795914,0.0335244681484997,0.0453569728132995,8.0819956530391e-39
NMR metabolomics,X23408.Triglycerides in VLDL,EGFL7,Epidermal growth factor-like protein 7,39980,0.0508049096347156,0.00389374673384974,0.0431731660363701,0.0584366532330611,1.0448830860913e-38
NMR metabolomics,X23408.Triglycerides in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0497887890307522,0.00382041120723573,0.0423007830645702,0.0572767949969343,1.3702721357863e-38
NMR metabolomics,X23408.Triglycerides in VLDL,HNMT,Histamine N-methyltransferase,40147,0.0582423928026836,0.00447341812910718,0.0494744932696335,0.0670102923357337,1.49802656643903e-38
NMR metabolomics,X23408.Triglycerides in VLDL,ADM,Pro-adrenomedullin,40489,0.0338189587905591,0.0025978666837003,0.0287271400905065,0.0389107774906117,1.51633685392832e-38
NMR metabolomics,X23408.Triglycerides in VLDL,FGF23,Fibroblast growth factor 23,40469,0.0773959897902102,0.00594808279608676,0.0657377475098802,0.0890542320705403,1.64089298618649e-38
NMR metabolomics,X23408.Triglycerides in VLDL,LONP1,"Lon protease homolog, mitochondrial",37628,0.109099077897343,0.00838398636968679,0.0926664646127565,0.125531691181929,1.78621543247661e-38
NMR metabolomics,X23408.Triglycerides in VLDL,RAB10,Ras-related protein Rab-10,37990,0.0674572871079686,0.00518518819564697,0.0572943182445005,0.0776202559714367,1.83443700054966e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G4A,Cytosolic phospholipase A2,40422,0.109107989825267,0.00839221964235792,0.0926592393262458,0.125556740324289,1.89042105529931e-38
NMR metabolomics,X23408.Triglycerides in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0833988619883928,0.00641550500502734,0.0708244721785393,0.0959732517982464,1.95343767515501e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PTX3,Pentraxin-related protein PTX3,40341,-0.0615851975860205,0.00473931001103227,-0.0708742452076438,-0.0522961499643972,2.06198022843862e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CD83,CD83 antigen,40341,0.0420870668894451,0.00324250721186248,0.0357317527541947,0.0484423810246956,2.4953515218295e-38
NMR metabolomics,X23408.Triglycerides in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0873011654428708,0.00672288304631345,0.0741243146720964,0.100478016213645,2.54187376176685e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA1,Paraneoplastic antigen Ma1,37628,0.0702238907113711,0.00540872762008094,0.0596227845760124,0.0808249968467297,2.60909604146623e-38
NMR metabolomics,X23408.Triglycerides in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0593731587795237,0.00457864110115078,0.0503990222212682,0.0683472953377793,3.2074058057869e-38
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0964079877930083,0.00743570032349617,0.0818340151589558,0.110981960427061,3.2499162108221e-38
NMR metabolomics,X23408.Triglycerides in VLDL,S100P,Protein S100-P,40042,0.0669109001308213,0.00517303134521813,0.0567717586941938,0.0770500415674488,4.50944447297531e-38
NMR metabolomics,X23408.Triglycerides in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0670563299801459,0.00518501728022164,0.0568936961109114,0.0772189638493803,4.58407351219335e-38
NMR metabolomics,X23408.Triglycerides in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0798215126758175,0.00617434796810833,0.0677197906583252,0.0919232346933098,4.92304061172972e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.06950888881939,0.00538062956847383,0.0589628548651812,0.0800549227735987,5.99868501453946e-38
NMR metabolomics,X23408.Triglycerides in VLDL,FGR,Tyrosine-protein kinase Fgr,39961,0.0688441270812055,0.00533440021135843,0.058388702666943,0.079299551495468,6.55180558456565e-38
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0372165622610533,0.00288780425229815,0.0315564659265489,0.0428766585955576,8.8272397676359e-38
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRD2,Protein ZNRD2,37901,0.0847339418684958,0.00657534429523382,0.0718462670498375,0.0976216166871541,8.95706644152525e-38
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0657704535746146,0.00510459685050043,0.0557654437476338,0.0757754634015955,9.29448790360823e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0958285031103881,0.00743979254476433,0.08124650972265,0.110410496498126,9.68241853559786e-38
NMR metabolomics,X23408.Triglycerides in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0821910734578105,0.00639107118132124,0.0696645739424208,0.0947175729732001,1.169869391438e-37
NMR metabolomics,X23408.Triglycerides in VLDL,MDK,Midkine,40352,0.0628210164766284,0.00488909273590755,0.0532383947142496,0.0724036382390072,1.33671267410389e-37
NMR metabolomics,X23408.Triglycerides in VLDL,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0613876854243004,0.00478446779752441,0.0520101285411525,0.0707652423074482,1.8280638021067e-37
NMR metabolomics,X23408.Triglycerides in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0788937478248151,0.00614990575902303,-0.0909475631125002,-0.0668399325371299,1.90309477286501e-37
NMR metabolomics,X23408.Triglycerides in VLDL,BLNK,B-cell linker protein,37598,0.0475229043536336,0.00370750225601099,0.0402561999318521,0.0547896087754152,2.17556129398472e-37
NMR metabolomics,X23408.Triglycerides in VLDL,DBN1,Drebrin,37598,0.0641163704888321,0.00500314476741202,0.0543102067447045,0.0739225342329596,2.25522242164446e-37
NMR metabolomics,X23408.Triglycerides in VLDL,IL12B,Interleukin-12 subunit beta,40516,0.0670214637514778,0.00523370890041977,0.056763394306655,0.0772795331963005,2.31947148248764e-37
NMR metabolomics,X23408.Triglycerides in VLDL,TTF2,Transcription termination factor 2,37572,0.0602054440814898,0.00470326230152054,0.0509870499705095,0.0694238381924701,2.7125741232775e-37
NMR metabolomics,X23408.Triglycerides in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.108436797166219,0.00848014940542509,0.0918157043315854,0.125057890000852,2.94783725450736e-37
NMR metabolomics,X23408.Triglycerides in VLDL,TREML2,Trem-like transcript 2 protein,40332,0.0413426800360831,0.00323541288759201,0.0350012707764027,0.0476840892957634,3.31065272623216e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PQBP1,Polyglutamine-binding protein 1,39980,0.0680268827611926,0.00532410213045561,0.0575916425854996,0.0784621229368856,3.38597050110493e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0534555204477625,0.00418187415283638,0.0452590471082032,0.0616519937873218,3.41139586097848e-37
NMR metabolomics,X23408.Triglycerides in VLDL,TGFA,Protransforming growth factor alpha,40341,0.0590099486709961,0.00462150357358246,0.0499518016667745,0.0680680956752177,3.74055780392393e-37
NMR metabolomics,X23408.Triglycerides in VLDL,XCL1,Lymphotactin,40489,0.0694111129493514,0.00543902868381203,0.0587506167290799,0.080071609169623,4.06709060161526e-37
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN2,Dynactin subunit 2,40305,0.115583495754379,0.0090627892808767,0.0978204287638606,0.133346562744897,4.52615640075478e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ING1,Inhibitor of growth protein 1,39925,0.0549218023483619,0.00430890234417964,0.0464763537537698,0.063367250942954,5.03008434868585e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0698490943167134,0.00547986703873895,0.0591085549207851,0.0805896337126418,5.39790274144128e-37
NMR metabolomics,X23408.Triglycerides in VLDL,LEPR,Leptin receptor,40359,-0.0376523764798781,0.00295748484451238,-0.0434490467751223,-0.0318557061846338,6.00719643648428e-37
NMR metabolomics,X23408.Triglycerides in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0703037201595215,0.00552734660814594,0.0594701208075555,0.0811373195114876,7.07702512379793e-37
NMR metabolomics,X23408.Triglycerides in VLDL,APOA2,Apolipoprotein A-II,37987,-0.0584713719466328,0.00459714574674036,-0.0674817776102439,-0.0494609662830217,7.53022545870357e-37
NMR metabolomics,X23408.Triglycerides in VLDL,EPPK1,Epiplakin,37628,0.0903329929537248,0.0071175307975863,0.0763826325904557,0.104283353316994,1.0789494201279e-36
NMR metabolomics,X23408.Triglycerides in VLDL,CD164,Sialomucin core protein 24,40332,0.0324880524784444,0.002561382545021,0.0274677426902033,0.0375083622666856,1.09553761967773e-36
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA6,Integrin alpha-6,40341,0.0650013731063906,0.00512575062909981,0.054954901873355,0.0750478443394262,1.12983015215019e-36
NMR metabolomics,X23408.Triglycerides in VLDL,ACYP1,Acylphosphatase-1,37622,0.0809875173690621,0.00639669332422903,0.0684499984535732,0.093525036284551,1.59047566889369e-36
NMR metabolomics,X23408.Triglycerides in VLDL,FGF2,Fibroblast growth factor 2,40341,0.0807902017740592,0.0063851327518458,0.0682753415804414,0.0933050619676769,1.61827965418372e-36
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG3,Proteasome assembly chaperone 3,40341,0.0625306007635426,0.00494248563897184,0.0528433289111578,0.0722178726159274,1.64317350416746e-36
NMR metabolomics,X23408.Triglycerides in VLDL,NFAT5,Nuclear factor of activated T-cells 5,37598,0.107135698252499,0.00847124906018269,0.0905320500945405,0.123739346410457,1.89516028590211e-36
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT16,U8 snoRNA-decapping enzyme,37880,0.106949995482276,0.00845854652818099,0.0903712442870415,0.123528746677511,1.94714824964384e-36
NMR metabolomics,X23408.Triglycerides in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.046767601107722,0.00371706754706725,0.0394821487154702,0.0540530534999738,3.95430251291264e-36
NMR metabolomics,X23408.Triglycerides in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0822311562117335,0.00653448975392118,0.069423556294048,0.095038756129419,4.17157726293498e-36
NMR metabolomics,X23408.Triglycerides in VLDL,ABHD14B,Protein ABHD14B,40171,0.070885746591089,0.0056445375632894,0.0598224529670418,0.0819490402151362,5.32941386657788e-36
NMR metabolomics,X23408.Triglycerides in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0362374225309167,0.0028894498098782,0.0305741009035554,0.0419007441582779,6.56562814515766e-36
NMR metabolomics,X23408.Triglycerides in VLDL,SCRG1,Scrapie-responsive protein 1,37990,0.0332966122836635,0.00265432729141064,0.0280941307924987,0.0384990937748284,6.76553912215957e-36
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0544208144263311,0.00434017460104861,0.0459140722082759,0.0629275566443864,7.33787491922171e-36
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD4B,FERM domain-containing protein 4B,37562,0.085351301355138,0.0068120198396596,0.0719997424694051,0.0987028602408708,8.25431689730427e-36
NMR metabolomics,X23408.Triglycerides in VLDL,GGH,Gamma-glutamyl hydrolase,40077,0.0413604843374073,0.00330424132922111,0.0348841713321339,0.0478367973426807,8.90388578164195e-36
NMR metabolomics,X23408.Triglycerides in VLDL,SDHB,Succinate dehydrogenase,37901,0.0860879741493023,0.0068789549181044,0.0726052225098177,0.0995707257887869,9.81195321021967e-36
NMR metabolomics,X23408.Triglycerides in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0743529703648353,0.00594452079873161,0.0627017095993213,0.0860042311303492,1.00574963839747e-35
NMR metabolomics,X23408.Triglycerides in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0368960324320283,0.00295122890562222,-0.0426804410870479,-0.0311116237770088,1.07164499715698e-35
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0678423166258429,0.00542396753419916,0.0572113402588125,0.0784732929928732,1.07808410771268e-35
NMR metabolomics,X23408.Triglycerides in VLDL,KLF4,Krueppel-like factor 4,37541,0.0473303834573795,0.00378500717408115,0.0399117693961804,0.0547489975185786,1.12496853274105e-35
NMR metabolomics,X23408.Triglycerides in VLDL,TSNAX,Translin-associated protein X,37562,0.0476438221951693,0.00381726470825723,0.0401619833669851,0.0551256610233534,1.50638287103628e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0446804290961471,0.00358099422226681,0.0376616804205041,0.05169917777179,1.58384046556929e-35
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH7,Protocadherin-7,37901,0.0420445287900471,0.00337263603756323,0.0354341621564232,0.048654895423671,1.78851884690079e-35
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0548742857737235,0.00440277694568276,0.0462448429601853,0.0635037285872617,1.85188353641901e-35
NMR metabolomics,X23408.Triglycerides in VLDL,OPLAH,5-oxoprolinase,37628,0.0819716598704995,0.00658894574790981,0.0690573262045962,0.0948859935364027,2.47832666906833e-35
NMR metabolomics,X23408.Triglycerides in VLDL,FEN1,Flap endonuclease 1,39980,0.0743811443913638,0.00598254373219654,0.0626553586762586,0.0861069301064691,2.54711189340367e-35
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0830119586626179,0.00668858503801205,0.0699023319881143,0.0961215853371216,3.30369102711273e-35
NMR metabolomics,X23408.Triglycerides in VLDL,MMP1,Interstitial collagenase,39757,0.111360041970882,0.00897254378431963,0.0937738561536151,0.128946227788148,3.35595697578984e-35
NMR metabolomics,X23408.Triglycerides in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.145999961009861,0.0118182990060072,0.122836094958087,0.169163827061636,6.72599169200787e-35
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN9,Septin-9,40305,0.0335090612231443,0.00271424119472189,0.0281891484814894,0.0388289739647992,7.43512493280109e-35
NMR metabolomics,X23408.Triglycerides in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.142532308294799,0.0115456627829521,0.119902809240213,0.165161807349385,7.47193096868008e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CD40LG,CD40 ligand,40516,0.0911405107074191,0.00738314868278292,0.0766695392891646,0.105611482125674,7.514157612423e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ACRBP,Acrosin-binding protein,37900,0.0450564928612143,0.00366142357267735,0.0378801026587667,0.0522328830636619,1.2952940224175e-34
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH1,Acid ceramidase,37882,0.0549163508244785,0.00446381315654748,0.0461672770376454,0.0636654246113115,1.34726877168091e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CCN4,CCN family member 4,40489,0.0485575682069284,0.00395018801820801,0.0408151996912407,0.0562999367226161,1.42273861929397e-34
NMR metabolomics,X23408.Triglycerides in VLDL,SPON2,Spondin-2,40267,-0.0409252068969439,0.00333179020819598,-0.047455515705008,-0.0343948980888798,1.60088982252604e-34
NMR metabolomics,X23408.Triglycerides in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0586908316386243,0.00477913096862002,0.0493237349401291,0.0680579283371196,1.79332591315052e-34
NMR metabolomics,X23408.Triglycerides in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0529648638652071,0.00431634534405518,0.044504826990859,0.0614249007395553,2.00387933503984e-34
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAL,Integrin alpha-L,37598,0.0517663244071666,0.00421997206878158,0.0434951791523547,0.0600374696619785,2.10067211630119e-34
NMR metabolomics,X23408.Triglycerides in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.103786393129206,0.0084776536837538,0.0871701919090484,0.120402594349363,2.65320593321024e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CA13,Carbonic anhydrase 13,40173,0.122206952395486,0.00999202308385049,0.102622587151139,0.141791317639833,3.05849800246252e-34
NMR metabolomics,X23408.Triglycerides in VLDL,TST,Thiosulfate sulfurtransferase,39923,0.08947080105264,0.00731870804750101,0.075126133279538,0.103815468825742,3.28973371652932e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CORO1A,Coronin-1A,39990,0.106159850682173,0.00868743683470371,0.0891324744861539,0.123187226878192,3.49168955558077e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CD84,SLAM family member 5,40341,0.0362461512449396,0.00297148207724063,0.0304220463735479,0.0420702561163312,4.52394924783511e-34
NMR metabolomics,X23408.Triglycerides in VLDL,AK2,"Adenylate kinase 2, mitochondrial",37942,0.124470201302415,0.0102051438076104,0.104468119439499,0.144472283165331,4.88331211334056e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DKK4,Dickkopf-related protein 4,40203,0.0535570230148887,0.00439939348997365,0.0449342117745403,0.062179834255237,6.09484625871781e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL1,Growth-regulated alpha protein,40329,0.114037693836558,0.00938260791888194,0.0956477823155497,0.132427605357567,7.70688185759052e-34
NMR metabolomics,X23408.Triglycerides in VLDL,GET3,ATPase GET3,37990,0.06602401236481,0.00543284765235715,0.05537563096619,0.07667239376343,8.31928763404206e-34
NMR metabolomics,X23408.Triglycerides in VLDL,PKN3,Serine/threonine-protein kinase N3,37714,0.0906768629743161,0.00746962860616264,0.0760363909062373,0.105317335042395,9.85759087869123e-34
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0530040286393886,0.00438024553444666,0.0444187473918732,0.0615893098869041,1.57684376902914e-33
NMR metabolomics,X23408.Triglycerides in VLDL,SCRN1,Secernin-1,40341,0.0656128028580237,0.00542598396944081,0.0549778742779198,0.0762477314381277,1.62726829837954e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PARD3,Partitioning defective 3 homolog,37714,0.0869237792528008,0.00718587464300026,0.0728394649525203,0.101008093553081,1.65470373285514e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0564061700430611,0.00466736822617425,0.0472581283197596,0.0655542117663626,1.7681855652548e-33
NMR metabolomics,X23408.Triglycerides in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0536621297361454,0.00443876911392415,0.0449621422728541,0.0623621171994368,1.78936343508938e-33
NMR metabolomics,X23408.Triglycerides in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.102040616129508,0.00844158167968415,0.0854951160373273,0.118586116221689,1.82552456174962e-33
NMR metabolomics,X23408.Triglycerides in VLDL,BTC,Probetacellulin,39980,0.0878211693908448,0.00727547280273431,0.0735612426974855,0.102081096084204,2.12453159190252e-33
NMR metabolomics,X23408.Triglycerides in VLDL,TREH,Trehalase,37998,0.0868952034838198,0.00720144068171345,0.0727803797476615,0.101010027219978,2.35738233051046e-33
NMR metabolomics,X23408.Triglycerides in VLDL,GLO1,Lactoylglutathione lyase,40042,0.0688930965138069,0.00571781090843199,0.0576861871332802,0.0801000058943336,2.76427628696735e-33
NMR metabolomics,X23408.Triglycerides in VLDL,F11,Coagulation factor XI,37810,0.0352505090913154,0.00292659031939186,0.0295143920653073,0.0409866261173234,3.0669367187858e-33
NMR metabolomics,X23408.Triglycerides in VLDL,RAB2B,Ras-related protein Rab-2B,37900,0.071436552302559,0.00593816783327802,0.0597977433493341,0.0830753612557839,3.65462234090231e-33
NMR metabolomics,X23408.Triglycerides in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0456871516199051,0.00380205453557854,0.0382351247301712,0.053139178509639,4.29530596487067e-33
NMR metabolomics,X23408.Triglycerides in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.049977530383329,0.00416355285282767,0.0418169667917867,0.0581380939748712,4.73400594138647e-33
NMR metabolomics,X23408.Triglycerides in VLDL,NADK,NAD kinase,40359,0.0619700299871964,0.00516603679205496,0.0518445978747687,0.0720954620996242,5.1973569254364e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CCL25,C-C motif chemokine 25,40516,0.0563311476445003,0.00471634556101945,0.0470871103449021,0.0655751849440984,9.62470198243938e-33
NMR metabolomics,X23408.Triglycerides in VLDL,SNX9,Sorting nexin-9,40359,0.0790491632557834,0.00662578727898642,0.06606262018897,0.0920357063225967,1.13099782477579e-32
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0502014999763923,0.00421075002520809,0.0419484299269845,0.0584545700258002,1.32328173742941e-32
NMR metabolomics,X23408.Triglycerides in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.041871809863379,0.00351899801913679,-0.0487690459808871,-0.0349745737458709,1.76110067682702e-32
NMR metabolomics,X23408.Triglycerides in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0773983927324203,0.00650503226771243,0.0646485294877039,0.0901482559771366,1.76834064449838e-32
NMR metabolomics,X23408.Triglycerides in VLDL,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0562919111362506,0.00473310991955541,0.047015015693922,0.0655688065785792,1.77611816918735e-32
NMR metabolomics,X23408.Triglycerides in VLDL,DMD,Dystrophin,37628,0.0599236724822216,0.00503648742538268,0.0500521571284716,0.0697951878359716,1.77952295848175e-32
NMR metabolomics,X23408.Triglycerides in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0850414986053649,0.00715444659196162,0.0710187832851202,0.0990642139256097,1.91455573935575e-32
NMR metabolomics,X23408.Triglycerides in VLDL,IL32,Interleukin-32,40341,-0.0489797381110864,0.00412168899165569,-0.0570582485347316,-0.0409012276874413,1.98058008889478e-32
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.042973182734113,0.00361893765798961,0.0358800649244533,0.0500663005437726,2.20555245295773e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PDZD2,PDZ domain-containing protein 2,37562,0.0705298581935786,0.00594467802085153,0.0588782892727096,0.0821814271144476,2.65185804222822e-32
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA2,Integrin alpha-2,37671,0.0388593152341377,0.00327682810769296,0.0324367321430595,0.0452818983252159,2.82281776225515e-32
NMR metabolomics,X23408.Triglycerides in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0347564403219165,0.00293230868587263,0.0290091152976061,0.0405037653462268,2.83610408599431e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PVR,Poliovirus receptor,40471,0.0419986806809813,0.00354820280412453,0.0350442031848972,0.0489531581770654,3.43839257853913e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CA14,Carbonic anhydrase 14,40489,-0.0393426551553165,0.00333382735951274,-0.0458769567799615,-0.0328083535306715,5.22909231386649e-32
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0466597854786039,0.0039549015714637,0.038908178398535,0.0544113925586727,5.45469629929605e-32
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0428568119090505,0.00364102897885787,0.0357203951104891,0.0499932287076119,7.9251654375033e-32
NMR metabolomics,X23408.Triglycerides in VLDL,RGS10,Regulator of G-protein signaling 10,37959,0.0681378991264693,0.005799213072212,0.0567714415049338,0.0795043567480048,1.01346730186819e-31
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0870524450318657,0.00741516629179358,0.0725187190999503,0.101586170963781,1.08480897292502e-31
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2,Brorin,40167,0.0440245428407397,0.00375414992281066,0.0366664089920308,0.0513826766894486,1.25693013241265e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0341610445769202,0.00291850421950926,0.0284407763066821,0.0398813128471584,1.70642695309523e-31
NMR metabolomics,X23408.Triglycerides in VLDL,BGLAP,Osteocalcin,37998,0.103335210949174,0.00883194599949012,0.0860245967901732,0.120645825108174,1.80256549640393e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CCL26,C-C motif chemokine 26,40341,0.100281937454153,0.00857551875846267,0.0834739206875664,0.11708995422074,1.8410596777379e-31
NMR metabolomics,X23408.Triglycerides in VLDL,BAG3,BAG family molecular chaperone regulator 3,40203,0.0447261513450789,0.00382926870173346,0.0372207846896813,0.0522315180004764,2.17096835341563e-31
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BP1,SH3 domain-binding protein 1,37901,0.0527254280107493,0.00452195719425209,0.0438623919100152,0.0615884641114834,2.88922505578762e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0352505973600486,0.00302546888931113,0.0293206783369988,0.0411805163830985,3.19532372528753e-31
NMR metabolomics,X23408.Triglycerides in VLDL,NID1,Nidogen-1,40355,0.0443974051482846,0.00381741737382591,0.0369152670955858,0.0518795432009834,3.86778176677268e-31
NMR metabolomics,X23408.Triglycerides in VLDL,MIA,Melanoma-derived growth regulatory protein,40411,0.0415183322942195,0.00357087708294522,0.0345194132116469,0.0485172513767921,4.01446290824973e-31
NMR metabolomics,X23408.Triglycerides in VLDL,C1R,Complement C1r subcomponent,38013,0.0223896361571645,0.00192633957429311,0.01861401059155,0.026165261722779,4.42581166264983e-31
NMR metabolomics,X23408.Triglycerides in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.133705884477311,0.0115117381850075,0.111142877634696,0.156268891319925,4.63020623917454e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1F,Protein phosphatase 1F,37990,0.058797989388135,0.00506164584262299,0.048877163536594,0.0687188152396761,4.77558578890826e-31
NMR metabolomics,X23408.Triglycerides in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0779501817051595,0.00671528824999696,0.0647882167351655,0.0911121466751535,5.01777901107604e-31
NMR metabolomics,X23408.Triglycerides in VLDL,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0331190965634443,0.00286228694238815,-0.038729178970525,-0.0275090141563635,7.69302609257736e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PTGES2,Prostaglandin E synthase 2,37484,0.061203973025301,0.00529307083749233,0.050829554183816,0.0715783918667859,8.96183512610863e-31
NMR metabolomics,X23408.Triglycerides in VLDL,RNASET2,Ribonuclease T2,40465,0.0294548531948317,0.00255014522719751,0.0244565685495246,0.0344531378401388,9.74186617179974e-31
NMR metabolomics,X23408.Triglycerides in VLDL,BLMH,Bleomycin hydrolase,40536,0.036002088203048,0.00311836280354724,0.0298900971080954,0.0421140792980006,1.03167051843185e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP25,Synaptosomal-associated protein 25,37541,0.052249976769267,0.00453284272076159,0.0433656050365743,0.0611343485019597,1.35533426798981e-30
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.0987495107584524,0.00857192966914205,0.081948528606934,0.115550492909971,1.38282101419616e-30
NMR metabolomics,X23408.Triglycerides in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.129664723845575,0.0112825100467609,-0.151778443537227,-0.107551004153924,1.90109598741561e-30
NMR metabolomics,X23408.Triglycerides in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.057880494042375,0.00503566947843701,0.0480105818646385,0.0677504062201115,1.95645292707921e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0546296435717873,0.00475476764230881,0.045310298992862,0.0639489881507126,2.06665129542967e-30
NMR metabolomics,X23408.Triglycerides in VLDL,UNC79,Protein unc-79 homolog,37482,0.0628916656407892,0.00547426427129172,0.0521621076690574,0.073621223612521,2.10846289071903e-30
NMR metabolomics,X23408.Triglycerides in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0528428450661758,0.0046021460833141,0.0438226387428802,0.0618630513894715,2.14972314690628e-30
NMR metabolomics,X23408.Triglycerides in VLDL,GNAS,Neuroendocrine secretory protein 55,37959,0.100337902577805,0.00873751183923277,0.0832123793729089,0.117463425782701,2.20725539859519e-30
NMR metabolomics,X23408.Triglycerides in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0764653329371974,0.00666801793296531,0.0633960177885854,0.0895346480858094,2.67937426310044e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CD302,CD302 antigen,40305,0.0331631816636397,0.0029030972790808,0.0274731109966413,0.038853252330638,4.19099160013781e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TPK1,Thiamin pyrophosphokinase 1,37990,0.0299644548540525,0.0026227190332855,0.0248239255488129,0.0351049841592921,4.3103276329108e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SWAP70,Switch-associated protein 70,37901,0.0388618927365162,0.00340394652477938,0.0321901575479486,0.0455336279250838,4.74468471632289e-30
NMR metabolomics,X23408.Triglycerides in VLDL,BAP18,Chromatin complexes subunit BAP18,37942,0.0715729116832676,0.00627232603281194,0.0592791526589562,0.083866670707579,5.06455479337946e-30
NMR metabolomics,X23408.Triglycerides in VLDL,NID2,Nidogen-2,40332,0.081238932301993,0.00712846862995284,0.0672671337872854,0.0952107308167006,5.69753900147339e-30
NMR metabolomics,X23408.Triglycerides in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0308959620676,0.00271074292598288,0.0255829059326736,0.0362090182025265,5.94632011222302e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB8,Serpin B8,40516,0.0599550680968875,0.00526541050595522,0.0496348635052153,0.0702752726885597,6.35196799715465e-30
NMR metabolomics,X23408.Triglycerides in VLDL,GBP1,Guanylate-binding protein 1,37931,0.0707832569661358,0.00623348471924507,0.0585656269164155,0.0830008870158562,9.52486336774574e-30
NMR metabolomics,X23408.Triglycerides in VLDL,NGRN,Neugrin,37942,0.0242160577063253,0.00213298372580773,0.0200354096037421,0.0283967058089085,9.76168173370132e-30
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0314703457366618,0.0027767010727551,0.0260280116340618,0.0369126798392618,1.22535597859068e-29
NMR metabolomics,X23408.Triglycerides in VLDL,BGN,Biglycan,39956,-0.133056926703732,0.01174627295716,-0.156079621699766,-0.110034231707698,1.25271769843621e-29
NMR metabolomics,X23408.Triglycerides in VLDL,LGMN,Legumain,40422,0.0387988937544677,0.0034273571185287,0.0320812738021514,0.0455165137067839,1.34906993221335e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA9,Serpin A9,40228,0.0787270463336147,0.00695878201832084,0.0650878335777059,0.0923662590895235,1.46515500740032e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CD46,Membrane cofactor protein,40250,0.0313109987961448,0.00276820649671246,0.0258853140625883,0.0367366835297012,1.50497957492221e-29
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0361402884343695,0.00319691994835414,0.0298743253355954,0.0424062515331436,1.61106256809788e-29
NMR metabolomics,X23408.Triglycerides in VLDL,PTGR1,Prostaglandin reductase 1,37990,0.0869320696891779,0.00768908889700878,0.0718614554510406,0.102002683927315,1.66363660198016e-29
NMR metabolomics,X23408.Triglycerides in VLDL,HPCAL1,Hippocalcin-like protein 1,40516,0.0800022232411426,0.00707945936869943,0.0661264828784917,0.0938779636037935,1.68392940472403e-29
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.099337971623676,0.00879253118052746,0.0821046105098422,0.11657133273751,1.82009591997492e-29
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0896807586469162,0.007951018878662,0.0740967616447386,0.105264755649094,2.15143882324354e-29
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0553406254268058,0.00491252502481073,0.0457120763781767,0.0649691744754348,2.5110809014935e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SCARA5,Scavenger receptor class A member 5,40471,0.0318587774795276,0.00283084552958914,0.0263103202415329,0.0374072347175223,2.84523329835048e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.063619153788273,0.00565952333886521,0.0525264880440972,0.0747118195324488,3.45301005474724e-29
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM1,Intercellular adhesion molecule 1,40291,0.0309441261868855,0.00275432989325955,0.0255456395960968,0.0363426127776742,3.55020783619017e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CA4,Carbonic anhydrase 4,40536,-0.0253046987958187,0.00225650138551096,-0.0297274415114202,-0.0208819560802172,4.45609281970728e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0584408552545344,0.00521699733613666,0.0482155404757066,0.0686661700333623,5.10814294735107e-29
NMR metabolomics,X23408.Triglycerides in VLDL,WAS,Wiskott-Aldrich syndrome protein,40044,0.0737962114710771,0.00659483417629645,0.060870336485536,0.0867220864566181,5.88429373521574e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CXADR,Coxsackievirus and adenovirus receptor,40341,0.057339293141177,0.00512571562529738,0.0472928905155941,0.0673856957667598,6.08430660097697e-29
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN6,Dynactin subunit 6,39961,0.0764787735286358,0.00683804672356079,0.0630762019504567,0.089881345106815,6.28024814446688e-29
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0652960142608409,0.00583882821038594,0.0538519109684845,0.0767401175531974,6.60697063622138e-29
NMR metabolomics,X23408.Triglycerides in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0440886611392082,0.0039508708089128,0.0363449543537391,0.0518323679246772,8.70096978266032e-29
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR2,Interferon gamma receptor 2,40228,0.0555802934403867,0.00498455211305179,0.0458105712988052,0.0653500155819682,9.12012689493278e-29
NMR metabolomics,X23408.Triglycerides in VLDL,FST,Follistatin,40396,0.0559310214213192,0.00501817300402904,0.0460954023334223,0.0657666405092161,9.59816567259556e-29
NMR metabolomics,X23408.Triglycerides in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0750582593948791,0.00675372006359404,0.0618209680702348,0.0882955507195235,1.37522456549051e-28
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX,Glutaredoxin-1,40260,0.0606615414438683,0.00546790526435407,0.0499444471257343,0.0713786357620023,1.70705829769765e-28
NMR metabolomics,X23408.Triglycerides in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0347379450412878,0.00313358928220907,0.028596110048158,0.0408797800344176,1.95151437248998e-28
NMR metabolomics,X23408.Triglycerides in VLDL,HEPH,Hephaestin,37990,0.0268855627356026,0.00242700576924276,0.0221286314278868,0.0316424940433184,2.13234913321788e-28
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0531357286510259,0.004805815015194,0.0437163312212457,0.0625551260808061,2.5991043540085e-28
NMR metabolomics,X23408.Triglycerides in VLDL,IMPA1,Inositol monophosphatase 1,40228,0.064920017470743,0.00588391810629318,0.0533875379824083,0.0764524969590776,3.34138162007558e-28
NMR metabolomics,X23408.Triglycerides in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0624255084267241,0.00566068856369313,0.0513305588418855,0.0735204580115626,3.55308182019304e-28
NMR metabolomics,X23408.Triglycerides in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0609002658051071,0.00552245871926883,0.0500762467153402,0.071724284894874,3.72851220857309e-28
NMR metabolomics,X23408.Triglycerides in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.101196395368437,0.00920251833844019,0.0831594594250942,0.11923333131178,5.0188534100618e-28
NMR metabolomics,X23408.Triglycerides in VLDL,STX16,Syntaxin-16,39980,0.0627915688569882,0.00571023446729286,0.0515995093010942,0.0739836284128822,5.05028242602964e-28
NMR metabolomics,X23408.Triglycerides in VLDL,ARFIP1,Arfaptin-1,37959,0.0731637628679339,0.00665289107451565,0.0601240963618832,0.0862034293739845,5.17695465400423e-28
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0946955678405773,0.00861301333357453,0.0778140617067712,0.111577073974383,5.37112439671176e-28
NMR metabolomics,X23408.Triglycerides in VLDL,ADA,Adenosine deaminase,40516,0.0360508834074503,0.00328441838020081,0.0296134233822567,0.0424883434326439,6.241525839135e-28
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0358272742749069,0.00326996421659108,0.0294181444103884,0.0422364041394254,7.77911234617352e-28
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP1,Secreted frizzled-related protein 1,40178,0.0460801327751577,0.00420957778941757,0.0378293603078993,0.0543309052424162,8.70043895011265e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PIGR,Polymeric immunoglobulin receptor,40154,0.0372210719981574,0.00340044035034496,0.0305562089114812,0.0438859350848335,8.75522352647912e-28
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA4,Annexin A4,40279,0.0758122812676068,0.00692658670975736,0.0622361713164824,0.0893883912187313,8.82034103535108e-28
NMR metabolomics,X23408.Triglycerides in VLDL,FGL1,Fibrinogen-like protein 1,37987,-0.0664906839890933,0.00607728794702184,-0.0784021683652561,-0.0545791996129305,9.60531887148631e-28
NMR metabolomics,X23408.Triglycerides in VLDL,GRK5,G protein-coupled receptor kinase 5,40042,0.055481821363161,0.0050861279030641,0.0455130106731554,0.0654506320531667,1.32139550918929e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CCL15,C-C motif chemokine 15,40536,0.046848642942897,0.00429783137092224,0.0384248934558894,0.0552723924299046,1.43075884843497e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CCS,Copper chaperone for superoxide dismutase,40228,0.0508107905160139,0.00466381022569673,0.0416697224736483,0.0599518585583795,1.53136626863062e-27
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0433696147967427,0.00398042177328219,0.0355679881211097,0.0511712414723758,1.57416867925159e-27
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA1,BolA-like protein 1,37541,0.057824476113904,0.00531400791738762,0.0474090205958242,0.0682399316319837,1.85078814138572e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.122087506914024,0.0112699505237209,0.0999984038875307,0.144176609940517,3.11067590184805e-27
NMR metabolomics,X23408.Triglycerides in VLDL,TNF,Tumor necrosis factor,40014,0.0416418344551501,0.0038473954773169,0.0341009393196089,0.0491827295906912,3.33415743329879e-27
NMR metabolomics,X23408.Triglycerides in VLDL,APOL1,Apolipoprotein L1,37987,0.068101776302594,0.00629874801915431,0.0557562301850515,0.0804473224201364,3.90024761060304e-27
NMR metabolomics,X23408.Triglycerides in VLDL,COLEC12,Collectin-12,40357,0.0266115833392406,0.00246881364802535,0.0217727085891109,0.0314504580893703,5.35637681486229e-27
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB2,Dynein regulatory complex protein 8,37714,0.0362426624500977,0.00336882137762312,0.0296397725499564,0.042845552350239,6.99476426196999e-27
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFA2,BPI fold-containing family A member 2,37150,-0.115611565804593,0.0107599979383828,-0.136701161763823,-0.0945219698453623,8.19514611775423e-27
NMR metabolomics,X23408.Triglycerides in VLDL,DENR,Density-regulated protein,37598,0.0599033846995925,0.00558016386469951,0.0489662635247814,0.0708405058744035,8.99523659721161e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ENO2,Gamma-enolase,40471,0.0681356632980765,0.00635370382271513,0.0556824038055549,0.0805889227905981,9.70238494310943e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA2,Annexin A2,37441,0.0743387700042653,0.0069332425958954,0.0607496145163103,0.0879279254922202,1.03706310852488e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0435270765778033,0.00406183436055968,0.0355658812311063,0.0514882719245003,1.05490290055963e-26
NMR metabolomics,X23408.Triglycerides in VLDL,MET,Hepatocyte growth factor receptor,40375,-0.0207997044948432,0.00194169561671518,-0.024605427903605,-0.0169939810860815,1.10067598792214e-26
NMR metabolomics,X23408.Triglycerides in VLDL,ERI1,3'-5' exoribonuclease 1,37714,0.0349014989446594,0.00325822394731177,0.0285153800079283,0.0412876178813904,1.15152253794408e-26
NMR metabolomics,X23408.Triglycerides in VLDL,TF,Serotransferrin,38013,0.0226185103178065,0.00211191641481395,0.0184791541447711,0.0267578664908418,1.16838895775026e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0744807099549115,0.00696183146099841,0.0608355202913546,0.0881258996184684,1.28039518489798e-26
NMR metabolomics,X23408.Triglycerides in VLDL,AMOTL2,Angiomotin-like protein 2,37855,0.0498616447177017,0.00466036754863757,0.0407273243223721,0.0589959651130314,1.31629356645718e-26
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1F,V-type proton ATPase subunit F,39925,0.0683092659772862,0.00639102204024653,0.055782862778403,0.0808356691761694,1.42923704474428e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0251430414945617,0.00235347580743484,0.0205302289119894,0.029755854077134,1.49897578256348e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CTSB,Cathepsin B,40353,-0.0557116172486275,0.00521891437292753,-0.0659406894195654,-0.0454825450776895,1.63962607787415e-26
NMR metabolomics,X23408.Triglycerides in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0246547571070244,0.00231085342676529,0.0201254843905644,0.0291840298234844,1.74613150585046e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0696540874479463,0.00653015701200377,0.0568549797044189,0.0824531951914737,1.87012564644004e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PALM,Paralemmin-1,37824,0.0302671606690562,0.00283839221587901,0.0247039119259333,0.035830409412179,1.92628116500936e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS27,Serine protease 27,40314,0.0416115054535871,0.00390918953177168,0.0339494939713146,0.0492735169358596,2.26959208130502e-26
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE6,Ribonuclease K6,37917,0.0304111860090069,0.00285695729953876,0.0248115497019109,0.0360108223161029,2.35165653230271e-26
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP4,Secreted frizzled-related protein 4,37671,0.0431071377949835,0.00405359588333096,0.0351620898636548,0.0510521857263122,2.63608688556193e-26
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0961164951539791,0.00910391230355547,0.0782728270390104,0.113960163268948,5.71313541786054e-26
NMR metabolomics,X23408.Triglycerides in VLDL,KIF22,Kinesin-like protein KIF22,37562,0.125131316198673,0.0118487132012647,0.101907838324195,0.148354794073152,5.7594879272375e-26
NMR metabolomics,X23408.Triglycerides in VLDL,FXN,"Frataxin, mitochondrial",40489,0.0753926175673661,0.00714540253249581,0.0613876286036743,0.0893976065310579,6.09930923712363e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CDA,Cytidine deaminase,37970,0.0468483655437173,0.00444136460984061,0.0381432909084297,0.0555534401790049,6.52917182833697e-26
NMR metabolomics,X23408.Triglycerides in VLDL,TLR3,Toll-like receptor 3,40516,0.061917629167857,0.00588377708954395,0.0503854260723508,0.0734498322633631,8.17351255021155e-26
NMR metabolomics,X23408.Triglycerides in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0714111204061373,0.00679520486823749,0.0580925188643918,0.0847297219478828,9.92572291206472e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0298609104060354,0.00284582208466972,0.0242830991200828,0.0354387216919881,1.13146030749973e-25
NMR metabolomics,X23408.Triglycerides in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0528327990323042,0.00503525680992432,0.0429636956848525,0.0627019023797558,1.13292045591216e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0246666533847264,0.00235311544050286,-0.0292787596481121,-0.0200545471213408,1.25857643284306e-25
NMR metabolomics,X23408.Triglycerides in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0412297912973221,0.00393662242016115,0.0335140113538063,0.048945571240838,1.44310859894602e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0228421822838678,0.00218178622171622,0.018565881289304,0.0271184832784316,1.44416579733962e-25
NMR metabolomics,X23408.Triglycerides in VLDL,TREML1,Trem-like transcript 1 protein,37987,0.0534659472315295,0.00510676736796677,0.0434566831903146,0.0634752112727444,1.49129332372218e-25
NMR metabolomics,X23408.Triglycerides in VLDL,MAGED1,Melanoma-associated antigen D1,39980,0.0491406578612715,0.00469976212757034,0.0399291240912336,0.0583521916313094,1.67179629624466e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CPQ,Carboxypeptidase Q,37986,0.0370114113913764,0.00354034698178533,0.0300723313070772,0.0439504914756757,1.75319889262606e-25
NMR metabolomics,X23408.Triglycerides in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.062713198270785,0.00601428846881862,0.0509251928719005,0.0745012036696695,2.31964286937559e-25
NMR metabolomics,X23408.Triglycerides in VLDL,STK4,Serine/threonine-protein kinase 4,40359,0.0865254657451677,0.00830225512224716,0.0702530457055633,0.102797885784772,2.37652843602967e-25
NMR metabolomics,X23408.Triglycerides in VLDL,NCF2,Neutrophil cytosol factor 2,40324,0.0836612600074978,0.00803225121027589,0.0679180476353571,0.0994044723796386,2.53798668317826e-25
NMR metabolomics,X23408.Triglycerides in VLDL,TPR,Nucleoprotein TPR,37562,0.0472912575872764,0.00455059612655524,0.0383720891792281,0.0562104259953246,3.36638615084349e-25
NMR metabolomics,X23408.Triglycerides in VLDL,COL6A3,Collagen alpha-3(VI) chain,40536,0.0344382674398227,0.00331528237473707,0.0279403139853381,0.0409362208943074,3.3877124893696e-25
NMR metabolomics,X23408.Triglycerides in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0572708130906833,0.0055315010668518,0.0464290709996538,0.0681125551817128,4.86324616856489e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CCL24,C-C motif chemokine 24,40396,0.0827778201351586,0.00800894961301486,0.0670802788936495,0.0984753613766677,5.82735417586195e-25
NMR metabolomics,X23408.Triglycerides in VLDL,STX6,Syntaxin-6,39980,0.0688236601844716,0.00665863591969911,0.0557727337818613,0.0818745865870819,5.83534276844536e-25
NMR metabolomics,X23408.Triglycerides in VLDL,TPMT,Thiopurine S-methyltransferase,39980,0.0737701043616441,0.00715497836959947,0.0597463467572292,0.0877938619660591,7.61155447382746e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CASP8,Caspase-8,40434,0.0616126619368988,0.00598099863303814,0.0498899046161441,0.0733354192576536,8.30279888039106e-25
NMR metabolomics,X23408.Triglycerides in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0372545075270898,0.00361749640489221,0.0301642145735011,0.0443448004806785,8.57097595867656e-25
NMR metabolomics,X23408.Triglycerides in VLDL,NAA10,N-alpha-acetyltransferase 10,37562,0.0512521869188997,0.00497562628022271,0.0414999594096631,0.0610044144281362,8.69945580928678e-25
NMR metabolomics,X23408.Triglycerides in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0680795231572091,0.00662162277017148,0.055101142527673,0.0810579037867452,1.05416333933249e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SF3B4,Splicing factor 3B subunit 4,40305,0.0727645307951317,0.00708308707619003,0.0588816801257992,0.0866473814644642,1.1144982696157e-24
NMR metabolomics,X23408.Triglycerides in VLDL,STX7,Syntaxin-7,37598,0.0500980494810288,0.00487923378484349,0.0405347512627356,0.0596613476993221,1.22181115060237e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0268200448066556,0.00261316698239163,0.021698237521168,0.0319418520921432,1.26717667157957e-24
NMR metabolomics,X23408.Triglycerides in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.030130307469081,0.00293883618888356,0.0243701885388692,0.0358904263992927,1.42679106293861e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CHI3L1,Chitinase-3-like protein 1,40054,0.0735280303537482,0.00718942647742609,0.0594367544579931,0.0876193062495033,1.78859168474369e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR2,Asialoglycoprotein receptor 2,37987,0.025560778565937,0.00250383795579614,0.0206532561725766,0.0304683009592975,2.22306586266274e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.055456360274658,0.00543255227886636,0.0448085578080799,0.0661041627412361,2.24068504128721e-24
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.040754972808649,0.00399523771364027,0.0329243068899141,0.0485856387273839,2.33389522752929e-24
NMR metabolomics,X23408.Triglycerides in VLDL,GAST,Gastrin,37942,0.128596074931904,0.0126167879768473,0.103867170497283,0.153324979366524,2.62454495015073e-24
NMR metabolomics,X23408.Triglycerides in VLDL,C7,Complement component C7,37678,-0.031083207180097,0.00305166279914138,-0.0370644662664141,-0.0251019480937799,2.82435441479374e-24
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_E,,40341,0.028340906261147,0.00278512696406137,0.0228820574115867,0.0337997551107072,3.01775903153179e-24
NMR metabolomics,X23408.Triglycerides in VLDL,RPE,Ribulose-phosphate 3-epimerase,37714,0.06889595524787,0.00677747352434323,0.0556121071401572,0.0821798033555827,3.46913893787764e-24
NMR metabolomics,X23408.Triglycerides in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.030673665166992,0.00302500172462411,-0.0366026685472552,-0.0247446617867287,4.44170587260857e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ENAH,Protein enabled homolog,40044,0.0463695156827568,0.00457662113223853,0.0373993382635693,0.0553396931019443,4.73804765013916e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0446566695055014,0.00440989795979956,-0.0533000695067086,-0.0360132695042943,4.98440942504249e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CCL14,C-C motif chemokine 14,40309,0.0381307088330701,0.00376874822771832,0.0307439623067422,0.045517455359398,5.45843576910311e-24
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0402586744110877,0.00397984070395564,0.0324581866313346,0.0480591621908407,5.73584209973407e-24
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.0409552592238325,0.00405164519879525,0.0330140346341938,0.0488964838134712,6.01560906511816e-24
NMR metabolomics,X23408.Triglycerides in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0370089489225264,0.00366430863336391,0.0298269040011331,0.0441909938439197,6.53403743025159e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CDH5,Cadherin-5,40536,-0.0296547825762836,0.00293637195715698,-0.0354100716123113,-0.0238994935402559,6.56817391659965e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.024594203783674,0.00243634642361265,0.0198189647933932,0.0293694427739548,7.08256451793949e-24
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.027908606458478,0.00276787160859451,0.0224835781056328,0.0333336348113233,8.01795223722994e-24
NMR metabolomics,X23408.Triglycerides in VLDL,POMC,Pro-opiomelanocortin,37628,0.0666264703724528,0.00661504814685632,0.0536609760046145,0.0795919647402912,8.96032759751259e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC80,Coiled-coil domain-containing protein 80,40359,0.034091366776218,0.00339569233779115,0.0274358097941474,0.0407469237582887,1.20066472923347e-23
NMR metabolomics,X23408.Triglycerides in VLDL,LIPF,Gastric triacylglycerol lipase,37628,0.0581501080817058,0.00579597292153543,0.0467900011554964,0.0695102150079153,1.32863693080578e-23
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0556184315839813,0.005546801631764,0.0447467003857239,0.0664901627822387,1.36578811180527e-23
NMR metabolomics,X23408.Triglycerides in VLDL,BMP6,Bone morphogenetic protein 6,40024,0.0410153407714077,0.00409271994168552,0.0329936096857041,0.0490370718571114,1.44492042171647e-23
NMR metabolomics,X23408.Triglycerides in VLDL,OMD,Osteomodulin,40422,-0.0429276366438911,0.0042847309918029,-0.0513257093878248,-0.0345295638999574,1.4799603881228e-23
NMR metabolomics,X23408.Triglycerides in VLDL,SPAG1,Sperm-associated antigen 1,37959,0.0558996093604778,0.00558200802271736,0.0449588736359517,0.0668403450850038,1.59401898223838e-23
NMR metabolomics,X23408.Triglycerides in VLDL,HDGF,Hepatoma-derived growth factor,40471,0.0924018092253727,0.00923178430083442,0.0743075119957372,0.110496106455008,1.62989993088019e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CTSF,Cathepsin F,40411,0.0385832947985456,0.00386777866662113,0.0310024486119682,0.046164140985123,2.28257271463315e-23
NMR metabolomics,X23408.Triglycerides in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.088380722631574,0.00885749126274237,0.071020039756599,0.105741405506549,2.30102475313025e-23
NMR metabolomics,X23408.Triglycerides in VLDL,MARCO,Macrophage receptor MARCO,40359,0.0255851919169599,0.00256743870743598,0.0205530120503853,0.0306173717835344,2.53193642003962e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN1,Contactin-1,40536,-0.0265701475616803,0.00266975430908357,-0.0318028660074841,-0.0213374291158765,2.87764839635161e-23
NMR metabolomics,X23408.Triglycerides in VLDL,RPL14,60S ribosomal protein L14,37628,0.0397092765991848,0.00401130791593227,0.0318471130839575,0.047571440114412,5.04217811068797e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CAPG,Macrophage-capping protein,40185,0.0555011495371821,0.00560889879252597,0.0445077079038312,0.0664945911705331,5.09881675187712e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CCL20,C-C motif chemokine 20,40516,0.0846182902133792,0.00857246783342491,0.0678162532598664,0.101420327166892,6.46576650099947e-23
NMR metabolomics,X23408.Triglycerides in VLDL,PZP,Pregnancy zone protein,38013,0.0623320486787744,0.00631695101901981,0.0499508246814955,0.0747132726760532,6.88161429725092e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0301879174962455,0.00306195469963191,-0.036189348707524,-0.0241864862849669,7.28405208472914e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.108248577967192,0.010977194188425,0.086733277357879,0.129763878576505,7.32777514632916e-23
NMR metabolomics,X23408.Triglycerides in VLDL,DNM1,Dynamin-1,37901,0.108382139657317,0.0109921521572021,0.0868375214292012,0.129926757885433,7.42026160070902e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN4,Cerebellin-4,40489,0.0300103627437645,0.00304563668198411,0.0240409148470757,0.0359798106404533,7.68167105211596e-23
NMR metabolomics,X23408.Triglycerides in VLDL,INSL5,Insulin-like peptide INSL5,37901,0.0897225662604463,0.00910465392001785,0.0718774445772113,0.107567687943681,7.82506742963154e-23
NMR metabolomics,X23408.Triglycerides in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0619355625663931,0.00628872939545891,0.0496096529512936,0.0742614721814926,8.3270037829463e-23
NMR metabolomics,X23408.Triglycerides in VLDL,TXN,Thioredoxin,37819,0.0424596859032533,0.00431765975178207,0.0339970727897604,0.0509222990167462,9.60256708422046e-23
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP3,Syntaxin-binding protein 3,39980,0.0420136342739014,0.00427406947326186,0.0336364581063081,0.0503908104414946,9.75284223858832e-23
NMR metabolomics,X23408.Triglycerides in VLDL,KLB,Beta-klotho,39961,-0.0698571770591975,0.00711758654598334,-0.0838076466893248,-0.0559067074290701,1.1327754752638e-22
NMR metabolomics,X23408.Triglycerides in VLDL,DKK3,Dickkopf-related protein 3,40536,-0.0279389681709815,0.00284745476225532,-0.0335199795050019,-0.0223579568369611,1.15839245923635e-22
NMR metabolomics,X23408.Triglycerides in VLDL,PMM2,Phosphomannomutase 2,37562,0.0574669765485304,0.00586298862218197,0.0459755188490538,0.0689584342480071,1.32441468267388e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0499363265344668,0.00509768627949452,0.0399448614266576,0.0599277916422761,1.36371106186617e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR2,TGF-beta receptor type-2,40411,0.0298739485271504,0.00305160993651321,0.0238927930515845,0.0358551040027163,1.44488688705771e-22
NMR metabolomics,X23408.Triglycerides in VLDL,APRT,Adenine phosphoribosyltransferase,40216,0.0458396196763305,0.0046849547961228,0.0366571082759298,0.0550221310767312,1.52246215059631e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CCL19,C-C motif chemokine 19,40471,0.123875098170333,0.0126663557660719,0.0990490408688325,0.148701155471834,1.58877541095961e-22
NMR metabolomics,X23408.Triglycerides in VLDL,C7orf50,Uncharacterized protein C7orf50,37942,0.0207990576920749,0.0021283665219054,0.0166274593091403,0.0249706560750095,1.75773000476954e-22
NMR metabolomics,X23408.Triglycerides in VLDL,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0207269833892187,0.00212209954163259,0.0165676682876188,0.0248862984908186,1.80147186387744e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0242049645979124,0.00247799939585209,-0.0290618434137825,-0.0193480857820423,1.83290409369123e-22
NMR metabolomics,X23408.Triglycerides in VLDL,REG4,Regenerating islet-derived protein 4,40379,0.0458699061005582,0.00470337634577178,0.0366512884628455,0.0550885237382709,2.07839547463363e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL8,Interleukin-8,40209,0.0639323258729198,0.0065571920777698,0.051080229400491,0.0767844223453486,2.1351740141162e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TCOF1,Treacle protein,37990,0.0285480193128419,0.0029301709832647,0.0228048841856431,0.0342911544400407,2.34541935359822e-22
NMR metabolomics,X23408.Triglycerides in VLDL,AFP,Alpha-fetoprotein,40182,0.065451418066202,0.00672144837173255,0.0522773792576062,0.0786254568747978,2.40790517899689e-22
NMR metabolomics,X23408.Triglycerides in VLDL,GSR,"Glutathione reductase, mitochondrial",37944,0.0208852583744652,0.0021455436205561,0.0166799928781752,0.0250905238707552,2.55079502661189e-22
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0288044560363783,0.00296002934059358,0.0230027985288149,0.0346061135439417,2.62798414905308e-22
NMR metabolomics,X23408.Triglycerides in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0911505791837311,0.00937353088668359,0.0727784586458313,0.109522699721631,2.7422186071291e-22
NMR metabolomics,X23408.Triglycerides in VLDL,SMS,Spermine synthase,37541,0.0602788604102813,0.00620266199549374,0.0481216428991135,0.072436077921449,2.99798970050713e-22
NMR metabolomics,X23408.Triglycerides in VLDL,ASS1,Argininosuccinate synthase,37562,0.0754352297529991,0.0077866574262113,0.060173381197625,0.0906970783083732,4.0319698632651e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CBLIF,Cobalamin binding intrinsic factor,40330,0.0683211388583405,0.00705692734939527,0.0544895612535257,0.0821527164631552,4.16265907225031e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0507427713878253,0.00524223154688804,0.0404679975559248,0.0610175452197259,4.25021397243484e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LTA,Lymphotoxin-alpha,40341,0.037638498381811,0.00389214322714844,0.0300098976566001,0.045267099107022,4.63419676127394e-22
NMR metabolomics,X23408.Triglycerides in VLDL,NRP2,Neuropilin-2,40332,-0.0271867340532,0.0028117152177558,-0.0326976958800014,-0.0216757722263986,4.69283104156856e-22
NMR metabolomics,X23408.Triglycerides in VLDL,GRSF1,G-rich sequence factor 1,37402,0.0738797237636184,0.00765487388484145,0.0588761709493291,0.0888832765779076,5.75284217205144e-22
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX6,Peroxiredoxin-6,40489,-0.0557314890362825,0.00578296912829605,-0.0670661085277427,-0.0443968695448222,6.38663310886005e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS7_LGALS7B,Galectin-7,40270,0.0374319030433195,0.00388464550441325,0.0298179978546696,0.0450458082319695,6.4806708480437e-22
NMR metabolomics,X23408.Triglycerides in VLDL,AK1,Adenylate kinase isoenzyme 1,40359,0.0595344400602211,0.00617895651700115,0.0474236852868988,0.0716451948335433,6.52786345881007e-22
NMR metabolomics,X23408.Triglycerides in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.04470244740144,0.00464045810117878,0.0356071495231296,0.0537977452797504,6.810030549209e-22
NMR metabolomics,X23408.Triglycerides in VLDL,THBD,Thrombomodulin,40359,0.0258027125573056,0.0026826253697113,0.0205447668326714,0.0310606582819397,7.66300811016388e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CIT,Citron Rho-interacting kinase,37572,0.0420137931428812,0.00437020514921194,0.0334481910504258,0.0505793952353366,8.25931751093039e-22
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0322927522850461,0.00336041967151346,0.0257063297288797,0.0388791748412124,8.3456684106207e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LAMB1,Laminin subunit beta-1,37628,0.0274424103771468,0.0028633893071033,0.0218301673352243,0.0330546534190693,1.09978655206023e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0572997742817923,0.00598679539867045,0.0455656553003982,0.0690338932631864,1.24541712067745e-21
NMR metabolomics,X23408.Triglycerides in VLDL,MMP12,Macrophage metalloelastase,40346,0.0478965763365364,0.00500713172947151,0.0380825981467722,0.0577105545263005,1.27466479348439e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0507461173809838,0.00530614778632291,0.0403460677197909,0.0611461670421767,1.33163112997273e-21
NMR metabolomics,X23408.Triglycerides in VLDL,XRCC4,DNA repair protein XRCC4,39961,0.034335616205376,0.00360455489222473,0.0272706886166155,0.0414005437941365,1.87793889503525e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0499907621573615,0.00524757366383816,0.0397055177762387,0.0602760065384843,1.89986527617974e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0495466209389596,0.00521658698412945,0.0393221104500659,0.0597711314278533,2.50765377575746e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ELOB,Elongin-B,37562,0.0369508110539536,0.00389384953165107,0.0293188659719175,0.0445827561359897,2.71616485175678e-21
NMR metabolomics,X23408.Triglycerides in VLDL,DSCAM,Down syndrome cell adhesion molecule,37959,0.0323376856789386,0.00341599851718536,0.0256423285852553,0.0390330427726219,3.36510885676157e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SERPING1,Plasma protease C1 inhibitor,37981,0.0170586325258899,0.00180304124011476,0.013524671695265,0.0205925933565148,3.54505497146691e-21
NMR metabolomics,X23408.Triglycerides in VLDL,AGR2,Anterior gradient protein 2 homolog,39839,0.0927054669437887,0.00980752199240812,0.0734827238386687,0.111928210048909,3.77599451187519e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0302329140645945,0.00320017977134138,-0.0365052664164236,-0.0239605617127654,4.03976957912485e-21
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP1,Ran-specific GTPase-activating protein,37628,0.0486366995525152,0.00515488348666329,0.0385331279186552,0.0587402711863753,4.55337242715394e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ULBP2,UL16-binding protein 2,40228,0.0340049217844179,0.00360514832167285,0.0269388310739391,0.0410710124948967,4.55771336392805e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PSME2,Proteasome activator complex subunit 2,40152,0.0337845029747531,0.00358295672958148,0.0267619077847734,0.0408070981647328,4.696465815637e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0797926873778402,0.00846306409477596,0.0632050817520793,0.0963802930036011,4.84818057305378e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SCRIB,Protein scribble homolog,37628,0.0850181312481932,0.00902855223094749,0.0673221688755361,0.10271409362085,5.42417481842773e-21
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC1,WAP four-disulfide core domain protein 1,37653,0.049786429064135,0.0052895111974171,0.0394189871171975,0.0601538710110725,5.6472119184242e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0346769452964657,0.00368930682027424,0.0274459039287282,0.0419079866642032,6.38265665972408e-21
NMR metabolomics,X23408.Triglycerides in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0656655557617211,0.00700001169042883,0.0519455328484806,0.0793855786749616,7.4133230871867e-21
NMR metabolomics,X23408.Triglycerides in VLDL,NPPB,Natriuretic peptides B,40042,-0.116317950442389,0.0124243139106307,-0.140669605707225,-0.0919662951775524,8.8602590551533e-21
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0262533450957747,0.00280546849852994,0.0207546268386561,0.0317520633528934,9.19980913176143e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0719923610638955,0.00769275131883078,0.0569145684789872,0.0870701536488039,9.35439657343156e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PTN,Pleiotrophin,40042,0.0454376892482594,0.00485747483897116,0.0359170385638759,0.0549583399326429,9.54792612025819e-21
NMR metabolomics,X23408.Triglycerides in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0502984029669694,0.00538179692379103,0.039750080996339,0.0608467249375998,1.02875777685747e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0358813119731635,0.00385034456784534,0.0283346366201867,0.0434279873261404,1.35401800224426e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PRL,Prolactin,40471,-0.0691250562237067,0.00742168497147775,-0.0836715587678031,-0.0545785536796103,1.388532633971e-20
NMR metabolomics,X23408.Triglycerides in VLDL,EDF1,Endothelial differentiation-related factor 1,37959,0.0628267239411754,0.0067505776799629,0.0495955916884481,0.0760578561939027,1.51664800738156e-20
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0521961082784028,0.00561218033955288,0.0411962348128792,0.0631959817439264,1.57961838533715e-20
NMR metabolomics,X23408.Triglycerides in VLDL,APOA1,Apolipoprotein A-I,38013,-0.024865158431294,0.00267349055718636,-0.0301051999233793,-0.0196251169392088,1.6067353000131e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4D,C-type lectin domain family 4 member D,40341,0.0549119700356514,0.00591839518959517,0.0433119154640449,0.0665120246072579,1.94147679414438e-20
NMR metabolomics,X23408.Triglycerides in VLDL,BRK1,Protein BRICK1,39961,0.0396610361615862,0.00427679203490767,0.0312785237731672,0.0480435485500053,2.03321660558028e-20
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA4,Laminin subunit alpha-4,40422,0.0293207108415326,0.00317147569094519,0.0231046184872801,0.0355368031957852,2.64010348229706e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD2,Sushi domain-containing protein 2,40332,-0.0256064691460711,0.0027721233648784,-0.0310398309412328,-0.0201731073509095,2.84582077117516e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CNDP1,Beta-Ala-His dipeptidase,40403,0.0408018100680507,0.00441811824177306,0.0321422983141756,0.0494613218219259,2.89827785188858e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD6,MICOS complex subunit MIC25,37900,0.0259389223194687,0.00281241512504375,0.020426588674383,0.0314512559645545,3.31330097624777e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CLTA,Clathrin light chain A,40042,0.0422507071003134,0.00458590948495249,0.0332623245098066,0.0512390896908203,3.56266759982172e-20
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL1,Fc receptor-like protein 1,40359,0.0400798547476169,0.00435366591050133,0.0315466695630343,0.0486130399321995,3.79802606254929e-20
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS4,Galectin-4,40357,0.0469989418420588,0.00510711739361288,0.0369889917505775,0.05700889193354,3.91832827403469e-20
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0312238460472779,0.00339393728609238,0.0245717289665369,0.037875963128019,4.03043907389491e-20
NMR metabolomics,X23408.Triglycerides in VLDL,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0677218556478397,0.00736002281944539,0.0532962109217267,0.0821475003739526,4.05820461466702e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SLIT2,Slit homolog 2 protein,39961,0.046652379012614,0.00507687481763056,0.0367017043700581,0.0566030536551699,4.45028092494767e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PPME1,Protein phosphatase methylesterase 1,40305,0.0544079886804621,0.00592286660408287,0.0427991701364597,0.0660168072244645,4.56814875100168e-20
NMR metabolomics,X23408.Triglycerides in VLDL,COL2A1,Collagen alpha-1(II) chain,37628,0.0733213271053491,0.00798580133565697,0.0576691564874614,0.0889734977232367,4.87934815840717e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CRYGD,Gamma-crystallin D,37942,0.0853667363394111,0.00930701209448808,0.0671249926342145,0.103608480044608,5.29264667997979e-20
NMR metabolomics,X23408.Triglycerides in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0586441898778109,0.00640105272127068,0.0460981265441204,0.0711902532115015,5.71849068416438e-20
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0595516208394576,0.00651293498486332,0.0467862682691255,0.0723169734097897,6.92048248679588e-20
NMR metabolomics,X23408.Triglycerides in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0590985817006793,0.00647424059695486,0.0464090701306478,0.0717880932707109,7.93519088031786e-20
NMR metabolomics,X23408.Triglycerides in VLDL,STAM,Signal transducing adapter molecule 1,37900,0.0332331655943856,0.00364127516365696,0.026096266273618,0.0403700649151533,8.04768311582191e-20
NMR metabolomics,X23408.Triglycerides in VLDL,DPT,Dermatopontin,40536,0.0233676154088738,0.00256116070932444,0.0183477404185979,0.0283874903991497,8.09336858323592e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0488036991138251,0.00537577938841049,0.0382671715125406,0.0593402267151097,1.25506586848174e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CD248,Endosialin,37998,-0.0352613542587117,0.00388689808226888,-0.0428796744999587,-0.0276430340174647,1.32926901657134e-19
NMR metabolomics,X23408.Triglycerides in VLDL,AHCY,Adenosylhomocysteinase,40359,0.0594215558144173,0.00655377378133945,0.046576159202992,0.0722669524258426,1.36635690317225e-19
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0288748710241046,0.00318598393269525,0.0226303425160219,0.0351193995321873,1.41147685505622e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ECI2,Enoyl-CoA delta isomerase 2,37562,0.055142890172707,0.00608923377371413,0.0432079919762273,0.0670777883691867,1.54515516194377e-19
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.044104900458329,0.00487381050424401,0.0345522318700107,0.0536575690466472,1.63729646380574e-19
NMR metabolomics,X23408.Triglycerides in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0173927255396917,0.00192279732641346,-0.0211614082994621,-0.0136240427799213,1.65886035611636e-19
NMR metabolomics,X23408.Triglycerides in VLDL,BAX,Apoptosis regulator BAX,39934,0.078180447963582,0.00864290498804957,0.0612403541870049,0.0951205417401592,1.66178519563066e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0415028739100909,0.004603263567847,0.0324804773171107,0.050525270503071,2.21078122328631e-19
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0363314831819703,0.00402953421623451,0.0284335961181507,0.04422937024579,2.21104500874801e-19
NMR metabolomics,X23408.Triglycerides in VLDL,SNX5,Sorting nexin-5,37628,0.0262049393510421,0.00291032892485022,0.0205006946583357,0.0319091840437486,2.46914431256474e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PER3,Period circadian protein homolog 3,37598,0.10301603044989,0.0114562448050617,0.0805617906319686,0.125470270267811,2.75290029278987e-19
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0270748812167514,0.00301796785287371,0.0211596642251189,0.0329900982083839,3.25078118783434e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK1D,Casein kinase I isoform delta,37598,0.0552893564972383,0.00618357977969871,0.0431695401290288,0.0674091728654477,4.35353213189519e-19
NMR metabolomics,X23408.Triglycerides in VLDL,BST2,Bone marrow stromal antigen 2,40471,0.046280268192879,0.00518003134145406,0.036127406763629,0.0564331296221289,4.53327412152982e-19
NMR metabolomics,X23408.Triglycerides in VLDL,FAP,Prolyl endopeptidase FAP,40536,0.0233572463565997,0.00261619800471034,0.0182294982673674,0.028484994445832,4.80106267602978e-19
NMR metabolomics,X23408.Triglycerides in VLDL,IL6R,Interleukin-6 receptor subunit alpha,40273,0.0290519212401385,0.00325586332279264,0.022670429127465,0.0354334133528121,5.02929978852731e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0307269017638194,0.00345095032206645,0.0239630391325691,0.0374907643950696,6.09187733978901e-19
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX1,Heme oxygenase 1,40184,-0.040328470774921,0.00453643719675444,-0.0492198876805597,-0.0314370538692823,6.76924728868378e-19
NMR metabolomics,X23408.Triglycerides in VLDL,APOC1,Apolipoprotein C-I,37981,0.0311929463571154,0.00351064834098225,0.0243120756087902,0.0380738171054406,7.17452792860008e-19
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0326525751563598,0.00368627860439818,0.0254274690917393,0.0398776812209802,9.05209620477541e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL1,Angiopoietin-related protein 1,40136,0.0252750668666767,0.00285999037421017,0.0196694857332248,0.0308806480001286,1.08144535036738e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0348215661212895,0.00394413269242897,0.0270910660441287,0.0425520661984503,1.16987593551344e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR3,Small proline-rich protein 3,37942,0.0609519644495929,0.00690838045348142,0.0474115387607693,0.0744923901384165,1.25089521163025e-18
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0246808608013506,0.00279993804885842,0.0191929822255881,0.0301687393771131,1.32147473282287e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PRG2,Bone marrow proteoglycan,37998,-0.0445796201452107,0.00506578751533631,-0.0545085636752698,-0.0346506766151515,1.53012914488677e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI2,Serpin I2,37901,0.047662115779611,0.0054277937491158,0.037023640031344,0.0583005915278779,1.81205238559508e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0622116677346345,0.00708743152665492,0.0483203019423909,0.0761030335268782,1.8392826231126e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB2,Plexin-B2,40472,0.019769118639428,0.0022555731661458,0.0153481952337822,0.0241900420450738,2.06013604620786e-18
NMR metabolomics,X23408.Triglycerides in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0353370159026948,0.0040410535348915,0.0274165509743074,0.0432574808310821,2.50359661256788e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CBS,Cystathionine beta-synthase,37628,0.0429497726489273,0.00492984102312475,0.0332872842436028,0.0526122610542518,3.33263387837207e-18
NMR metabolomics,X23408.Triglycerides in VLDL,BSG,Basigin,40502,0.0169905559214216,0.00195330213694164,0.013162083733016,0.0208190281098272,3.68826302364067e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CASP9,Caspase-9,37598,0.0526182159872786,0.00606216571336054,0.040736371189092,0.0645000607854653,4.42837988554604e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0275245932670072,0.00317198869258567,-0.0337416911044751,-0.0213074954295393,4.50706029388736e-18
NMR metabolomics,X23408.Triglycerides in VLDL,S100A12,Protein S100-A12,40139,0.0640285985288733,0.00739915011246564,0.0495262643084407,0.078530932749306,5.47228310841534e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CRYM,Ketimine reductase mu-crystallin,37541,0.0646172769095629,0.00748449349526805,0.0499476696588376,0.0792868841602883,6.63319295196483e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CLGN,Calmegin,37572,0.0372140759706246,0.0043132936097559,0.0287600204955031,0.0456681314457462,6.96985195983145e-18
NMR metabolomics,X23408.Triglycerides in VLDL,MSTN,Growth/differentiation factor 8,40042,0.0426420360598625,0.00494994838442594,0.0329401372263877,0.0523439348933374,7.6797927112085e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0382343194176863,0.00443946288358404,0.0295329721658615,0.046935666669511,7.83535368349559e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.028761286324741,0.00333974613288183,0.0222153839042926,0.0353071887451894,7.8593819878144e-18
NMR metabolomics,X23408.Triglycerides in VLDL,GDF2,Growth/differentiation factor 2,40359,0.029735914422303,0.00345515256087018,0.0229638154029975,0.0365080134416086,8.24536567894503e-18
NMR metabolomics,X23408.Triglycerides in VLDL,DPP7,Dipeptidyl peptidase 2,40251,0.0482381050152065,0.0056082393236695,0.0372459559408143,0.0592302540895987,8.61313284734393e-18
NMR metabolomics,X23408.Triglycerides in VLDL,HRG,Histidine-rich glycoprotein,37934,0.0262833868127802,0.00305599798103592,0.0202936307699498,0.0322731428556106,8.79824763456358e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0488924493476231,0.00569366443417214,0.0377328670566457,0.0600520316386005,9.89029597549818e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SPTLC1,Serine palmitoyltransferase 1,37942,0.0299252059575242,0.00348550657193224,0.023093613076537,0.0367567988385114,1.00160939602991e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0363665948060259,0.00423852252766166,0.028059090651809,0.0446740989602428,1.03722786016138e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0522404572870044,0.00610051013977831,0.0402834574130389,0.0641974571609699,1.19635414821811e-17
NMR metabolomics,X23408.Triglycerides in VLDL,MMP3,Stromelysin-1,40332,-0.0400006339056445,0.00467946942835312,-0.0491723939852166,-0.0308288738260723,1.36364387957819e-17
NMR metabolomics,X23408.Triglycerides in VLDL,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0435701033154505,0.00510357174274676,-0.0535731039312341,-0.0335671026996669,1.49837946873786e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL4,ADAMTS-like protein 4,37628,0.0194824189889351,0.0022820784895313,0.0150095451494538,0.0239552928284165,1.52538348625811e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD300E,CMRF35-like molecule 2,40436,0.0329628864279773,0.00386583578005765,0.0253858482990643,0.0405399245568903,1.6386508976088e-17
NMR metabolomics,X23408.Triglycerides in VLDL,VCAM1,Vascular cell adhesion protein 1,40372,-0.0222638813180531,0.00261500998682067,-0.0273893008922216,-0.0171384617438846,1.83042669953156e-17
NMR metabolomics,X23408.Triglycerides in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0317867709329867,0.00374749984567177,-0.0391318706305033,-0.02444167123547,2.40355698205481e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA3,Protein disulfide-isomerase A3,37671,0.0210175852736051,0.00248007273823443,0.0161566427066656,0.0258785278405445,2.60703277656349e-17
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.040925851779138,0.00483325688123268,0.0314526682919219,0.0503990352663541,2.76177689197953e-17
NMR metabolomics,X23408.Triglycerides in VLDL,DAPK2,Death-associated protein kinase 2,37598,0.0430438130542097,0.00508368007480991,0.0330798001075823,0.0530078260008371,2.78162316442824e-17
NMR metabolomics,X23408.Triglycerides in VLDL,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0216791119619047,0.00256317636668974,0.0166552862831928,0.0267029376406166,3.00070686817118e-17
NMR metabolomics,X23408.Triglycerides in VLDL,C5,Complement C5,38013,0.0125440062777468,0.00148332907516455,0.00963668129042432,0.0154513312650694,3.03046045664568e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0538587431670951,0.00637569785148898,0.0413623753781767,0.0663551109560135,3.278932146448e-17
NMR metabolomics,X23408.Triglycerides in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0684889826428625,0.00811036253396433,0.0525926720762924,0.0843852932094326,3.3174856735113e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0413033025302584,0.00489048436383537,0.0317179531771411,0.0508886518833757,3.33790399665472e-17
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0388803524953011,0.00461947956204715,0.0298261725536887,0.0479345324369135,4.21120596082979e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0360611403712151,0.00428619472658507,-0.0444620820353219,-0.0276601987071084,4.31964424261898e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD300A,CMRF35-like molecule 8,37671,0.0241578522182808,0.00287190960279764,0.0185289093967974,0.0297867950397642,4.4499671502857e-17
NMR metabolomics,X23408.Triglycerides in VLDL,APOBR,Apolipoprotein B receptor,37628,-0.0346221025101746,0.00411851248012802,-0.0426943869712255,-0.0265498180491237,4.65657860665448e-17
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0467744923694694,0.0055710160552351,0.0358553009012086,0.0576936838377301,5.07620761454783e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD93,Complement component C1q receptor,39725,-0.025637904687095,0.00305605291750249,-0.0316277684053999,-0.0196480409687901,5.31783725382027e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SBSN,Suprabasin,37977,-0.0273445423235279,0.00326149895993117,-0.033737080284993,-0.0209520043620628,5.61582231479267e-17
NMR metabolomics,X23408.Triglycerides in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0304755033155256,0.00363883457360799,0.0233433875512539,0.0376076190797972,5.98589465718006e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CTSC,Dipeptidyl peptidase 1,40349,0.0344416084281222,0.00411978767498066,0.0263668245851601,0.0425163922710843,6.78328993339754e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA7,Thyroxine-binding globulin,38013,0.0151090098858778,0.00181422545433986,0.0115531279953717,0.018664891776384,8.9985890758878e-17
NMR metabolomics,X23408.Triglycerides in VLDL,KITLG,Kit ligand,40359,-0.0292917088792909,0.00352068747472823,-0.0361922563297582,-0.0223911614288236,9.51208514862092e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0444432838779866,0.00534661748903249,0.0339639135994829,0.0549226541564903,1.01201015202848e-16
NMR metabolomics,X23408.Triglycerides in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0389956941559175,0.00470605857302559,0.0297718193527874,0.0482195689590476,1.26096574205886e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0273905476066681,0.00330663857405204,-0.03387155921181,-0.0209095360015261,1.29237861751469e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0391022168845743,0.00472231751309488,0.0298464745589083,0.0483579592102402,1.32538831696188e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CSDE1,Cold shock domain-containing protein E1,37562,0.0940786503471658,0.0113625939779118,0.0718079661504587,0.116349334543873,1.35393610535071e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CX3CL1,Fractalkine,40228,-0.0273437966621159,0.00330821069258105,-0.0338278896195747,-0.020859703704657,1.50162450441169e-16
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.029653745131441,0.00358849730029367,0.0226202904228654,0.0366871998400166,1.54736439275996e-16
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL3,Follistatin-related protein 3,40293,0.0249726561388255,0.00302315603626265,0.0190472703077507,0.0308980419699003,1.56478984525875e-16
NMR metabolomics,X23408.Triglycerides in VLDL,MPO,Myeloperoxidase,40332,0.0373032042556946,0.00452797329077549,0.0284283766057746,0.0461780319056146,1.88032819013779e-16
NMR metabolomics,X23408.Triglycerides in VLDL,MATN2,Matrilin-2,40379,0.0236383043227626,0.00287138900120454,0.0180103818804017,0.0292662267651235,1.97661382351157e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SEL1L,Protein sel-1 homolog 1,37628,0.0259197861307502,0.00315396714551582,0.0197380105255392,0.0321015617359612,2.25849466800447e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS22,Brain-specific serine protease 4,37598,0.0281888770869344,0.00343402567385716,0.0214581867661743,0.0349195674076944,2.44314406020797e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0192076827799577,0.00234328713421875,-0.0238005255630265,-0.014614839996889,2.6509923068076e-16
NMR metabolomics,X23408.Triglycerides in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0511566104486172,0.00624472669552984,0.0389169461253787,0.0633962747718557,2.76871122278286e-16
NMR metabolomics,X23408.Triglycerides in VLDL,LBP,Lipopolysaccharide-binding protein,40403,-0.0461193500177207,0.00563361768509787,-0.0571612406805126,-0.0350774593549289,2.89202111514456e-16
NMR metabolomics,X23408.Triglycerides in VLDL,FRZB,Secreted frizzled-related protein 3,40176,0.0210704028362649,0.00257841188102713,0.0160167155494518,0.0261240901230781,3.26623836879474e-16
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1B,Meprin A subunit beta,40359,0.0935430245796909,0.0114523631863737,0.0710963927343984,0.115989656424983,3.36867434141164e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0177267502519123,0.00217260927594408,0.0134684360710619,0.0219850644327627,3.66794226178038e-16
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0356253696308468,0.00436950631693216,0.0270611372496598,0.0441896020120338,3.80716477766459e-16
NMR metabolomics,X23408.Triglycerides in VLDL,BRDT,Bromodomain testis-specific protein,37562,0.0293974873824599,0.00361469128657286,0.0223126924607771,0.0364822823041427,4.57073412173965e-16
NMR metabolomics,X23408.Triglycerides in VLDL,S100A14,Protein S100-A14,37959,0.0424452726637147,0.00522401309654271,0.0322062069944909,0.0526843383329384,4.85864800613784e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CD1C,T-cell surface glycoprotein CD1c,40411,0.0188127038310679,0.00231636117578523,0.0142726359265288,0.0233527717356069,4.93191796870114e-16
NMR metabolomics,X23408.Triglycerides in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0203009485665153,0.00250084105101624,0.0153993001065235,0.0252025970265071,5.09682151350037e-16
NMR metabolomics,X23408.Triglycerides in VLDL,GRN,Progranulin,40262,0.0190365121394015,0.00235024989771892,0.0144300223398724,0.0236430019389305,5.90457116837867e-16
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC1,MANSC domain-containing protein 1,40411,-0.0214860187817957,0.00265366671381975,-0.0266872055408824,-0.0162848320227089,6.05006397403319e-16
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0298399828755862,0.0036857847333858,0.02261584479815,0.0370641209530224,6.09788525806187e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CA2,Carbonic anhydrase 2,40291,0.0548908094778956,0.00684422189111381,0.0414761345713125,0.0683054843844787,1.13068071230924e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CST5,Cystatin-D,40070,0.0427565014727341,0.00534007153525618,0.0322899612636319,0.0532230416818362,1.26044195856414e-15
NMR metabolomics,X23408.Triglycerides in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0304259818695117,0.00380370801478988,0.0229707141605235,0.0378812495784998,1.35847644363548e-15
NMR metabolomics,X23408.Triglycerides in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0790525460053549,0.00989117521509391,0.0596658425837708,0.0984392494269389,1.43263895690447e-15
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0423568561929463,0.00531229846240867,0.0319447512066253,0.0527689611792673,1.64882433751763e-15
NMR metabolomics,X23408.Triglycerides in VLDL,AGT,Angiotensinogen,37987,0.0187418840370945,0.00235037297341835,0.0141351530091945,0.0233486150649944,1.65871904303642e-15
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL2,Fc receptor-like protein 2,40442,0.0375456422162122,0.004711316808058,0.0283114612724185,0.0467798231600058,1.70343722021866e-15
NMR metabolomics,X23408.Triglycerides in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0362994597699631,0.00456164553388397,0.0273586345235505,0.0452402850163757,1.87591908441539e-15
NMR metabolomics,X23408.Triglycerides in VLDL,DHPS,Deoxyhypusine synthase,37900,0.0317942504694867,0.00399722737662887,0.0239596848112941,0.0396288161276793,1.94823131764167e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0374994904997567,0.0047302019103624,0.0282282947554464,0.046770686244067,2.38327608782747e-15
NMR metabolomics,X23408.Triglycerides in VLDL,C2orf69,UPF0565 protein C2orf69,37572,0.0464223061610829,0.00585463922640271,0.0349472132773336,0.0578973990448322,2.38422595315822e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ALCAM,CD166 antigen,40536,0.0148642081444514,0.00187725326938516,0.0111847917364565,0.0185436245524463,2.56894508866751e-15
NMR metabolomics,X23408.Triglycerides in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.02141062818758,0.00270542955668962,0.0161079862564683,0.0267132701186917,2.65607226287615e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CD276,CD276 antigen,40357,-0.0275493432635963,0.00348324335881977,-0.034376500246883,-0.0207221862803095,2.76181244237546e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CD28,T-cell-specific surface glycoprotein CD28,39980,0.027557872500236,0.00348504419674062,0.0207271858746244,0.0343885591258476,2.80256152421102e-15
NMR metabolomics,X23408.Triglycerides in VLDL,RHOC,Rho-related GTP-binding protein RhoC,40152,0.088785877443635,0.0112333036544559,0.0667686022809013,0.110803152606369,2.88373122536344e-15
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP8,GTPase IMAP family member 8,37482,0.0395964930475604,0.00502603001888513,0.0297454742105456,0.0494475118845753,3.5812902021685e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0505774276505695,0.00642750560466317,0.0379795166654297,0.0631753386357093,3.80654742612169e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0364307620799237,0.0046355725761716,0.0273450398306274,0.04551648432922,4.12628106506659e-15
NMR metabolomics,X23408.Triglycerides in VLDL,IL6,Interleukin-6,40305,0.0554430892488488,0.00705839161534712,0.0416086416827684,0.0692775368149292,4.25537686641064e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SNX2,Sorting nexin-2,37900,0.0594181938586909,0.00757085369875183,0.0445793206091373,0.0742570671082445,4.53528401757314e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CD80,T-lymphocyte activation antigen CD80,37990,0.0258901577535104,0.00330349744490129,0.0194153027615039,0.0323650127455169,4.94966361733124e-15
NMR metabolomics,X23408.Triglycerides in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0328025258378407,0.00418629607608823,0.0245973855287078,0.0410076661469736,5.01970470970142e-15
NMR metabolomics,X23408.Triglycerides in VLDL,FABP6,Gastrotropin,40017,0.0423829338145885,0.00541029533507384,0.0317787549578438,0.0529871126713332,5.03936306817861e-15
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0293530831553143,0.00375672698963104,0.0219898982556375,0.0367162680549912,5.91052856647787e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0182428969055866,0.00234280371804752,0.0136510016182134,0.0228347921929597,7.29971805453819e-15
NMR metabolomics,X23408.Triglycerides in VLDL,LACRT,Extracellular glycoprotein lacritin,37863,0.0401402600819915,0.00517109708319094,0.0300049097989373,0.0502756103650458,8.93347242629747e-15
NMR metabolomics,X23408.Triglycerides in VLDL,KLK7,Kallikrein-7,37352,0.0291983526786931,0.00376675870677628,0.0218155056134115,0.0365811997439746,9.75330977564914e-15
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFD,Vascular endothelial growth factor D,40483,-0.0249590953800557,0.00322290818406599,-0.031275995420825,-0.0186421953392863,1.01847316075628e-14
NMR metabolomics,X23408.Triglycerides in VLDL,COPB2,Coatomer subunit beta',37562,0.0324832014298671,0.00419670324486886,0.0242576630699242,0.0407087397898101,1.06535126765147e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SCT,Secretin,37572,0.0345296057641667,0.00446342163288656,0.025781299363709,0.0432779121646244,1.09953921147868e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CD300C,CMRF35-like molecule 6,40471,0.025520635814105,0.00330146534637233,0.0190497637352153,0.0319915078929948,1.1382059384494e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CR1,Complement receptor type 1,37959,0.0271775199687626,0.00351609200856414,0.0202859796319769,0.0340690603055483,1.15603592520253e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PPL,Periplakin,37598,0.0247767966848583,0.00320565205373703,0.0184937186595337,0.0310598747101829,1.16155214610279e-14
NMR metabolomics,X23408.Triglycerides in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0265449831895922,0.00344026297281255,0.0198020677628796,0.0332878986163048,1.27181684733394e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0312222565052757,0.00405558688390074,-0.0391712067977211,-0.0232733062128302,1.45673759319219e-14
NMR metabolomics,X23408.Triglycerides in VLDL,RGMB,RGM domain family member B,40471,0.0193259232679182,0.00251338182152696,0.0143996948977254,0.0242521516381111,1.56611139864161e-14
NMR metabolomics,X23408.Triglycerides in VLDL,RBP2,Retinol-binding protein 2,40305,-0.0565026757079872,0.00736307279498656,-0.0709342983861608,-0.0420710530298135,1.76674100684455e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN3,Calsyntenin-3,37942,0.0227308374229881,0.00296855523771403,0.0169124691570686,0.0285492056889076,2.02921824097257e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CCL21,C-C motif chemokine 21,40422,0.0314745619447967,0.00411441297758987,0.0234103125087206,0.0395388113808729,2.12685388675093e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ZBP1,Z-DNA-binding protein 1,37598,0.0299215761682172,0.00391210445681956,0.0222538514328509,0.0375893009035836,2.1751405951482e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CA6,Carbonic anhydrase 6,40295,-0.0472228869355765,0.00617756593555564,-0.0593309161692655,-0.0351148577018874,2.22169796387711e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IL18BP,Interleukin-18-binding protein,40403,0.0223926068834369,0.00295120786935003,0.0166082394595108,0.0281769743073629,3.43813201937716e-14
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0302782726486667,0.00400357232789532,0.0224312708859919,0.0381252744113415,4.20711213572544e-14
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0251196980109869,0.00332224840664916,-0.0316313048880192,-0.0186080911339545,4.21561670777174e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.0190021280801634,0.00251534768489377,-0.0239322095425552,-0.0140720466177716,4.47468839780019e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0167323134205035,0.00221566268099905,0.0123896145657454,0.0210750122752616,4.52170183719541e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0208127330694225,0.00275635938579665,-0.026215197465584,-0.0154102686732611,4.56002381102349e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0407181850289499,0.00540120500391228,0.0301318232212819,0.051304546836618,5.05743513944113e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1,Macrophage colony-stimulating factor 1,40422,0.0197395544602805,0.00262009644572189,0.0146041654266656,0.0248749434938955,5.18777836575757e-14
NMR metabolomics,X23408.Triglycerides in VLDL,DGKZ,Diacylglycerol kinase zeta,40044,0.0255788940666837,0.00339671929384839,0.0189213242507409,0.0322364638826266,5.33223959537337e-14
NMR metabolomics,X23408.Triglycerides in VLDL,INSR,Insulin receptor,37598,0.0123396666633307,0.00164128240725508,0.00912275314511078,0.0155565801815507,5.90812076973352e-14
NMR metabolomics,X23408.Triglycerides in VLDL,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0278861399228269,0.00371038351962663,0.0206137882243587,0.0351584916212951,5.96936853239471e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.0195037964734753,0.00260107107670813,-0.0246018957838232,-0.0144056971631273,6.8018204370496e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0274987824669675,0.00366935962392757,0.0203068376040695,0.0346907273298655,7.01987250416022e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L2,Seizure 6-like protein 2,40305,-0.0171650810321658,0.00229810637938066,-0.0216693695357519,-0.0126607925285797,8.48626962609902e-14
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR2,Folate receptor beta,40471,-0.0212640842409966,0.00285246779462091,-0.0268549211184536,-0.0156732473635396,9.47241868499813e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0323574631646676,0.00434404389908791,0.0238431371224553,0.0408717892068799,1.00143093986032e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR2,Complement factor H-related protein 2,37911,0.0413156218553608,0.00554809180351752,0.0304413619204665,0.0521898817902552,1.01431348821981e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CD209,CD209 antigen,40382,-0.0279603063404914,0.00376284938637604,-0.0353354911377884,-0.0205851215431943,1.13568642954553e-13
NMR metabolomics,X23408.Triglycerides in VLDL,VGF,Neurosecretory protein VGF,37959,0.0219976819643554,0.00296162081048409,0.0161929051758066,0.0278024587529042,1.17228984550516e-13
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA1,Ephrin-A1,40303,0.0196246226153506,0.0026452595847912,0.0144399138291599,0.0248093314015414,1.24179796393443e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CDH1,Cadherin-1,39806,0.02878764115508,0.00388329836027239,0.0211763763689461,0.0363989059412138,1.29723030992122e-13
NMR metabolomics,X23408.Triglycerides in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0328219416302524,0.00443688980477487,0.0241256376128937,0.0415182456476112,1.4719581556363e-13
NMR metabolomics,X23408.Triglycerides in VLDL,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0552122202589172,0.00748200848950255,-0.0698769568983421,-0.0405474836194922,1.66940912394436e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CFC1,Cryptic protein,39980,0.0329416536438728,0.00447206817261418,0.024176400025549,0.0417069072621966,1.84533692105715e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN2,Calsyntenin-2,40516,-0.0278392588539457,0.00377986747075166,-0.0352477990966189,-0.0204307186112724,1.85542074675866e-13
NMR metabolomics,X23408.Triglycerides in VLDL,S100A11,Protein S100-A11,40207,0.032006224799446,0.0043510575860449,0.023478151930798,0.040534297668094,1.98884805388713e-13
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE3,Eosinophil cationic protein,40288,0.0772618901969579,0.0105156860857458,0.0566511454688962,0.0978726349250197,2.12109631008354e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CD101,Immunoglobulin superfamily member 2,37901,0.030342266948512,0.00412932804977953,0.0222487839709441,0.0384357499260799,2.12803607205212e-13
NMR metabolomics,X23408.Triglycerides in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0171649787414996,0.00233728258640309,0.0125839048721495,0.0217460526108496,2.17377138720998e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CRH,Corticoliberin,39947,0.0617180262353401,0.00841833321759982,0.0452180931288445,0.0782179593418358,2.39042836864012e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1,Programmed cell death protein 1,40455,0.0310507269945903,0.00423844024333384,0.0227433841176559,0.0393580698715246,2.48462773604539e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CD59,CD59 glycoprotein,39665,0.0160182905237929,0.00218748307920906,0.0117308236885431,0.0203057573590426,2.55199397819084e-13
NMR metabolomics,X23408.Triglycerides in VLDL,GPR15L,Protein GPR15L,37901,0.0427619372465792,0.00585472065236184,0.03128668476795,0.0542371897252084,2.95402037831747e-13
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB2,Lamin-B2,37942,0.0193986336715736,0.00265653900537892,0.0141918172210309,0.0246054501221163,2.98914606669814e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM4,Intercellular adhesion molecule 4,40341,-0.0372836344711755,0.005109258601144,-0.0472977813294177,-0.0272694876129332,3.07545367671954e-13
NMR metabolomics,X23408.Triglycerides in VLDL,NFIC,Nuclear factor 1 C-type,37959,0.0309410924896255,0.00423969105557404,0.0226312980207004,0.0392508869585506,3.08473661522825e-13
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP5,Vesicle-associated membrane protein 5,40042,0.0395533211072419,0.0054267492222614,0.0289168926316096,0.0501897495828743,3.28248501155271e-13
NMR metabolomics,X23408.Triglycerides in VLDL,HEPACAM2,HEPACAM family member 2,37942,-0.0287938651123238,0.00395527797253662,-0.0365462099384956,-0.021041520286152,3.52661087226588e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PVALB,Parvalbumin alpha,40417,0.0794464655078369,0.0109424992467893,0.0579991669841299,0.100893764031544,4.03856403645189e-13
NMR metabolomics,X23408.Triglycerides in VLDL,LYZL2,Lysozyme-like protein 2,37482,0.025244859630497,0.00348532554517979,0.0184136215619447,0.0320760976990494,4.62889533045168e-13
NMR metabolomics,X23408.Triglycerides in VLDL,OSM,Oncostatin-M,40268,0.0505487242068848,0.00702062730266841,0.0367882946936547,0.0643091537201149,6.29080143915716e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA11,Integrin alpha-11,40341,-0.0237140722802148,0.00329763604631933,-0.0301774389310007,-0.0172507056294289,6.70696420258548e-13
NMR metabolomics,X23408.Triglycerides in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0181559270308966,0.00252795537965416,0.0132011344867744,0.0231107195750187,7.22784470180512e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PI3,Elafin,40074,0.0372352466706629,0.00518787239825538,0.0270670167700823,0.0474034765712434,7.42658507225466e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ALPP,"Alkaline phosphatase, placental type",40305,0.0715587532172049,0.00997065536173884,0.0520162687081968,0.091101237726213,7.44501268239999e-13
NMR metabolomics,X23408.Triglycerides in VLDL,C4BPB,C4b-binding protein beta chain,40411,0.0286146436800169,0.00399328715730957,0.0207878008516901,0.0364414865083436,8.0782731836762e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0354641306292169,0.0049567914174267,0.0257488194510606,0.0451794418073732,8.76331456018259e-13
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0230792992720756,0.00322722037896336,0.0167539473293074,0.0294046512148438,9.03042940970881e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO1,Roundabout homolog 1,40379,0.0166503651101756,0.00233130013985737,0.0120810168360552,0.0212197133842961,9.58950710484416e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PGA4,Pepsin A-4,37987,0.0470615939244788,0.00660334228582244,0.0341190430442668,0.0600041448046908,1.07824436541719e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC3B,Tetranectin,37681,0.0145631933421387,0.00204685434347966,0.0105513588289185,0.0185750278553588,1.17747078744317e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.055223030358105,0.00777153928288239,0.0399908133636555,0.0704552473525545,1.24826600999881e-12
NMR metabolomics,X23408.Triglycerides in VLDL,VCAN,Versican core protein,40471,-0.0206694175146915,0.00291221157658459,-0.0263773522047973,-0.0149614828245857,1.3236191217661e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM1,Neural cell adhesion molecule 1,40403,-0.0189850196237885,0.00267513528775949,-0.0242282847877971,-0.0137417544597799,1.33010677600863e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TAFA5,Chemokine-like protein TAFA-5,40305,0.0246021828878325,0.00347195071465662,0.0177971594871055,0.0314072062885595,1.4387399036328e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GC,Vitamin D-binding protein,38013,0.0178595482225634,0.00252297577812827,0.012914515697432,0.0228045807476948,1.52598862108012e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CPE,Carboxypeptidase E,40360,-0.0261789012538618,0.00370475346528643,-0.0334402180458232,-0.0189175844619004,1.6572078941047e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0244495642453367,0.00346602618010778,0.0176561529323254,0.0312429755583479,1.8223986798048e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF2,Scavenger receptor class F member 2,40471,-0.0202813258297665,0.00287928523323109,-0.0259247248868995,-0.0146379267726336,1.94571155495243e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX2,Neuronal pentraxin-2,37998,-0.0222873228803258,0.00317384293640643,-0.0285080550356824,-0.0160665907249692,2.2883193198286e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.018948089461894,0.00269922188741063,0.0136576145625692,0.0242385643612188,2.31061920553648e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0257170029362369,0.0036744574012317,0.0185150664298228,0.032918939442651,2.68270365519991e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0251640506464953,0.003599416407422,0.0181091944879482,0.0322189068050424,2.83524651219519e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0242860298939579,0.00347346923255099,0.017478030198158,0.0310940295897579,2.84394768393923e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.0277934056133309,0.00398180925937478,0.0199890594649563,0.0355977517617054,3.0881023551599e-12
NMR metabolomics,X23408.Triglycerides in VLDL,KLRK1,NKG2-D type II integral membrane protein,37942,0.0312622292384085,0.00448014899669987,0.0224811372048768,0.0400433212719403,3.13511214609129e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0384550909708919,0.00552561992179054,0.0276248759241824,0.0492853060176013,3.55071105998556e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0286676037697568,0.00412262416874018,0.020587260399026,0.0367479471404875,3.69564798492658e-12
NMR metabolomics,X23408.Triglycerides in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0371263368145655,0.00534131619372937,0.0266573570748559,0.0475953165542751,3.80004939209146e-12
NMR metabolomics,X23408.Triglycerides in VLDL,C1QA,Complement C1q subcomponent subunit A,40442,-0.0152859359319833,0.00220148906730785,-0.0196008545039067,-0.01097101736006,3.97354112420252e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SLC16A1,Monocarboxylate transporter 1,39961,0.0404274167920958,0.00582457851950787,0.0290112428938604,0.0518435906903312,4.05249503332989e-12
NMR metabolomics,X23408.Triglycerides in VLDL,EPCAM,Epithelial cell adhesion molecule,40358,-0.0669970875397418,0.00966462456241094,-0.0859397516820673,-0.0480544233974164,4.30279652378544e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LY75,Lymphocyte antigen 75,40341,0.0261152567266414,0.00376760921896087,0.0187307426574781,0.0334997707958047,4.3235893237417e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0248461843971689,0.00358886849879681,0.0178120021395272,0.0318803666548106,4.61830905452094e-12
NMR metabolomics,X23408.Triglycerides in VLDL,FCRLB,Fc receptor-like B,39980,0.0408648845935454,0.00591553318145712,0.0292704395578895,0.0524593296292014,5.1039612390605e-12
NMR metabolomics,X23408.Triglycerides in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0292854304856568,0.0042456919456605,0.0209638742721623,0.0376069866991514,5.49065248149047e-12
NMR metabolomics,X23408.Triglycerides in VLDL,COL15A1,Collagen alpha-1(XV) chain,37998,0.0173615563512184,0.0025180478811433,0.0124261825041775,0.0222969301982593,5.63113856081931e-12
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM3,Myomesin-3,37671,-0.0603145890335202,0.00875901637801614,-0.0774822611344318,-0.0431469169326085,5.99757575475943e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL9,C-X-C motif chemokine 9,40422,0.0450688680861613,0.00655764358668908,0.0322158866562507,0.0579218495160719,6.53176061405684e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0250304096902026,0.00364193720084396,0.0178922127765485,0.0321686066038568,6.57022108424525e-12
NMR metabolomics,X23408.Triglycerides in VLDL,BCAM,Basal cell adhesion molecule,40332,-0.0157725320274918,0.00229605235922007,-0.0202727946515631,-0.0112722694034205,6.68602446658196e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0363759086385053,0.00529873552751375,0.0259903870045784,0.0467614302724323,6.94738575715085e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0280277436959584,0.0040890366847002,0.020013231793946,0.0360422555979708,7.47529308122389e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CKAP4,Cytoskeleton-associated protein 4,40457,0.0173165074459673,0.00253238395598772,0.0123530348922313,0.0222799799997032,8.31958745300609e-12
NMR metabolomics,X23408.Triglycerides in VLDL,AZU1,Azurocidin,39809,0.0514830440650242,0.00754250419596258,0.0366997358409375,0.0662663522891109,9.07599234112424e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CCN5,CCN family member 5,40332,0.0259339639388468,0.00380263755138275,0.0184807943381366,0.0333871335395569,9.43291130777663e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GSTT2B,Glutathione S-transferase theta-2B,37942,0.158164605432165,0.0231955987806873,0.112701231822018,0.203627979042312,9.57552810502679e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0285881936347165,0.00420133961178867,0.0203535679956107,0.0368228192738223,1.0499512760012e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FABP3,"Fatty acid-binding protein, heart",37990,0.0313765340086466,0.00461637238231882,0.0223284441393018,0.0404246238779915,1.11450465510478e-11
NMR metabolomics,X23408.Triglycerides in VLDL,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0395328445411966,0.00582782269712727,0.0281103120548272,0.0509553770275661,1.21563900187097e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0188433813945077,0.00277804607870607,0.0133984110802438,0.0242883517087716,1.22761841246214e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.033891427548999,0.00499796961106311,0.0240954071113153,0.0436874479866827,1.23618781725375e-11
NMR metabolomics,X23408.Triglycerides in VLDL,RALY,RNA-binding protein Raly,37900,0.0317675624567705,0.00468926985648597,0.022576593538058,0.040958531375483,1.30010121173566e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SPARCL1,SPARC-like protein 1,40346,-0.0180874868785498,0.0026724072805653,-0.0233254051484578,-0.0128495686086418,1.34919069514054e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0264447460686145,0.00390924791668076,0.0187826201519202,0.0341068719853088,1.39104718303563e-11
NMR metabolomics,X23408.Triglycerides in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0212309016064361,0.00314349736394228,0.0150696467731093,0.027392156439763,1.48856730513062e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GBP4,Guanylate-binding protein 4,39961,0.0321868042170693,0.0047803432517619,0.022817331443616,0.0415562769905227,1.71849852950344e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SHISA5,Protein shisa-5,37998,0.016251849768289,0.00241649702584165,0.0115155155976394,0.0209881839389386,1.82164679905035e-11
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO3,R-spondin-3,40489,0.0185815395925097,0.00276864535896253,0.0131549946889431,0.0240080844960762,1.99198757125091e-11
NMR metabolomics,X23408.Triglycerides in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0284096347820098,0.00423407105587438,0.0201108555124961,0.0367084140515236,2.01648381003254e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4M,C-type lectin domain family 4 member M,37969,-0.0314867652336171,0.00471022159715861,-0.040718799564048,-0.0222547309031862,2.40356374618397e-11
NMR metabolomics,X23408.Triglycerides in VLDL,ENSA,Alpha-endosulfine,37900,0.0342458911564408,0.00512849067701145,0.0241940494294983,0.0442977328833832,2.52465116329185e-11
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0393011657876856,0.00589509313361216,0.0277467832458057,0.0508555483295654,2.71956210725761e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.0135890081435536,0.00204655161747364,0.00957776697330526,0.0176002493138019,3.23976080828369e-11
NMR metabolomics,X23408.Triglycerides in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0235902250125097,0.0035549724397266,0.0166224790306456,0.0305579709943739,3.35279914956708e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0478145740015315,0.00720771856639405,0.0336874456113991,0.0619417023916638,3.39843577926692e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0383206464129223,0.00578329207282901,0.0269853939501775,0.0496558988756672,3.58145894173871e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TNC,Tenascin,40403,-0.0302713459483546,0.00457693985257427,-0.0392421480594002,-0.021300543837309,3.86266670695132e-11
NMR metabolomics,X23408.Triglycerides in VLDL,B2M,Beta-2-microglobulin,38013,0.0203670897749718,0.00308059701044847,0.0143291196344928,0.0264050599154507,3.94923106978724e-11
NMR metabolomics,X23408.Triglycerides in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0465786325928616,0.00705348789595826,0.0327537963167834,0.0604034688689398,4.16662316481159e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR5,Complement factor H-related protein 5,37785,0.0267664132907595,0.00406031047612436,0.0188082047575557,0.0347246218239632,4.4964035500515e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TFF3,Trefoil factor 3,40309,0.0340888801870386,0.00517364965733394,0.0239485268586641,0.0442292335154131,4.56924257302991e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0180040742121816,0.00273608980547554,-0.0233668102309137,-0.0126413381934496,4.84466432146875e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0498241795619155,0.00757470595038722,0.0349777558991565,0.0646706032246744,4.95805791845421e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0168176421862644,0.00256761165665428,0.011785123339222,0.0218501610333067,5.93289825204912e-11
NMR metabolomics,X23408.Triglycerides in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0423705244704944,0.00647356320826141,0.029682340582302,0.0550587083586867,6.16559037950563e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0214217099621005,0.00327533105688326,0.0150020610906093,0.0278413588335917,6.32441462041089e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0244254126516312,0.00373705876367018,0.0171007774748376,0.0317500478284247,6.55244384983325e-11
NMR metabolomics,X23408.Triglycerides in VLDL,YAP1,Transcriptional coactivator YAP1,37942,0.0168928135298719,0.00258830510575409,0.0118197355225939,0.02196589153715,6.96872997370456e-11
NMR metabolomics,X23408.Triglycerides in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0255754563186866,0.00392176809996686,0.0178887908427515,0.0332621217946216,7.2138963285452e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA5,Protein disulfide-isomerase A5,37482,0.0389120901262521,0.0059686027509505,0.0272136287343891,0.050610551518115,7.3160022250286e-11
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO2,Amphoterin-induced protein 2,40305,0.0142083591092693,0.0021822932737608,0.00993106429269818,0.0184856539258405,7.70252222085113e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0367208638219944,0.00564537755605099,0.0256559238121344,0.0477858038318543,8.02301634906865e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0258304806091891,0.00398150721122704,-0.0336342347431941,-0.0180267264751841,8.97904634986887e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0241214870940725,0.00371812031419619,0.016833971278248,0.0314090029098971,8.9820439202295e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GAS2,Growth arrest-specific protein 2,37714,0.0337491569299461,0.00520268669643745,0.0235518910049287,0.0439464228549634,9.07477877820517e-11
NMR metabolomics,X23408.Triglycerides in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0432377101450889,0.00666773182827106,0.0301689557616777,0.0563064645285002,9.21291812488445e-11
NMR metabolomics,X23408.Triglycerides in VLDL,MSLN,Mesothelin,40271,0.0340004543244798,0.00524603970856177,0.0237182164956987,0.0442826921532608,9.37084949043156e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0157381860413681,0.00243178234809703,-0.0205044794436383,-0.010971892639098,1.00210832504299e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MBL2,Mannose-binding protein C,37810,-0.0669216935635296,0.0103581506829745,-0.0872236689021597,-0.0466197182248995,1.07779068905261e-10
NMR metabolomics,X23408.Triglycerides in VLDL,RCOR1,REST corepressor 1,40042,0.0280090286861403,0.00434150405183662,0.0194996807445406,0.0365183766277401,1.14044880735664e-10
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2,Apoptosis regulator Bcl-2,37901,0.0337332867002916,0.00525267506627178,0.023438043570399,0.0440285298301843,1.3891208792726e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CENPF,Centromere protein F,37714,0.0340877728145878,0.00530943356669948,0.0236812830238568,0.0444942626053188,1.40705877221282e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LPA,Apolipoprotein(a),37735,-0.109503191623285,0.0170667105110537,-0.14295394422495,-0.0760524390216196,1.44471026461438e-10
NMR metabolomics,X23408.Triglycerides in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0169835966573081,0.002654211825192,0.0117813414799318,0.0221858518346844,1.61032657987794e-10
NMR metabolomics,X23408.Triglycerides in VLDL,HSBP1,Heat shock factor-binding protein 1,37628,0.0593378715947155,0.0092894154599545,0.0411306172932047,0.0775451258962263,1.74074145331023e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0187462181993674,0.0029377483478078,-0.0245042049610706,-0.0129882314376641,1.81710522053297e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0628077089864835,0.00984938708174499,0.0435029103062633,0.0821125076667036,1.86876068838962e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0252511016717727,0.00396111448049637,0.0174873172899998,0.0330148860535456,1.88355994242617e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MST1,Hepatocyte growth factor-like protein,37787,0.0381085773298951,0.00598074830645041,0.0263863106492523,0.0498308440105379,1.92870473106338e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CTSH,Pro-cathepsin H,40013,0.0446845701404998,0.00701580586147325,0.0309335906520122,0.0584355496289873,1.95440736019183e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CABP2,Calcium-binding protein 2,37572,0.040413735000604,0.00635716543934151,0.0279536907394946,0.0528737792617133,2.12276787677716e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0291826069248098,0.00460694483859254,0.0201529950411685,0.0382122188084512,2.44695885543275e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CAT,Catalase,37786,0.0335033980380286,0.00528900355124762,0.0231369510775833,0.0438698449984739,2.45698498682235e-10
NMR metabolomics,X23408.Triglycerides in VLDL,OLFM4,Olfactomedin-4,37177,0.0757983402412397,0.0119780333456576,0.0523213948837509,0.0992752855987285,2.56503388219367e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LF,CMRF35-like molecule 1,40489,0.0372172936251887,0.00588366593842639,0.025685308385873,0.0487492788645044,2.59054404818565e-10
NMR metabolomics,X23408.Triglycerides in VLDL,AFAP1,Actin filament-associated protein 1,37671,0.0520857589854965,0.00823324214839071,0.0359486043746507,0.0682229135963423,2.59245075886093e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LCP1,Plastin-2,37998,0.0289410033565623,0.00457617491453358,0.0199717005240765,0.0379103061890481,2.6240969453249e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FABP1,"Fatty acid-binding protein, liver",40357,0.0568798209328957,0.00900077413089657,0.0392383036363384,0.074521338229453,2.69505636863882e-10
NMR metabolomics,X23408.Triglycerides in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0200636631510165,0.00317590083166133,-0.0262884287810727,-0.0138388975209603,2.72968422959449e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SCN4B,Sodium channel subunit beta-4,37628,0.0257409174912623,0.00407793571968083,0.0177481634806879,0.0337336715018367,2.8383847505102e-10
NMR metabolomics,X23408.Triglycerides in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0164435582136752,0.00260570264067415,0.0113363810379539,0.0215507353893966,2.85297358999427e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA12,Serpin A12,39903,0.069699666321679,0.0110730949939273,0.0479964001335816,0.0914029325097764,3.16700149993721e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ECE1,Endothelin-converting enzyme 1,39961,0.0215060883277327,0.00341928575250542,0.0148042882528221,0.0282078884026434,3.26722591267535e-10
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L15,Bcl-2-like protein 15,37598,0.0345226463561064,0.00549282331697478,0.0237567126548358,0.045288580057377,3.38110141447178e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN4,Contactin-4,40332,-0.0147786037701873,0.0023567061032233,-0.019397747732505,-0.0101594598078696,3.68313560677903e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0178762880656749,0.00285090174404202,0.0122885206473525,0.0234640554839972,3.69354610888798e-10
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0356787749361616,0.00569330399420136,0.0245198991075269,0.0468376507647963,3.78236239045582e-10
NMR metabolomics,X23408.Triglycerides in VLDL,GM2A,Ganglioside GM2 activator,37714,0.0234314284327762,0.00373950874241759,0.0161019912976377,0.0307608655679147,3.82117382585078e-10
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.026147799718529,0.00417664593602908,-0.034334025753146,-0.017961573683912,3.93658289776383e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MDM1,Nuclear protein MDM1,37572,0.0190107032768605,0.00304066011725148,0.0130510094470476,0.0249703971066734,4.17355249311102e-10
NMR metabolomics,X23408.Triglycerides in VLDL,AGER,Advanced glycosylation end product-specific receptor,40311,0.0245348224767406,0.00392557464849699,0.0168406961656865,0.0322289487877947,4.20953795950048e-10
NMR metabolomics,X23408.Triglycerides in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0209210733144642,0.00335409823035075,0.0143470407829767,0.0274951058459517,4.55994140501924e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ITGBL1,Integrin beta-like protein 1,37998,0.0211659243892713,0.00339345316363176,0.014514756188553,0.0278170925899895,4.58476387884484e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN1,Tetraspanin-1,40042,0.01844032502979,0.00295916275309399,0.0126403660337258,0.0242402840258542,4.73552832474503e-10
NMR metabolomics,X23408.Triglycerides in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0157851841566044,0.00253634805438529,-0.0207564263431995,-0.0108139419700092,5.00642586643711e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN10,Ataxin-10,39961,0.0436650514881638,0.00702322363793251,0.0298995331578161,0.0574305698185115,5.1893504031734e-10
NMR metabolomics,X23408.Triglycerides in VLDL,BOC,Brother of CDO,40042,-0.0142002150595061,0.00228856332543984,-0.0186857991773682,-0.009714630941644,5.61287274858756e-10
NMR metabolomics,X23408.Triglycerides in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0310583286804669,0.00500986519799445,0.0212389928923978,0.040877664468536,5.80963403859163e-10
NMR metabolomics,X23408.Triglycerides in VLDL,JAM2,Junctional adhesion molecule B,40471,0.015680093691585,0.00252954528001041,0.0107221849427646,0.0206380024404054,5.82959469413385e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0218065921714482,0.00352080218635015,0.0149058198862019,0.0287073644566945,6.05416467917587e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.0327199490870783,0.00529467746682786,0.0223423812520957,0.0430975169220609,6.57596928307691e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL3,Fc receptor-like protein 3,40044,0.0327943688577638,0.00530889863108902,0.0223889275408293,0.0431998101746983,6.68487196451192e-10
NMR metabolomics,X23408.Triglycerides in VLDL,IL17D,Interleukin-17D,40044,0.0205246558706454,0.00332288460525173,0.014011802044352,0.0270375096969388,6.7054528138366e-10
NMR metabolomics,X23408.Triglycerides in VLDL,IL1B,Interleukin-1 beta,39946,0.0337539669199032,0.00546494089271427,0.0230426827701832,0.0444652510696231,6.71931724151147e-10
NMR metabolomics,X23408.Triglycerides in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0135441939271753,0.00219531692889136,0.00924137274654822,0.0178470151078023,7.01407467769445e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA1,Annexin A1,37608,0.0247599126598859,0.00403321561131484,0.0168548100617088,0.032665015258063,8.54305371082562e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0229764252022968,0.00374842524216165,0.01562951172766,0.0303233386769336,9.0608828407337e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0156600096180613,0.00255708840271404,-0.0206719028873808,-0.0106481163487417,9.33158538626579e-10
NMR metabolomics,X23408.Triglycerides in VLDL,DGCR6,Protein DGCR6,37541,0.0270128837654342,0.0044220143017315,0.0183457357340405,0.035680031796828,1.03275179666898e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN2,Prefoldin subunit 2,39961,0.0332629684392974,0.00544698421939227,0.0225868793692885,0.0439390575093062,1.04153423991789e-09
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE1,Ribonuclease pancreatic,37987,0.0142644390102849,0.00234639975366125,0.00966549549310888,0.018863382527461,1.23963264471322e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CST7,Cystatin-F,40376,0.0541256948787652,0.00891608752910668,0.0366501633217161,0.0716012264358143,1.30351840958812e-09
NMR metabolomics,X23408.Triglycerides in VLDL,KIF1C,Kinesin-like protein KIF1C,37562,0.022188246590668,0.00365646802570807,0.0150215692602802,0.0293549239210558,1.32902614932967e-09
NMR metabolomics,X23408.Triglycerides in VLDL,GBA,Lysosomal acid glucosylceramidase,37572,0.0311365080317654,0.00513741800808165,0.0210671687359254,0.0412058473276055,1.39219051672939e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PREB,Prolactin regulatory element-binding protein,40044,0.0173667591341787,0.00287610646444599,0.0117295904638646,0.0230039278044929,1.5929212698361e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0280965537126515,0.00466283278015561,0.0189574014635466,0.0372357059617565,1.72842631917411e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB6,Integrin beta-6,40044,0.0176173960617794,0.00292654979818284,0.0118813584573411,0.0233534336662178,1.78490665078848e-09
NMR metabolomics,X23408.Triglycerides in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0494929691726686,0.0082211554271589,0.0333795045354372,0.0656064338099001,1.78860101082957e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PAEP,Glycodelin,40228,-0.0766904573453808,0.0127419050109791,-0.1016645911669,-0.0517163235238617,1.79650315283077e-09
NMR metabolomics,X23408.Triglycerides in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.051136848953647,0.00850051404241748,0.0344758414305087,0.0677978564767852,1.83006873654661e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD1,Leiomodin-1,37959,-0.0210865970387868,0.00352474906305803,-0.0279951052023806,-0.0141780888751931,2.25379508873357e-09
NMR metabolomics,X23408.Triglycerides in VLDL,KLK6,Kallikrein-6,40387,0.0174766367578323,0.00294911530241449,0.0116963707650999,0.0232569027505647,3.16685135538473e-09
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS1,Nephrin,37598,0.019977694504519,0.00337435108929743,0.013363966369496,0.026591422639542,3.29060545855586e-09
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.035747526292398,0.00605707878068687,0.0238756518822518,0.0476194007025443,3.68239186179661e-09
NMR metabolomics,X23408.Triglycerides in VLDL,S100A13,Protein S100-A13,37598,0.0199774239973351,0.00338893857444103,0.0133351043914307,0.0266197436032396,3.84123248227082e-09
NMR metabolomics,X23408.Triglycerides in VLDL,GDF15,Growth/differentiation factor 15,40536,0.0245597592311905,0.00416717333023451,0.0163920995039308,0.0327274189584501,3.85365055788919e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SPOCK1,Testican-1,40228,0.0142412427962503,0.00243732803471092,0.00946407984821694,0.0190184057442838,5.22875611720087e-09
NMR metabolomics,X23408.Triglycerides in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0116217063675221,0.00199403287359263,-0.0155300107997636,-0.00771340193528051,5.73248436549369e-09
NMR metabolomics,X23408.Triglycerides in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0243937952373742,0.00418597859060154,0.0161892771997952,0.0325983132749533,5.75705733872978e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CA7,Carbonic anhydrase 7,37714,-0.0198562587324254,0.00342280177690385,-0.026564950215157,-0.0131475672496939,6.73562860258527e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0176769666153629,0.0030531241576396,0.0116928432663893,0.0236610899643365,7.2082070125892e-09
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.018766895665609,0.00324499144298621,0.012406712437356,0.0251270788938619,7.48481413991466e-09
NMR metabolomics,X23408.Triglycerides in VLDL,EGFLAM,Pikachurin,37901,0.0172643540666779,0.00299115387241738,0.0114016924767398,0.0231270156566159,8.0157202961332e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PADI4,Protein-arginine deiminase type-4,39934,0.038882054717187,0.0067372528131129,0.0256770392034857,0.0520870702308883,8.02131829813843e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0201293902145645,0.00349178836990826,0.0132854850095443,0.0269732954195847,8.32826394955557e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CILP,Cartilage intermediate layer protein 1,37998,0.03015360684142,0.00523259184391969,0.0198977268273374,0.0404094868555026,8.46042779816361e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LIF,Leukemia inhibitory factor,39961,0.0294255620188592,0.00510715900087015,0.0194155303771537,0.0394355936605647,8.48858204549803e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CD7,T-cell antigen CD7,37567,0.0240400617875579,0.0041747418639487,0.0158575677342184,0.0322225558408973,8.67906180999669e-09
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFB,Vascular endothelial growth factor B,37598,0.0158996930855533,0.00277508994871744,0.0104605167860672,0.0213388693850395,1.0297614339995e-08
NMR metabolomics,X23408.Triglycerides in VLDL,FSHB,Follitropin subunit beta,37628,0.0389174515751322,0.00679660643550582,0.0255961029615408,0.0522388001887236,1.05062872212038e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0198543286384731,0.00347208351695991,0.0130490449452317,0.0266596123317146,1.09958920983624e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAM,Integrin alpha-M,40332,-0.0175502447636562,0.00307174186861244,-0.0235708588261366,-0.0115296307011759,1.12692690303465e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.022466716201158,0.00393917917683324,0.0147459250145648,0.0301875073877511,1.19579151525397e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TNXB,Tenascin-X,40332,-0.0140726965656532,0.00247060985272677,-0.0189150918769977,-0.00923030125430875,1.24792898450156e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0212565690751361,0.00375392462922106,0.0138988768018628,0.0286142613484093,1.52238416306266e-08
NMR metabolomics,X23408.Triglycerides in VLDL,IFNG,Interferon gamma,40044,0.0623455795389078,0.0110249304208287,0.0407367159140836,0.0839544431637321,1.58613172870366e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LTB,Lymphotoxin-beta,37900,0.0193939027047009,0.00344632192525323,0.0126391117312046,0.0261486936781973,1.86577774200246e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0396278883152595,0.00706367966690024,0.025783076168135,0.0534727004623839,2.06192469624386e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN8,Septin-8,37921,0.0172477140542921,0.00309695729188594,0.0111776777621957,0.0233177503463885,2.60743667542176e-08
NMR metabolomics,X23408.Triglycerides in VLDL,RAB37,Ras-related protein Rab-37,40044,0.0450058999875613,0.00808586762535876,0.0291575994418582,0.0608542005332645,2.64956894054679e-08
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0299015321373088,0.00537652608030832,0.0193635410199045,0.0404395232547131,2.71866017350978e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CCL28,C-C motif chemokine 28,40278,0.0320191753708851,0.00577901861152377,0.0206922988922985,0.0433460518494717,3.06261527186366e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0224840517118555,0.00407871229031452,0.014489775622839,0.0304783278008719,3.59312232525622e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0242552024000711,0.00440420400213443,0.0156229625558876,0.0328874422442546,3.71100417324955e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0192945513671396,0.00350578814562935,0.0124232066017061,0.0261658961325732,3.7792390387641e-08
NMR metabolomics,X23408.Triglycerides in VLDL,DSG3,Desmoglein-3,40419,0.0178466613564427,0.00324493308042854,0.0114865925188027,0.0242067301940826,3.85941582675754e-08
NMR metabolomics,X23408.Triglycerides in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0257987321136968,0.00470939115749576,-0.0350291387823885,-0.0165683254450051,4.36342225099702e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC2,PDZ domain-containing protein GIPC2,37942,0.0154996468724374,0.00283410424551904,0.00994480255122003,0.0210544911936547,4.6070287497689e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0469485228484741,0.00859161211324182,0.0301089631065202,0.0637880825904281,4.7128121169751e-08
NMR metabolomics,X23408.Triglycerides in VLDL,XG,Glycoprotein Xg,40458,0.0158027765350876,0.00290248321855125,0.0101139094267271,0.021491643643448,5.26951784773139e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO2,Roundabout homolog 2,40471,0.0122851361357681,0.00225669006842115,0.00786202360166262,0.0167082486698735,5.29009764505018e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CCN3,CCN family member 3,40522,0.0177921464404079,0.0032713189211741,0.0113803613549066,0.0242039315259091,5.44152035237672e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0159724332873698,0.00294095096595097,-0.0217366971806337,-0.0102081693941059,5.68645360608033e-08
NMR metabolomics,X23408.Triglycerides in VLDL,KLK11,Kallikrein-11,40260,0.0155855848140048,0.00288019865063097,0.00994039545876813,0.0212307741692415,6.34841419893114e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D17,TBC1 domain family member 17,39961,0.024110395882778,0.00446198841812663,0.0153648985832498,0.0328558931823062,6.63141794264866e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MTPN,Myotrophin,40042,0.0173590473514001,0.00321332275270797,0.0110609347560924,0.0236571599467077,6.67901119647725e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN3,Perilipin-3,40359,0.0222013414773591,0.00411016733955484,0.0141454134918316,0.0302572694628866,6.70107502425608e-08
NMR metabolomics,X23408.Triglycerides in VLDL,APOM,Apolipoprotein M,40372,0.0139693336403289,0.0025893152203278,0.00889427580848643,0.0190443914721714,6.95059889126128e-08
NMR metabolomics,X23408.Triglycerides in VLDL,HYAL1,Hyaluronidase-1,40214,0.0120051917413672,0.00222793272949437,0.00763844359155823,0.0163719398911762,7.20730934700036e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GLYR1,Putative oxidoreductase GLYR1,37900,0.0317579544110598,0.00589411573194988,0.020205487576438,0.0433104212456816,7.24151626737592e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0361904694532772,0.00672049211645214,-0.0493626340015233,-0.023018304905031,7.36248541542743e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.014173717780086,0.00263567582818267,0.00900779315684797,0.019339642403324,7.65234631370217e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CYTL1,Cytokine-like protein 1,37998,0.0120099664549677,0.0022356138287646,0.0076281633505891,0.0163917695593463,7.91067244496518e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP7,GTPase IMAP family member 7,37671,-0.0169187466672963,0.00315492371671718,-0.0231023971520619,-0.0107350961825306,8.33907745933399e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CASP1,Caspase-1,39961,0.0349840460675769,0.00652449052363956,0.0221960446412433,0.0477720474939104,8.35036933373477e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MUC16,Mucin-16,40305,0.0972805234367552,0.0181473321450061,0.0617117524325432,0.132849294440967,8.41086354608213e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0222133110014045,0.00414641533940607,0.0140863369361686,0.0303402850666404,8.56754350431956e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PRKD2,Serine/threonine-protein kinase D2,37562,0.0247207623305785,0.00461632973387287,0.0156727560521877,0.0337687686089693,8.6967402221002e-08
NMR metabolomics,X23408.Triglycerides in VLDL,KLK8,Kallikrein-8,39801,0.0184280149920941,0.00344278483367141,0.0116801567180981,0.02517587326609,8.79224321235277e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0157020844636307,0.00293963823899995,0.00994039351519076,0.0214637754120706,9.34802103454696e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CD14,Monocyte differentiation antigen CD14,40048,0.0214758762445268,0.00402717675883593,0.0135826097972084,0.0293691426918452,9.80920041992764e-08
NMR metabolomics,X23408.Triglycerides in VLDL,OBP2B,Odorant-binding protein 2b,40184,-0.0342143748902922,0.00641964690288347,-0.0467968828199438,-0.0216318669606406,9.97674301169064e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPB1,Signal-regulatory protein beta-1,40335,0.0231658973989728,0.00435184230121119,0.0146362864885989,0.0316955083093467,1.0332134480723e-07
NMR metabolomics,X23408.Triglycerides in VLDL,DSG4,Desmoglein-4,40250,0.0262342909565498,0.00492850406172657,0.0165744229955658,0.0358941589175339,1.0348029360645e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CDH3,Cadherin-3,40471,0.0182808254698581,0.00343564584186569,0.0115469596198013,0.0250146913199148,1.04628197074881e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FGA,Fibrinogen alpha chain,37698,0.0159174216951663,0.00299135868636563,0.0100543586698897,0.021780484720443,1.04802429043698e-07
NMR metabolomics,X23408.Triglycerides in VLDL,RAB44,Ras-related protein Rab-44,37900,0.0206010965286234,0.00387527354590512,0.0130055603786493,0.0281966326785974,1.07747272987223e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP3,Cysteine-rich secretory protein 3,37875,-0.013942386086467,0.00262521603058282,-0.0190878095064093,-0.00879696266652463,1.10796708519702e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1A,Protein phosphatase 1A,39980,0.0159747382253552,0.00301082040447003,0.010073530232594,0.0218759462181165,1.13735213575114e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CRLF1,Cytokine receptor-like factor 1,40422,0.0134764681364678,0.00254697697387499,0.00848439326767284,0.0184685430052628,1.23146579906929e-07
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA2,Ephrin type-A receptor 2,39759,0.0158071028570503,0.00298744171812176,0.00995171708953167,0.021662488624569,1.23202007372087e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ICOSLG,ICOS ligand,40305,0.00974463237479604,0.00185147098303058,0.00611574924805611,0.013373515501536,1.43426863756199e-07
NMR metabolomics,X23408.Triglycerides in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.028067117713719,0.00534262333272197,-0.0385386594458541,-0.017595575981584,1.51216528506139e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.053064191421326,0.0101010612365242,0.0332661113977385,0.0728622714449135,1.51712501239268e-07
NMR metabolomics,X23408.Triglycerides in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0274033119496959,0.00521776622013259,0.0171764901582361,0.0376301337411558,1.52504717939945e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0211510746160529,0.00402830463235749,0.0132555975366322,0.0290465516954736,1.53591087156979e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0225158437222012,0.00428829892320368,0.014110777832722,0.0309209096116804,1.54004866418632e-07
NMR metabolomics,X23408.Triglycerides in VLDL,RPS10,40S ribosomal protein S10,37562,-0.0215468895760739,0.00411739389496652,-0.0296169816102082,-0.0134767975419395,1.69227623831696e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CDH15,Cadherin-15,40435,0.0224724204146108,0.00429507084444784,0.014054081559493,0.0308907592697286,1.69673439988151e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LYAR,Cell growth-regulating nucleolar protein,39980,0.026665204583008,0.00509883303416113,0.0166714918360522,0.0366589173299638,1.7201871330547e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3,Granulocyte colony-stimulating factor,40044,0.0247514505486831,0.00473841691316407,0.0154641533988815,0.0340387476984847,1.77764760838171e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PROCR,Endothelial protein C receptor,37562,-0.0187527995914614,0.00359798721617447,-0.0258048545351634,-0.0117007446477594,1.89627133458834e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GPC1,Glypican-1,40489,0.0148088079243972,0.00284575279368898,0.00923113244876676,0.0203864834000276,1.97631046971964e-07
NMR metabolomics,X23408.Triglycerides in VLDL,APOA4,Apolipoprotein A-IV,38013,0.0186134056707429,0.00357685046767476,0.0116027787541003,0.0256240325873854,1.98045859131556e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GSN,Gelsolin,37928,-0.00961578955696229,0.00184816865633741,-0.0132382001233836,-0.00599337899054097,1.9910841318671e-07
NMR metabolomics,X23408.Triglycerides in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.01282176659923,0.00247452988997067,0.00797168801488754,0.0176718451835726,2.22825818294909e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0327919806480831,0.00633016798128199,0.0203848514047704,0.0451991098913958,2.24273035252075e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0330002188790573,0.00638386546994228,-0.0455125952001441,-0.0204878425579704,2.38310082104117e-07
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0146237541953215,0.00282969648580726,-0.0201699593075037,-0.00907754908313924,2.40102155095824e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CGA,Glycoprotein hormones alpha chain,40332,0.0446180041711863,0.00868910118304766,0.0275873658524129,0.0616486424899597,2.85571661343998e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LUZP2,Leucine zipper protein 2,37900,0.0223111328583944,0.00434498285009482,0.0137949664722086,0.0308272992445803,2.86209440198345e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI1,Neuroserpin,37642,0.0159198044669466,0.00310343588552691,0.00983707013131387,0.0220025388025794,2.94266772920205e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GNLY,Granulysin,40332,0.0251958776293295,0.0049236597759146,0.0155455044685368,0.0348462507901221,3.13544062695486e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.0130867231912869,0.00255918483580138,0.0080707209131162,0.0181027254694576,3.19681672333688e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0187329755617229,0.00366409806618124,-0.0259146077714381,-0.0115513433520077,3.22271658819486e-07
NMR metabolomics,X23408.Triglycerides in VLDL,COL1A1,Collagen alpha-1(I) chain,40536,-0.0128653284858304,0.00251775579195143,-0.0178001298380552,-0.00793052713360556,3.26123988684315e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TSHB,Thyrotropin subunit beta,40359,0.041460839360003,0.00812448547464884,0.0255368478296912,0.0573848308903147,3.37812358339849e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0131012489755479,0.00257026573336522,-0.0181389698129437,-0.00806352813815204,3.49479732158055e-07
NMR metabolomics,X23408.Triglycerides in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0163112017142333,0.00320041661090986,-0.0225840182716166,-0.01003838515685,3.50523803521009e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0195270769519178,0.00383150456112697,0.012017328012109,0.0270368258917267,3.50774299195156e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GZMH,Granzyme H,40042,0.036839630836472,0.00723510400770884,0.0226588269813627,0.0510204346915814,3.58831977153055e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CLU,Clusterin,38013,0.0163140069297431,0.00321598800763855,0.0100106704347715,0.0226173434247146,3.97220896734299e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ITM2A,Integral membrane protein 2A,40341,-0.0290577055402719,0.00573096027510552,-0.0402903876794787,-0.0178250234010651,4.01649657462047e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR1,Folate receptor alpha,40299,0.0139377411581264,0.00274995808676733,0.00854782330806241,0.0193276590081903,4.05804228544995e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TPM3,Tropomyosin alpha-3 chain,37562,-0.0209160367402782,0.00413346492033044,-0.0290176279841259,-0.0128144454964305,4.2455293356416e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3D,Protein FAM3D,37901,0.0403689854205158,0.00800012714670933,0.0246887362129655,0.056049234628066,4.56941486726464e-07
NMR metabolomics,X23408.Triglycerides in VLDL,KRT19,"Keratin, type I cytoskeletal 19",40310,0.0331861873043846,0.00658880680128662,0.0202721259738628,0.0461002486349063,4.78697163751068e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FUCA1,Tissue alpha-L-fucosidase,40437,0.039591166051026,0.00786770304091612,0.0241704680908304,0.0550118640112216,4.90370910634886e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0126563311012011,0.00251618905672887,-0.0175880616523897,-0.00772460055001256,4.96865590705888e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MRC1,Macrophage mannose receptor 1,37987,0.0138130301290112,0.0027462501363548,0.00843037986175574,0.0191956803962666,4.97335856034681e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CA12,Carbonic anhydrase 12,40305,-0.0156932427288463,0.00312836035274739,-0.0218248290202312,-0.00956165643746144,5.32060393421267e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TPSAB1,Tryptase alpha/beta-1,40498,0.0256031559077116,0.00510962886040708,0.0155882833413137,0.0356180284741094,5.4790440220626e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN5,Contactin-5,40367,-0.017999800722651,0.00359264650830167,-0.0250413878789223,-0.0109582135663797,5.49625302571849e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.0104603421260007,0.00208843814288267,0.00636700336595063,0.0145536808860507,5.54963528856561e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TEK,Angiopoietin-1 receptor,40411,0.0104259512509543,0.00208579776722218,0.00633778762719885,0.0145141148747098,5.83769542326492e-07
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP3,Dual specificity protein phosphatase 3,39961,0.0411269410920284,0.0082300050971823,0.0249961311015511,0.0572577510825057,5.8803835744198e-07
NMR metabolomics,X23408.Triglycerides in VLDL,VIT,Vitrin,37990,0.0178828149171169,0.0035837005250022,0.0108587618881126,0.0249068679461212,6.11158546720892e-07
NMR metabolomics,X23408.Triglycerides in VLDL,UROS,Uroporphyrinogen-III synthase,37572,0.0339432093532832,0.00682843560480253,0.0205594755678702,0.0473269431386961,6.74974999419331e-07
NMR metabolomics,X23408.Triglycerides in VLDL,BRD1,Bromodomain-containing protein 1,37714,-0.0149896811432109,0.00301959675722214,-0.0209080907873663,-0.00907127149905552,6.98658431137894e-07
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0160070503650246,0.00324011022070452,-0.0223576663976054,-0.00965643433244372,7.89745357132733e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0169034593288437,0.00342293624978693,0.0101945042792614,0.0236124143784261,7.97777247271528e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2,Ataxin-2,37541,0.0553091864054324,0.0112141263916451,0.0333294986778079,0.0772888741330568,8.23492229724376e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF8,SLAM family member 8,39980,0.0255946795489053,0.00519157719323108,0.0154191882501724,0.0357701708476382,8.30618448379065e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0200981211105347,0.00408259584827197,0.0120962332479217,0.0281000089731478,8.61366532186578e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GBP2,Guanylate-binding protein 2,40044,0.0284158060710338,0.00577491447505104,0.0170969736999337,0.0397346384421338,8.71781581634909e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MILR1,Allergin-1,40044,-0.0238406289460089,0.00484584359892083,-0.0333384823998937,-0.0143427754921241,8.75118741223072e-07
NMR metabolomics,X23408.Triglycerides in VLDL,DPP4,Dipeptidyl peptidase 4,40068,0.014234417448171,0.00289697450800632,0.00855634741247864,0.0199124874838634,9.0350105751539e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FGF16,Fibroblast growth factor 16,37598,0.0234863307787652,0.00478555380211822,0.0141066453266135,0.0328660162309169,9.32290384649853e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SCG3,Secretogranin-3,40379,-0.0158684724273499,0.00323384120052561,-0.0222068011803801,-0.00953014367431976,9.33920591257747e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0267660313206968,0.00546322531791809,0.0160581096975774,0.0374739529438163,9.73228511132589e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0187386713977523,0.00382849483963123,0.0112348215120751,0.0262425212834295,9.96780736330791e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0126075872711614,0.002577922956511,0.00755485827639987,0.017660316265923,1.01511785844441e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0159508736961483,0.0032749596440185,0.009531952793872,0.0223697945984245,1.12349717329512e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PRUNE2,Protein prune homolog 2,37714,0.0140040395426872,0.00287741465354283,0.00836430682174324,0.0196437722636311,1.14676931561108e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.012479209206189,0.00256685017924546,0.00744818285486792,0.0175102355575101,1.17505661076396e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DCN,Decorin,40042,-0.0107234916971146,0.0022115172036293,-0.015058065416228,-0.00638891797800115,1.25326416956312e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0293132566495244,0.00607921592266668,0.0173979934410977,0.0412285198579511,1.43552820354005e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0144446624238905,0.00300032883633426,0.00856401790467538,0.0203253069431057,1.49034813540232e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB1A1,Uteroglobin,40384,0.0264018491500782,0.00549829395023648,0.0156251930076147,0.0371785052925417,1.58654234846553e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CD109,CD109 antigen,40332,-0.0155520524687702,0.00324163248388253,-0.02190565213718,-0.00919845280036045,1.62037926802872e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0660558616724476,0.013815572408625,0.0389773397515427,0.0931343835933526,1.75798318056956e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DLL4,Delta-like protein 4,37628,0.039224989235179,0.008211496469062,0.0231304561558174,0.0553195223145405,1.79992040213608e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5,Eukaryotic translation initiation factor 5,37562,0.0210468340757307,0.00442374306140738,0.0123762976753722,0.0297173704760891,1.97901270496532e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SNX18,Sorting nexin-18,37901,0.02102208379286,0.00442236516341505,0.0123542480725665,0.0296899195131535,2.01912472020733e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0127209191280497,0.00267872738984324,0.0074706134439569,0.0179712248121424,2.06389495119871e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CA1,Carbonic anhydrase 1,40003,0.0287358183333083,0.00606352429383773,0.0168513107173863,0.0406203259492302,2.1653937395352e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0271166592777377,0.00573010652457155,0.0158856504895775,0.038347668065898,2.24219393444344e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0166873191621865,0.00353710421248638,0.00975459490571318,0.0236200434186598,2.40426191867789e-06
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R1,Interleukin-1 receptor type 1,40303,-0.0101782866219017,0.00216587298877393,-0.0144233976798986,-0.00593317556390483,2.63130041051886e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6,Seizure protein 6 homolog,37572,-0.0142939041873028,0.0030440374441538,-0.0202602175778442,-0.00832759079676135,2.68379314300644e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GZMB,Granzyme B,40341,0.0285355756957019,0.00609917932348603,0.0165811842216693,0.0404899671697346,2.91231490189029e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL1,Follistatin-related protein 1,37628,-0.0102210115965468,0.00218943374853298,-0.0145123017436715,-0.00592972144942219,3.06644321404702e-06
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0221771391203702,0.00475648536217621,0.0128544278105048,0.0314998504302356,3.15464344687311e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CLASP1,CLIP-associating protein 1,37482,0.0323705293099465,0.00695237495953132,0.0187438743892651,0.0459971842306279,3.25533283881558e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LXN,Latexin,40183,-0.0298803560521993,0.00643038072622497,-0.0424839022756003,-0.0172768098287984,3.3994399890248e-06
NMR metabolomics,X23408.Triglycerides in VLDL,THBS4,Thrombospondin-4,40355,0.0202844152501145,0.00437085667024888,0.0117175361764267,0.0288512943238023,3.49777670320838e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00696859231506763,0.00150430795466755,0.00402014872391923,0.00991703590621602,3.64241478751232e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0184129391453772,0.00397535407432162,0.0106212451597069,0.0262046331310476,3.65492390515937e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0154024666934129,0.00332631850570321,0.00888288242223463,0.0219220509645912,3.68297781431885e-06
NMR metabolomics,X23408.Triglycerides in VLDL,AMPD3,AMP deaminase 3,37942,0.0325093753076512,0.00705425207115486,0.0186830412481877,0.0463357093671147,4.09342214718269e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC6A,C-type lectin domain family 6 member A,39980,0.0209133716090124,0.00454211374388075,0.0120108286710061,0.0298159145470187,4.17086091456178e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PKD1,Polycystin-1,37990,0.011581118564163,0.00251553367312806,0.00665067256483196,0.0165115645634939,4.18541261630692e-06
NMR metabolomics,X23408.Triglycerides in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0181274922011972,0.00394132637861682,0.0104024924991083,0.0258524919032862,4.27808236117992e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.00946229268058961,0.00206018601526306,-0.0135002572705052,-0.00542432809067401,4.41000772260493e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0306554708547803,0.00667882911346306,0.0175649657923927,0.0437459759171679,4.47428835937514e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL,Podocalyxin,40305,0.00674566190213516,0.0014723598722722,0.00385983655248164,0.00963148725178867,4.65102734892332e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB6,Ephrin type-B receptor 6,40192,0.0138380501671398,0.00302663217350765,0.00790585110706478,0.0197702492272148,4.86548955155863e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EDN1,Endothelin-1,37628,0.0129320491807604,0.00283247104587417,0.00738040593084707,0.0184836924306738,5.02475890051817e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CALB1,Calbindin,40305,0.0187269269794982,0.00410823639761228,0.0106747836401781,0.0267790703188183,5.19335375427211e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.00923598271399949,0.00202708047659417,-0.0132090604481241,-0.00526290497987491,5.24580835265959e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0175573387036893,0.00385941292083703,0.00999288937884871,0.0251217880285299,5.4241822006756e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PRTG,Protogenin,40489,0.0110915683519677,0.00244082149883693,0.00630755821424729,0.0158755784896881,5.55482263577078e-06
NMR metabolomics,X23408.Triglycerides in VLDL,C8B,Complement component C8 beta chain,38013,0.0134745012230274,0.00296873009617561,0.00765579023452324,0.0192932122115316,5.70590718821827e-06
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD9,COMM domain-containing protein 9,37900,0.0172896554546535,0.00381975585217067,0.00980293398439897,0.024776376924908,6.05182951233291e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FOSB,Protein fosB,39961,0.0171512804412582,0.00379538331993012,0.00971232913419518,0.0245902317483213,6.25959779132469e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.025722306676699,0.00569266782443292,0.0145646777408104,0.0368799356125875,6.27394352512916e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM5,Intercellular adhesion molecule 5,40359,0.0192739771581825,0.00427575599839827,0.0108934954013219,0.0276544589150431,6.59907577577038e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD9,Enhancer of filamentation 1,37598,0.0144790601104026,0.00321763121613023,0.00817250292678738,0.0207856172940179,6.85647575285477e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP1,Dipeptidase 1,40192,-0.0221327637134353,0.00492713321889151,-0.0317899448224627,-0.012475582604408,7.10539985496623e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0222622433811358,0.00496069471557014,0.0125392817386183,0.0319852050236533,7.25847052561635e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CDH6,Cadherin-6,40359,-0.016480607770916,0.00367497078079211,-0.0236835505012685,-0.00927766504056343,7.35775254448498e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY2,Protein canopy homolog 2,40042,0.026583618562776,0.00592964168752765,0.0149615208552218,0.0382057162703301,7.40651147494475e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CD200,OX-2 membrane glycoprotein,40341,-0.0113002358981917,0.0025208975198397,-0.0162411950370775,-0.00635927675930589,7.42463225128633e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EBI3_IL27,Interleukin-27,40453,-0.0135035654926221,0.0030237127848434,-0.0194300425509151,-0.00757708843432899,8.02827411522614e-06
NMR metabolomics,X23408.Triglycerides in VLDL,RETN,Resistin,40283,0.0178925802464699,0.00401932460611162,0.0100147040184911,0.0257704564744487,8.57999191922895e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.017445702590028,0.00392532862970493,-0.0251393467042497,-0.00975205847580636,8.88636534695439e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1D,V-type proton ATPase subunit D,40305,0.0112994729161215,0.00254860816682866,0.00630420090913733,0.0162947449231057,9.330133164883e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0149498594405832,0.00338114215037017,0.00832282082585772,0.0215768980553088,9.86424213705392e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LHB,Lutropin subunit beta,39980,0.0363990807460208,0.00823620229563038,0.0202561242465852,0.0525420372454563,9.96455397675099e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ELAVL4,ELAV-like protein 4,37541,0.0374664228943885,0.00849119533720256,0.0208236800334715,0.0541091657553055,1.03055411476446e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PSPN,Persephin,40341,0.0423495319987269,0.00963448317741377,0.0234659449709959,0.0612331190264579,1.11173250511679e-05
NMR metabolomics,X23408.Triglycerides in VLDL,KLK14,Kallikrein-14,40489,-0.0195777134977204,0.00445563900167872,-0.0283107659410107,-0.0108446610544302,1.12040088548298e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.0148903520199621,0.00339570256587114,0.00823477499085461,0.0215459290490695,1.16714579230872e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ECM1,Extracellular matrix protein 1,37655,0.0157601237560407,0.00360104408995538,0.0087020773397282,0.0228181701723533,1.21502663085491e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EP300,Histone acetyltransferase p300,37598,0.0127119808978263,0.00290542089587307,0.00701735594191507,0.0184066058537375,1.22220708144492e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC1,Sialoadhesin,40422,0.0182853224102894,0.00419788431831138,0.0100574691463991,0.0265131756741797,1.33382368132335e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SOD3,Extracellular superoxide dismutase,37987,-0.0249744904665889,0.00574924681071986,-0.0362430142155998,-0.013705966717578,1.40956741216625e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FCAR,Immunoglobulin alpha Fc receptor,40341,0.0197920571624922,0.00456009300589231,0.0108542748709433,0.0287298394540412,1.43183981460123e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0140839042765085,0.00325561840511265,0.00770289220248775,0.0204649163505293,1.52746944565197e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0222466034900019,0.00515220860107758,0.0121482746318898,0.0323449323481139,1.58665282633095e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DNPEP,Aspartyl aminopeptidase,37942,0.0249598717187714,0.00578239157042133,0.0136263842407456,0.0362933591967972,1.59630703151578e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN8,Tetraspanin-8,37901,0.0435906548796808,0.0101059741277627,0.023782945589266,0.0633983641700957,1.6194236934771e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SIL1,Nucleotide exchange factor SIL1,37628,0.0134059580002728,0.003116416971512,0.00729778073610929,0.0195141352644363,1.70697381893525e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0251401434373031,0.00584712722711199,0.0136797740721637,0.0366005128024426,1.72168002395018e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0248918464305828,0.00579015706836542,0.0135431385765865,0.036240554284579,1.72822817171659e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD6,Programmed cell death protein 6,40359,-0.0290749918093669,0.00676484037443693,-0.0423340789432632,-0.0158159046754705,1.73404667921044e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0259180535193187,0.0060307218165323,0.0140978387589154,0.037738268279722,1.73850190494817e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AOC3,Membrane primary amine oxidase,40403,-0.0126558318360525,0.00294640789953277,-0.0184307913191368,-0.00688087235296831,1.75455450031201e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GFRAL,GDNF family receptor alpha-like,37477,-0.0258782326396509,0.00603249779227152,-0.037701928312503,-0.0140545369667987,1.80120743969217e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0246943572073771,0.00576207196510437,0.0134006961557725,0.0359880182589816,1.83472389170894e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EPO,Erythropoietin,40341,0.0324891334546484,0.00758819825193422,0.0176162648808574,0.0473620020284395,1.86697653345407e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0206165633185577,0.00481511784708694,0.0111789323382673,0.0300541942988481,1.8684624578319e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0160234531986581,0.00374407601212699,0.0086850642148892,0.023361842182427,1.88283890310292e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BCAN,Brevican core protein,40228,-0.0138936875533867,0.00324998590465452,-0.0202636599265095,-0.0075237151802638,1.9226059408505e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0149216380484547,0.00349214745016748,0.00807702904612649,0.021766247050783,1.94062387009962e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NEFL,Neurofilament light polypeptide,39903,0.0176822312181072,0.00414430518011215,0.00955939306508741,0.025805069371127,1.99626131390858e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BLVRB,Flavin reductase,40332,0.0274438419804608,0.00643546491317887,0.0148303307506302,0.0400573532102914,2.01536285662097e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0118733339961727,0.00278683750873001,0.00641113247906187,0.0173355355132835,2.05151997731668e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ALPI,Intestinal-type alkaline phosphatase,37598,0.0503383658762739,0.0118219621763498,0.0271673200106283,0.0735094117419196,2.0766119445682e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH1,Protocadherin-1,40475,0.00897664143757991,0.00211157352790315,0.00483795732288974,0.0131153255522701,2.13868031382611e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0215203278930861,0.00507433494587114,-0.0314660243869936,-0.0115746313991787,2.24038055699212e-05
NMR metabolomics,X23408.Triglycerides in VLDL,HMBS,Porphobilinogen deaminase,40489,0.0186387905368079,0.00440772202933957,0.0099996553593023,0.0272779257143134,2.36382535854181e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0108653068874864,0.00257565738928535,0.00581701840448713,0.0159135953704857,2.47577762959988e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK13,Mitogen-activated protein kinase 13,37482,0.0169583458862324,0.00402076197296674,0.00907765241921759,0.0248390393532472,2.48480737218502e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX1,Peroxiredoxin-1,39953,-0.0364284247204349,0.0086486496343573,-0.0533797780037752,-0.0194770714370946,2.54508764280521e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CST1,Cystatin-SN,36179,0.0427510463485541,0.0101520519900173,0.0228530244481203,0.062649068248988,2.56056504465295e-05
NMR metabolomics,X23408.Triglycerides in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.013610479116162,0.00323816104092254,0.00726368347595387,0.0199572747563702,2.64660689600529e-05
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0198694983641933,0.00472804861000271,-0.0291364736397986,-0.0106025230885879,2.65753553952188e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TNR,Tenascin-R,40228,-0.0172845365196619,0.00411474309836431,-0.0253494329924559,-0.00921964004686785,2.67628841506648e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK2,Protein AHNAK2,37628,0.0116680858491099,0.00278741501063647,0.00620475242826242,0.0171314192699574,2.85771903749843e-05
NMR metabolomics,X23408.Triglycerides in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0182288292859413,0.00435710063381429,0.00968891204366532,0.0267687465282173,2.8833851881107e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SAA4,Serum amyloid A-4 protein,38013,0.0132710642430514,0.00317465556712296,0.0070487393314904,0.0194933891546124,2.92930889744019e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SATB1,DNA-binding protein SATB1,37959,0.0122474326401235,0.00293200191294129,0.00650070889075856,0.0179941563894884,2.97029696894448e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RPA2,Replication protein A 32 kDa subunit,37598,0.0132693905217086,0.00317823719226568,0.00704004562486787,0.0194987354185493,2.99802438604494e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0230327831875137,0.0055251430573081,0.0122035027951898,0.0338620635798376,3.07973570435603e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.0178186809867334,0.00427951453700782,0.0094308324941981,0.0262065294792688,3.14743548428548e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0154579267455941,0.00371646904457019,0.00817364741823653,0.0227422060729517,3.21197004299947e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAP,Cartilage-associated protein,37572,0.0195887470493633,0.00471513792935158,0.0103470767078342,0.0288304173908924,3.28154330304326e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G1B,Phospholipase A2,40514,-0.0168741076154332,0.0040641779241581,-0.0248398963467831,-0.00890831888408333,3.31411204112387e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TFF2,Trefoil factor 2,40396,0.0229281529531284,0.00552558173912761,0.0120980127444383,0.0337582931618186,3.34996594097375e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MATN3,Matrilin-3,40203,-0.0125775057884769,0.00303132125911948,-0.0185188954563511,-0.00663611612060274,3.35416121103914e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IL15,Interleukin-15,40341,0.0131411911111235,0.00317805031732047,0.00691221248917535,0.0193701697330716,3.56800920375726e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD48,CD48 antigen,40396,0.0117566949239436,0.00284377228286805,0.00618290124952221,0.017330488598365,3.58030822918783e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CST6,Cystatin-M,39992,0.0191617621715543,0.00464443700899585,0.0100586656339225,0.0282648587091862,3.71461250344504e-05
NMR metabolomics,X23408.Triglycerides in VLDL,APOB,Apolipoprotein B-100,37987,0.00895363505356674,0.00217107574355069,0.00469832659620739,0.0132089435109261,3.74483500483678e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PMS1,PMS1 protein homolog 1,37572,0.0208404845022219,0.00506322515281863,0.0109165632026974,0.0307644058017464,3.8777893470927e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PADI2,Protein-arginine deiminase type-2,40044,0.0224032927223559,0.00544572275677683,0.0117296761190734,0.0330769093256385,3.90985681850112e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.0116981259222159,0.00284348983653679,0.00612488584260378,0.017271366001828,3.91246282518979e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CLPS,Colipase,40311,0.0273152753193826,0.00665250631708328,0.0142763629378994,0.0403541877008659,4.04564434749019e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.0124229033961119,0.00305446946758267,0.00643614323964984,0.0184096635525739,4.78268461317244e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FABP9,Fatty acid-binding protein 9,40341,0.0219525803243076,0.00541724357736893,0.0113347829126645,0.0325703777359507,5.09464245182804e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ENO1,Alpha-enolase,40299,0.0311095896866399,0.00768611669734067,0.0160448009598522,0.0461743784134276,5.20124590568967e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF7,SLAM family member 7,40341,-0.0226204060661563,0.00559442377027339,-0.0335854766558921,-0.0116553354764205,5.29336708748184e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL2,Chordin-like protein 2,40359,0.0222981459506371,0.005518462756693,0.0114819589475189,0.0331143329537554,5.35550540598265e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.0118281904537129,0.00293132759285968,0.00608278837170792,0.0175735925357179,5.48412359686408e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SLC13A1,Solute carrier family 13 member 1,37900,0.0243685698757607,0.00604460751523442,0.0125211391459012,0.0362160006056201,5.573796733107e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CA9,Carbonic anhydrase 9,40489,-0.0174952708731644,0.00436495770887939,-0.026050587982568,-0.00893995376376082,6.14809354288544e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0223123547193491,0.00556955840803686,0.0113960202395969,0.0332286891991014,6.20034489673078e-05
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.0170242927743199,0.0042538822409536,0.00868668358205085,0.025361901966589,6.31285624441574e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SNU13,NHP2-like protein 1,37562,0.024239559741601,0.00607400272214231,0.0123345144062021,0.0361446050769999,6.62353664268626e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0334294694099859,0.00840518650428593,-0.0499036349583863,-0.0169553038615855,7.00382857240427e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BMP10,Bone morphogenetic protein 10,37671,-0.0111050585476959,0.0027934700370115,-0.0165802598202384,-0.00562985727515336,7.06456219687931e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.0102545022480954,0.0025894789387927,0.00517912352806173,0.0153298809681291,7.52579275850602e-05
NMR metabolomics,X23408.Triglycerides in VLDL,KLK4,Kallikrein-4,40489,-0.0232937180942878,0.00589948573586918,-0.0348567101365914,-0.0117307260519842,7.90007578567846e-05
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0136460049903695,0.00346815109819793,0.00684842883790154,0.0204435811428374,8.37324959384901e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6A,Ras-related protein Rab-6A,40341,0.0182051000407493,0.004628808172146,0.0091326360233431,0.0272775640581554,8.4248769608541e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RGMA,Repulsive guidance molecule A,40471,-0.011781582080889,0.00300018656540776,-0.0176619477490882,-0.00590121641268975,8.63902694310722e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0295774941238534,0.00753186629242035,0.0148150361907095,0.0443399520569973,8.64619678007026e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM2,Myomesin-2,37562,-0.0179230347218797,0.00457622533790638,-0.0268924363841762,-0.00895363305958316,9.02788958018721e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.014339623879159,0.00366419347814631,0.00715780466199219,0.0215214430963257,9.13791898889887e-05
NMR metabolomics,X23408.Triglycerides in VLDL,STX5,Syntaxin-5,37598,0.0159573841841364,0.00408039135416028,0.00795981712998227,0.0239549512382906,9.24730398124489e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0569985740100622,0.0145843265509107,0.0284132939702772,0.0855838540498472,9.33690629165071e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0263950227349069,0.00675491658973512,0.0131553862190261,0.0396346592507878,9.36346332172673e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0206102724157106,0.005275038270441,0.0102711974056463,0.030949347425775,9.3853884330833e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RAB39B,Ras-related protein Rab-39B,37562,0.0338790519391088,0.00867775978316986,0.0168706427640959,0.0508874611141218,9.50408039720192e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00957613058906215,0.00245446688554927,0.00476537549338558,0.0143868856847387,9.59841940487134e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0196324638503216,0.00503380329080341,0.00976620940034696,0.0294987183002963,9.66104400692233e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0160246708688233,0.0041184388604421,-0.0240968110352899,-0.00795253070235683,0.000100254830212769
NMR metabolomics,X23408.Triglycerides in VLDL,IL34,Interleukin-34,39934,0.0135293100464735,0.00348370719389234,0.00670124394644448,0.0203573761465024,0.000103350762415079
NMR metabolomics,X23408.Triglycerides in VLDL,PCDHB15,Protocadherin beta-15,37900,-0.0152143639660115,0.00392172179022638,-0.0229009386748552,-0.00752778925716779,0.000105165439565628
NMR metabolomics,X23408.Triglycerides in VLDL,CD58,Lymphocyte function-associated antigen 3,40335,-0.00664793120235387,0.00171461900783035,-0.0100085844577013,-0.00328727794700639,0.000106088233921501
NMR metabolomics,X23408.Triglycerides in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0675317970693831,0.0174224820015816,0.0333837323462831,0.101679861792483,0.000106559326105123
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0143528670304191,0.00370485044994301,0.00709136014853084,0.0216143739123074,0.000107459590425685
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB2A2,Mammaglobin-A,37562,-0.0120637819184997,0.00312342021235552,-0.0181856855347165,-0.00594187830228287,0.000112835617887985
NMR metabolomics,X23408.Triglycerides in VLDL,F3,Tissue factor,40393,-0.010504968132958,0.00272401915304323,-0.0158440456729228,-0.0051658905929933,0.000115510888902685
NMR metabolomics,X23408.Triglycerides in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0133347400798387,0.0034586708608691,0.00655574519253524,0.0201137349671421,0.000115979675999024
NMR metabolomics,X23408.Triglycerides in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.0128624605981728,0.00333950268784203,-0.0194078858663432,-0.00631703533000244,0.000117903219360688
NMR metabolomics,X23408.Triglycerides in VLDL,IL19,Interleukin-19,39924,0.0253206963426613,0.00658338959285799,0.0124172527406596,0.038224139944663,0.000120469935337758
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0147795770849093,0.00384608148029992,0.00724125738352142,0.0223178967862971,0.000122142220031259
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0389088680409572,0.0101315894469528,0.0190509527249297,0.0587667833569848,0.000123338416240833
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.0119889176573851,0.00312742901331621,0.00585915679128536,0.0181186785234849,0.000126838705492156
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO4,Roundabout homolog 4,37628,-0.00667166164505517,0.00174105753691407,-0.0100841344174067,-0.0032591888727036,0.000127717094488623
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A2,Collagen alpha-2(IX) chain,37714,0.0172125838428685,0.00451909352212691,0.00835516053949979,0.0260700071462373,0.000140239864491164
NMR metabolomics,X23408.Triglycerides in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.022969746693245,0.00603403629676587,0.0111430355515839,0.0347964578349061,0.00014147308948203
NMR metabolomics,X23408.Triglycerides in VLDL,HGFAC,Hepatocyte growth factor activator,37849,0.0106735023222395,0.00281565075116392,0.00515482684995825,0.0161921777945208,0.000150835573337976
NMR metabolomics,X23408.Triglycerides in VLDL,VWF,von Willebrand factor,40536,-0.0262610565403119,0.006931457000459,-0.0398467122612115,-0.0126754008194123,0.00015200305372249
NMR metabolomics,X23408.Triglycerides in VLDL,EXTL1,Exostosin-like 1,37562,0.0175629602348931,0.00465009707851086,0.00844876996101177,0.0266771505087743,0.000159492984697859
NMR metabolomics,X23408.Triglycerides in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.0121513254215853,0.00322165670717096,-0.0184657725676404,-0.00583687827553023,0.000162683785650135
NMR metabolomics,X23408.Triglycerides in VLDL,MYOC,Myocilin,40332,-0.0167575691801688,0.00444857982293191,-0.0254767856331153,-0.00803835272722225,0.000165852129986178
NMR metabolomics,X23408.Triglycerides in VLDL,CD160,CD160 antigen,40516,0.0166693081452924,0.00442915565844537,0.00798816305473946,0.0253504532358453,0.00016812035604306
NMR metabolomics,X23408.Triglycerides in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0262490831112162,0.0069881896765654,0.012552231345148,0.0399459348772844,0.000173246543466199
NMR metabolomics,X23408.Triglycerides in VLDL,REG1B,Lithostathine-1-beta,40536,0.0203382984223962,0.00541839199735618,0.00971825010757808,0.0309583467372143,0.000174949069629123
NMR metabolomics,X23408.Triglycerides in VLDL,ERC2,ERC protein 2,37572,0.0280161036985823,0.0074919385539121,0.0133319041329146,0.04270030326425,0.000185170939719876
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.00932088698731976,0.00249838920959323,0.00442404413651702,0.0142177298381225,0.000191567752473677
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH1,Neurexophilin-1,39961,0.0136459649035921,0.00366013812435203,0.00647209417986213,0.0208198356273221,0.000193488328068821
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS5,Transmembrane protease serine 5,40159,-0.0136194418208499,0.00366341549609579,-0.0207997361931976,-0.00643914744850216,0.000201751628830609
NMR metabolomics,X23408.Triglycerides in VLDL,JUN,Transcription factor AP-1,40044,0.0186984267628486,0.00503431521531229,0.00883116894083654,0.0285656845848607,0.00020456283305687
NMR metabolomics,X23408.Triglycerides in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0138806556475982,0.00374022483239289,0.00654981497610811,0.0212114963190882,0.000207010915983573
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD5,Sushi domain-containing protein 5,37604,-0.0123696872540564,0.0033329525806964,-0.0189022743122214,-0.00583710019589147,0.00020702325200569
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.0106576514595516,0.00287392702771684,0.00502475448522662,0.0162905484338766,0.000209287575755087
NMR metabolomics,X23408.Triglycerides in VLDL,CALCB,Calcitonin gene-related peptide 2,37942,0.0143839615638421,0.00388392698376924,0.00677146467565438,0.0219964584520298,0.000213528424190368
NMR metabolomics,X23408.Triglycerides in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0212072272825046,0.00574030872542821,0.0099562221806653,0.0324582323843439,0.000221119599787281
NMR metabolomics,X23408.Triglycerides in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00702435448664345,0.00190303202043633,-0.0107542972466986,-0.00329441172658825,0.000224127379617194
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.0113807971450628,0.00310029611744069,-0.0174573775352466,-0.00530421675487908,0.000242681925932676
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0138334917391499,0.00376990975082615,-0.0212225148507692,-0.00644446862753067,0.000244006346775077
NMR metabolomics,X23408.Triglycerides in VLDL,PI16,Peptidase inhibitor 16,37987,-0.00878460387175003,0.00239553421347417,-0.0134798509301594,-0.00408935681334065,0.000246280497501472
NMR metabolomics,X23408.Triglycerides in VLDL,CLIC5,Chloride intracellular channel protein 5,37572,-0.0115211456203971,0.00314316449355941,-0.0176817480277735,-0.00536054321302061,0.000247867851316738
NMR metabolomics,X23408.Triglycerides in VLDL,RCC1,Regulator of chromosome condensation,37900,0.0181881132205928,0.00497322397950097,0.00844059422077086,0.0279356322204147,0.000255950816113918
NMR metabolomics,X23408.Triglycerides in VLDL,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0136862288880664,0.00374505270442876,-0.0210265321887467,-0.00634592558738599,0.000258709089528145
NMR metabolomics,X23408.Triglycerides in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.00955879320801878,0.00261710774081542,0.00442926203602055,0.014688324380017,0.000260756360706324
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5A,Cytochrome b5,37482,0.0258619870121128,0.00715249824780878,0.0118430904464076,0.039880883577818,0.000300554187292505
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0193666536358152,0.00536704520679184,0.00884724503050319,0.0298860622411272,0.000309014443842955
NMR metabolomics,X23408.Triglycerides in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0252216629870019,0.007001839369853,0.01149805782209,0.0389452681519137,0.000316553385785887
NMR metabolomics,X23408.Triglycerides in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.0153242940717992,0.00425939450816671,0.00697588083579248,0.023672707307806,0.000322143663417051
NMR metabolomics,X23408.Triglycerides in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0172803962361756,0.00480698111565789,0.00785871324948612,0.026702079222865,0.000325580136369676
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.0169649281219403,0.00472634946143148,0.00770128317753464,0.026228573066346,0.000332568279106658
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0226673956815779,0.0063261921818571,0.010268059005138,0.0350667323580178,0.000340591461436053
NMR metabolomics,X23408.Triglycerides in VLDL,FMR1,Synaptic functional regulator FMR1,39980,0.0122080702275368,0.00340961117983479,0.00552523231506059,0.018890908140013,0.000344000480794626
NMR metabolomics,X23408.Triglycerides in VLDL,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0189492528776258,0.00529315424907647,-0.0293238352058157,-0.00857467054943594,0.000344897523235086
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC7A,C-type lectin domain family 7 member A,40516,0.0202394263020432,0.00567991336819105,0.00910679610038875,0.0313720565036976,0.000367235849902856
NMR metabolomics,X23408.Triglycerides in VLDL,CR2,Complement receptor type 2,40403,0.0160444138843742,0.00450646971978606,0.00721173323359348,0.0248770945351549,0.000371499571077341
NMR metabolomics,X23408.Triglycerides in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0186606893956126,0.0052432151516367,0.00838398769840465,0.0289373910928205,0.000373561071992873
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC10A,C-type lectin domain family 10 member A,40228,-0.0124329293715975,0.00349738657646468,-0.0192878070614682,-0.00557805168172669,0.000379199935302074
NMR metabolomics,X23408.Triglycerides in VLDL,MYL3,Myosin light chain 3,37628,-0.0236450715418976,0.00665803084386116,-0.0366948119958655,-0.0105953310879297,0.000384581503742834
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM1,Myomesin-1,37541,0.016211990865045,0.00456510592366652,0.00726438325465861,0.0251595984754314,0.000384701901102098
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR4,Complement factor H-related protein 4,37973,0.0252387582103569,0.00713454531365535,0.0112550493955924,0.0392224670251214,0.000405222313457927
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0170944985440835,0.00483464866011872,-0.0265704099179162,-0.00761858717025083,0.00040765113594944
NMR metabolomics,X23408.Triglycerides in VLDL,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0134889839293641,0.00382080214384061,-0.0209777561312917,-0.00600021172743651,0.000416344103107741
NMR metabolomics,X23408.Triglycerides in VLDL,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0211780020371548,0.00600092228588999,0.00941619435681044,0.0329398097174992,0.000418367373736635
NMR metabolomics,X23408.Triglycerides in VLDL,COL5A1,Collagen alpha-1(V) chain,37671,0.0136545729907172,0.00386955094895764,0.00607025313076021,0.0212388928506742,0.00041898809644312
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM26,Tripartite motif-containing protein 26,37482,0.0188778516308131,0.00535984897721229,0.00837254763547701,0.0293831556261492,0.00042962914103573
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN2,Alpha-actinin-2,37562,-0.0187240961710532,0.00532518839964339,-0.0291614654343542,-0.0082867269077521,0.000439353061576329
NMR metabolomics,X23408.Triglycerides in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.00963094278406815,0.00274656132625887,-0.0150142029835355,-0.00424768258460076,0.000455224884218325
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN1,Nectin-1,37598,0.0108770562608179,0.00311092476678426,0.00477964371792076,0.0169744688037151,0.000473126293654047
NMR metabolomics,X23408.Triglycerides in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0131813502897438,0.00377964285036516,0.00577325030302807,0.0205894502764595,0.000489229956933622
NMR metabolomics,X23408.Triglycerides in VLDL,TYMP,Thymidine phosphorylase,40257,0.0223830822108183,0.00645929734737461,0.00972285940996403,0.0350433050116725,0.000531143869404377
NMR metabolomics,X23408.Triglycerides in VLDL,NME1,Nucleoside diphosphate kinase A,37598,-0.00741524398087984,0.0021402955136041,-0.0116102231875439,-0.0032202647742158,0.000532735961825918
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0148118840142935,0.00428691236464922,0.00640953577958103,0.023214232249006,0.000551703338822789
NMR metabolomics,X23408.Triglycerides in VLDL,NUP50,Nuclear pore complex protein Nup50,37562,-0.0119122648242035,0.00346300707798645,-0.0186997586970569,-0.00512477095135004,0.000583823761794533
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549,UPF0606 protein KIAA1549,37714,0.0236395659188993,0.00690710226916582,0.0101016454713343,0.0371774863664643,0.00062235203331113
NMR metabolomics,X23408.Triglycerides in VLDL,AKAP12,A-kinase anchor protein 12,37671,-0.00726559263018992,0.0021229509486798,-0.0114265764896023,-0.00310460877077751,0.000622583963459727
NMR metabolomics,X23408.Triglycerides in VLDL,OPTC,Opticin,40305,-0.014904420635098,0.00436735556916133,-0.0234644375506542,-0.00634440371954176,0.000644863717440131
NMR metabolomics,X23408.Triglycerides in VLDL,HBQ1,Hemoglobin subunit theta-1,40489,-0.019501874761837,0.00573121744270395,-0.0307350609495368,-0.00826868857413728,0.00066875405124973
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.0103852834634537,0.00305947345442059,0.00438871549278934,0.016381851434118,0.000689653605006069
NMR metabolomics,X23408.Triglycerides in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0203130581874024,0.0059911616699622,-0.0320557350605283,-0.00857038131427644,0.000699703541021992
NMR metabolomics,X23408.Triglycerides in VLDL,MMP8,Neutrophil collagenase,40442,0.0240068383555919,0.00710078701064091,0.0100892958147357,0.0379243808964481,0.000724296028955627
NMR metabolomics,X23408.Triglycerides in VLDL,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0143676986218504,0.00425054201289592,-0.0226987609671264,-0.0060366362765744,0.000726446549063682
NMR metabolomics,X23408.Triglycerides in VLDL,CD27,CD27 antigen,40411,0.0133120616831828,0.00394486375257435,0.00558012872813706,0.0210439946382285,0.000741178634592368
NMR metabolomics,X23408.Triglycerides in VLDL,MMP9,Matrix metalloproteinase-9,40312,0.0199968320715076,0.00593236752874333,0.00836939171517063,0.0316242724278445,0.000751287282207832
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171B,Protein FAM171B,37900,0.009087601858685,0.00269598150945312,0.00380347810015688,0.0143717256172131,0.000751624546662832
NMR metabolomics,X23408.Triglycerides in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.0121022662116754,0.00359717760640858,0.00505179810311455,0.0191527343202362,0.00076897835876127
NMR metabolomics,X23408.Triglycerides in VLDL,CPA4,Carboxypeptidase A4,37410,0.0143754213284663,0.00427903758413083,0.00598850766356988,0.0227623349933627,0.000783092490545853
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL1,Chordin-like protein 1,40396,0.00993439475009313,0.00295826042031684,0.00413620432627212,0.0157325851739141,0.000786388533911042
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0158307564894822,0.00472131369482462,0.00657698164762595,0.0250845313313385,0.000801202199318896
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.0106903413399595,0.00320385126700707,-0.0169698898232933,-0.0044107928566256,0.000849666335818436
NMR metabolomics,X23408.Triglycerides in VLDL,ARTN,Artemin,40044,0.0144314864005892,0.00432522067399699,0.0059540538795551,0.0229089189216233,0.000850112721050627
NMR metabolomics,X23408.Triglycerides in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00743885267174147,0.00223397859684317,0.00306025462192886,0.0118174507215541,0.000870834784917278
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB4,Ephrin type-B receptor 4,40536,-0.00793349890876806,0.00238796706328133,-0.0126139143527995,-0.00325308346473665,0.00089483610752027
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.0098478719012372,0.00296617248996635,0.00403417382090315,0.0156615699815712,0.000902428852674999
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00805742081299487,0.00242896718647525,-0.0128181964984864,-0.00329664512750337,0.000911571805268908
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.0094107240028603,0.00284657618377566,0.00383143468266,0.0149900133230606,0.000948520308882298
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0282064355266418,0.00855336515257764,0.0114418398275896,0.0449710312256939,0.00097738812144253
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0193879981159133,0.00588287660650577,0.00785755996716195,0.0309184362646646,0.000984052059864227
NMR metabolomics,X23408.Triglycerides in VLDL,FBLN2,Fibulin-2,37998,-0.00986198979063475,0.0030018617910418,-0.0157456389010767,-0.00397834068019283,0.00102135822962022
NMR metabolomics,X23408.Triglycerides in VLDL,CDH23,Cadherin-23,37942,-0.00845432024862268,0.00257374776961125,-0.0134988658770607,-0.00340977462018463,0.00102304561410677
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00907343126468498,0.00276746990830822,0.00364919024440087,0.0144976722849691,0.00104587703918001
NMR metabolomics,X23408.Triglycerides in VLDL,SPP1,Osteopontin,40497,-0.0151105912079117,0.00461765653258316,-0.0241611980117747,-0.00605998440404872,0.00106882585962994
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS,RNA-binding protein with multiple splicing,37598,0.0205245484475558,0.00629851644405486,0.00817945621720823,0.0328696406779033,0.00112235012334672
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00846510099302811,0.00259840961681275,-0.0135579838419811,-0.00337221814407512,0.00112563404390494
NMR metabolomics,X23408.Triglycerides in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.00862423198991268,0.0026559297107927,0.00341860975675899,0.0138298542230664,0.00116847933205298
NMR metabolomics,X23408.Triglycerides in VLDL,DDI2,Protein DDI1 homolog 2,37671,0.0247021386827808,0.00761177747540784,0.00978305483098143,0.0396212225345801,0.00117638475742265
NMR metabolomics,X23408.Triglycerides in VLDL,FDX1,"Adrenodoxin, mitochondrial",37562,0.0198603002630535,0.00612628752023903,0.00785277672338505,0.031867823802722,0.00119067175029239
NMR metabolomics,X23408.Triglycerides in VLDL,CDK1,Cyclin-dependent kinase 1,37482,0.0115467383884086,0.00356643725462871,0.00455652136933636,0.0185369554074809,0.00120836347447381
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0128766937743241,0.00398030908139123,-0.0206780995738509,-0.00507528797479726,0.0012190205275066
NMR metabolomics,X23408.Triglycerides in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.0114935844354481,0.00355897193145523,0.00451799944979581,0.0184691694211003,0.00124326217758073
NMR metabolomics,X23408.Triglycerides in VLDL,PRKCQ,Protein kinase C theta type,40044,0.0139075388310192,0.00430999844433099,0.00545994188013046,0.0223551357819079,0.00125437742918152
NMR metabolomics,X23408.Triglycerides in VLDL,TK1,"Thymidine kinase, cytosolic",37714,0.0140303518453297,0.00435679970808065,0.00549102441749163,0.0225696792731678,0.00128349704255718
NMR metabolomics,X23408.Triglycerides in VLDL,APOE,Apolipoprotein E,38013,0.023447490023408,0.00728874852771523,0.00916154290908616,0.0377334371377299,0.00129868389308656
NMR metabolomics,X23408.Triglycerides in VLDL,CLC,Galectin-10,40333,-0.0205120309381162,0.00637681140175127,-0.0330105812855487,-0.00801348059068371,0.00129952282057455
NMR metabolomics,X23408.Triglycerides in VLDL,ODAM,Odontogenic ameloblast-associated protein,39934,0.0167099187486624,0.00520244683861007,0.0065131229449867,0.0269067145523382,0.00132113924773538
NMR metabolomics,X23408.Triglycerides in VLDL,LEO1,RNA polymerase-associated protein LEO1,37959,0.00959202190213823,0.00301606470224054,0.00368053508574678,0.0155035087185297,0.00147449772328203
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0187187345155247,0.00588916533112036,0.00717597046652882,0.0302614985645206,0.00148380887238273
NMR metabolomics,X23408.Triglycerides in VLDL,SAT1,Diamine acetyltransferase 1,37562,-0.0161761668379923,0.00509235767853857,-0.0261571878879279,-0.00619514578805674,0.00149379674967067
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0184964902285684,0.00584076915451735,-0.0299443977714225,-0.00704858268571443,0.00154484702953878
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0116431448594061,0.00368296248997401,-0.0188617513397551,-0.004424538379057,0.00157385087337024
NMR metabolomics,X23408.Triglycerides in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.020473037980739,0.00648333011355719,0.00776571095816695,0.0331803650033111,0.00159322770173495
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA7A,Semaphorin-7A,40490,0.00822161044094262,0.00260882524864692,0.00310831295359465,0.0133349079282906,0.00162754873145082
NMR metabolomics,X23408.Triglycerides in VLDL,LIFR,Leukemia inhibitory factor receptor,40341,-0.00746946929612209,0.00237429272490972,-0.0121230830369451,-0.00281585555529904,0.00165838710319521
NMR metabolomics,X23408.Triglycerides in VLDL,PRELP,Prolargin,40357,0.00704313547118208,0.00225007485109004,0.0026329887630456,0.0114532821793186,0.00175016363344811
NMR metabolomics,X23408.Triglycerides in VLDL,TERF1,Telomeric repeat-binding factor 1,37598,-0.00905658133797911,0.00289664738434029,-0.0147340102112861,-0.00337915246467213,0.00177241814271617
NMR metabolomics,X23408.Triglycerides in VLDL,NCAN,Neurocan core protein,40471,-0.0112986810733413,0.00361530216538753,-0.0183846733175008,-0.00421268882918175,0.00177978379003742
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.00977562122228909,0.00314019298666001,-0.0159303994761427,-0.00362084296843546,0.00185553293412932
NMR metabolomics,X23408.Triglycerides in VLDL,STX3,Syntaxin-3,37942,0.0116395119597481,0.00376752487503933,0.00425516320467099,0.0190238607148252,0.00200947391065465
NMR metabolomics,X23408.Triglycerides in VLDL,TFF1,Trefoil factor 1,40261,0.0231853273392852,0.0075449338777936,0.00839725693880978,0.0379733977397607,0.00212303034298702
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2B,Sodium channel subunit beta-2,37572,-0.00887524435263253,0.00289022595440847,-0.0145400872232731,-0.00321040148199193,0.00213937911356899
NMR metabolomics,X23408.Triglycerides in VLDL,SAFB2,Scaffold attachment factor B2,37959,0.00827408443606816,0.00269601870690136,0.00298988777054149,0.0135582811015948,0.00215201492050663
NMR metabolomics,X23408.Triglycerides in VLDL,ARG1,Arginase-1,40227,0.0157196808917455,0.00512875908825674,0.00566731307876226,0.0257720487047287,0.00218032750633581
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC2,MAM domain-containing protein 2,37990,-0.0100927341289869,0.00330513931460443,-0.0165708071856116,-0.00361466107236226,0.00226515645394272
NMR metabolomics,X23408.Triglycerides in VLDL,RBM19,Probable RNA-binding protein 19,37562,-0.0141607279167269,0.00466588055322651,-0.0233058538010509,-0.00501560203240293,0.00241044841963952
NMR metabolomics,X23408.Triglycerides in VLDL,CFD,Complement factor D,38013,0.00561386927722219,0.00185170835888637,0.00198452089380491,0.00924321766063947,0.00243620208809973
NMR metabolomics,X23408.Triglycerides in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0124789091744184,0.00412024002156885,0.00440323873214345,0.0205545796166934,0.00246096129945241
NMR metabolomics,X23408.Triglycerides in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0184582385695359,0.00609865401149887,-0.0304116004320737,-0.00650487670699815,0.00247710872363085
NMR metabolomics,X23408.Triglycerides in VLDL,RLN2,Prorelaxin H2,37643,0.0413339515266739,0.0137296226699454,0.0144238910935808,0.0682440119597669,0.00261253539785891
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC12A,C-type lectin domain family 12 member A,37598,0.00599535616639686,0.00199421851974768,0.00208668786769139,0.00990402446510232,0.002648875087215
NMR metabolomics,X23408.Triglycerides in VLDL,ACRV1,Acrosomal protein SP-10,37598,0.0103184413844042,0.00343529570252535,0.0035852618074545,0.0170516209613539,0.00267260200650712
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.0141790560428973,0.00472632440418103,-0.0234426518750921,-0.00491546021070248,0.00270471384268112
NMR metabolomics,X23408.Triglycerides in VLDL,SAG,S-arrestin,37541,-0.0156138449795452,0.00520910531856168,-0.0258236914039261,-0.0054039985551643,0.00272791573396657
NMR metabolomics,X23408.Triglycerides in VLDL,CD2,T-cell surface antigen CD2,37562,0.0111511032352395,0.00372264510837379,0.00385471882282685,0.0184474876476521,0.00274526738129191
NMR metabolomics,X23408.Triglycerides in VLDL,MKI67,Proliferation marker protein Ki-67,37598,0.0110074363740245,0.00367931338930821,0.00379598213098045,0.0182188906170686,0.00277934881631644
NMR metabolomics,X23408.Triglycerides in VLDL,EGFR,Epidermal growth factor receptor,40536,0.00473546852188148,0.00158686940597171,0.00162520448617694,0.00784573255758603,0.00284787365112734
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL14,C-X-C motif chemokine 14,40044,0.0178053988920137,0.00596866036665211,0.00610682457337562,0.0295039732106519,0.00285741308166867
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.0148936354158401,0.00499366108453836,0.00510605969014494,0.0246812111415353,0.00286340906584165
NMR metabolomics,X23408.Triglycerides in VLDL,CAPS,Calcyphosin,37942,0.0275485376737345,0.00924001805740875,0.0094381022812134,0.0456589730662557,0.00287410659445279
NMR metabolomics,X23408.Triglycerides in VLDL,DDA1,DET1- and DDB1-associated protein 1,37562,0.0118294889047674,0.00397250297665544,0.00404338307052269,0.019615594739012,0.00290815868203551
NMR metabolomics,X23408.Triglycerides in VLDL,DRAXIN,Draxin,40228,0.0125093960172417,0.00420110072018023,0.00427523860568841,0.0207435534287949,0.00290911420123009
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GL3,Endophilin-A3,37643,0.0240466222943482,0.00808269254368232,0.00820454490873088,0.0398886996799656,0.00293446885678987
NMR metabolomics,X23408.Triglycerides in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0181186381449656,0.00609432378787079,-0.0300635127691924,-0.00617376352073887,0.00295405465690816
NMR metabolomics,X23408.Triglycerides in VLDL,IL11,Interleukin-11,40044,0.0183610008362079,0.00620385154325589,0.00620145181142633,0.0305205498609894,0.00308488699727641
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00748438420771774,0.00253896407334113,-0.0124607537914664,-0.00250801462396913,0.00320581692155451
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00899410265029114,0.00305249819865386,-0.0149769991196527,-0.00301120618092958,0.00321887693172415
NMR metabolomics,X23408.Triglycerides in VLDL,ENG,Endoglin,40536,-0.00485822005448738,0.001653061698608,-0.00809822098375907,-0.0016182191252157,0.00329823506602909
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.00896027068278397,0.00305278505315856,-0.0149437293869748,-0.00297681197859319,0.00333999458365633
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL6,Fc receptor-like protein 6,40341,0.0191758797392531,0.00654811382775177,0.00634157663685968,0.0320101828416466,0.00341130931864069
NMR metabolomics,X23408.Triglycerides in VLDL,C1QL2,Complement C1q-like protein 2,37598,0.0122190178357869,0.00418493574627803,0.00401654377308191,0.0204214918984918,0.00350893114032476
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.00972405561931841,0.00333964873591541,0.00317834409692422,0.0162697671417126,0.00359967680476738
NMR metabolomics,X23408.Triglycerides in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0252164321791373,0.00867103590291529,0.00822120180942337,0.0422116625488513,0.00364220024523972
NMR metabolomics,X23408.Triglycerides in VLDL,NMI,N-myc-interactor,37857,0.0202362059321789,0.00696677517003802,0.00658132659890439,0.0338910852654534,0.00368237262371618
NMR metabolomics,X23408.Triglycerides in VLDL,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00651505899576429,0.00224402808919935,0.00211676394093357,0.010913354050595,0.00369777629170788
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR4,Fibroblast growth factor receptor 4,37671,0.0150900192613053,0.0052090698343031,0.00488024238607124,0.0252997961365394,0.00377519429944927
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.0102020226504695,0.00352230547793953,0.003298303913708,0.017105741387231,0.00377980303625692
NMR metabolomics,X23408.Triglycerides in VLDL,NTF4,Neurotrophin-4,39980,0.011459544910642,0.00396343515680129,0.00369121200331145,0.0192278778179725,0.00384163816118392
NMR metabolomics,X23408.Triglycerides in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0183596369941426,0.00636210064862538,-0.0308293542654483,-0.00588991972283687,0.0039108025270739
NMR metabolomics,X23408.Triglycerides in VLDL,NRXN3,Neurexin-3,37572,0.00978014546873159,0.00339582835027048,0.00312432190220144,0.0164359690352617,0.00398259374202832
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0140737262024503,0.00490210883289278,0.00446559288998049,0.0236818595149202,0.00409874640930946
NMR metabolomics,X23408.Triglycerides in VLDL,GSAP,Gamma-secretase-activating protein,39980,0.0248007014025188,0.00867780161679612,0.00779221023359837,0.0418091925714392,0.00426957960096531
NMR metabolomics,X23408.Triglycerides in VLDL,MELTF,Melanotransferrin,37990,0.00811902947831503,0.00284133973967428,0.00255000358855345,0.0136880553680766,0.00427690428345288
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR1,Cadherin-related family member 1,39961,0.0121467830507359,0.00426951866582763,0.00377852646571372,0.020515039635758,0.00444695104403853
NMR metabolomics,X23408.Triglycerides in VLDL,L1CAM,Neural cell adhesion molecule L1,40411,-0.00779757366359756,0.00274467974170679,-0.0131771459573429,-0.00241800136985225,0.00450324236705637
NMR metabolomics,X23408.Triglycerides in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00614072119637453,0.00216737022448985,0.00189267555637441,0.0103887668363746,0.00461341242893888
NMR metabolomics,X23408.Triglycerides in VLDL,SDK2,Protein sidekick-2,37671,0.0105184253832151,0.003715215522704,0.00323660295871523,0.0178002478077149,0.0046447359530228
NMR metabolomics,X23408.Triglycerides in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0245831307334507,0.00868926756790819,0.00755216630035067,0.0416140951665508,0.00467451198114338
NMR metabolomics,X23408.Triglycerides in VLDL,AMBN,Ameloblastin,40044,-0.00814745240252264,0.00288375820877912,-0.0137996184917297,-0.00249528631331558,0.00472978949129154
NMR metabolomics,X23408.Triglycerides in VLDL,CD99,CD99 antigen,40332,-0.00532437832453565,0.00188477359463651,-0.0090185345700232,-0.00163022207904809,0.00473479605453615
NMR metabolomics,X23408.Triglycerides in VLDL,TXNL1,Thioredoxin-like protein 1,37525,0.0262607251711984,0.00930477555134198,0.00802336509056817,0.0444980852518287,0.00477548106202618
NMR metabolomics,X23408.Triglycerides in VLDL,SCP2,Non-specific lipid-transfer protein,39980,0.0212696281750008,0.00757550098974518,0.00642164623510025,0.0361176101149013,0.00499610845779386
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0795754212073448,0.0283790420633676,0.0239524987631443,0.135198343651545,0.0050530828108192
NMR metabolomics,X23408.Triglycerides in VLDL,CDH22,Cadherin-22,37714,-0.0080446150822214,0.00287459009734306,-0.0136788116730138,-0.002410418491429,0.00514105278122541
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0100377375852998,0.00359247587058371,0.00299648487895571,0.0170789902916439,0.00521195188783024
NMR metabolomics,X23408.Triglycerides in VLDL,CLMP,CXADR-like membrane protein,40489,0.00552288976802223,0.00197803250616079,0.00164594605594709,0.00939983348009737,0.00524270846030213
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM3,Intercellular adhesion molecule 3,40536,-0.00681646605894479,0.00244773505030309,-0.0116140267575388,-0.00201890536035073,0.00536224499939219
NMR metabolomics,X23408.Triglycerides in VLDL,PRR4,Proline-rich protein 4,37577,-0.0186858336017353,0.00671481684603474,-0.0318468746199634,-0.00552479258350723,0.00539729532450351
NMR metabolomics,X23408.Triglycerides in VLDL,FOLH1,Glutamate carboxypeptidase 2,37598,0.0291121477326877,0.0104951332612577,0.00854168654062266,0.0496826089247527,0.00554717242369015
NMR metabolomics,X23408.Triglycerides in VLDL,MYH4,Myosin-4,37562,-0.0128640829479851,0.00463904069163929,-0.0219566027035981,-0.00377156319237205,0.00556197224620125
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.00719592832823197,0.00259578121320127,-0.0122836595061065,-0.00210819715035749,0.00557614243230804
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00682206020521382,0.00246357313476329,0.00199345686107777,0.0116506635493499,0.00562783917933903
NMR metabolomics,X23408.Triglycerides in VLDL,AREG,Amphiregulin,40305,0.0132699712332415,0.00479776457114265,0.00386635267380186,0.022673589792681,0.00568376531599431
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0154433930705658,0.00560735809756393,-0.0264338149417911,-0.00445297119934046,0.0058915508376143
NMR metabolomics,X23408.Triglycerides in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0165675209641338,0.00602639877488074,0.00475577936536751,0.0283792625629,0.00598302078364937
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0142151078692168,0.00517153908925229,0.00407889125428231,0.0243513244841513,0.00599095830714434
NMR metabolomics,X23408.Triglycerides in VLDL,TSC1,Hamartin,37598,0.0204145226927884,0.00743417832968194,0.00584353316661176,0.034985512218965,0.00604021413765711
NMR metabolomics,X23408.Triglycerides in VLDL,CENPJ,Centromere protein J,37714,0.0196145633298414,0.00714573477031718,0.0056089231800197,0.0336202034796631,0.00606047181916894
NMR metabolomics,X23408.Triglycerides in VLDL,TCN1,Transcobalamin-1,37766,0.00881243496816848,0.00321707988554346,0.00250695839250329,0.0151179115438337,0.00616586334336512
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL2,Kin of IRRE-like protein 2,39961,0.0106641744824231,0.00389826094455599,0.00302358303109334,0.0183047659337528,0.00623330006776671
NMR metabolomics,X23408.Triglycerides in VLDL,CEP164,Centrosomal protein of 164 kDa,40044,0.0169741747704311,0.0062143726493842,0.00479400437763808,0.0291543451632241,0.00631294949348648
NMR metabolomics,X23408.Triglycerides in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00957146730456199,0.00350645366250675,0.00269881812604876,0.0164441164830752,0.00634810716292302
NMR metabolomics,X23408.Triglycerides in VLDL,NDRG1,Protein NDRG1,39961,0.0182196448286257,0.00667982866721584,0.00512718064088263,0.0313121090163687,0.00638761063372414
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN7,Septin-7,37714,0.0139474590516001,0.00511747177395204,0.00391721437465415,0.0239777037285461,0.00642964190167015
NMR metabolomics,X23408.Triglycerides in VLDL,NINJ1,Ninjurin-1,39980,0.0148958279533887,0.00546930135753419,0.00417599729262167,0.0256156586141557,0.00646597663891425
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00389456181494614,0.00143369012054194,0.00108452917868393,0.00670459445120834,0.00660681826848724
NMR metabolomics,X23408.Triglycerides in VLDL,CHAD,Chondroadherin,37671,0.014212197103187,0.00523426578403394,0.00395303616648052,0.0244713580398936,0.00663172356243346
NMR metabolomics,X23408.Triglycerides in VLDL,SYT1,Synaptotagmin-1,37942,0.0102687839248136,0.00380973485274752,0.00280170361342844,0.0177358642361987,0.00703899599034265
NMR metabolomics,X23408.Triglycerides in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.010030505755265,0.00372353246329678,-0.0173286293833267,-0.00273238212720335,0.00707293771363496
NMR metabolomics,X23408.Triglycerides in VLDL,BRD3,Bromodomain-containing protein 3,37562,0.0126737873388002,0.00471817377368554,0.0034261667423765,0.0219214079352238,0.00723687209205929
NMR metabolomics,X23408.Triglycerides in VLDL,MYH7B,Myosin-7B,37482,-0.0119585832014178,0.00445521932233139,-0.0206908130731873,-0.00322635332964825,0.00728012120947872
NMR metabolomics,X23408.Triglycerides in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00845210910640271,0.00314961940490989,-0.0146253631400261,-0.00227885507277933,0.00729258975409713
NMR metabolomics,X23408.Triglycerides in VLDL,CEP290,Centrosomal protein of 290 kDa,37714,0.013904141395078,0.00519598640437018,0.00372000804251242,0.0240882747476435,0.00746118146466961
NMR metabolomics,X23408.Triglycerides in VLDL,TMOD4,Tropomodulin-4,37482,-0.0108955584011324,0.00408234248636128,-0.0188969496744005,-0.00289416712786427,0.00761835670859544
NMR metabolomics,X23408.Triglycerides in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0107083483696308,0.00401306503874696,-0.0185739558455748,-0.00284274089368677,0.00763137010687005
NMR metabolomics,X23408.Triglycerides in VLDL,PTTG1,Securin,37714,0.0107485908735719,0.00403007655871769,0.00284964081848519,0.0186475409286585,0.00766032809741167
NMR metabolomics,X23408.Triglycerides in VLDL,SSB,Lupus La protein,39961,0.0156449353657312,0.00586840072866156,0.00414286993755453,0.0271470007939079,0.00768478676848035
NMR metabolomics,X23408.Triglycerides in VLDL,TUBB3,Tubulin beta-3 chain,37541,-0.00721628359951751,0.00271308791875834,-0.0125339359202839,-0.00189863127875115,0.00782812511726856
NMR metabolomics,X23408.Triglycerides in VLDL,NGF,Beta-nerve growth factor,40228,0.00314118987118441,0.00118301808776628,0.000822474419162501,0.00545990532320632,0.00793330122829211
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00829773474495625,0.00313017122959977,-0.0144328703549718,-0.0021625991349407,0.00803767520528241
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH12,Protocadherin-12,37959,0.00660451892575867,0.00249381764041171,0.00171663635055171,0.0114924015009656,0.00809781260623566
NMR metabolomics,X23408.Triglycerides in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0176795277061613,0.00672087888065003,-0.0308524503122354,-0.00450660510008726,0.0085332233926164
NMR metabolomics,X23408.Triglycerides in VLDL,SLC12A2,Solute carrier family 12 member 2,37562,-0.00729663613029219,0.00278762977315084,-0.0127603904856678,-0.00183288177491654,0.00886768070370081
NMR metabolomics,X23408.Triglycerides in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0166998438556111,0.00642251180654277,-0.0292879669964349,-0.00411172071478723,0.00932726624090404
NMR metabolomics,X23408.Triglycerides in VLDL,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0145688092434063,0.0056097698237543,0.00357366038884782,0.0255639580979647,0.00941353793670074
NMR metabolomics,X23408.Triglycerides in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0172811843379693,0.00665964756039029,0.00422827511960436,0.0303340935563343,0.00947184800809063
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0113589598360766,0.00439525859889765,-0.019973666689916,-0.00274425298223724,0.00976455445082145
NMR metabolomics,X23408.Triglycerides in VLDL,PEPD,Xaa-Pro dipeptidase,37987,0.00648214260670331,0.00251052598739826,0.00156151167140272,0.0114027735420039,0.00983377042114587
NMR metabolomics,X23408.Triglycerides in VLDL,IFNW1,Interferon omega-1,37562,-0.00923815250073334,0.00358842479982863,-0.0162714651083974,-0.00220483989306922,0.0100513782532887
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.0100268871668088,0.0039047466237502,0.00237358378425845,0.0176801905493592,0.0102434897639828
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL5,Fc receptor-like protein 5,40332,-0.0139408825165404,0.00543171855052061,-0.0245870508755608,-0.00329471415752001,0.0102800886139958
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00673452209710716,0.00263010427405379,0.00157951771996173,0.0118895264742526,0.0104598977293879
NMR metabolomics,X23408.Triglycerides in VLDL,S100G,Protein S100-G,37959,-0.0110308823448685,0.00433178474169861,-0.0195211804385978,-0.00254058425113924,0.0108919752904106
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF21,Immunoglobulin superfamily member 21,37628,0.00965684875476154,0.00380929639859543,0.00219062781351449,0.0171230696960086,0.0112538201518677
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.0113895116314053,0.00449369148204082,0.00258187632660529,0.0201971469362053,0.0112686977672243
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC4,MANSC domain-containing protein 4,37562,0.0162100912785013,0.00640553190932377,0.00365524873622674,0.0287649338207759,0.0113970832464386
NMR metabolomics,X23408.Triglycerides in VLDL,GUK1,Guanylate kinase,37562,-0.00984083219183226,0.00391538629849052,-0.0175149893368737,-0.00216667504679083,0.0119701218536027
NMR metabolomics,X23408.Triglycerides in VLDL,BMP4,Bone morphogenetic protein 4,40203,-0.0110385883987728,0.00440514437745644,-0.0196726713785874,-0.0024045054189582,0.0122260811646487
NMR metabolomics,X23408.Triglycerides in VLDL,SDC1,Syndecan-1,40359,0.00971259532068564,0.00387957531766481,0.00210862769806261,0.0173165629433087,0.0123064029649286
NMR metabolomics,X23408.Triglycerides in VLDL,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00423682205156426,0.00169431548055967,0.000915963709667304,0.00755768039346121,0.0124079453176258
NMR metabolomics,X23408.Triglycerides in VLDL,POF1B,Protein POF1B,37598,0.0112551886882176,0.00452248861265037,0.0023911110074229,0.0201192663690123,0.0128328204053536
NMR metabolomics,X23408.Triglycerides in VLDL,CTNNA1,Catenin alpha-1,37541,-0.00880120652602951,0.00354009648761904,-0.0157397956417628,-0.00186261741029619,0.0129257731616433
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP2,Dipeptidase 2,40305,-0.00689595589695768,0.00278006273097267,-0.0123448788496641,-0.00144703294425126,0.0131299885215349
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS53,Serine protease 53,37942,0.00884521127546258,0.00357515183030016,0.00183791368807427,0.0158525088628509,0.0133701922517306
NMR metabolomics,X23408.Triglycerides in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0139905998795688,0.0056582702070476,0.00290039027375547,0.025080809485382,0.0134241410743307
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA6,Corticosteroid-binding globulin,38013,0.00428991719972492,0.00173785839969009,0.00088371473633234,0.0076961196631175,0.0135800049989845
NMR metabolomics,X23408.Triglycerides in VLDL,TEF,Thyrotroph embryonic factor,37562,0.0103218791308463,0.00419829025125976,0.00209323023837721,0.0185505280233155,0.0139611701098897
NMR metabolomics,X23408.Triglycerides in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0114155277451853,0.00465949875547885,0.00228291018444673,0.0205481453059238,0.0143003575264506
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00736074485640332,0.00300470683800552,-0.0132499702588941,-0.0014715194539125,0.0143069791728132
NMR metabolomics,X23408.Triglycerides in VLDL,VIM,Vimentin,40042,0.0280879705829132,0.0114945397716873,0.00555867263040611,0.0506172685354203,0.0145528538997164
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.00825439765032812,0.003381192708234,0.00162725994218948,0.0148815353584667,0.0146466636259079
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG4,Proteasome assembly chaperone 4,37598,0.013407174025578,0.00549665531173599,0.00263372961457547,0.0241806184365805,0.0147349376566876
NMR metabolomics,X23408.Triglycerides in VLDL,MYO6,Unconventional myosin-VI,37959,0.00885269836843895,0.00364814918749789,0.00170232596094309,0.0160030707759348,0.0152529001292993
NMR metabolomics,X23408.Triglycerides in VLDL,VASN,Vasorin,40116,-0.00645886588701758,0.00266230357107271,-0.0116769808863201,-0.00124075088771507,0.0152756305422055
NMR metabolomics,X23408.Triglycerides in VLDL,ACE,Angiotensin-converting enzyme,37987,-0.00602738845678335,0.00248501946233384,-0.0108980266029577,-0.00115675031060902,0.0153007499699562
NMR metabolomics,X23408.Triglycerides in VLDL,CADPS,Calcium-dependent secretion activator 1,37572,-0.0106393468246763,0.00439025620585476,-0.0192442489881516,-0.00203444466120098,0.0153894234244662
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA1,Alpha-1-antitrypsin,37779,-0.00191239235168881,0.00079022022778989,-0.00346122399815699,-0.000363560705220621,0.0155305846472045
NMR metabolomics,X23408.Triglycerides in VLDL,GLI2,Zinc finger protein GLI2,37598,-0.00792438017703981,0.00328283750536151,-0.0143587416875484,-0.00149001866653124,0.015797179034497
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.0100756387931649,0.00418718826143639,0.00186874980074962,0.0182825277855803,0.0161265652075361
NMR metabolomics,X23408.Triglycerides in VLDL,LEG1,Protein LEG1 homolog,37231,-0.0163050408007303,0.00678823492004697,-0.0296099812440223,-0.00300010035743822,0.0163218576190184
NMR metabolomics,X23408.Triglycerides in VLDL,QSOX1,Sulfhydryl oxidase 1,37761,0.0104844155546438,0.0043661130221729,0.00192683403118496,0.0190419970781027,0.0163498666571757
NMR metabolomics,X23408.Triglycerides in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.0067947487626425,0.0028299854996013,0.00124797718342395,0.012341520341861,0.0163648731438502
NMR metabolomics,X23408.Triglycerides in VLDL,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0167688320915122,0.00701542396152357,-0.0305190630560984,-0.00301860112692602,0.0168495332990852
NMR metabolomics,X23408.Triglycerides in VLDL,IDS,Iduronate 2-sulfatase,40516,0.00199557568748093,0.000838535956360496,0.00035204521301436,0.0036391061619475,0.017332078348189
NMR metabolomics,X23408.Triglycerides in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.00651205554219464,0.00273798503511161,0.00114560487337588,0.0118785062110134,0.0173991386492642
NMR metabolomics,X23408.Triglycerides in VLDL,TNN,Tenascin-N,37998,0.0100903310194461,0.00426082100999041,0.00173912183986491,0.0184415401990273,0.0178904756565929
NMR metabolomics,X23408.Triglycerides in VLDL,GSTP1,Glutathione S-transferase P,39871,-0.0160583426647347,0.00678158098854031,-0.0293502414022737,-0.00276644392719569,0.0178999459494655
NMR metabolomics,X23408.Triglycerides in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.0132761717863662,0.00561234205443353,-0.0242763622130559,-0.00227598135967651,0.0180187702524014
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.00658441183727048,0.00278377153828356,-0.0120406040523063,-0.0011282196222347,0.0180307183196349
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.0115754718617502,0.00489398416009255,-0.0211676808155316,-0.00198326290796877,0.0180326407893208
NMR metabolomics,X23408.Triglycerides in VLDL,CLSPN,Claspin,39925,0.00780844132176176,0.00331629167172937,0.00130850964517221,0.0143083729983513,0.0185565674770044
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA4,Ephrin type-A receptor 4,37671,0.00642733320162117,0.00274453129562139,0.00104805186220324,0.0118066145410391,0.0192022056940482
NMR metabolomics,X23408.Triglycerides in VLDL,SLC4A1,Band 3 anion transport protein,37998,-0.0105258528863012,0.00449734787021314,-0.019340654711919,-0.0017110510606835,0.0192745484811658
NMR metabolomics,X23408.Triglycerides in VLDL,CD33,Myeloid cell surface antigen CD33,40411,0.0180062483669025,0.00769866578729187,0.00291686342381046,0.0330956333099946,0.0193539662688392
NMR metabolomics,X23408.Triglycerides in VLDL,DCTPP1,dCTP pyrophosphatase 1,40359,0.00719088318668528,0.0030754895399046,0.00116292368847226,0.0132188426848983,0.0193930187743245
NMR metabolomics,X23408.Triglycerides in VLDL,GAD1,Glutamate decarboxylase 1,37482,-0.00588975383690818,0.00252104263733855,-0.0108309974060917,-0.000948510267724614,0.0194939578775769
NMR metabolomics,X23408.Triglycerides in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00838066481672059,0.00360011586485082,0.00132443772161298,0.0154368919118282,0.0199331719079657
NMR metabolomics,X23408.Triglycerides in VLDL,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00684612345282813,0.00294373478712242,-0.0126158436355881,-0.00107640327006819,0.0200520159843599
NMR metabolomics,X23408.Triglycerides in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.0110989310720403,0.00477756367899631,-0.0204629558828731,-0.00173490626120754,0.0201870468324069
NMR metabolomics,X23408.Triglycerides in VLDL,CTRC,Chymotrypsin-C,40360,0.0139642164360767,0.00608362902686267,0.0020403035434259,0.0258881293287276,0.0217245312333979
NMR metabolomics,X23408.Triglycerides in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00450230520334058,0.00196903064121914,-0.00836160526013008,-0.000643005146551071,0.0222374320004378
NMR metabolomics,X23408.Triglycerides in VLDL,KLK1,Kallikrein-1,40209,-0.0281911897880625,0.0123755985582824,-0.052447362962296,-0.00393501661382899,0.0227419471989951
NMR metabolomics,X23408.Triglycerides in VLDL,EFHD1,EF-hand domain-containing protein D1,37959,0.00768857662954801,0.00337950669589954,0.00106474350558491,0.0143124097535111,0.0229179995805418
NMR metabolomics,X23408.Triglycerides in VLDL,GPR101,Probable G-protein coupled receptor 101,37541,-0.0142710843064974,0.00630127831997907,-0.0266215898136564,-0.00192057879933846,0.0235417303676902
NMR metabolomics,X23408.Triglycerides in VLDL,COMP,Cartilage oligomeric matrix protein,40198,0.00741099197150748,0.00328147625685761,0.000979298508066564,0.0138426854349484,0.0239323464615082
NMR metabolomics,X23408.Triglycerides in VLDL,TJP3,Tight junction protein ZO-3,37541,-0.00966032663731082,0.00428859671937834,-0.0180659762072924,-0.00125467706732928,0.0243033240769822
NMR metabolomics,X23408.Triglycerides in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0207233181068995,0.00924017878817187,0.00261256768208268,0.0388340685317164,0.0249298116267928
NMR metabolomics,X23408.Triglycerides in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00720837087441636,0.00322277019777642,0.000891741286774584,0.0135250004620581,0.025322213287407
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA3,GDNF family receptor alpha-3,40194,-0.0061894996025738,0.00276912848621537,-0.0116169914355559,-0.000762007769591679,0.0254195265095123
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00961882223636955,0.00430340285917144,-0.0180534918403456,-0.00118415263239353,0.0254231884319038
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B4,Protein ATP1B4,37482,-0.00921131976129243,0.00412308332101652,-0.0172925630704848,-0.00113007645210005,0.02549435783164
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB116,Beta-defensin 116,37541,-0.0172438716728114,0.00771971487321164,-0.0323745128243062,-0.00211323052131661,0.0255167057324229
NMR metabolomics,X23408.Triglycerides in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0107599361615825,0.00483267120070435,0.00128790060820197,0.020231971714963,0.0259951023686184
NMR metabolomics,X23408.Triglycerides in VLDL,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00823645974564496,0.00373076530013777,-0.015548759733915,-0.000924159757374938,0.0272815241086428
NMR metabolomics,X23408.Triglycerides in VLDL,NRCAM,Neuronal cell adhesion molecule,40359,0.00597781681734479,0.00271275226102814,0.000660822385729635,0.01129481124896,0.0275668688739235
NMR metabolomics,X23408.Triglycerides in VLDL,RAD51,DNA repair protein RAD51 homolog 1,37714,0.0116541978199347,0.0052967101043455,0.00127264601541749,0.0220357496244519,0.0278048514410063
NMR metabolomics,X23408.Triglycerides in VLDL,EPN1,Epsin-1,37714,0.00948613218502439,0.0043125724149745,0.00103349025167436,0.0179387741183744,0.0278492196817725
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00913212399915755,0.00415176726765393,-0.0172695878437592,-0.000994660154555859,0.027854473243379
NMR metabolomics,X23408.Triglycerides in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00883904154372443,0.00402784993276226,-0.0167336274119385,-0.000944455675510407,0.0282183308236039
NMR metabolomics,X23408.Triglycerides in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00566000102541856,0.00258306182563788,0.000597199847168321,0.0107228022036688,0.0284550792790536
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.00739915359437694,0.00337713902317628,0.000779961108951436,0.0140183460798024,0.0284694748243261
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00625852620629572,0.00287426863509142,0.000624959681516548,0.0118920927310749,0.0294660637562042
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.0068662830968646,0.00315389316397934,-0.0130479136982641,-0.000684652495465094,0.029489148126074
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA2,GDNF family receptor alpha-2,40305,0.00447979609178566,0.00205809580204218,0.00044592831978299,0.00851366386378833,0.0295198795834983
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN2,Neuroligin-2,37541,-0.0102353343381296,0.00471354374137329,-0.0194738800712212,-0.00099678860503794,0.0299133153557793
NMR metabolomics,X23408.Triglycerides in VLDL,PSAPL1,Proactivator polypeptide-like 1,37901,-0.0106757626536208,0.00492448457075527,-0.0203277524123011,-0.00102377289494049,0.0301842013747849
NMR metabolomics,X23408.Triglycerides in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,0.00729820460774889,0.00336777663955425,0.000697362394222555,0.0138990468212752,0.0302443307628617
NMR metabolomics,X23408.Triglycerides in VLDL,S100A16,Protein S100-A16,39934,0.0130740990390456,0.00603896388740243,0.00123772981973689,0.0249104682583544,0.030406182144515
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3G,Semaphorin-3G,37671,0.00909544820123427,0.00420978641817112,0.000844266821618873,0.0173466295808497,0.0307481334656313
NMR metabolomics,X23408.Triglycerides in VLDL,GPNMB,Transmembrane glycoprotein NMB,39957,0.00591853737451973,0.00274054192798107,0.000547075195676831,0.0112899995533626,0.0308171480352698
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0118125133418975,0.00547810599157808,0.00107542559840444,0.0225496010853905,0.03107712317797
NMR metabolomics,X23408.Triglycerides in VLDL,GBP6,Guanylate-binding protein 6,37562,-0.00996181342450801,0.00462895114412202,-0.0190345576669872,-0.000889069182028848,0.0314102711561942
NMR metabolomics,X23408.Triglycerides in VLDL,NEO1,Neogenin,37959,0.00446902472215977,0.00207730721203461,0.000397502586571945,0.0085405468577476,0.0314658876623686
NMR metabolomics,X23408.Triglycerides in VLDL,IL33,Interleukin-33,40044,0.00805357039236339,0.00375818464458384,0.000687528488979055,0.0154196122957477,0.0321332159010409
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR1,Interferon gamma receptor 1,40422,0.00424139112878201,0.00198634276655999,0.000348159306324435,0.00813462295123959,0.0327535984109236
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.00694789594196129,0.00325791577590661,-0.0133334108627382,-0.000562381021184334,0.0329713401667935
NMR metabolomics,X23408.Triglycerides in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0248409803343146,0.0116703150194009,0.00196716289628891,0.0477147977723403,0.0333062098028225
NMR metabolomics,X23408.Triglycerides in VLDL,INHBB,Inhibin beta B chain,37671,0.0106619949775638,0.0050168847784576,0.000828900811786888,0.0204950891433407,0.0335865688634011
NMR metabolomics,X23408.Triglycerides in VLDL,STX1B,Syntaxin-1B,37572,0.00883796954467664,0.00418727097360007,0.000630918436420505,0.0170450206529328,0.0348190992393867
NMR metabolomics,X23408.Triglycerides in VLDL,IL17A,Interleukin-17A,40028,0.00873938773021712,0.00414530244005284,0.000614594947713562,0.0168641805127207,0.0350241757866742
NMR metabolomics,X23408.Triglycerides in VLDL,SPON1,Spondin-1,40379,0.0067202679435673,0.00319081670984713,0.000466267192266937,0.0129742686948677,0.0352088542580425
NMR metabolomics,X23408.Triglycerides in VLDL,RALB,Ras-related protein Ral-B,37598,0.00605087140159013,0.00288709019662022,0.000392174616214493,0.0117095681869658,0.0361156975237618
NMR metabolomics,X23408.Triglycerides in VLDL,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00929823048457635,0.00444074479364666,-0.0180020902801238,-0.00059437068902889,0.0362927445438047
NMR metabolomics,X23408.Triglycerides in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0116584400801235,0.00557201829165415,0.000737284228481388,0.0225795959317657,0.0364261125862339
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1L,Allograft inflammatory factor 1-like,37628,0.0118128948436896,0.00565009042177406,0.000738717617012488,0.0228870720703668,0.0365700952003959
NMR metabolomics,X23408.Triglycerides in VLDL,MSLNL,Mesothelin-like protein,37572,-0.00763139209249396,0.00366518795794162,-0.0148151604900595,-0.000447623694928381,0.0373500697207602
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RA,Interleukin-17 receptor A,40332,0.00886513346535854,0.00425842848162435,0.00051861364137481,0.0172116532893423,0.0373780676715458
NMR metabolomics,X23408.Triglycerides in VLDL,MN1,Transcriptional activator MN1,37572,-0.0121065437966113,0.00581626462183255,-0.0235064224554031,-0.000706665137819537,0.0374076777221599
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA10,Annexin A10,39961,0.0165986367176915,0.00801838335195901,0.000882605347851805,0.0323146680875311,0.0384620477368805
NMR metabolomics,X23408.Triglycerides in VLDL,NRTN,Neurturin,40044,0.00983014487864722,0.00480994296344167,0.000402656670301548,0.0192576330869929,0.040998637553202
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RG,Cytokine receptor common subunit gamma,37900,0.00763960131984237,0.00376184641646246,0.000266382343575936,0.0150128202961088,0.0422937430005582
NMR metabolomics,X23408.Triglycerides in VLDL,NOP56,Nucleolar protein 56,37562,0.0218317880071665,0.0107884006593088,0.000686522714921194,0.0429770532994118,0.0430279400088861
NMR metabolomics,X23408.Triglycerides in VLDL,ERVV_1,,37562,-0.00953304098932778,0.00471386229390272,-0.0187722110853771,-0.000293870893278449,0.0431613133153275
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB1,Lamin-B1,37874,0.0111982682582883,0.00554341233239481,0.000333180086794426,0.0220633564297821,0.0433924495104089
NMR metabolomics,X23408.Triglycerides in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.011050920947486,0.00549882513902538,0.000273223674996301,0.0218286182199758,0.0444841339174104
NMR metabolomics,X23408.Triglycerides in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0134315277196733,0.00672848492378986,0.0002436972690452,0.0266193581703014,0.0459301578672644
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0100771690697487,0.00507499304383736,0.000130182703827458,0.0200241554356699,0.0470927974056453
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.012293114792361,0.00620456482192551,0.000132167741386966,0.024454061843335,0.0475745967272722
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.0106113740654296,0.0053735955255997,-0.021143621295605,-7.91268352542136e-05,0.0483203340762406
NMR metabolomics,X23408.Triglycerides in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.010042725692579,0.00508804826808012,-0.0200153002980161,-7.01510871420029e-05,0.0484268660016421
NMR metabolomics,X23408.Triglycerides in VLDL,CORO6,Coronin-6,37541,-0.00701717159772137,0.00355571186721626,-0.0139863668574652,-4.79763379774888e-05,0.0484604500134126
NMR metabolomics,X23408.Triglycerides in VLDL,TG,Thyroglobulin,37900,-0.0225510508146962,0.0114371177132557,-0.0449678015326773,-0.000134300096715129,0.0486594753259958
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF1,Formylglycine-generating enzyme,37598,0.01285622753358,0.00654382673654107,3.03271299595207e-05,0.0256821279372005,0.049477590903074
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX1,Neuronal pentraxin-1,40332,0.00752059185916008,0.0038290421703597,1.56692052550754e-05,0.0150255145130651,0.0495368166791916
NMR metabolomics,X23408.Triglycerides in VLDL,IL25,Interleukin-25,37429,0.00668260822463857,0.00340505874917731,8.69307625102952e-06,0.0133565233730261,0.0497194711632469
NMR metabolomics,X23408.Triglycerides in VLDL,CEP152,Centrosomal protein of 152 kDa,37482,0.00794507433335181,0.00404982720474685,7.41301204798712e-06,0.0158827356546556,0.0498034835713237
NMR metabolomics,X23408.Triglycerides in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.0140854354069595,0.00719289558939749,-0.0281835107621786,1.26399482595647e-05,0.0502224713898351
NMR metabolomics,X23408.Triglycerides in VLDL,BSND,Barttin,37482,-0.00650998269586684,0.00334443801351689,-0.0130650812023599,4.51158106262546e-05,0.0516149472917959
NMR metabolomics,X23408.Triglycerides in VLDL,RGS8,Regulator of G-protein signaling 8,40044,0.0125665332290728,0.00645981231178307,-9.46989020220324e-05,0.0252277653601676,0.0517519838812852
NMR metabolomics,X23408.Triglycerides in VLDL,NTF3,Neurotrophin-3,40341,0.00658958456313408,0.00338922893848157,-5.3304156289808e-05,0.013232473282558,0.0518802264224289
NMR metabolomics,X23408.Triglycerides in VLDL,CA11,Carbonic anhydrase-related protein 11,39980,0.00623813992316924,0.00321403410302648,-6.1366918762659e-05,0.0125376467651011,0.0522876827268841
NMR metabolomics,X23408.Triglycerides in VLDL,CHGA,Chromogranin-A,37998,-0.0170547925322974,0.00878832491439936,-0.0342799093645201,0.000170324299925351,0.0523251973888752
NMR metabolomics,X23408.Triglycerides in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0128993174599786,0.00665834537792756,-0.000151039480759453,0.0259496744007166,0.0527281502966467
NMR metabolomics,X23408.Triglycerides in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00482078402208114,0.0024907438763756,-0.00970264201977733,6.10739756150376e-05,0.0529530748994316
NMR metabolomics,X23408.Triglycerides in VLDL,CDH17,Cadherin-17,40359,-0.0126538641444892,0.00656657693524803,-0.0255243549375754,0.000216626648596903,0.0539960837192965
NMR metabolomics,X23408.Triglycerides in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00552840656429732,0.00286965295230087,-9.61132222123996e-05,0.011152926350807,0.0540626283104775
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00614813436321072,0.00319182407372404,-0.000107840821288408,0.0124041095477098,0.0540992180372786
NMR metabolomics,X23408.Triglycerides in VLDL,SLK,STE20-like serine/threonine-protein kinase,37714,0.014558138845632,0.0075777915312824,-0.000294332555681459,0.0294106102469455,0.0547331354612306
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00625886957119387,0.00326867996395794,-0.0126654823005514,0.000147743158163696,0.0555397074183201
NMR metabolomics,X23408.Triglycerides in VLDL,BEX3,Protein BEX3,37482,-0.00891717275864736,0.00465834835786811,-0.0180475355400689,0.000213190022774127,0.0556120343748919
NMR metabolomics,X23408.Triglycerides in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0106857118984146,0.0055835855305316,-0.000258115741427352,0.0216295395382565,0.0556710296391424
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00548690236124572,0.00286753683311492,-0.011107274554151,0.000133469831659522,0.0557115397753438
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00552980108310425,0.00289506061521357,-0.000144517722714341,0.0112041198889228,0.0561406101372187
NMR metabolomics,X23408.Triglycerides in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0168645153968221,0.00883550435400433,-0.000453073137026392,0.0341821039306706,0.0563200011873798
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,0.00719259940021078,0.00378526181489099,-0.000226513756975561,0.0146117125573971,0.0574303746130495
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0128486497165532,0.00680509024152144,-0.000489327156828806,0.0261866265899352,0.0590313209341537
NMR metabolomics,X23408.Triglycerides in VLDL,DCLRE1C,Protein artemis,37482,-0.00582698980671804,0.00309693301453032,-0.0118969785151975,0.000242998901761383,0.0599213668967828
NMR metabolomics,X23408.Triglycerides in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.00682166172092747,0.00365449585623863,-0.000341150157300241,0.0139844735991552,0.0619722717363159
NMR metabolomics,X23408.Triglycerides in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0166632472902447,0.00893557597190388,-0.000850481614686937,0.0341769761951763,0.0622286074185892
NMR metabolomics,X23408.Triglycerides in VLDL,JCHAIN,Immunoglobulin J chain,40044,-0.0111786339322977,0.00600020899743395,-0.0229390435672683,0.000581775702672802,0.0624753206997783
NMR metabolomics,X23408.Triglycerides in VLDL,RYR1,Ryanodine receptor 1,37562,-0.0061480372166477,0.00336975351502742,-0.0127527541061014,0.000456679672806042,0.0681027645813656
NMR metabolomics,X23408.Triglycerides in VLDL,APOH,Beta-2-glycoprotein 1,40332,0.00626721778084395,0.00344361924730809,-0.000482275943879916,0.0130167115055678,0.0687853070588685
NMR metabolomics,X23408.Triglycerides in VLDL,TFRC,Transferrin receptor protein 1,40391,-0.00696976576581008,0.00383494441666372,-0.014486256822471,0.000546725290850817,0.0691691581216001
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA2013,Uncharacterized protein KIAA2013,37900,0.0101049689733593,0.00560258674734589,-0.000876101051438687,0.0210860389981572,0.0713123882670814
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD1,Sphingomyelin phosphodiesterase,40380,0.00830943121659422,0.00461174876457888,-0.000729596361980379,0.0173484587951688,0.0715963834344144
NMR metabolomics,X23408.Triglycerides in VLDL,DCC,Netrin receptor DCC,37572,0.00409492527299537,0.0022762424031906,-0.000366509837258214,0.00855636038324895,0.0720440721498789
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1B,Protein phosphatase 1B,37598,0.0111016496154743,0.00618571888040717,-0.00102235939012376,0.0232256586210723,0.0727208692752101
NMR metabolomics,X23408.Triglycerides in VLDL,KEL,Kell blood group glycoprotein,39961,0.00617737802098012,0.00345947612543406,-0.000603195184870629,0.0129579512268309,0.0741771426958496
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM25,Transmembrane protein 25,37959,-0.0076009526238867,0.00426768092807656,-0.0159656072429167,0.000763701995143359,0.0749267683309385
NMR metabolomics,X23408.Triglycerides in VLDL,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00850610704854702,0.00477904004714449,-0.0178730255409502,0.000860811443856179,0.0751191265040095
NMR metabolomics,X23408.Triglycerides in VLDL,DDX1,ATP-dependent RNA helicase DDX1,37901,0.00896246211998921,0.00503902544535471,-0.00091402775290602,0.0188389519928844,0.0753262720680231
NMR metabolomics,X23408.Triglycerides in VLDL,RRP15,RRP15-like protein,37541,-0.01576669809325,0.00889679908646547,-0.0332044243027224,0.00167102811622227,0.0763885244710282
NMR metabolomics,X23408.Triglycerides in VLDL,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00660828716079257,0.00373754659966704,-0.00071730417455484,0.01393387849614,0.0770705263517292
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF75D,Zinc finger protein 75D,37714,0.0102491023468366,0.00580194889174164,-0.00112271748097699,0.0216209221746502,0.077336167833152
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00437797032372953,0.00248437476528814,-0.000491404216235224,0.00924734486369429,0.0780544663216104
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM132A,Transmembrane protein 132A,37628,0.0107869689786652,0.00612633134881874,-0.00122064046501953,0.0227945784223499,0.0783030626099752
NMR metabolomics,X23408.Triglycerides in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00849022208744023,0.00483066311786001,-0.000977877623565387,0.0179583217984459,0.0788442667598988
NMR metabolomics,X23408.Triglycerides in VLDL,COPE,Coatomer subunit epsilon,39961,0.0082498066855472,0.0046960501596488,-0.000954451627364447,0.0174540649984588,0.0789794160270016
NMR metabolomics,X23408.Triglycerides in VLDL,LTO1,Protein LTO1 homolog,40044,0.00699437629665032,0.00399959273396735,-0.000844825461925687,0.0148335780552263,0.0803500937693209
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA1,Laminin subunit alpha-1,37562,-0.00957036198995721,0.00547402778543375,-0.0202994564494074,0.00115873246949295,0.0804317302020476
NMR metabolomics,X23408.Triglycerides in VLDL,SOX9,Transcription factor SOX-9,37572,0.00460150558626105,0.0026454289442022,-0.000583535144375265,0.00978654631689736,0.0819847920663948
NMR metabolomics,X23408.Triglycerides in VLDL,SULT1A1,Sulfotransferase 1A1,40471,-0.0216818292603336,0.0124743535023193,-0.0461315621248794,0.00276790360421228,0.082210215191629
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN4,Prefoldin subunit 4,37482,0.00920041966717874,0.00530044907883978,-0.00118846052734724,0.0195892998617047,0.082626175732001
NMR metabolomics,X23408.Triglycerides in VLDL,TSLP,Thymic stromal lymphopoietin,40042,0.0102536013015753,0.00591601299812152,-0.00134178417474286,0.0218489867778935,0.0830808737682942
NMR metabolomics,X23408.Triglycerides in VLDL,RASA1,Ras GTPase-activating protein 1,39961,0.00547596005303273,0.0031651478882238,-0.000727729807885924,0.0116796499139514,0.0836358208030036
NMR metabolomics,X23408.Triglycerides in VLDL,DOCK9,Dedicator of cytokinesis protein 9,37541,0.020151347705539,0.0116602273158243,-0.00270269783347661,0.0430053932445546,0.0839737625806249
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.00600208693037297,0.00347849702606821,-0.000815767240720727,0.0128199411014667,0.0844632998854624
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,-0.00484267639373667,0.00280905143458189,-0.0103484172055172,0.000663064418043822,0.0847353032240544
NMR metabolomics,X23408.Triglycerides in VLDL,REST,RE1-silencing transcription factor,37482,-0.0060131262150035,0.00349652679256529,-0.0128663187284315,0.000840066298424482,0.0855029801858691
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1,Methionine aminopeptidase 1,39961,0.00511513853088358,0.00298461906244457,-0.000734714831507788,0.0109649918932749,0.0865793899160936
NMR metabolomics,X23408.Triglycerides in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.0104614445179296,0.00610604640560905,-0.0224292954729233,0.00150640643706415,0.0866823532754413
NMR metabolomics,X23408.Triglycerides in VLDL,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00839080663824378,0.00489845610717704,-0.0012101673318232,0.0179917806083108,0.0867466358646398
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.0159330172816928,0.00930544831708575,-0.0341716959831809,0.00230566141979527,0.0868790842358417
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0229263084835489,0.0134127256164827,-0.0492152506918549,0.00336263372475713,0.0874191731714733
NMR metabolomics,X23408.Triglycerides in VLDL,UNG,Uracil-DNA glycosylase,37900,0.00563436149316768,0.00330079993378985,-0.000835206377060439,0.0121039293633958,0.0878509933659861
NMR metabolomics,X23408.Triglycerides in VLDL,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00541241516833134,0.00317369065407272,-0.0116328488503139,0.000808018513651188,0.088143499434227
NMR metabolomics,X23408.Triglycerides in VLDL,TTN,Titin,37562,-0.0108442752440209,0.00640064738573081,-0.0233895441200533,0.00170099363201149,0.0902421800590811
NMR metabolomics,X23408.Triglycerides in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.0117305652326708,0.00692559254023927,-0.0253047266115398,0.0018435961461982,0.090327180366988
NMR metabolomics,X23408.Triglycerides in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0135219864734453,0.00800704316541839,-0.00217181813077475,0.0292157910776653,0.0912890659852736
NMR metabolomics,X23408.Triglycerides in VLDL,KIF20B,Kinesin-like protein KIF20B,37541,0.0128562718302442,0.0076246510771469,-0.00208804428096375,0.0278005879414521,0.0917915927081728
NMR metabolomics,X23408.Triglycerides in VLDL,DSC2,Desmocollin-2,40177,-0.00551468741250241,0.00327244874472939,-0.011928686952172,0.000899312127167199,0.0919723798564929
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB1,Scavenger receptor class B member 1,39961,0.00967345806577714,0.00576027533602231,-0.0016166815928266,0.0209635977243809,0.0931060343296596
NMR metabolomics,X23408.Triglycerides in VLDL,CD55,Complement decay-accelerating factor,39802,0.004276652757682,0.00254975602562605,-0.000720869052545053,0.00927417456790906,0.0935082572284932
NMR metabolomics,X23408.Triglycerides in VLDL,CD5L,CD5 antigen-like,37934,0.00758287632155225,0.00453441305963459,-0.00130457327533154,0.016470325918436,0.0944893675134138
NMR metabolomics,X23408.Triglycerides in VLDL,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00656727483244216,0.00393065733464732,-0.0142713632083509,0.0011368135434666,0.0947884480108413
NMR metabolomics,X23408.Triglycerides in VLDL,IL36G,Interleukin-36 gamma,37551,0.0112244441139018,0.00672668804594915,-0.00195986445615851,0.0244087526839621,0.0952119564992186
NMR metabolomics,X23408.Triglycerides in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.0105012126748803,0.0063292133833113,-0.00190404555640982,0.0229064709061705,0.0971057599476103
NMR metabolomics,X23408.Triglycerides in VLDL,DNLZ,DNL-type zinc finger protein,37541,-0.0153712642827903,0.0092847503101968,-0.033569374890776,0.00282684632519546,0.0978392276810435
NMR metabolomics,X23408.Triglycerides in VLDL,RTKN2,Rhotekin-2,37562,-0.00850063777811933,0.00513752733573352,-0.018570191356157,0.00156891579991836,0.0980262412840762
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.0101538540204843,0.00613743141699631,-0.00187551155682845,0.0221832195977971,0.0980673109545695
NMR metabolomics,X23408.Triglycerides in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0134730789466357,0.00815122040087556,-0.00250331303908042,0.0294494709323518,0.0983769729055068
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00845502422741084,0.0051473878570335,-0.0185439044271965,0.00163385597237482,0.100492722768474
NMR metabolomics,X23408.Triglycerides in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.0110028158841186,0.00673328099130834,-0.00219441485884574,0.0242000466270829,0.10225935468062
NMR metabolomics,X23408.Triglycerides in VLDL,SPRING1,SREBP regulating gene protein,37482,0.0091568108219587,0.0056172028310095,-0.00185290672681991,0.0201665283707373,0.103096691400026
NMR metabolomics,X23408.Triglycerides in VLDL,IL36A,Interleukin-36 alpha,37598,-0.00938838249011003,0.00576689679824793,-0.020691500214676,0.00191473523445591,0.103553463859297
NMR metabolomics,X23408.Triglycerides in VLDL,GSTM4,Glutathione S-transferase Mu 4,37562,-0.0113629630712996,0.00698586485015,-0.0250552581775936,0.00232933203499442,0.103853557158758
NMR metabolomics,X23408.Triglycerides in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0140479796000746,0.00864808407060216,-0.00290226517830563,0.0309982243784548,0.10431372161846
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.00872570214493971,0.00537994247587425,-0.00181898510777382,0.0192703893976532,0.10484925908991
NMR metabolomics,X23408.Triglycerides in VLDL,CD70,CD70 antigen,40341,-0.00652997470518464,0.00403249345493632,-0.0144336618768598,0.00137371246649054,0.105394148224858
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN4,Alpha-actinin-4,40044,0.00509331103509838,0.00315690397332072,-0.00109422075261024,0.011280842822807,0.106680472110741
NMR metabolomics,X23408.Triglycerides in VLDL,PLAU,Urokinase-type plasminogen activator,40332,-0.00458075089383251,0.00285057955409973,-0.010167886819868,0.00100638503220296,0.10808428882177
NMR metabolomics,X23408.Triglycerides in VLDL,MSMB,Beta-microseminoprotein,40236,0.0107441728191787,0.00671849569376205,-0.00242407874059491,0.0239124243789523,0.109797689627613
NMR metabolomics,X23408.Triglycerides in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00984335255970357,0.00616766023074968,-0.00224526149256581,0.0219319666119729,0.110517503038489
NMR metabolomics,X23408.Triglycerides in VLDL,OSTN,Osteocrin,37572,-0.00667659469774147,0.00419550639484117,-0.0148997872316302,0.00154659783614723,0.11155086944036
NMR metabolomics,X23408.Triglycerides in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.0039554888382185,0.00249358198682811,-0.000931931855964597,0.00884290953240159,0.112701931310912
NMR metabolomics,X23408.Triglycerides in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.00482798157612826,0.00305658979938488,-0.0108188975829226,0.0011629344306661,0.114233952610612
NMR metabolomics,X23408.Triglycerides in VLDL,ZPR1,Zinc finger protein ZPR1,37541,0.0149735353467651,0.00948689764300741,-0.00362078403352937,0.0335678547270597,0.114512041706471
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00702117080345702,0.00445424260464273,-0.00170914470164273,0.0157514863085568,0.114983489674893
NMR metabolomics,X23408.Triglycerides in VLDL,PAPPA,Pappalysin-1,40044,0.00718668705277938,0.00456883977649131,-0.00176823890914358,0.0161416130147023,0.115744070619229
NMR metabolomics,X23408.Triglycerides in VLDL,CD86,T-lymphocyte activation antigen CD86,37901,0.00446446904520914,0.00284499079754528,-0.00111171291797961,0.0100406510083979,0.116615905660307
NMR metabolomics,X23408.Triglycerides in VLDL,CBX2,Chromobox protein homolog 2,37562,-0.00629213142130789,0.0040104372581518,-0.0141525884472854,0.00156832560466963,0.116686287282018
NMR metabolomics,X23408.Triglycerides in VLDL,RBP7,Retinoid-binding protein 7,37901,0.00890381273117603,0.00568572629508853,-0.0022402108071975,0.0200478362695496,0.117373570930783
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN2,Contactin-2,40489,0.00680708440936105,0.00435037454372876,-0.00171964969634732,0.0153338185150694,0.117670122111257
NMR metabolomics,X23408.Triglycerides in VLDL,CLNS1A,Methylosome subunit pICln,37572,0.00512423571941076,0.00327545559208077,-0.00129565724106754,0.0115441286798891,0.117739682659309
NMR metabolomics,X23408.Triglycerides in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00876712604220318,0.00562261782977848,-0.019787456988569,0.00225320490416264,0.118958906835144
NMR metabolomics,X23408.Triglycerides in VLDL,PDCL2,Phosducin-like protein 2,37482,0.00819779848084403,0.00525979838575683,-0.00211140635523936,0.0185070033169274,0.119120920436638
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00571817148421361,0.00367507750671401,-0.00148498042894585,0.0129213233973731,0.119748073784038
NMR metabolomics,X23408.Triglycerides in VLDL,GKN1,Gastrokine-1,39602,0.00420933324254308,0.00271585054104457,-0.00111373381790429,0.00953240030299045,0.121183182376941
NMR metabolomics,X23408.Triglycerides in VLDL,DENND2B,DENN domain-containing protein 2B,37562,-0.00790381524515515,0.00511808553912886,-0.0179352629018477,0.00212763241153741,0.122541902974268
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.00671231894884264,0.00434890311065164,-0.0152361690457199,0.00181153114803457,0.122741210027663
NMR metabolomics,X23408.Triglycerides in VLDL,OGN,Mimecan,40332,0.00609523918707098,0.0039527023893983,-0.00165205749614969,0.0138425358702916,0.1230829391103
NMR metabolomics,X23408.Triglycerides in VLDL,TCN2,Transcobalamin-2,40497,0.00444326628855761,0.00289608714794112,-0.00123306452140699,0.0101195970985222,0.124992583895923
NMR metabolomics,X23408.Triglycerides in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.0070617420727656,0.00460758412327335,-0.00196912280885017,0.0160926069543814,0.125389324827347
NMR metabolomics,X23408.Triglycerides in VLDL,WIF1,Wnt inhibitory factor 1,40489,-0.00507829635442516,0.0033209796286595,-0.0115874164265978,0.00143082371774746,0.12624546635539
NMR metabolomics,X23408.Triglycerides in VLDL,RELB,Transcription factor RelB,37598,0.00764409984236383,0.00502886088523725,-0.00221246749270119,0.0175006671774288,0.128523466066611
NMR metabolomics,X23408.Triglycerides in VLDL,CA3,Carbonic anhydrase 3,40500,0.00899705627469647,0.00592143227978374,-0.00260895099367965,0.0206030635430726,0.128680179625823
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.0108121617403677,0.00713778901997208,-0.0031779047387776,0.0248022282195129,0.129852122677018
NMR metabolomics,X23408.Triglycerides in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00806169515212078,0.00535317202882844,-0.00243052202438295,0.0185539123286245,0.13210002922515
NMR metabolomics,X23408.Triglycerides in VLDL,KLHL41,Kelch-like protein 41,37959,0.00694955372182547,0.00462665824992358,-0.00211869644802474,0.0160178038916757,0.133103013360521
NMR metabolomics,X23408.Triglycerides in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00345449828207472,0.00230221088168057,-0.00796683161016863,0.00105783504601919,0.133504838296046
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D1,DCN1-like protein 1,37541,-0.0108930475743705,0.00729804513392685,-0.0251972160368671,0.00341112088812614,0.135566548994891
NMR metabolomics,X23408.Triglycerides in VLDL,SHPK,Sedoheptulokinase,37714,-0.0062316341004159,0.0041800804571249,-0.0144245917963807,0.0019613235955489,0.136039669952309
NMR metabolomics,X23408.Triglycerides in VLDL,LYPLA2,Acyl-protein thioesterase 2,37541,0.0157038205060982,0.0105572241364535,-0.00498833880135065,0.0363959798135471,0.136908151903983
NMR metabolomics,X23408.Triglycerides in VLDL,TAP1,Antigen peptide transporter 1,37714,-0.00892801353569906,0.00601368735695852,-0.0207148407553378,0.00285881368393964,0.137669470745317
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN15,Tetraspanin-15,37562,-0.00738898402311285,0.00497860934259425,-0.0171470583345976,0.00236909028837188,0.137794186077948
NMR metabolomics,X23408.Triglycerides in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.00667519956519959,0.00450807266355269,-0.00216062285536368,0.0155110219857629,0.138701148953316
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00563202404918028,0.00380797912146181,-0.00183161502888487,0.0130956631272454,0.139162731720253
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00650760554415443,0.00440676941693832,-0.00212966251304469,0.0151448736013535,0.139771628625679
NMR metabolomics,X23408.Triglycerides in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00507077565628542,0.00344699824502888,-0.00168534090397119,0.011826892216542,0.141296173987349
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0163207863741202,0.0110949053748077,-0.00542522816050286,0.0380668009087433,0.141310011006297
NMR metabolomics,X23408.Triglycerides in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00698483020708109,0.00475475705895617,-0.00233449362847301,0.0163041540426352,0.141852242646667
NMR metabolomics,X23408.Triglycerides in VLDL,MUC2,Mucin-2,37998,0.0129600168015826,0.00882889251599301,-0.00434461252976369,0.0302646461329289,0.142151976159419
NMR metabolomics,X23408.Triglycerides in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.00452860993896598,0.00309514987505744,-0.00153788381614662,0.0105951036940786,0.143451675673511
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1,DNA topoisomerase 1,37901,0.0151563622948431,0.0103955702515575,-0.00521895539820966,0.0355316799878958,0.144873946068722
NMR metabolomics,X23408.Triglycerides in VLDL,GFAP,Glial fibrillary acidic protein,39959,0.00662789333396346,0.0045484190594618,-0.00228700802258168,0.0155427946905086,0.145085246835342
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL2,Podocalyxin-like protein 2,40411,-0.00385436004464093,0.00264723157780799,-0.00904293393714459,0.00133421384786273,0.145413244777895
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00516144621307085,0.00355090398276193,-0.0121212180192842,0.00179832559314254,0.146092868702186
NMR metabolomics,X23408.Triglycerides in VLDL,SELENOP,Selenoprotein P,38013,-0.00318431665621332,0.00219825663509644,-0.00749289966100234,0.0011242663485757,0.147482344886515
NMR metabolomics,X23408.Triglycerides in VLDL,SOX2,Transcription factor SOX-2,37937,0.00329161360264767,0.00227251219512425,-0.00116251029979586,0.0077457375050912,0.147515312664086
NMR metabolomics,X23408.Triglycerides in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.00293086965153204,0.00203649142034863,-0.00692239283541535,0.00106065353235126,0.1501202495036
NMR metabolomics,X23408.Triglycerides in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00715227548676903,0.00497566293097786,-0.0169045748314856,0.00260002385794758,0.150613534220012
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171A2,Protein FAM171A2,37959,0.0224557367040596,0.0156712309025628,-0.00825987586496348,0.0531713492730826,0.151901720011473
NMR metabolomics,X23408.Triglycerides in VLDL,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00542044774372293,0.0037972472797893,-0.01286305241211,0.0020221569246641,0.153468954177008
NMR metabolomics,X23408.Triglycerides in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00311010504832522,0.00218198148395967,-0.00116657866023574,0.00738678875688619,0.154077446469423
NMR metabolomics,X23408.Triglycerides in VLDL,MMP13,Collagenase 3,39961,-0.00455835336896007,0.00320265321370639,-0.0108355536678246,0.00171884692990446,0.154667779904205
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00438925343150769,0.00308830702355672,-0.0104423351976789,0.00166382833466348,0.155268192619681
NMR metabolomics,X23408.Triglycerides in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00501398723666539,0.00352898935251135,-0.0119308063675876,0.00190283189425686,0.155398762696498
NMR metabolomics,X23408.Triglycerides in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00570448800096937,0.00402802445238004,-0.00219043992569551,0.0135994159276343,0.156736337768519
NMR metabolomics,X23408.Triglycerides in VLDL,UBQLN3,Ubiquilin-3,37562,-0.00615294803948333,0.00440079944822051,-0.0147785149579955,0.00247261887902887,0.162093706713833
NMR metabolomics,X23408.Triglycerides in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00515580365528217,0.00368984836314214,-0.0123879064470408,0.00207629913647642,0.162348771040858
NMR metabolomics,X23408.Triglycerides in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00400257790671509,0.00286879945110285,-0.00962542483087667,0.00162026901744648,0.162975437760162
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC1,Plexin domain-containing protein 1,39980,0.00459658550308009,0.00329671581101738,-0.00186497748651398,0.0110581484926742,0.163249300772707
NMR metabolomics,X23408.Triglycerides in VLDL,FGF12,Fibroblast growth factor 12,37598,0.00654048935515214,0.00470232760509431,-0.00267607275083271,0.015757051461137,0.16427788236582
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA6C,Semaphorin-6C,37598,0.00360999042978544,0.00259573038079662,-0.00147764111657593,0.00869762197614682,0.164327314035796
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L,Seizure 6-like protein,40411,-0.0036759415904699,0.00266284303841736,-0.00889511394576792,0.00154323076482813,0.167465166975299
NMR metabolomics,X23408.Triglycerides in VLDL,INSL4,Early placenta insulin-like peptide,37900,-0.00724645871858012,0.00527300791518914,-0.0175815542323508,0.0030886367951906,0.169385360764613
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP29,Dual specificity phosphatase 29,37572,-0.0089061914403754,0.00649811848857958,-0.0216425036779914,0.00383012079724059,0.170529359000381
NMR metabolomics,X23408.Triglycerides in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00893298915712343,0.00657750529094304,-0.00395892121312492,0.0218248995273718,0.174447890244766
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0112600362383045,0.00830456109989449,-0.0275369759940978,0.00501690351748866,0.175158282142432
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00605426002281442,0.00447600940431486,-0.0148272384552715,0.00271871840964271,0.176206023605592
NMR metabolomics,X23408.Triglycerides in VLDL,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00735078080293926,0.00543548101272433,-0.00330276198200042,0.0180043235878789,0.176276737893375
NMR metabolomics,X23408.Triglycerides in VLDL,ACAN,Aggrecan core protein,40224,0.00371568641418661,0.00275125932503567,-0.00167678186288331,0.00910815469125653,0.176862133736608
NMR metabolomics,X23408.Triglycerides in VLDL,AXL,Tyrosine-protein kinase receptor UFO,40403,-0.00358545625902204,0.00266825832116593,-0.00881524256850726,0.00164433005046318,0.179050279278671
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR1,TGF-beta receptor type-1,37598,0.00281907225353315,0.00210046606170967,-0.0012978412274178,0.0069359857344841,0.17958107980109
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.0103759665367898,0.00778040584871657,-0.00487362892669473,0.0256255620002742,0.182353737507817
NMR metabolomics,X23408.Triglycerides in VLDL,WNT9A,Protein Wnt-9a,40044,0.00371045001069477,0.00278566807746601,-0.00174945942113862,0.00917035944252816,0.182886719916015
NMR metabolomics,X23408.Triglycerides in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.006775062944881,0.00509063893048942,-0.0167527152486403,0.00320258935887826,0.183249484831848
NMR metabolomics,X23408.Triglycerides in VLDL,CHIT1,Chitotriosidase-1,40398,0.019206297994642,0.0144827908489448,-0.00917997206928976,0.0475925680585739,0.184810271145949
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.00410633794867484,0.00311380850091989,-0.0102094026104778,0.00199672671312814,0.18727175525092
NMR metabolomics,X23408.Triglycerides in VLDL,GPR158,Probable G-protein coupled receptor 158,37959,0.00473580256952441,0.00359371203806585,-0.00230787302508465,0.0117794781641335,0.187592133674006
NMR metabolomics,X23408.Triglycerides in VLDL,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00445738962599628,0.00340146861047513,-0.00220948885053498,0.0111242681025275,0.190072337023984
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP2,Cysteine-rich secretory protein 2,40489,-0.00777572172803947,0.00594521675969569,-0.019428346577043,0.00387690312096408,0.190927532853522
NMR metabolomics,X23408.Triglycerides in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00648360633784932,0.00495905644303226,-0.0162033569661926,0.00323614429049392,0.191090502877282
NMR metabolomics,X23408.Triglycerides in VLDL,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00430188847836288,0.00329603622335806,-0.00215834251941891,0.0107621194761447,0.191857109121479
NMR metabolomics,X23408.Triglycerides in VLDL,PALM3,Paralemmin-3,37562,0.00922176269633111,0.00706972955810875,-0.00463490723756205,0.0230784326302243,0.192119774277693
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN1,Calsyntenin-1,39961,0.00658611830475218,0.00510696674655248,-0.00342353651849067,0.016595773127995,0.197196972051496
NMR metabolomics,X23408.Triglycerides in VLDL,THBS2,Thrombospondin-2,40332,0.00447870471380599,0.00347492575968727,-0.00233214977518107,0.011289559202793,0.197464346794725
NMR metabolomics,X23408.Triglycerides in VLDL,LY6D,Lymphocyte antigen 6D,40268,0.00465594174211351,0.00362578553516624,-0.00245059790681231,0.0117624813910393,0.199118972154101
NMR metabolomics,X23408.Triglycerides in VLDL,EVPL,Envoplakin,37714,-0.00430699338012473,0.00336557108495153,-0.0109035127066297,0.00228952594638026,0.200665517716105
NMR metabolomics,X23408.Triglycerides in VLDL,SHH,Sonic hedgehog protein,37598,-0.00540543988503405,0.00423859649941136,-0.0137130890238803,0.00290220925381221,0.202229139157013
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA5,Annexin A5,39896,0.00377919596556459,0.00297063821241988,-0.00204325493077838,0.00960164686190756,0.203327196873966
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_DRA,,40288,-0.00444842730628961,0.00349734665287968,-0.0113032267459338,0.00240637213335457,0.20341187622429
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00582123899658648,0.00458216118099707,-0.0148022749113407,0.00315979691816778,0.203960093318429
NMR metabolomics,X23408.Triglycerides in VLDL,ACTA2,"Actin, aortic smooth muscle",40042,-0.00538073551051314,0.00423934274422956,-0.0136898472892031,0.0029283762681768,0.204375088504809
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RB,Cytokine receptor common subunit beta,37598,-0.00538188309359356,0.00431893754090772,-0.0138470006737727,0.00308323448658557,0.212745213979421
NMR metabolomics,X23408.Triglycerides in VLDL,SELL,L-selectin,38013,-0.00280689914592711,0.00225377043629778,-0.00722428920107077,0.00161049090921654,0.212997559428496
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0210037261665715,0.0168872404269897,-0.0541027174034713,0.0120952650703283,0.213608450407872
NMR metabolomics,X23408.Triglycerides in VLDL,STEAP4,Metalloreductase STEAP4,37541,-0.00914122375141562,0.00735240800443138,-0.0235519434401011,0.00526949593726989,0.213780831650171
NMR metabolomics,X23408.Triglycerides in VLDL,NXPE4,NXPE family member 4,37562,-0.00440599529511581,0.00354684511392669,-0.0113578117184121,0.00254582112818051,0.214174153831491
NMR metabolomics,X23408.Triglycerides in VLDL,ESPL1,Separin,37482,-0.00690271175477411,0.00559087237583366,-0.0178608216114081,0.00405539810185986,0.216986973653441
NMR metabolomics,X23408.Triglycerides in VLDL,FZD10,Frizzled-10,37572,0.0073242406176872,0.00593878981521933,-0.00431578742014269,0.0189642686555171,0.21749027737418
NMR metabolomics,X23408.Triglycerides in VLDL,OTOA,Otoancorin,37541,-0.00658750303708442,0.00534904539411495,-0.0170716320095497,0.00389662593538088,0.218147306815381
NMR metabolomics,X23408.Triglycerides in VLDL,IL4R,Interleukin-4 receptor subunit alpha,40341,0.00433070115353343,0.00351998156982329,-0.00256846272332022,0.0112298650303871,0.218595785512179
NMR metabolomics,X23408.Triglycerides in VLDL,KDM3A,Lysine-specific demethylase 3A,37598,-0.0110389320698414,0.00903491297525325,-0.0287473615013378,0.00666949736165498,0.221802020411208
NMR metabolomics,X23408.Triglycerides in VLDL,TEX33,Testis-expressed protein 33,37714,-0.00467663459495943,0.00385115211599409,-0.0122248927423078,0.00287162355238898,0.224636909419248
NMR metabolomics,X23408.Triglycerides in VLDL,LY96,Lymphocyte antigen 96,40228,0.00407236602075424,0.00336644108933589,-0.00252585851434411,0.0106705905558526,0.226414182078755
NMR metabolomics,X23408.Triglycerides in VLDL,TLR4,Toll-like receptor 4,37598,0.00334451997177939,0.00277193706006317,-0.00208847666594442,0.00877751660950319,0.227621739604856
NMR metabolomics,X23408.Triglycerides in VLDL,FBN2,Fibrillin-2,37572,0.00715439043278712,0.00594005923518827,-0.00448812566818189,0.0187969065337561,0.22844483146449
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM2,Intercellular adhesion molecule 2,40536,0.00363834251792212,0.00302276292805503,-0.00228627282106574,0.00956295785690998,0.22874337765476
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC2,Plexin domain-containing protein 2,37942,-0.0031234163367576,0.00260201026409396,-0.00822335645438177,0.00197652378086656,0.230010595258986
NMR metabolomics,X23408.Triglycerides in VLDL,TLR2,Toll-like receptor 2,37714,0.00267529879304479,0.00224162195682098,-0.00171828024232433,0.00706887782841391,0.232708408211561
NMR metabolomics,X23408.Triglycerides in VLDL,GJA8,Gap junction alpha-8 protein,37482,0.00723422246960523,0.00607477699457828,-0.00467234043976819,0.0191407853789786,0.233729367943689
NMR metabolomics,X23408.Triglycerides in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00742258593961627,0.00625852700882424,-0.0196892988769118,0.00484412699767925,0.235645635024038
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX2,Peroxiredoxin-2,37763,0.00722855360009341,0.00610404505716663,-0.00473537471195318,0.01919248191214,0.236345747357148
NMR metabolomics,X23408.Triglycerides in VLDL,CRNN,Cornulin,39857,0.00761991235418746,0.00645036005122408,-0.00502279334621174,0.0202626180545867,0.237495522761038
NMR metabolomics,X23408.Triglycerides in VLDL,PITHD1,PITH domain-containing protein 1,37457,-0.00944970760965764,0.00800712444668632,-0.0251436715251628,0.00624425630584755,0.237957195952226
NMR metabolomics,X23408.Triglycerides in VLDL,BTLA,B- and T-lymphocyte attenuator,37482,0.0101655233676266,0.00866534600164949,-0.0068185547956064,0.0271496015308596,0.240767620187355
NMR metabolomics,X23408.Triglycerides in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00752251933276989,0.00642070623843151,-0.0201071035600957,0.00506206489455587,0.241377549718101
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL1,Interferon lambda-1,39961,0.00512128948030567,0.00440359537180634,-0.00350975744843475,0.0137523364090461,0.244855866789031
NMR metabolomics,X23408.Triglycerides in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.00309774511817586,0.00266392542297553,-0.00212354871085619,0.00831903894720791,0.244907973478436
NMR metabolomics,X23408.Triglycerides in VLDL,PRND,Prion-like protein doppel,37942,-0.00606479160733446,0.00522951148403609,-0.0163146341160452,0.00418505090137627,0.246181594048807
NMR metabolomics,X23408.Triglycerides in VLDL,CEP112,Centrosomal protein of 112 kDa,37562,0.00533193881684773,0.00460268228284853,-0.00368931845753538,0.0143531960912308,0.246704956005689
NMR metabolomics,X23408.Triglycerides in VLDL,IL10,Interleukin-10,40044,0.00967572968828756,0.00835793355495875,-0.00670582007943158,0.0260572794560067,0.247016427672929
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4C,Semaphorin-4C,40305,-0.00317756275876233,0.00274580955219931,-0.00855934948107298,0.00220422396354831,0.247191441315998
NMR metabolomics,X23408.Triglycerides in VLDL,DLGAP5,Disks large-associated protein 5,37959,-0.00605733518176731,0.00523707521142098,-0.0163220025961524,0.0042073322326178,0.247445820111565
NMR metabolomics,X23408.Triglycerides in VLDL,KLK15,Kallikrein-15,37880,0.00575305636445035,0.00498964626543539,-0.00402665031580302,0.0155327630447037,0.248931383713174
NMR metabolomics,X23408.Triglycerides in VLDL,DKKL1,Dickkopf-like protein 1,40305,-0.00982970036640275,0.00852573224574004,-0.0265401355680532,0.00688073483524774,0.248950343666728
NMR metabolomics,X23408.Triglycerides in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00785301164774446,0.00688256086814106,-0.021342830949301,0.00563680765381202,0.25389017858894
NMR metabolomics,X23408.Triglycerides in VLDL,RLN1,Prorelaxin H1,37959,-0.00916122018509054,0.00804064382220899,-0.0249208820766202,0.00659844170643908,0.254571565918694
NMR metabolomics,X23408.Triglycerides in VLDL,IL22,Interleukin-22,37900,0.0072356160183671,0.00635378950834553,-0.00521781141799014,0.0196890434547243,0.254812085373794
NMR metabolomics,X23408.Triglycerides in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00494631593584574,0.0043538415049083,-0.013479845285466,0.00358721341377453,0.255943625448619
NMR metabolomics,X23408.Triglycerides in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00466980014746199,0.00412028928251445,-0.0127455671411903,0.00340596684626632,0.257080850986923
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP4,Contactin-associated protein-like 4,37572,0.0110784011797181,0.00989852095291631,-0.00832269988799792,0.030479502247434,0.263076326214813
NMR metabolomics,X23408.Triglycerides in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00434793251251526,0.00388508496075856,-0.00326683401057152,0.011962699035602,0.263102701288072
NMR metabolomics,X23408.Triglycerides in VLDL,GPA33,Cell surface A33 antigen,40305,0.0147697200063589,0.0132058335655333,-0.0111137137820863,0.0406531537948041,0.263402934495973
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO1,R-spondin-1,40228,0.00383368039381234,0.00343535164508769,-0.00289960883055952,0.0105669696181842,0.264460569143568
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1,Huntingtin-interacting protein 1,37562,0.00368050013910023,0.00331943102089703,-0.00282558466185795,0.0101865849400584,0.267547856187841
NMR metabolomics,X23408.Triglycerides in VLDL,IL24,Interleukin-24,40044,0.00530620092585474,0.00479379386501632,-0.00408963504957724,0.0147020369012867,0.268358707477637
NMR metabolomics,X23408.Triglycerides in VLDL,FGF5,Fibroblast growth factor 5,40044,-0.00345661739409109,0.0031334323769069,-0.00959814485282862,0.00268491006464643,0.269983009771992
NMR metabolomics,X23408.Triglycerides in VLDL,ISM2,Isthmin-2,37998,-0.00478956752398591,0.00434228540218784,-0.0133004469122741,0.00372131186430227,0.270044087330199
NMR metabolomics,X23408.Triglycerides in VLDL,CHP1,Calcineurin B homologous protein 1,37541,0.00783843968260837,0.00712538855625395,-0.00612732188764938,0.0218042012528661,0.271321030160971
NMR metabolomics,X23408.Triglycerides in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.00850711859193839,0.00773560834760031,-0.023668910953235,0.00665467376935822,0.271467815398377
NMR metabolomics,X23408.Triglycerides in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00388816393104853,0.00353965989811462,-0.00304956946925612,0.0108258973313532,0.272025134086209
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.0020248103527108,0.00184882397886538,-0.00159888464586534,0.00564850535128694,0.273453609616787
NMR metabolomics,X23408.Triglycerides in VLDL,SCIN,Adseverin,37541,0.00779500755692206,0.00716655578025809,-0.00625144177238381,0.0218414568862279,0.276750995092025
NMR metabolomics,X23408.Triglycerides in VLDL,DBH,Dopamine beta-hydroxylase,37967,-0.0110794729674934,0.0102717387175394,-0.0312120808538706,0.0090531349188838,0.280769024644916
NMR metabolomics,X23408.Triglycerides in VLDL,COL3A1,Collagen alpha-1(III) chain,37998,0.00241475933105007,0.00225016639348163,-0.00199556680017392,0.00682508546227406,0.283224279544509
NMR metabolomics,X23408.Triglycerides in VLDL,GUCA2A,Guanylin,40276,-0.00347336553003016,0.00325071080338559,-0.00984475870466592,0.0028980276446056,0.285313959800907
NMR metabolomics,X23408.Triglycerides in VLDL,CNTF,Ciliary neurotrophic factor,37541,-0.00352620284282943,0.00330570146089622,-0.010005377706186,0.00295297202052716,0.28612548567564
NMR metabolomics,X23408.Triglycerides in VLDL,NOS1,"Nitric oxide synthase, brain",39961,0.00509000527204779,0.0048449294466393,-0.00440605644336523,0.0145860669874608,0.293466070457573
NMR metabolomics,X23408.Triglycerides in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00459274305187237,0.00438528067909754,-0.00400240707915881,0.0131878931829036,0.294976264587152
NMR metabolomics,X23408.Triglycerides in VLDL,NELL2,Protein kinase C-binding protein NELL2,40422,0.00285825036888855,0.00274004297728783,-0.0025122338665956,0.0082287346043727,0.296898919858156
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00333771011557213,0.00319990448839084,-0.00293410268167391,0.00960952291281818,0.296936605545838
NMR metabolomics,X23408.Triglycerides in VLDL,YY1,Transcriptional repressor protein YY1,37598,0.00285037433015061,0.00273909703713984,-0.00251825586264348,0.0082190045229447,0.298068511410442
NMR metabolomics,X23408.Triglycerides in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00439265826968448,0.00423329382781373,-0.00390459763283044,0.0126899141721994,0.299453784222989
NMR metabolomics,X23408.Triglycerides in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00249433858646412,0.00243253941587227,-0.00726211584157376,0.00227343866864552,0.305190342084558
NMR metabolomics,X23408.Triglycerides in VLDL,CDSN,Corneodesmosin,40456,-0.0042837330193786,0.00418843419533473,-0.0124930640422347,0.00392559800347748,0.306440174357712
NMR metabolomics,X23408.Triglycerides in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.011900445321956,0.0116529627111682,-0.0109393615919337,0.0347402522358457,0.307160659433039
NMR metabolomics,X23408.Triglycerides in VLDL,SLC44A4,Choline transporter-like protein 4,37572,-0.00697427957210672,0.00683119739654185,-0.0203634264693287,0.00641486732511531,0.307299131549051
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB118,Beta-defensin 118,37541,0.00580503117863876,0.00568733796924621,-0.00534215124108382,0.0169522135983613,0.307418349665084
NMR metabolomics,X23408.Triglycerides in VLDL,LTA4H,Leukotriene A-4 hydrolase,40489,0.00572440290411015,0.00562110640606744,-0.00529296565178203,0.0167417714600023,0.308514408466073
NMR metabolomics,X23408.Triglycerides in VLDL,CA8,Carbonic anhydrase-related protein,37598,-0.00275263805176079,0.00271337062615479,-0.00807084447902417,0.0025655683755026,0.310376337302193
NMR metabolomics,X23408.Triglycerides in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00317712216793329,0.00317550114518579,-0.00304686007663085,0.00940110441249743,0.317082025217026
NMR metabolomics,X23408.Triglycerides in VLDL,DUOX2,Dual oxidase 2,40042,0.00703122725829326,0.00704176878686638,-0.00677063956396484,0.0208330940805514,0.318051007911378
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH3,Neurexophilin-3,37598,0.00293854793936117,0.00295396489027085,-0.0028512232455697,0.00872831912429204,0.319861133077095
NMR metabolomics,X23408.Triglycerides in VLDL,ASPN,Asporin,37990,0.00262985316648745,0.00265441245533247,-0.00257279524596419,0.0078325015789391,0.321826475750629
NMR metabolomics,X23408.Triglycerides in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00672048456485742,0.00683430598881544,-0.0201157243029357,0.00667475517322085,0.325455518694607
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.00679716968686048,0.00693103946045025,-0.020382007029343,0.00678766765562201,0.326765997397348
NMR metabolomics,X23408.Triglycerides in VLDL,TNNI3,"Troponin I, cardiac muscle",40042,0.0080526321103916,0.00822436754676987,-0.00806712828127735,0.0241723925020605,0.327536523204963
NMR metabolomics,X23408.Triglycerides in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00488848990085563,0.00501188606485481,-0.0147117865879711,0.00493480678625979,0.329390291888301
NMR metabolomics,X23408.Triglycerides in VLDL,MUCL3,Mucin-like protein 3,37482,-0.00428542835399715,0.00439619647337507,-0.0129019734418123,0.00433111673381798,0.329675764195494
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL2,Interferon lambda-2,37541,0.00614558153883355,0.00632037328913942,-0.00624235010787971,0.0185335131855468,0.330897055825463
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.00800976150325954,0.00826401432777022,-0.00818770657917009,0.0242072295856892,0.332443334247754
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS2,Podocin,37598,-0.00986698517593925,0.01023325468926,-0.0299241643668887,0.0101901940150103,0.334959432585907
NMR metabolomics,X23408.Triglycerides in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00474832224061046,0.00493373171516572,-0.00492179192111434,0.0144184364023353,0.335856514196547
NMR metabolomics,X23408.Triglycerides in VLDL,CCNE1,G1/S-specific cyclin-E1,37598,0.00879086346005116,0.00913664677549904,-0.00911696421992696,0.0266986911400293,0.335989827053323
NMR metabolomics,X23408.Triglycerides in VLDL,EDNRB,Endothelin receptor type B,37598,0.00441245090063806,0.00462274866466822,-0.00464813648211165,0.0134730382833878,0.339844077791528
NMR metabolomics,X23408.Triglycerides in VLDL,GAL,Galanin peptides,40422,-0.00575440494564962,0.00605530529464583,-0.0176228033231555,0.00611399343185621,0.341970166046665
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00744153945644988,0.00787444658565778,-0.00799237585143938,0.0228754547643391,0.344661446302493
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00450605167779049,0.00482987117141679,-0.0139725991737674,0.00496049581818641,0.35086057348926
NMR metabolomics,X23408.Triglycerides in VLDL,TP53BP1,TP53-binding protein 1,37598,0.00807288324045127,0.00867125862869626,-0.00892278367179341,0.0250685501526959,0.351874152696079
NMR metabolomics,X23408.Triglycerides in VLDL,TAGLN3,Transgelin-3,37482,-0.00553597186494155,0.00595004219731354,-0.0171980545716761,0.00612611084179298,0.352176679620273
NMR metabolomics,X23408.Triglycerides in VLDL,LAYN,Layilin,40192,0.00309747786220127,0.0033338753325502,-0.00343691778959713,0.00963187351399967,0.3528555083008
NMR metabolomics,X23408.Triglycerides in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.0033648405796219,0.003627155925907,-0.0104740661943996,0.00374438503515582,0.353588180332694
NMR metabolomics,X23408.Triglycerides in VLDL,CD82,CD82 antigen,37714,-0.00378353688506631,0.00408435904216004,-0.0117888806077,0.00422180683756738,0.354282135352947
NMR metabolomics,X23408.Triglycerides in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00384690130675687,0.00418160990501529,-0.00434905410707309,0.0120428567205868,0.35761214350746
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.0026042307168281,0.00283997028736107,-0.0029621110463996,0.0081705724800558,0.359160889210797
NMR metabolomics,X23408.Triglycerides in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00541983655442324,0.00592951774731377,-0.0170416913391582,0.00620201823031175,0.360710851905657
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D2,DCN1-like protein 2,37482,0.00720592713645046,0.00788942886766947,-0.00825735344418171,0.0226692077170826,0.361067577188248
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00304579735703125,0.00335840136530348,-0.00353666931896357,0.00962826403302608,0.364463394155761
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.00290506728976227,0.00321146037704612,-0.00338939504924812,0.00919952962877266,0.365696694441634
NMR metabolomics,X23408.Triglycerides in VLDL,ABO,Histo-blood group ABO system transferase,37987,-0.0126809488090799,0.0140365365880683,-0.0401925605216938,0.014830662903534,0.366316804595098
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,40208,0.00351841501325462,0.00391407397256592,-0.00415316997297458,0.0111899999994838,0.368712326675778
NMR metabolomics,X23408.Triglycerides in VLDL,PLB1,"Phospholipase B1, membrane-associated",37942,-0.00530952336607778,0.00590891103219055,-0.0168909889891713,0.00627194225701569,0.368902003910732
NMR metabolomics,X23408.Triglycerides in VLDL,SLC51B,Organic solute transporter subunit beta,37562,0.00694733008283925,0.00776055443479547,-0.00826335660935986,0.0221580167750384,0.370690989987117
NMR metabolomics,X23408.Triglycerides in VLDL,PRTN3,Myeloblastin,39897,0.00408586720690327,0.00456766612242559,-0.00486675839305087,0.0130384928068574,0.371057847682875
NMR metabolomics,X23408.Triglycerides in VLDL,MORC3,MORC family CW-type zinc finger protein 3,37942,0.00243900657082469,0.00275296628581775,-0.0029568073493781,0.00783482049102748,0.375657113913298
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37942,0.00614366005819282,0.00693900214939101,-0.00745678415461356,0.0197441042709992,0.375967004492353
NMR metabolomics,X23408.Triglycerides in VLDL,IGLC2,Immunoglobulin lambda constant 2,37978,0.00208888675046148,0.00236388081910686,-0.00254431965498797,0.00672209315591092,0.376890956277677
NMR metabolomics,X23408.Triglycerides in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00289366232109148,0.00327646799919861,-0.00931553959952075,0.00352821495733779,0.377160671048536
NMR metabolomics,X23408.Triglycerides in VLDL,H2AP,Huntingtin-interacting protein M,37482,-0.0044764938956946,0.00508265199279415,-0.0144384918015711,0.00548550401018193,0.378474914522302
NMR metabolomics,X23408.Triglycerides in VLDL,CDAN1,Codanin-1,37942,0.00198955948925274,0.00226198081430079,-0.0024439229067768,0.00642304188528229,0.379110593736254
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.0048382945627417,0.00553405678858108,-0.0060084567428772,0.0156850458683606,0.381983856302937
NMR metabolomics,X23408.Triglycerides in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.0049368166897851,0.00564941484094517,-0.00613603639846742,0.0160096697780376,0.382208770062721
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA2,Paraneoplastic antigen Ma2,37541,0.00369458472171755,0.00424008423078407,-0.00461598037061922,0.0120051498140543,0.383580690409466
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC8,Histone deacetylase 8,37598,0.00529918633026801,0.00610180899751816,-0.0066603593048676,0.0172587319654036,0.385157581700774
NMR metabolomics,X23408.Triglycerides in VLDL,FGF9,Fibroblast growth factor 9,37457,0.00342901444280692,0.00395981076448517,-0.00433221465558401,0.0111902435411978,0.386531297466732
NMR metabolomics,X23408.Triglycerides in VLDL,NENF,Neudesin,37900,0.00909971332004882,0.0105456097563608,-0.0115696818024184,0.0297691084425161,0.388212705374381
NMR metabolomics,X23408.Triglycerides in VLDL,PSCA,Prostate stem cell antigen,37901,0.0218166817142685,0.0253169077992987,-0.0278044575723569,0.0714378210008939,0.388844025093409
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.00412504587946187,0.00479829503371447,-0.0135297041455422,0.00527961238661848,0.389975711650236
NMR metabolomics,X23408.Triglycerides in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.00483669722626058,0.00563488096769835,-0.0158810639229493,0.0062076694704282,0.39071522491255
NMR metabolomics,X23408.Triglycerides in VLDL,GH2,Growth hormone variant,39980,0.0140064834365663,0.0163960925598019,-0.0181298579806454,0.0461428248537781,0.392975562637025
NMR metabolomics,X23408.Triglycerides in VLDL,TBR1,T-box brain protein 1,37572,0.00405085900876113,0.00475638967636638,-0.00527166475691698,0.0133733827744392,0.394414616365888
NMR metabolomics,X23408.Triglycerides in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00564482767854447,0.00662935809593898,-0.00734871418949594,0.0186383695465849,0.39451296290782
NMR metabolomics,X23408.Triglycerides in VLDL,MERTK,Tyrosine-protein kinase Mer,40516,-0.00215503850556433,0.00253721592319329,-0.00712798171502317,0.00281790470389452,0.395687349436497
NMR metabolomics,X23408.Triglycerides in VLDL,GAGE2A,G antigen 2A,37482,0.00514168087190897,0.00607460019254073,-0.00676453550547087,0.0170478972492888,0.397332397533977
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.00221631548846895,0.00263620986888224,-0.00295065585454024,0.00738328683147814,0.400517169592706
NMR metabolomics,X23408.Triglycerides in VLDL,LCN15,Lipocalin-15,37959,-0.00519201023143349,0.00621597115305457,-0.0173753136914205,0.00699129322855347,0.403580840225276
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK2B,Divergent protein kinase domain 2B,37671,0.00216659914097562,0.00260146365331528,-0.00293226961952233,0.00726546790147357,0.404950852923137
NMR metabolomics,X23408.Triglycerides in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00470383449171423,0.00565578979559212,-0.0157891824910748,0.00638151350764633,0.405602021708426
NMR metabolomics,X23408.Triglycerides in VLDL,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.00783702319828693,0.009424822895052,-0.0263096760725889,0.010635629676015,0.405689419637597
NMR metabolomics,X23408.Triglycerides in VLDL,FGF6,Fibroblast growth factor 6,37598,-0.00345252731996337,0.00419636132598918,-0.0116773955189022,0.00477234087897542,0.410669024162733
NMR metabolomics,X23408.Triglycerides in VLDL,MAPT,Microtubule-associated protein tau,39961,0.00424751907797389,0.00516272335681868,-0.00587141870139072,0.0143664568573385,0.410675116015917
NMR metabolomics,X23408.Triglycerides in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00286788787791167,0.00351993677052435,-0.00403118819231606,0.0097669639481394,0.415226902326582
NMR metabolomics,X23408.Triglycerides in VLDL,PCARE,Photoreceptor cilium actin regulator,37541,0.00680514586166833,0.00840809102175601,-0.00967471254097345,0.0232850042643101,0.41832464059718
NMR metabolomics,X23408.Triglycerides in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.00270643377722575,0.00336728881097556,-0.00930631984673785,0.00389345229228636,0.421560254374774
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB5,Integrin beta-5,40411,0.00287046981689447,0.00359352077008412,-0.00417283089247041,0.00991377052625935,0.424423857507366
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00384132485546933,0.00486271114366697,-0.00568958898611793,0.0133722386970566,0.429568134632385
NMR metabolomics,X23408.Triglycerides in VLDL,HRAS,GTPase Hras,37697,-0.00754867800807654,0.00960079939087887,-0.0263662448141991,0.011268888798046,0.431732085752307
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.00431495760707199,0.00553601732033447,-0.00653563634078357,0.0151655515549276,0.435735954593294
NMR metabolomics,X23408.Triglycerides in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.00223170973499522,0.00287641327764129,-0.00786947975917215,0.00340606028918171,0.437841968720309
NMR metabolomics,X23408.Triglycerides in VLDL,EVI2B,Protein EVI2B,37482,0.00318767153645525,0.00410993745219847,-0.00486780586985374,0.0112431489427642,0.437998694707432
NMR metabolomics,X23408.Triglycerides in VLDL,NEB,Nebulin,37562,0.00273514271088168,0.00355142618510796,-0.00422565261192992,0.00969593803369328,0.441222820173775
NMR metabolomics,X23408.Triglycerides in VLDL,CAPN3,Calpain-3,37900,0.00278558826188973,0.0036169994548833,-0.00430373066968153,0.009874907193461,0.44123164115456
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO1,Amphoterin-induced protein 1,37572,0.00374675807865928,0.00486990268385763,-0.00579825118170169,0.0132917673390202,0.441687415073224
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00287970700174783,0.00378246040847031,-0.0102933294023496,0.00453391539885397,0.446472656500377
NMR metabolomics,X23408.Triglycerides in VLDL,PYDC1,Pyrin domain-containing protein 1,37628,-0.00316771059323301,0.0041620718701143,-0.011325371458657,0.00498995027219101,0.446617031996271
NMR metabolomics,X23408.Triglycerides in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,-0.00188854211254187,0.0025021237850443,-0.00679270473122869,0.00301562050614496,0.450397163039711
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAX,Integrin alpha-X,37714,0.00405561062519269,0.00538778999696332,-0.00650445776885542,0.0146156790192408,0.451618906180347
NMR metabolomics,X23408.Triglycerides in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00531791054573528,0.00709003965667753,-0.00857856718135268,0.0192143882728232,0.45323580712902
NMR metabolomics,X23408.Triglycerides in VLDL,PRG3,Proteoglycan 3,37998,-0.00362241344925496,0.00487745484042898,-0.0131822249364958,0.00593739803798585,0.457685179979267
NMR metabolomics,X23408.Triglycerides in VLDL,VNN2,Vascular non-inflammatory molecule 2,40305,0.0032297911368709,0.00435314224492501,-0.00530236766318212,0.0117619499369239,0.458131788641031
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL5,ADAMTS-like protein 5,37990,-0.0027991153836566,0.00377394575351635,-0.0101960490605486,0.00459781829323545,0.458285226829182
NMR metabolomics,X23408.Triglycerides in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.0062416037966635,0.00844744434363831,-0.0103153871168676,0.0227985947101946,0.459996240021287
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD7,FERM domain-containing protein 7,37572,0.00239454477410687,0.00324469570421084,-0.00396505880614638,0.00875414835436011,0.460535262475386
NMR metabolomics,X23408.Triglycerides in VLDL,NPTXR,Neuronal pentraxin receptor,40359,0.00242538917090032,0.00329269028448503,-0.00402828378669034,0.00887906212849098,0.461377697317831
NMR metabolomics,X23408.Triglycerides in VLDL,CGN,Cingulin,37572,0.003013750018148,0.0040922743515161,-0.00500710771082355,0.0110346077471195,0.461470859772011
NMR metabolomics,X23408.Triglycerides in VLDL,DHODH,Dihydroorotate dehydrogenase,37562,0.00346812326411977,0.00471457431566669,-0.00577244239458695,0.0127086889228265,0.461976683437787
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00291617387962277,0.00398651695980017,-0.0107297471208311,0.00489739936158557,0.46448110473822
NMR metabolomics,X23408.Triglycerides in VLDL,CASQ2,Calsequestrin-2,37562,-0.00357553675477892,0.00489062216306211,-0.0131611561943807,0.00601008268482281,0.464730779465145
NMR metabolomics,X23408.Triglycerides in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00399585730205362,0.0055063100086159,-0.00679651031483354,0.0147882249189408,0.468043738588416
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR3,Folate receptor gamma,40355,-0.0129427051978455,0.017881150771357,-0.0479897607097053,0.0221043503140143,0.469187903871123
NMR metabolomics,X23408.Triglycerides in VLDL,CCND2,G1/S-specific cyclin-D2,37714,0.00257367937277211,0.00357787071570905,-0.00443894723001762,0.00958630597556185,0.471948632522328
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00842714031295536,0.0117675452602003,-0.0146372483970373,0.031491529022948,0.473919325314577
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.0081916229534366,0.0115648748409756,-0.0144755317348755,0.0308587776417487,0.478757450086227
NMR metabolomics,X23408.Triglycerides in VLDL,C9orf40,Uncharacterized protein C9orf40,37901,0.00565007105023534,0.00802094163550763,-0.0100709745553596,0.0213711166558303,0.481186607191981
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00246927043076809,0.00351507257066199,-0.0044202718077294,0.00935881266926559,0.482391933601973
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA2,Protein disulfide-isomerase A2,37482,-0.00283696950747602,0.00405623032842185,-0.0107871809511828,0.00511324193623081,0.484308101163286
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP2,Contactin-associated protein-like 2,40341,-0.00272063820968572,0.0038936396478218,-0.0103521719194165,0.00491089550004501,0.484725329365685
NMR metabolomics,X23408.Triglycerides in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00320997882120252,0.0046280831077251,-0.00586106406993868,0.0122810217123437,0.487953463187527
NMR metabolomics,X23408.Triglycerides in VLDL,ARG2,"Arginase-2, mitochondrial",37900,0.00300225763552891,0.00433093733248596,-0.00548637953614358,0.0114908948072014,0.48818850391713
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6B,Ras-related protein Rab-6B,39961,0.00327872030256624,0.00473988302847908,-0.00601145043325276,0.0125688910383852,0.489117123732231
NMR metabolomics,X23408.Triglycerides in VLDL,PROK1,Prokineticin-1,40341,-0.0046200639146848,0.00668037567444254,-0.0177136002365922,0.00847347240722259,0.489206555921487
NMR metabolomics,X23408.Triglycerides in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00308489927540373,0.00448048294690875,-0.0118666458513449,0.00569684730053741,0.491137982320474
NMR metabolomics,X23408.Triglycerides in VLDL,KLK12,Kallikrein-12,39980,-0.00954628507612439,0.0139089054810121,-0.0368077398189082,0.0177151696666594,0.492506853430416
NMR metabolomics,X23408.Triglycerides in VLDL,IL17C,Interleukin-17C,40044,-0.00467731963225097,0.00681788571773011,-0.018040375639002,0.00868573637450004,0.492700183739916
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3,Microfibril-associated glycoprotein 3,40042,0.00330615982029887,0.00483611201505787,-0.00617261972921456,0.0127849393698123,0.494212653576513
NMR metabolomics,X23408.Triglycerides in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00417608023884194,0.00615417341525762,-0.00788609965506301,0.0162382601327469,0.497417790856699
NMR metabolomics,X23408.Triglycerides in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00277380100180913,0.00409988308099768,-0.00526196983694632,0.0108095718405646,0.498699276696932
NMR metabolomics,X23408.Triglycerides in VLDL,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00366858300910182,0.00544410502802226,-0.00700186284582181,0.0143390288640255,0.500410129662353
NMR metabolomics,X23408.Triglycerides in VLDL,LPO,Lactoperoxidase,39831,-0.00385967857603677,0.00574775871369842,-0.0151252856548857,0.00740592850281214,0.501905653016446
NMR metabolomics,X23408.Triglycerides in VLDL,MMP15,Matrix metalloproteinase-15,37990,0.00325877757197636,0.0048570337700006,-0.00626100861722482,0.0127785637611775,0.502270286808593
NMR metabolomics,X23408.Triglycerides in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.00396252878539956,0.00591181543281762,-0.0155496870337221,0.00762462946292298,0.502693558507037
NMR metabolomics,X23408.Triglycerides in VLDL,HMMR,Hyaluronan mediated motility receptor,37460,-0.00317253137879298,0.00475127745220094,-0.0124850351851068,0.00613997242752086,0.504323058339132
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC9,Histone deacetylase 9,37541,-0.0040980446750519,0.00618998315971168,-0.0162304116680868,0.00803432231798299,0.507954320193884
NMR metabolomics,X23408.Triglycerides in VLDL,GPHA2,Glycoprotein hormone alpha-2,37901,0.00314779289994534,0.00477069228216075,-0.00620276397308973,0.0124983497729804,0.509381356528
NMR metabolomics,X23408.Triglycerides in VLDL,TLR1,Toll-like receptor 1,37598,0.00168395475071435,0.00255276911499798,-0.00331947271468169,0.0066873822161104,0.509484835155831
NMR metabolomics,X23408.Triglycerides in VLDL,IL1A,Interleukin-1 alpha,40044,0.00342384010948958,0.00523501036475424,-0.00683678020542872,0.0136844604244079,0.513103812085616
NMR metabolomics,X23408.Triglycerides in VLDL,CDC123,Cell division cycle protein 123 homolog,37482,0.0040560252203422,0.00625302450098186,-0.00819990280158224,0.0163119532422666,0.516575969903595
NMR metabolomics,X23408.Triglycerides in VLDL,PRR5,Proline-rich protein 5,37598,0.00304797813231168,0.00470588733698165,-0.00617556104817236,0.0122715173127957,0.517193764944227
NMR metabolomics,X23408.Triglycerides in VLDL,TPSG1,Tryptase gamma,37598,-0.00171696830494182,0.00266257127741395,-0.00693560800867316,0.00350167139878952,0.519033405564389
NMR metabolomics,X23408.Triglycerides in VLDL,ERCC1,DNA excision repair protein ERCC-1,37482,0.00210767771380702,0.00327632631217289,-0.00431392185805184,0.00852927728566589,0.520037411614399
NMR metabolomics,X23408.Triglycerides in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.0014084212279929,0.00218993552288672,-0.00288385239686508,0.00570069485285088,0.520146549472474
NMR metabolomics,X23408.Triglycerides in VLDL,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.0026629448054852,0.00415868137691959,-0.0108139603042476,0.0054880706932772,0.521966433775424
NMR metabolomics,X23408.Triglycerides in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00263421090006153,0.00412013589693086,-0.00544125545792294,0.010709677258046,0.522605792770295
NMR metabolomics,X23408.Triglycerides in VLDL,FGF20,Fibroblast growth factor 20,37598,-0.00278252136088646,0.00436130638211158,-0.0113306818698252,0.00576563914805223,0.523483615344642
NMR metabolomics,X23408.Triglycerides in VLDL,IL31,Interleukin-31,37598,-0.00359701620310997,0.00567789653783165,-0.01472569341726,0.00753166101104007,0.526410297911962
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN1,Cerebellin-1,37541,-0.00598697384967977,0.00957983060791259,-0.0247634418411884,0.0127894941418289,0.532010746524486
NMR metabolomics,X23408.Triglycerides in VLDL,DAND5,DAN domain family member 5,37598,-0.00328729970739153,0.0053112431501224,-0.0136973362816314,0.00712273686684838,0.535971712371394
NMR metabolomics,X23408.Triglycerides in VLDL,TNPO1,Transportin-1,37714,-0.00213466269507803,0.00346067323761049,-0.00891758224079459,0.00464825685063853,0.53735447297248
NMR metabolomics,X23408.Triglycerides in VLDL,MTR,Methionine synthase,37562,0.00390868718723265,0.00638220348116119,-0.00860043163584329,0.0164178060103086,0.540260364607318
NMR metabolomics,X23408.Triglycerides in VLDL,AGBL2,Cytosolic carboxypeptidase 2,37541,0.00543823603368398,0.00888742883750589,-0.0119811244878276,0.0228575965551955,0.540613185460114
NMR metabolomics,X23408.Triglycerides in VLDL,HCG22,Protein PBMUCL2,37562,-0.00318666933663855,0.00520931590525905,-0.0133969285109463,0.00702358983766919,0.540730254488932
NMR metabolomics,X23408.Triglycerides in VLDL,IL20,Interleukin-20,40044,0.00301571922940237,0.00495785255453991,-0.00670167177749585,0.0127331102363006,0.543016438178105
NMR metabolomics,X23408.Triglycerides in VLDL,IL13,Interleukin-13,40044,0.00283526760031973,0.00466188443777106,-0.00630202589771153,0.011972561098351,0.54307656918676
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAC1,Cartilage acidic protein 1,40536,0.00171977232431901,0.00284031411277324,-0.00384724333671654,0.00728678798535456,0.544864224563594
NMR metabolomics,X23408.Triglycerides in VLDL,RBP1,Retinol-binding protein 1,37572,0.00406459620553898,0.00671746454904435,-0.00910163431058795,0.0172308267216659,0.545137023899765
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.00477771097006288,0.0078970688913628,-0.020255965997134,0.0107005440570082,0.545190806594479
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,0.00176790550677956,0.0029331924707023,-0.00398115173579695,0.00751696274935606,0.54670247356378
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC2L,C-type lectin domain family 2 member L,37572,0.00290748098682394,0.0048387204808299,-0.00657641115560266,0.0123913731292505,0.547931585808134
NMR metabolomics,X23408.Triglycerides in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00548284437289249,0.00914915319874287,-0.0124494958966435,0.0234151846424285,0.549000893579489
NMR metabolomics,X23408.Triglycerides in VLDL,RAP1A,Ras-related protein Rap-1A,37598,0.00406510249854782,0.00680027182750586,-0.00926343028336366,0.0173936352804593,0.549993501190291
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00223171322391755,0.00374251582145625,-0.0051036177861367,0.0095670442339718,0.550975932965542
NMR metabolomics,X23408.Triglycerides in VLDL,PGM2,Phosphoglucomutase-2,37572,0.00345336251356676,0.00584869866587575,-0.00801008687154972,0.0149168118986832,0.554899352410658
NMR metabolomics,X23408.Triglycerides in VLDL,KRT14,"Keratin, type I cytoskeletal 14",39530,0.00163652258602749,0.00277775710309732,-0.00380788133604325,0.00708092650809823,0.555767793656457
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00415905146310862,0.00712790421575384,-0.0098116407997689,0.0181297437259861,0.559574425079101
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB7,Integrin beta-7,40489,0.00256231737478481,0.00441681647160313,-0.00609464290955733,0.0112192776591269,0.561836687132113
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN1,Neuroligin-1,37572,-0.00392742264001446,0.00679587495017345,-0.0172473375423544,0.00939249226232551,0.563332958939787
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00327090438263308,0.00571354715894385,-0.00792764804889686,0.014469456814163,0.567005091875568
NMR metabolomics,X23408.Triglycerides in VLDL,IGLON5,IgLON family member 5,37482,-0.00518622829262893,0.00918827473891212,-0.0231952467808967,0.0128227901956388,0.572464549835361
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF174,Zinc finger protein 174,37598,-0.00213522976870644,0.00378708363864645,-0.00955791370045348,0.0052874541630406,0.572886926939769
NMR metabolomics,X23408.Triglycerides in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.00292644675721024,0.00527379031225469,-0.0132630757692294,0.00741018225480894,0.578969868161723
NMR metabolomics,X23408.Triglycerides in VLDL,REG1A,Lithostathine-1-alpha,40274,0.00262340453697842,0.00473274253387198,-0.00665277082941066,0.0118995799033675,0.579374827990209
NMR metabolomics,X23408.Triglycerides in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.00321545241314871,0.0058491963750078,-0.00824897248186657,0.014679877308164,0.582517026898864
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00371754794777002,0.00677406583587573,-0.00955962109054641,0.0169947169860864,0.583157965584238
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3B,Sodium channel subunit beta-3,37541,0.00245805117481921,0.00448071168209848,-0.00632414372209381,0.0112402460717322,0.583299645432079
NMR metabolomics,X23408.Triglycerides in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00214334978133836,0.00396592580509767,-0.00991656435932979,0.00562986479665307,0.588901922261197
NMR metabolomics,X23408.Triglycerides in VLDL,PMCH,Pro-MCH,37562,-0.00446335840749109,0.00828669972336959,-0.0207052898652955,0.0117785730503133,0.590160211425033
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.00177840748235659,0.00330679468750141,-0.00825972506985937,0.00470291010514618,0.590721498697477
NMR metabolomics,X23408.Triglycerides in VLDL,BTNL10,Butyrophilin-like protein 10,37482,0.00217904821531364,0.00408250527305569,-0.00582266211987552,0.0101807585505028,0.593521747084434
NMR metabolomics,X23408.Triglycerides in VLDL,MB,Myoglobin,40536,-0.00253112610141324,0.00476545014447622,-0.0118714083845866,0.00680915618176014,0.595328387391639
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A14,Zinc transporter ZIP14,39961,0.00172017567282789,0.00324528092575004,-0.0046405749416422,0.00808092628729797,0.596081751033028
NMR metabolomics,X23408.Triglycerides in VLDL,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00207202421109598,0.00393307784623139,-0.00563680836751754,0.0097808567897095,0.598325865541923
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAV,Integrin alpha-V,40489,-0.000833864132338694,0.00158829347885836,-0.00394691935090108,0.00227919108622369,0.599586047194071
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00195290173875488,0.00372371636346443,-0.00534558233363541,0.00925138581114518,0.599974697625706
NMR metabolomics,X23408.Triglycerides in VLDL,CHGB,Secretogranin-1,40406,-0.00203027468781888,0.00391247491409422,-0.00969872551944354,0.00563817614380579,0.603821374099467
NMR metabolomics,X23408.Triglycerides in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.00632788852933492,0.0122929238153964,-0.0177662421488419,0.0304220192075118,0.606729029568574
NMR metabolomics,X23408.Triglycerides in VLDL,SPESP1,Sperm equatorial segment protein 1,37990,0.00137459072065175,0.00268641725505986,-0.00389078709926558,0.00663996854056908,0.608882096475287
NMR metabolomics,X23408.Triglycerides in VLDL,HEBP1,Heme-binding protein 1,40042,0.00267718495138682,0.00529198801171958,-0.00769511155158356,0.0130494814543572,0.612938221676974
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4C,C-type lectin domain family 4 member C,40341,0.00221735850713244,0.00442803377555988,-0.00646158769296492,0.0108963047072298,0.61655074122646
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00327722219284515,0.00654701475562839,-0.0095549267281865,0.0161093711138768,0.616684002778212
NMR metabolomics,X23408.Triglycerides in VLDL,STC2,Stanniocalcin-2,40309,0.0013160985488075,0.00263579695019666,-0.00385006347357795,0.00648226057119295,0.61756292177839
NMR metabolomics,X23408.Triglycerides in VLDL,FOS,Proto-oncogene c-Fos,37457,0.00170385480706581,0.00342508360895262,-0.00500930906648133,0.00841701868061295,0.61887049674034
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00371908321443805,0.00757825393400002,-0.0185724609250781,0.011134294496202,0.623606142682809
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.0040915152757767,0.00839541238039539,-0.0205465235413517,0.0123634929897983,0.626017586179099
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN3,Neuronal-specific septin-3,37959,-0.00347048629326989,0.00718250224999078,-0.0175481907032518,0.010607218116712,0.628971332686922
NMR metabolomics,X23408.Triglycerides in VLDL,ALMS1,Alstrom syndrome protein 1,37714,0.00211604159015248,0.00439570267794435,-0.00649953565861844,0.0107316188389234,0.630248210088561
NMR metabolomics,X23408.Triglycerides in VLDL,DOC2B,Double C2-like domain-containing protein beta,37572,0.00168155069178109,0.00351183567793083,-0.00520164723696334,0.00856474862052552,0.632071925276688
NMR metabolomics,X23408.Triglycerides in VLDL,NRN1,Neuritin,37959,-0.00170884374798242,0.00356926472544297,-0.00870460260985063,0.0052869151138858,0.632112627158064
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.00211662605288806,0.00447602801491045,-0.0108896409621126,0.00665638885633643,0.636304930494827
NMR metabolomics,X23408.Triglycerides in VLDL,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00225590507748944,0.00477295155634783,-0.0070990799729523,0.0116108901279312,0.636475306670089
NMR metabolomics,X23408.Triglycerides in VLDL,RBM25,RNA-binding protein 25,37482,-0.00213430745718756,0.00451918401036101,-0.0109919081174951,0.00672329320312001,0.636736869484009
NMR metabolomics,X23408.Triglycerides in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00171097697252864,0.00364661560576035,-0.00543638961476166,0.00885834355981893,0.638936199563911
NMR metabolomics,X23408.Triglycerides in VLDL,PRRT3,Proline-rich transmembrane protein 3,37628,0.00171093060056217,0.00366452836749607,-0.00547154499973013,0.00889340620085447,0.640586504927872
NMR metabolomics,X23408.Triglycerides in VLDL,S100A3,Protein S100-A3,37900,0.00208623472446712,0.0044742852403282,-0.00668336434657615,0.0108558337955104,0.641028243102165
NMR metabolomics,X23408.Triglycerides in VLDL,PGR,Progesterone receptor,37598,-0.0046253323602658,0.0101011677163937,-0.0244236210843975,0.0151729563638659,0.647031310018888
NMR metabolomics,X23408.Triglycerides in VLDL,HSP90B1,Endoplasmin,39878,-0.00312044589978019,0.00681935197254455,-0.0164863757659675,0.0102454839664071,0.647255725550359
NMR metabolomics,X23408.Triglycerides in VLDL,CTSV,Cathepsin L2,40444,0.00187764283872969,0.00411836417294922,-0.00619435094025079,0.00994963661771017,0.648454004188323
NMR metabolomics,X23408.Triglycerides in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37562,-0.00145616906408684,0.0031989531830771,-0.00772611730291795,0.00481377917474428,0.648971644940106
NMR metabolomics,X23408.Triglycerides in VLDL,CYTH3,Cytohesin-3,37482,0.00324010211974191,0.00719555502593673,-0.0108631857310941,0.0173433899705779,0.652507272440109
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR1B,Cornifin-B,37714,0.00372122118038681,0.00831281538106272,-0.0125718969664961,0.0200143393272697,0.654414046177835
NMR metabolomics,X23408.Triglycerides in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00280933494725776,0.00628929663391514,-0.00951768645521591,0.0151363563497314,0.655109752302364
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.00213848620574135,0.00480007266094369,-0.011546628621191,0.00726965620970828,0.655956417087106
NMR metabolomics,X23408.Triglycerides in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.00129937782486697,0.00292669945179511,-0.00703570875038539,0.00443695310065145,0.657068878633341
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00275558604638397,0.00622325287248885,-0.0149531616764621,0.00944198958369417,0.657925799563919
NMR metabolomics,X23408.Triglycerides in VLDL,FZD8,Frizzled-8,37541,0.00189106748201954,0.00438177379227085,-0.00669720915083132,0.0104793441148704,0.666056866278531
NMR metabolomics,X23408.Triglycerides in VLDL,TCP11,T-complex protein 11 homolog,37714,-0.00254401440389921,0.00592864095008462,-0.0141641506660651,0.00907612185826665,0.667853178963002
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00219295449067344,0.00511992556375569,-0.0122280085956346,0.00784209961428771,0.668426839274745
NMR metabolomics,X23408.Triglycerides in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00278515312540457,0.00650316458314483,-0.00996104945755929,0.0155313557083684,0.668456810460247
NMR metabolomics,X23408.Triglycerides in VLDL,CPLX2,Complexin-2,37482,-0.00129313829555015,0.00302264247832302,-0.00721751755306327,0.00463124096196298,0.668791318960671
NMR metabolomics,X23408.Triglycerides in VLDL,TEX101,Testis-expressed protein 101,37572,0.00163240739580215,0.00383003388758288,-0.0058744590238603,0.00913927381546459,0.669960177545855
NMR metabolomics,X23408.Triglycerides in VLDL,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00322181354688463,0.00761242111475285,-0.011698531838031,0.0181421589318002,0.672133577694197
NMR metabolomics,X23408.Triglycerides in VLDL,ENPEP,Glutamyl aminopeptidase,37562,-0.00191078409445997,0.00452321731044196,-0.0107762900229262,0.00695472183400627,0.672711431819412
NMR metabolomics,X23408.Triglycerides in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00238250910645434,0.00565269755982634,-0.00869677811080529,0.013461796323714,0.673410224344739
NMR metabolomics,X23408.Triglycerides in VLDL,NPTN,Neuroplastin,39980,0.00341132695700393,0.00820743414968016,-0.0126752439763692,0.019497897890377,0.677680174026704
NMR metabolomics,X23408.Triglycerides in VLDL,PSMA1,Proteasome subunit alpha type-1,39980,-0.00187789790643527,0.00452295021253453,-0.010742880323003,0.00698708451013242,0.678006255887973
NMR metabolomics,X23408.Triglycerides in VLDL,RUVBL1,RuvB-like 1,39980,0.00433246872166082,0.0104361879202051,-0.0161224596019412,0.0247873970452629,0.678045879177936
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.00223296030487952,0.0054359900927695,-0.00842158027694869,0.0128875008867077,0.681245324056306
NMR metabolomics,X23408.Triglycerides in VLDL,SCGN,Secretagogin,40044,0.00174453735295004,0.00426324005442784,-0.00661141315372852,0.0101004878596286,0.682395154801437
NMR metabolomics,X23408.Triglycerides in VLDL,CDC25A,M-phase inducer phosphatase 1,37482,-0.00163434152632548,0.00399538594837671,-0.00946529798514383,0.00619661493249286,0.682504382554351
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00108286149620301,0.00265207942639165,-0.00411521417952461,0.00628093717193064,0.683054062200003
NMR metabolomics,X23408.Triglycerides in VLDL,PALLD,Palladin,37598,-0.0016494312648397,0.00405002317851345,-0.00958747669472607,0.00628861416504667,0.68382025557994
NMR metabolomics,X23408.Triglycerides in VLDL,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00295421469003692,0.00728523604073189,-0.0113248479497976,0.0172332773298714,0.685111367198883
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL1,Kin of IRRE-like protein 1,37541,-0.00244216262581744,0.00602576147959943,-0.0142526551258323,0.00936832987419743,0.685273205381995
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD2,Leiomodin-2,37541,0.00253025446743181,0.00634572238045644,-0.00990736139826281,0.0149678703331264,0.690095809991562
NMR metabolomics,X23408.Triglycerides in VLDL,BRD2,Bromodomain-containing protein 2,37541,-0.00133919100613109,0.00337152766621635,-0.00794738523191514,0.00526900321965296,0.691222037274494
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC11A,C-type lectin domain family 11 member A,40296,0.00184842940832773,0.00465456003222725,-0.00727450825483769,0.0109713670714931,0.691282653427375
NMR metabolomics,X23408.Triglycerides in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00195011363346894,0.00491844909172704,-0.0115902738532539,0.00769004658631605,0.691750413358311
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00191198870967865,0.00482763014719936,-0.0075501663788321,0.0113741437981894,0.692073713791952
NMR metabolomics,X23408.Triglycerides in VLDL,TPBGL,Trophoblast glycoprotein-like,37572,0.00159151424478552,0.00407165237335304,-0.00638892440698644,0.00957195289655748,0.69589468748585
NMR metabolomics,X23408.Triglycerides in VLDL,TPT1,Translationally-controlled tumor protein,40044,0.00251336754050983,0.00646385093294885,-0.0101557802880699,0.0151825153690896,0.697403968089279
NMR metabolomics,X23408.Triglycerides in VLDL,TFAP2A,Transcription factor AP-2-alpha,37541,-0.00228516662477337,0.00591980158956035,-0.0138879777403117,0.00931764449076491,0.699487528412533
NMR metabolomics,X23408.Triglycerides in VLDL,HK2,Hexokinase-2,40042,-0.00103694968947675,0.00268712185866885,-0.0063037085324677,0.0042298091535142,0.699578927740916
NMR metabolomics,X23408.Triglycerides in VLDL,PKLR,Pyruvate kinase PKLR,40374,0.00247269209171137,0.00645250083398065,-0.0101742095428907,0.0151195937263135,0.701565819604375
NMR metabolomics,X23408.Triglycerides in VLDL,IL3,Interleukin-3,37482,-0.00220844324908159,0.00587234876637605,-0.0137182468311786,0.00930136033301547,0.706867301848941
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.00151129839195064,0.00402856051287214,-0.00940727699718003,0.00638468021327875,0.707557946541563
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00301346721778871,0.00805155813185757,-0.0187945211562295,0.0127675867206521,0.70820849683353
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00182815251677424,0.00489603981663145,-0.0077680855238234,0.0114243905573719,0.708860146512864
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT3,Kunitz-type protease inhibitor 3,37901,0.0045489552019557,0.0125384685781116,-0.020026443211143,0.0291243536150543,0.716760064557904
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.00269687699299465,0.00766933733569009,-0.0177287781709472,0.0123350241849579,0.725110871008495
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB5,Serpin B5,40042,-0.00166585266167019,0.00473998671717913,-0.0109562266273413,0.0076245213040009,0.7252580063821
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT2,Angiopoietin-2,40489,-0.00130945596803682,0.00375733834247648,-0.00867383911929073,0.00605492718321708,0.727464581213371
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC12,WAP four-disulfide core domain protein 12,40465,0.00214475180951803,0.00619677874028282,-0.0100009345214363,0.0142904381404724,0.729266448666196
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.000929660968799151,0.00269934967997765,-0.00436106440395704,0.00622038634155534,0.730548647856847
NMR metabolomics,X23408.Triglycerides in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00114656893923472,0.00336561843220755,-0.00545004318789207,0.00774318106636151,0.733356680839474
NMR metabolomics,X23408.Triglycerides in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,0.00242286523672626,0.0071356084960048,-0.0115629274154431,0.0164086578888957,0.734203131858381
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC50,Coiled-coil domain-containing protein 50,37959,0.00257903509739352,0.00764204370677866,-0.0123993705678927,0.0175574407626797,0.735760509395482
NMR metabolomics,X23408.Triglycerides in VLDL,HBZ,Hemoglobin subunit zeta,37990,-0.00343166939177953,0.0102210123284941,-0.023464853555628,0.016601514772069,0.737067219730847
NMR metabolomics,X23408.Triglycerides in VLDL,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00119486408585778,0.00359204316937147,-0.00584554052611031,0.00823526869782587,0.739409921291129
NMR metabolomics,X23408.Triglycerides in VLDL,SLC1A4,Neutral amino acid transporter A,37572,0.00168724695822827,0.00512205973304001,-0.00835199011853015,0.0117264840349867,0.741852653113162
NMR metabolomics,X23408.Triglycerides in VLDL,IL17F,Interleukin-17F,40044,0.00254263053742149,0.00773094151846589,-0.0126100148387717,0.0176952759136146,0.742243134723173
NMR metabolomics,X23408.Triglycerides in VLDL,PCNA,Proliferating cell nuclear antigen,37482,0.00199202204197132,0.00609875763228325,-0.00996154291730385,0.0139455870012465,0.743954877200904
NMR metabolomics,X23408.Triglycerides in VLDL,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00157726583331532,0.00483833179154863,-0.0110603961447506,0.00790586447811998,0.744433491036158
NMR metabolomics,X23408.Triglycerides in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,40128,-0.00552621141099814,0.0169724393256199,-0.0387921924892132,0.0277397696672169,0.744732019268287
NMR metabolomics,X23408.Triglycerides in VLDL,IL21R,Interleukin-21 receptor,37598,0.00177886387561811,0.00546383738140287,-0.00893025739193152,0.0124879851431677,0.744754570679932
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A1,Collagen alpha-1(IX) chain,40341,-0.00148593808037871,0.00457403394758229,-0.01045104461764,0.00747916845688258,0.745288427414261
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00241742281945794,0.00745560555748002,-0.0170304097121188,0.0121955640732029,0.745758954237932
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00259490302934621,0.00804237930892875,-0.0183579664748466,0.0131681604161541,0.746962645311821
NMR metabolomics,X23408.Triglycerides in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.00110433826671514,0.00344145153265147,-0.00784958327071201,0.00564090673728173,0.748295536874561
NMR metabolomics,X23408.Triglycerides in VLDL,MYL4,Myosin light chain 4,37628,-0.00159472917101881,0.0051274230415205,-0.011644478332399,0.00845501999036138,0.755790625592888
NMR metabolomics,X23408.Triglycerides in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00169690265302681,0.0054763010486821,-0.0124304527084437,0.00903664740239011,0.756670154026644
NMR metabolomics,X23408.Triglycerides in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00141853343747718,0.00460162322950825,-0.00760064809235899,0.0104377149673134,0.757882380773625
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.00197496473622595,0.00643400246354512,-0.0106356800923225,0.0145856095647744,0.758880664865709
NMR metabolomics,X23408.Triglycerides in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37562,0.00122656168514348,0.00401562074204776,-0.00664405496927013,0.00909717833955708,0.760030128904207
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,-0.00120719720113583,0.00402445480368943,-0.00909512861636712,0.00668073421409546,0.764207450738379
NMR metabolomics,X23408.Triglycerides in VLDL,DPP10,Inactive dipeptidyl peptidase 10,40341,0.00097516880385243,0.00330247648607836,-0.00549768510886116,0.00744802271656602,0.767780718337582
NMR metabolomics,X23408.Triglycerides in VLDL,ENOPH1,Enolase-phosphatase E1,37900,0.00164396899337119,0.00558475988988006,-0.00930216039079374,0.0125900983775361,0.768482026850474
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.00208900120075132,0.00720587134461796,-0.0120345066346999,0.0162125090362025,0.771895306160143
NMR metabolomics,X23408.Triglycerides in VLDL,PXDNL,Peroxidasin-like protein,37900,0.0015832499452856,0.00570771788922814,-0.00960387711760155,0.0127703770081728,0.781486795499506
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB2,Beta-crystallin B2,37942,-0.00185329363588965,0.00669700995966383,-0.0149794331568308,0.0112728458850515,0.781988226291026
NMR metabolomics,X23408.Triglycerides in VLDL,CLINT1,Clathrin interactor 1,37482,-0.0012029255395355,0.00447966896210016,-0.00998307670525181,0.00757722562618081,0.788295631317461
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00155220343436783,0.00588901742879816,-0.00999027072607657,0.0130946775948122,0.792110832333654
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1,Integrin beta-1,40333,0.000550626720334744,0.00212341913739478,-0.00361127478895902,0.00471252822962851,0.795398370403424
NMR metabolomics,X23408.Triglycerides in VLDL,INSL3,Insulin-like 3,37942,-0.00150498571764649,0.0058137964673375,-0.012900026793628,0.00989005535833501,0.795743712442382
NMR metabolomics,X23408.Triglycerides in VLDL,HMCN2,Hemicentin-2,37648,0.0014376738470741,0.00556902869124472,-0.00947762238776555,0.0123529700819138,0.796291139150047
NMR metabolomics,X23408.Triglycerides in VLDL,IL4,Interleukin-4,40044,0.00224246456362512,0.00873124648782957,-0.0148707785525208,0.0193557076797711,0.797311760567305
NMR metabolomics,X23408.Triglycerides in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.00167504232040778,0.00655567407616737,-0.0145241635096958,0.0111740788688803,0.798332943473598
NMR metabolomics,X23408.Triglycerides in VLDL,ACHE,Acetylcholinesterase,37671,0.000791550204995921,0.00311066032465143,-0.00530534403132089,0.00688844444131273,0.799141285395696
NMR metabolomics,X23408.Triglycerides in VLDL,IL5,Interleukin-5,40044,-0.00360574836710824,0.0141764828316904,-0.0313916547172214,0.0241801579830049,0.799230711127643
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA10,Ephrin type-A receptor 10,39961,-0.00161071489193196,0.00635057855877566,-0.0140578488671322,0.0108364190832683,0.799782632110146
NMR metabolomics,X23408.Triglycerides in VLDL,ANK2,Ankyrin-2,37562,0.00182964884629794,0.00724119957075303,-0.012363102312378,0.0160224000049739,0.800525598060679
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.000787156020890723,0.00316800406979717,-0.00542213195591172,0.00699644399769317,0.803774170272387
NMR metabolomics,X23408.Triglycerides in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.000576546047566553,0.00235342018992527,-0.00403615752468697,0.00518924961982008,0.806473366890165
NMR metabolomics,X23408.Triglycerides in VLDL,CD177,CD177 antigen,40316,0.00301233586843522,0.0124057369614923,-0.0213029085760897,0.0273275803129601,0.808149553096452
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00131169219500795,0.00550621405269208,-0.00948048734826853,0.0121038717382844,0.811713946464456
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.00108888750904507,0.00460373616842402,-0.00793443538106601,0.0101122103991562,0.813030782496491
NMR metabolomics,X23408.Triglycerides in VLDL,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00192454613609099,0.00828041656606273,-0.0181541626055739,0.014305070333392,0.816214303844065
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_A,,37959,0.00073483524139439,0.00318559332384566,-0.00550892767334311,0.00697859815613189,0.81757115600298
NMR metabolomics,X23408.Triglycerides in VLDL,SHD,SH2 domain-containing adapter protein D,37531,0.00193082546450778,0.00856285311831554,-0.0148523666473907,0.0187140175764062,0.821602742997814
NMR metabolomics,X23408.Triglycerides in VLDL,CASP4,Caspase-4,37714,0.00366003796558135,0.0166622883310105,-0.0289980471631992,0.0363181230943619,0.826139353367011
NMR metabolomics,X23408.Triglycerides in VLDL,UNC5D,Netrin receptor UNC5D,37598,-0.000562406822783937,0.00260757117017005,-0.00567324631631724,0.00454843267074936,0.829238782435223
NMR metabolomics,X23408.Triglycerides in VLDL,IKZF2,Zinc finger protein Helios,39980,0.00196228616354432,0.00910066687696648,-0.01587502091531,0.0197995932423986,0.829286764905423
NMR metabolomics,X23408.Triglycerides in VLDL,FGF7,Fibroblast growth factor 7,37482,0.00168838087168633,0.00790444489707239,-0.0138043311265755,0.0171810928699482,0.830863185743038
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB2,Integrin beta-2,40221,0.000593423220731009,0.00278493625631871,-0.00486505184165367,0.00605189828311569,0.831264797112825
NMR metabolomics,X23408.Triglycerides in VLDL,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00201851925087226,0.00947855062776625,-0.0165594399795496,0.0205964784812941,0.831364180113698
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.000833122381148935,0.0039326140172011,-0.00687480109256522,0.00854104585486309,0.832227702039381
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.000751959394646873,0.00359630374862261,-0.00629679595265345,0.00780071474194719,0.834379344724406
NMR metabolomics,X23408.Triglycerides in VLDL,DLL1,Delta-like protein 1,40411,0.00059147679486115,0.0028401122226179,-0.00497514316146993,0.00615809675119223,0.835029987965436
NMR metabolomics,X23408.Triglycerides in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.000492946257011684,0.00238099394029139,-0.00417380186595945,0.00515969437998281,0.835986107356523
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF830,Zinc finger protein 830,37900,-0.0016045144186533,0.00787040413505473,-0.0170305065233606,0.013821477686054,0.8384606436716
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL12,Stromal cell-derived factor 1,40044,-0.000797189817476705,0.00394544196728641,-0.00853025607335806,0.00693587643840465,0.839877642912283
NMR metabolomics,X23408.Triglycerides in VLDL,ANPEP,Aminopeptidase N,40370,0.00055336823660673,0.00274273409214049,-0.00482239058398864,0.0059291270572021,0.840108583439764
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2A,Pancreatic alpha-amylase,39695,0.000893566804513857,0.00458525587191985,-0.00809353470444905,0.00988066831347676,0.845490830887114
NMR metabolomics,X23408.Triglycerides in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37598,-0.000948092968526769,0.00492464365370776,-0.010600394529794,0.00870420859274044,0.847337785995811
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2BP,LRP2-binding protein,37572,0.00160440377589219,0.00847004953793973,-0.0149968933184697,0.0182057008702541,0.849765933633531
NMR metabolomics,X23408.Triglycerides in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.000888139478838971,0.00473402485905979,-0.00839054924491822,0.0101668282025962,0.851187091209549
NMR metabolomics,X23408.Triglycerides in VLDL,MAG,Myelin-associated glycoprotein,37572,0.000842110982277734,0.00454482885960593,-0.0080657535825499,0.00974997554710537,0.853004506868104
NMR metabolomics,X23408.Triglycerides in VLDL,THY1,Thy-1 membrane glycoprotein,40471,-0.000488201752577352,0.00271762282823596,-0.00581474249591983,0.00483833899076513,0.857435164542667
NMR metabolomics,X23408.Triglycerides in VLDL,TET2,Methylcytosine dioxygenase TET2,37697,0.00174905736993394,0.00982325911130732,-0.0175045304882284,0.0210026452280963,0.858684346258904
NMR metabolomics,X23408.Triglycerides in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.000870585917747953,0.00494770630707476,-0.0105680902796145,0.00882691844411858,0.860329583109613
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.000834752337708527,0.00476220220920242,-0.0101686686677453,0.00849916399232822,0.860856786757942
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH17,Protocadherin-17,40359,0.000590580435175756,0.00337974609482832,-0.00603372191068775,0.00721488278103926,0.86128532213397
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD4,Sushi domain-containing protein 4,37900,-0.000758800880278338,0.00434505428011538,-0.00927510726930448,0.00775750550874781,0.861368653379432
NMR metabolomics,X23408.Triglycerides in VLDL,FGF3,Fibroblast growth factor 3,37598,0.000504016162984429,0.00297255430290075,-0.00532219027070104,0.0063302225966699,0.865361475376686
NMR metabolomics,X23408.Triglycerides in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.000938248572205465,0.00557765418868737,-0.00999395363762177,0.0118704507820327,0.86641625000451
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF1,Signaling lymphocytic activation molecule,40044,0.000970000355782259,0.00578113438322,-0.0103610230353289,0.0123010237468935,0.866752868099884
NMR metabolomics,X23408.Triglycerides in VLDL,TXK,Tyrosine-protein kinase TXK,37714,0.0012399219213928,0.00740130750319345,-0.0132666407848664,0.015746484627652,0.866957631799789
NMR metabolomics,X23408.Triglycerides in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.000570749312565233,0.00346289768578904,-0.00621653015158129,0.00735802877671175,0.86908905352979
NMR metabolomics,X23408.Triglycerides in VLDL,EFNB2,Ephrin-B2,37572,0.000912157961529841,0.00564568144141888,-0.0101533776636512,0.0119776935867108,0.871649034180157
NMR metabolomics,X23408.Triglycerides in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.000645046307993092,0.00400287217531311,-0.00849067577160678,0.0072005831556206,0.871980991739205
NMR metabolomics,X23408.Triglycerides in VLDL,NME3,Nucleoside diphosphate kinase 3,40379,-0.000367090492211521,0.0023240650406909,-0.00492225797196569,0.00418807698754265,0.874496702330068
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,-0.000629183761409676,0.00401717602113219,-0.00850284876282877,0.00724448124000941,0.875544044763588
NMR metabolomics,X23408.Triglycerides in VLDL,MLLT1,Protein ENL,37482,0.00108707293564491,0.00698808709830609,-0.012609577777035,0.0147837236483249,0.876381577229482
NMR metabolomics,X23408.Triglycerides in VLDL,TP73,Tumor protein p73,37572,0.000521895210217149,0.00340932802538106,-0.00616038771952973,0.00720417813996402,0.87833863443607
NMR metabolomics,X23408.Triglycerides in VLDL,MAGEA3,Melanoma-associated antigen 3,37714,0.00125081713957304,0.00824655689193384,-0.0149124343686173,0.0174140686477634,0.879443610712058
NMR metabolomics,X23408.Triglycerides in VLDL,IL2,Interleukin-2,40044,-0.000446486351083688,0.00304477292589239,-0.00641424128583277,0.00552126858366539,0.8834178551768
NMR metabolomics,X23408.Triglycerides in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000566596339842609,0.0039219336214134,-0.00825358623781288,0.00712039355812766,0.885132657961787
NMR metabolomics,X23408.Triglycerides in VLDL,CEP350,Centrosome-associated protein 350,37482,0.000513804171359173,0.00365574101400475,-0.00665144821609014,0.00767905655880848,0.888229833132244
NMR metabolomics,X23408.Triglycerides in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00081271020531155,0.00591357240462629,-0.0124033121183791,0.010777891707756,0.890691980361073
NMR metabolomics,X23408.Triglycerides in VLDL,ADA2,Adenosine deaminase 2,40258,-0.000557388229665116,0.0040647852732169,-0.00852436736517025,0.00740959090584002,0.89093285394152
NMR metabolomics,X23408.Triglycerides in VLDL,NOS2,"Nitric oxide synthase, inducible",37562,0.000522869400876493,0.00383139467560589,-0.00698666416331104,0.00803240296506403,0.891452047247377
NMR metabolomics,X23408.Triglycerides in VLDL,PRC1,Protein regulator of cytokinesis 1,37900,-0.00060260999187557,0.00454547146216238,-0.00951173405771384,0.0083065140739627,0.894532512810109
NMR metabolomics,X23408.Triglycerides in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.000360718899740366,0.00274832222195873,-0.00502599265529875,0.00574743045477949,0.89557908933581
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,-0.000645839210677331,0.00493173363364874,-0.0103120371326289,0.00902035871127421,0.895812245026491
NMR metabolomics,X23408.Triglycerides in VLDL,KLK3,Prostate-specific antigen,37998,-0.000729219278753411,0.00557123800784085,-0.0116488457741215,0.0101904072166147,0.895864278265546
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN7,Tetraspanin-7,37541,-0.00116877629055327,0.00894191204161869,-0.0186949238921259,0.0163573713110194,0.896008590828155
NMR metabolomics,X23408.Triglycerides in VLDL,OMP,Olfactory marker protein,37541,0.000639586914193852,0.00494385050146584,-0.0090503600686792,0.0103295338970669,0.897066716508843
NMR metabolomics,X23408.Triglycerides in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-0.000625858135063946,0.00493420238961557,-0.0102968948187105,0.00904517854858258,0.89906833660141
NMR metabolomics,X23408.Triglycerides in VLDL,CDH4,Cadherin-4,37541,0.000610134582914656,0.00483407761930772,-0.00886465755092847,0.0100849267167578,0.899563434908431
NMR metabolomics,X23408.Triglycerides in VLDL,NCLN,Nicalin,40044,-0.000652470013690016,0.0051908240862882,-0.0108264852228149,0.00952154519543485,0.899973550014554
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.000778589646949256,0.00621226392280907,-0.0113974476417565,0.012954626935655,0.900263394112962
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40536,-0.000354708764016785,0.00286126823375394,-0.0059627945021745,0.00525337697414093,0.901341313219459
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2B,Alpha-amylase 2B,39311,-0.000559943971109872,0.00469444983144633,-0.00976106564074468,0.00864117769852494,0.905056828921363
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.00044344187354217,0.00377331185076219,-0.00783913310103606,0.00695224935395172,0.906449034258919
NMR metabolomics,X23408.Triglycerides in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.0005690779669608,0.00530555783324257,-0.0109679713201162,0.00982981538619464,0.91458376602878
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,-0.000434105821789123,0.00410399029341273,-0.00847792679687807,0.00760971515329982,0.915761278456525
NMR metabolomics,X23408.Triglycerides in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.000564675461954931,0.00535664764411032,-0.0110637048444112,0.00993435392050131,0.916047463181987
NMR metabolomics,X23408.Triglycerides in VLDL,IGFL4,Insulin growth factor-like family member 4,37598,0.000809409705706956,0.00767869624823104,-0.0142408349408259,0.0158596543522398,0.916052261788892
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3A,Uroplakin-3a,37541,0.000509550121997232,0.00488680797630179,-0.00906859351155428,0.0100876937555487,0.916956251211707
NMR metabolomics,X23408.Triglycerides in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,37482,-0.00063686497278075,0.00619330548245091,-0.0127757437183845,0.011502013772823,0.91809853288082
NMR metabolomics,X23408.Triglycerides in VLDL,MORN4,MORN repeat-containing protein 4,37482,0.000770510091346042,0.00769552447024341,-0.014312717870331,0.0158537380530231,0.920247071519365
NMR metabolomics,X23408.Triglycerides in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.00046422301262366,0.00481085359777496,-0.00896505003901527,0.00989349606426259,0.923128979235118
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK1C,Divergent protein kinase domain 1C,37572,-0.000385913216544211,0.00418478944911944,-0.00858810053681832,0.00781627410372989,0.926526187457309
NMR metabolomics,X23408.Triglycerides in VLDL,MYL6B,Myosin light chain 6B,37572,-0.000820387402991247,0.00902089283991618,-0.018501337369227,0.0168605625632445,0.927539240578199
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37990,0.000555366675296801,0.00616298205312573,-0.0115240781488296,0.0126348114994232,0.928198510261005
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN4,Nectin-4,40411,0.000260409969504953,0.00296498713887056,-0.00555096482268134,0.00607178476169125,0.930014195673529
NMR metabolomics,X23408.Triglycerides in VLDL,TPSD1,Tryptase delta,37959,-0.000311658415699856,0.00372259514596565,-0.00760794490179253,0.00698462807039282,0.933279708575792
NMR metabolomics,X23408.Triglycerides in VLDL,FH,"Fumarate hydratase, mitochondrial",37541,-0.000678524606159222,0.00835216107485117,-0.0170487603128675,0.0156917111005491,0.935252803566882
NMR metabolomics,X23408.Triglycerides in VLDL,KHDC3L,KH domain-containing protein 3,37482,-0.000539512021254525,0.00665393158239177,-0.0135812179227424,0.0125021938802333,0.935378231889541
NMR metabolomics,X23408.Triglycerides in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.000570241995505218,0.00720274330470014,-0.0135471348817071,0.0146876188727175,0.936898314469291
NMR metabolomics,X23408.Triglycerides in VLDL,ESR1,Estrogen receptor,37598,0.000426707901944626,0.00567903379061838,-0.0107041983276674,0.0115576141315567,0.940106524727932
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.000407370532103818,0.00556176824003042,-0.0113084362825634,0.0104936952183558,0.941612443461458
NMR metabolomics,X23408.Triglycerides in VLDL,IL9,Interleukin-9,37714,-0.000406325122419699,0.0056077576167769,-0.0113975300513024,0.010584879806463,0.942238773831519
NMR metabolomics,X23408.Triglycerides in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.000529849438104947,0.00737586264837597,-0.013926841352712,0.0149865402289219,0.942733847552626
NMR metabolomics,X23408.Triglycerides in VLDL,EXOSC10,Exosome component 10,37562,-0.000427417197435433,0.00612701838993941,-0.0124363732417167,0.0115815388468458,0.944386217294637
NMR metabolomics,X23408.Triglycerides in VLDL,SKIV2L,Helicase SKI2W,37562,-0.00026938971386566,0.00395822029520992,-0.0080275014924771,0.00748872206474578,0.945740269154391
NMR metabolomics,X23408.Triglycerides in VLDL,SHC1,SHC-transforming protein 1,37482,0.000763587954859689,0.0113917814301042,-0.0215643036481445,0.0230914795578639,0.946559069213103
NMR metabolomics,X23408.Triglycerides in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,-0.000315515474753038,0.00492852188944622,-0.00997541837806763,0.00934438742856156,0.948956652083778
NMR metabolomics,X23408.Triglycerides in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.000371458551212288,0.0065532747967827,-0.0124729600504818,0.0132158771529064,0.954798668109758
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.000158849791536894,0.00302118371204165,-0.00576267028406475,0.00608036986713853,0.958068398733774
NMR metabolomics,X23408.Triglycerides in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,-0.000208776091090366,0.00415286666641893,-0.00834839475727147,0.00793084257509074,0.959905769846791
NMR metabolomics,X23408.Triglycerides in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.000224397550837268,0.00474324135427405,-0.0095211506052144,0.00907235550353987,0.962267752114537
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA11,Serpin A11,40536,-0.000177823045860725,0.00389625496760222,-0.00781448278236108,0.00745883669063963,0.963598169034145
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,9.89657047406285e-05,0.00266214292270654,-0.00511883442376419,0.00531676583324545,0.970345771085109
NMR metabolomics,X23408.Triglycerides in VLDL,REN,Renin,40359,-0.00025364749277858,0.0069157820401576,-0.0138085802914875,0.0133012853059303,0.970743312831803
NMR metabolomics,X23408.Triglycerides in VLDL,EPB41L5,Band 4.1-like protein 5,37572,0.000226240537533683,0.00621015845569305,-0.0119456700356247,0.0123981511106921,0.970939474464801
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,0.000219416948271262,0.00637497167389914,-0.0122755275325711,0.0127143614291136,0.972543876068255
NMR metabolomics,X23408.Triglycerides in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,-0.000218499056197584,0.0076461579606442,-0.0152049686590602,0.014767970546665,0.977202932956164
NMR metabolomics,X23408.Triglycerides in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,8.00083774894585e-05,0.00287367566055452,-0.0055523959171974,0.00571241267217632,0.977788717002381
NMR metabolomics,X23408.Triglycerides in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,8.85974134179941e-05,0.00319601655222011,-0.00617559502893342,0.00635278985576941,0.977884870023113
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1A,C-type lectin domain family 1 member A,40042,8.66775334325387e-05,0.00320854943475187,-0.00620207935868113,0.0063754344255462,0.978448471259864
NMR metabolomics,X23408.Triglycerides in VLDL,GAD2,Glutamate decarboxylase 2,37598,-0.000124738782254796,0.00462157540939726,-0.00918302658467342,0.00893354902016383,0.978467694772473
NMR metabolomics,X23408.Triglycerides in VLDL,KCNIP4,Kv channel-interacting protein 4,39961,0.000126782279185953,0.00498818969255894,-0.00965006951822958,0.00990363407660148,0.979723084320501
NMR metabolomics,X23408.Triglycerides in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.000349656646967776,0.0138038388975196,-0.0267058675921706,0.0274051808861061,0.979791820484308
NMR metabolomics,X23408.Triglycerides in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,37541,-0.000149411713438056,0.00621300100564898,-0.0123268936845101,0.0120280702576339,0.980814499771274
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN6,Prefoldin subunit 6,37572,-0.000154436309976905,0.00644806247056542,-0.0127926387522851,0.0124837661323313,0.980892210738771
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RB,Interleukin-20 receptor subunit beta,37598,7.42909761538119e-05,0.00416282929349937,-0.00808485443910494,0.00823343639141257,0.985761763218147
NMR metabolomics,X23408.Triglycerides in VLDL,ZP3,Zona pellucida sperm-binding protein 3,37628,0.00036235497533553,0.0256074938678794,-0.049828333005708,0.0505530429563791,0.988710246012116
NMR metabolomics,X23408.Triglycerides in VLDL,EPGN,Epigen,37900,-6.22213368657024e-05,0.00482046580057353,-0.00951033430598983,0.00938589163225842,0.989701588067913
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,6.62872144980267e-05,0.00583834403820881,-0.0113768671003912,0.0115094415293873,0.99094134008727
NMR metabolomics,X23408.Triglycerides in VLDL,CRX,Cone-rod homeobox protein,40042,0.000115191725551426,0.0104380829438294,-0.0203434508443543,0.0205738342954571,0.991195092013022
NMR metabolomics,X23408.Triglycerides in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-1.60904687592542e-05,0.00270379845473633,-0.00531553544004246,0.00528335450252395,0.995251856196299
